data_1ujv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ujv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.235 0.316 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtm -89.07 113.88 25.06 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.734 -169.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.5 m -78.1 137.31 38.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 159.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -131.42 161.77 31.71 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -119.81 144.89 47.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.7 pt -138.89 162.81 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.368 1.467 . . . . 0.0 109.333 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.4 t -132.14 137.28 55.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.894 0.854 . . . . 0.0 108.713 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -97.62 85.56 3.62 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 121.883 -0.511 . . . . 0.0 111.569 -166.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.32 -69.25 1.23 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.579 0.609 . . . . 0.0 114.445 -166.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.64 -62.41 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.247 1.419 . . . . 0.0 109.183 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -65.1 6.4 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.997 2.519 . . . . 0.0 114.653 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.63 71.6 1.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 63.54 173.06 0.17 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.499 1.919 . . . . 0.0 111.188 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.54 49.1 0.87 Allowed Glycine 0 C--O 1.222 -0.605 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -157.97 163.55 37.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.7 p -121.17 161.75 21.32 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.381 1.072 . . . . 0.0 108.805 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 pt -123.34 162.94 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.061 0.934 . . . . 0.0 110.132 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.77 140.31 40.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 107.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.75 121.04 18.22 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 p -110.2 168.47 7.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -64.97 -10.52 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.507 1.471 . . . . 0.0 112.224 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 p -114.58 7.2 16.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 112.758 -170.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.52 -172.5 15.76 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -171.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -77.07 149.98 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.666 -0.902 . . . . 0.0 108.751 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -130.17 164.02 25.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.588 1.155 . . . . 0.0 108.498 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.52 122.39 22.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -73.99 -62.33 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -154.66 145.58 22.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.19 136.64 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.7 mt -119.63 -8.94 9.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 111.313 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -155.81 108.51 2.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.362 2.265 . . . . 0.0 106.842 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.97 -53.7 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.16 0.984 . . . . 0.0 110.07 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -72.86 -4.19 30.31 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.065 -1.022 . . . . 0.0 112.521 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.77 -16.17 79.31 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.15 -0.969 . . . . 0.0 111.797 163.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.7 p -150.23 57.99 2.9 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 118.956 1.378 . . . . 0.0 113.541 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.27 112.32 1.53 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.342 2.028 . . . . 0.0 111.534 -170.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.75 -5.96 37.57 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.514 1.53 . . . . 0.0 113.62 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.81 139.37 41.72 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.377 1.589 . . . . 0.0 109.795 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.8 m -123.82 9.84 8.88 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 66.2 152.3 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.056 2.142 . . . . 0.0 112.784 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.88 -3.0 0.17 Allowed Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.896 1.236 . . . . 0.0 115.31 -170.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.98 158.43 19.34 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.286 2.043 . . . . 0.0 109.718 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.86 114.11 26.85 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.626 1.57 . . . . 0.0 109.978 -161.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.1 mt -65.26 129.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.812 1.245 . . . . 0.0 109.298 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.78 -51.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.429 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.5 145.54 51.87 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.834 1.652 . . . . 0.0 109.873 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.6 mt -125.06 122.26 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 45.05 42.26 6.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.264 1.426 . . . . 0.0 111.656 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 65.76 8.39 5.22 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.177 1.391 . . . . 0.0 113.609 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -77.68 138.6 39.16 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.641 -1.287 . . . . 0.0 108.031 163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.67 116.86 22.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.672 2.389 . . . . 0.0 108.33 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.53 13.61 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 125.449 1.5 . . . . 0.0 112.016 -169.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.44 -55.41 35.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 118.319 -2.738 . . . . 0.0 112.562 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -81.45 -6.77 59.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.596 0.758 . . . . 0.0 111.095 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.46 135.17 55.81 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.28 1.832 . . . . 0.0 111.203 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -63.41 160.81 15.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.037 171.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -48.77 -49.57 38.01 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.25 0.62 . . . . 0.0 111.012 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -42.92 73.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.043 1.737 . . . . 0.0 112.227 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.442 1.497 . . . . 0.0 108.069 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.22 -43.76 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 110.617 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.33 -42.58 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 124.26 1.024 . . . . 0.0 109.926 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -44.47 91.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.183 0.993 . . . . 0.0 110.156 -176.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.04 -44.48 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.519 -0.738 . . . . 0.0 109.146 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.5 -23.73 66.96 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.57 -0.706 . . . . 0.0 111.571 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -72.95 -42.92 62.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.943 1.247 . . . . 0.0 109.977 171.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -55.55 -35.45 65.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.109 0.868 . . . . 0.0 110.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 81.9 m -54.67 138.8 61.38 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.3 141.14 55.52 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.827 3.685 . . . . 0.0 110.814 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mm -70.86 142.28 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.97 -2.08 28.16 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.446 1.974 . . . . 0.0 113.385 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.4 m -103.01 165.02 11.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.076 1.35 . . . . 0.0 107.862 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -69.21 153.35 43.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 123.128 1.442 . . . . 0.0 111.216 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -140.6 141.46 35.16 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.061 2.144 . . . . 0.0 105.653 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 m -112.62 115.9 29.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.04 153.01 28.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mt -126.55 122.41 60.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.72 164.14 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.708 0.803 . . . . 0.0 110.764 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -84.13 124.02 30.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.383 0.673 . . . . 0.0 111.13 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 108.471 176.29 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 mtm -88.78 150.06 23.12 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.9 m -116.04 148.29 40.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -145.46 168.3 20.88 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 128.62 2.768 . . . . 0.0 107.457 -172.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.12 153.97 51.03 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.247 -0.908 . . . . 0.0 108.591 170.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 pt -134.07 167.38 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 126.461 1.905 . . . . 0.0 109.227 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.7 139.67 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 152.56 40.98 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.09 74.72 0.28 Allowed Glycine 0 C--O 1.238 0.377 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.27 -166.92 0.08 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.051 1.34 . . . . 0.0 111.157 -167.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 40.47 9.7 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 131.579 3.952 . . . . 0.0 118.643 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.16 67.93 1.86 Allowed Glycine 0 N--CA 1.445 -0.736 0 O-C-N 120.65 -1.281 . . . . 0.0 110.553 -165.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 63.75 174.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.227 2.211 . . . . 0.0 111.544 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.81 34.96 4.95 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.545 1.545 . . . . 0.0 110.233 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -140.89 167.03 23.17 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 p -129.96 151.38 50.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.6 pt -114.22 144.96 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.77 131.36 46.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.09 144.41 50.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.6 p -138.57 167.0 21.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 127.676 2.391 . . . . 0.0 105.567 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.71 -36.45 97.13 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 p -79.0 -28.39 43.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.576 1.95 . . . . 0.0 111.684 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.99 -134.34 4.79 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -162.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -106.63 147.2 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.952 . . . . 0.0 110.094 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -146.78 161.13 41.28 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.234 1.014 . . . . 0.0 108.342 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -77.26 114.49 17.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -63.37 -61.36 2.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.105 1.362 . . . . 0.0 108.759 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -157.08 154.23 29.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.86 114.25 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.9 mt -87.63 -25.11 23.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.798 0.839 . . . . 0.0 110.106 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -150.1 96.15 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.011 1.724 . . . . 0.0 107.598 -169.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 mt -60.47 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 109.949 -166.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -64.12 -12.39 39.0 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.48 -34.96 63.22 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 119.232 0.924 . . . . 0.0 111.426 170.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.3 m -126.87 67.64 69.19 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.467 1.107 . . . . 0.0 108.703 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.55 132.92 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.38 2.053 . . . . 0.0 109.124 -172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.05 -3.4 71.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.259 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.94 135.08 49.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.22 1.51 . . . . 0.0 107.003 166.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.7 m -137.17 131.69 32.88 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.85 153.47 41.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.245 0.618 . . . . 0.0 111.89 -163.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.94 37.14 93.92 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -166.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.48 -173.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.081 1.352 . . . . 0.0 110.389 160.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.38 122.45 20.25 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 154.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.7 mt -69.52 129.51 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.28 -58.08 2.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.521 1.128 . . . . 0.0 111.425 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -136.61 131.67 34.05 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.19 127.24 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 45.55 38.56 4.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.105 1.762 . . . . 0.0 111.575 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 61.1 18.47 9.04 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.14 1.776 . . . . 0.0 114.056 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -92.49 135.52 33.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 156.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.83 138.62 36.22 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.227 0.536 . . . . 0.0 110.067 173.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.89 10.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 126.35 1.86 . . . . 0.0 108.347 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -24.51 66.99 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 119.265 -2.147 . . . . 0.0 112.477 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.55 -13.01 16.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.137 0.88 . . . . 0.0 110.598 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -59.38 127.73 33.57 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 126.366 1.866 . . . . 0.0 111.67 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.09 162.11 3.65 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.362 1.039 . . . . 0.0 110.316 176.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -49.85 -48.33 51.18 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.169 0.588 . . . . 0.0 109.989 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -58.38 -36.13 73.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.724 1.21 . . . . 0.0 111.848 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.45 -47.71 54.08 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.198 1.399 . . . . 0.0 107.818 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.03 -46.48 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.937 0.895 . . . . 0.0 109.462 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.07 -42.83 91.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.886 0.874 . . . . 0.0 110.851 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -30.73 70.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.42 0.688 . . . . 0.0 111.914 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.25 -40.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.6 mt -62.03 -27.59 68.99 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.001 -1.062 . . . . 0.0 110.773 172.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -69.6 -29.91 67.54 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.653 -1.279 . . . . 0.0 111.863 172.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.72 -22.45 53.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.213 0.915 . . . . 0.0 111.24 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.57 132.88 91.24 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 118.974 0.806 . . . . 0.0 110.476 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.19 132.45 46.95 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.526 2.818 . . . . 0.0 109.595 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -72.13 106.84 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.85 6.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.059 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -136.09 163.34 30.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 118.839 1.32 . . . . 0.0 109.736 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.31 143.65 57.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.28 1.038 . . . . 0.0 111.025 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -131.03 135.17 47.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.478 1.911 . . . . 0.0 105.929 171.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 m -111.5 128.38 55.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -164.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -129.23 137.09 50.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -112.15 129.94 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.81 145.61 35.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 109.711 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -76.04 99.84 4.73 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 109.679 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 . . . . . 0 C--O 1.232 0.161 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 172.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 mtm -106.7 118.03 35.61 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.771 0.796 . . . . 0.0 109.682 174.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.3 m -84.33 143.69 29.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.6 mt -143.87 168.08 20.8 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.089 2.156 . . . . 0.0 106.351 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.6 m -127.47 148.5 50.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.167 0.987 . . . . 0.0 109.169 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.7 pt -139.68 160.03 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.846 1.258 . . . . 0.0 111.126 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.1 t -129.06 113.69 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 123.011 1.386 . . . . 0.0 108.615 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.65 102.82 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.08 2.152 . . . . 0.0 108.643 168.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.83 -62.31 3.88 Favored Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.32 -62.44 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 109.225 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.0 51.35 0.5 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.42 2.288 . . . . 0.0 111.913 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.66 47.47 12.98 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.113 1.816 . . . . 0.0 113.597 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 84.9 -11.46 0.78 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 130.54 3.536 . . . . 0.0 113.72 174.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -60.6 1.95 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.86 1.209 . . . . 0.0 111.552 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -49.4 151.05 1.63 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.051 1.426 . . . . 0.0 110.38 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -125.18 159.48 31.43 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -171.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 pt -126.87 152.44 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.526 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.93 137.24 49.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.745 1.218 . . . . 0.0 109.453 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -71.65 124.46 24.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 126.064 1.745 . . . . 0.0 109.389 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 p -120.69 159.75 47.22 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -58.91 -28.87 88.74 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.388 2.725 . . . . 0.0 111.878 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 p -98.23 -5.63 32.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.238 2.615 . . . . 0.0 113.61 -168.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.59 173.72 17.11 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -76.72 145.52 38.62 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.411 -1.052 . . . . 0.0 109.461 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -129.15 151.07 50.23 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.25 108.44 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -66.72 -62.25 1.55 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -155.06 143.19 20.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -90.98 126.61 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 127.044 2.138 . . . . 0.0 106.211 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.7 mt -110.78 -17.95 13.24 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.319 0.648 . . . . 0.0 111.029 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -133.96 77.21 1.7 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.315 1.446 . . . . 0.0 108.165 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.53 -39.61 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.658 1.183 . . . . 0.0 111.222 -169.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -10.4 59.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.87 -15.9 66.61 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 119.27 0.941 . . . . 0.0 111.798 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.0 m -130.77 70.73 82.55 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 118.56 1.18 . . . . 0.0 109.91 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -60.42 121.56 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.758 2.972 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.85 71.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.687 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.58 144.81 56.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.325 1.562 . . . . 0.0 109.822 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.0 m -129.53 161.78 29.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.89 1.328 . . . . 0.0 110.444 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.56 136.17 57.76 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.449 1.5 . . . . 0.0 108.261 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.22 17.77 70.5 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.565 1.555 . . . . 0.0 115.044 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.76 101.42 0.64 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.16 1.98 . . . . 0.0 111.405 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.69 114.26 6.89 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.531 1.932 . . . . 0.0 111.09 -167.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.55 134.38 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.607 1.094 . . . . 0.0 110.545 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.9 t -119.55 -49.51 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.232 1.413 . . . . 0.0 110.062 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.89 146.11 49.97 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.545 0.688 . . . . 0.0 109.549 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -121.29 135.58 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 153.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 32.28 54.42 0.33 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.638 2.375 . . . . 0.0 113.306 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 47.78 4.49 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 130.421 3.488 . . . . 0.0 118.813 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -26.16 67.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.059 1.754 . . . . 0.0 113.055 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 65.88 126.42 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 130.299 3.44 . . . . 0.0 111.336 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.87 20.78 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.644 1.978 . . . . 0.0 108.49 -163.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -59.94 4.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 119.5 -2.0 . . . . 0.0 112.343 173.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -76.89 -12.17 59.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.159 0.583 . . . . 0.0 111.794 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.93 131.6 50.16 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 126.119 1.768 . . . . 0.0 110.396 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 160.14 15.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.474 174.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -43.24 -50.85 6.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.834 0.854 . . . . 0.0 110.53 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.1 m -60.39 -32.72 71.58 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.814 0.846 . . . . 0.0 112.016 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.39 -45.25 60.56 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.23 -38.22 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.402 0.681 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.9 -52.07 65.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.049 1.34 . . . . 0.0 109.743 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.23 -39.6 93.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.618 1.167 . . . . 0.0 109.942 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.2 mt -56.92 -55.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.65 1.18 . . . . 0.0 110.14 169.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.8 -21.98 66.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.411 0.551 . . . . 0.0 111.604 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -70.66 -40.82 72.79 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.543 -1.348 . . . . 0.0 110.226 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -74.31 -21.7 59.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.921 0.889 . . . . 0.0 113.272 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.8 m -55.09 128.79 66.34 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 168.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -61.89 140.07 83.18 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.761 2.974 . . . . 0.0 111.689 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.01 117.28 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.68 49.65 5.32 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -145.63 155.49 43.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.939 -1.33 . . . . 0.0 108.681 160.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -70.17 129.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 168.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -101.89 142.75 32.7 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.524 1.529 . . . . 0.0 107.414 165.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -104.89 126.8 52.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.15 156.99 47.33 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.83 135.11 63.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.42 159.34 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 110.17 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -81.84 122.59 27.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.162 0.585 . . . . 0.0 110.826 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 N--CA 1.461 0.115 0 C-N-CA 123.876 0.87 . . . . 0.0 111.738 173.72 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.238 0.469 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.8 mtm -111.11 114.82 28.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.201 1.0 . . . . 0.0 109.07 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.1 m -83.72 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 168.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.5 mt -138.99 168.67 19.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.136 2.174 . . . . 0.0 107.258 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 m -123.09 149.85 43.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.9 pt -130.82 154.37 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.898 1.679 . . . . 0.0 108.637 165.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 104.6 3.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -68.85 118.09 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.998 1.719 . . . . 0.0 109.629 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.84 -63.29 2.22 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.176 0.893 . . . . 0.0 111.007 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.34 -58.11 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.396 1.078 . . . . 0.0 110.87 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -76.69 56.54 1.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.879 2.072 . . . . 0.0 110.138 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.76 61.59 2.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.178 1.371 . . . . 0.0 111.796 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 69.69 -71.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 126.988 2.115 . . . . 0.0 109.418 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.21 -52.4 0.66 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.09 158.68 1.05 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.647 1.213 . . . . 0.0 111.76 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.3 p -115.51 151.92 33.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.252 -173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.1 159.92 16.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.96 129.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.146 2.578 . . . . 0.0 106.603 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.77 128.35 35.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 p -122.99 168.4 12.17 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.509 1.124 . . . . 0.0 108.081 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.01 -35.56 92.66 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.238 2.625 . . . . 0.0 110.595 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -82.37 6.81 15.88 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.221 2.209 . . . . 0.0 113.367 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.47 -157.02 18.35 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -84.76 141.45 30.52 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.788 -0.83 . . . . 0.0 110.176 -169.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -132.02 165.56 23.69 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.639 1.176 . . . . 0.0 108.74 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -89.38 124.44 42.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -73.71 -68.4 0.51 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.114 1.366 . . . . 0.0 108.663 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -155.06 137.93 15.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.1 mt -85.09 129.21 38.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 mt -108.57 -8.11 15.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.576 0.75 . . . . 0.0 111.225 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -149.64 114.17 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.44 -55.93 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.571 1.148 . . . . 0.0 110.055 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -57.16 -32.73 66.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.931 0.787 . . . . 0.0 110.889 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.04 75.03 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 123.413 0.53 . . . . 0.0 113.287 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.7 m -132.94 73.34 75.74 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 119.132 1.466 . . . . 0.0 111.159 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.95 110.55 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.718 1 C-N-CA 125.971 4.447 . . . . 0.0 115.671 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.82 55.25 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.061 -1.025 . . . . 0.0 113.446 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -55.73 152.92 8.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.769 2.027 . . . . 0.0 109.768 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.2 m -144.69 151.12 38.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.108 1.363 . . . . 0.0 111.515 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -60.39 142.65 54.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.693 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.52 10.3 48.31 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.886 -2.063 . . . . 0.0 114.712 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -53.86 115.96 2.28 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.614 1.707 . . . . 0.0 106.405 166.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.54 103.62 8.6 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.85 143.59 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.514 1.052 . . . . 0.0 109.043 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.8 t -130.46 -52.24 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.294 1.038 . . . . 0.0 110.021 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -130.05 145.72 51.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -126.49 125.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.45 38.99 11.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.153 2.181 . . . . 0.0 110.551 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 72.77 -1.42 3.01 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.956 2.102 . . . . 0.0 113.263 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -78.85 135.47 37.04 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.744 -1.222 . . . . 0.0 108.066 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -71.8 121.53 19.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.977 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.88 6.37 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 111.913 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -59.97 -45.12 93.73 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.289 1.404 . . . . 0.0 110.097 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -88.27 24.86 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.574 1.549 . . . . 0.0 111.384 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.83 140.62 52.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.483 1.513 . . . . 0.0 110.133 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.8 m -67.93 158.23 33.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.596 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -47.57 -51.55 20.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.057 0.943 . . . . 0.0 110.996 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.6 m -67.1 -27.03 67.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.828 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.8 -43.53 71.93 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.471 1.032 . . . . 0.0 108.965 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.1 -36.97 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.154 -0.966 . . . . 0.0 110.325 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.8 t -57.74 -47.72 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.58 0.752 . . . . 0.0 109.411 169.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.9 -30.61 69.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.022 0.915 . . . . 0.0 112.575 -172.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.4 mt -67.88 -48.15 76.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.21 -25.26 67.7 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.959 -1.088 . . . . 0.0 111.893 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -74.39 -35.33 63.48 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.345 -1.472 . . . . 0.0 110.808 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.68 -49.72 56.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.974 0.806 . . . . 0.0 108.944 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.7 m -42.03 115.33 1.5 Allowed Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.696 1.599 . . . . 0.0 112.376 -170.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.88 127.61 25.79 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.913 3.075 . . . . 0.0 107.391 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.73 141.09 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.43 16.19 48.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.805 1.669 . . . . 0.0 114.019 -171.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.8 t -87.28 160.68 18.33 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.691 1.745 . . . . 0.0 106.975 164.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.29 135.45 36.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.9 m -120.52 109.8 15.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -87.05 104.28 16.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.904 2.482 . . . . 0.0 108.474 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.29 160.27 14.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.394 0.543 . . . . 0.0 109.565 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.74 130.76 68.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.32 150.56 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.5 1.12 . . . . 0.0 108.853 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 116.98 22.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.041 1.736 . . . . 0.0 108.55 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.9 mtp -131.48 114.71 15.25 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.739 1.216 . . . . 0.0 108.383 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 m -78.27 142.77 37.58 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 164.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.2 mt -142.84 168.48 19.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.78 2.432 . . . . 0.0 107.006 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.86 155.6 37.75 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.14 -0.975 . . . . 0.0 108.731 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.3 pt -132.83 169.85 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 166.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 t -115.65 151.14 17.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 162.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 56.9 tttt -70.02 165.4 21.91 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.809 -1.182 . . . . 0.0 110.091 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -136.62 165.61 24.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.07 -24.25 60.65 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -165.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -75.89 12.86 0.97 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.222 1.374 . . . . 0.0 111.004 165.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.426 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 72.71 69.71 1.35 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.729 1.633 . . . . 0.0 109.817 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 77.0 168.08 0.24 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.69 2.796 . . . . 0.0 111.236 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.86 28.16 9.11 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.152 1.834 . . . . 0.0 111.71 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -138.45 172.92 12.18 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.2 p -131.01 146.8 52.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.134 1.374 . . . . 0.0 108.039 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.48 152.17 19.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -126.48 154.16 44.11 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.53 1.932 . . . . 0.0 108.032 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.06 128.62 36.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.538 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 p -121.79 159.01 52.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 11.33 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.037 3.158 . . . . 0.0 114.332 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.4 p -127.18 -6.1 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.38 0.991 . . . . 0.0 112.863 -168.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.56 170.0 12.6 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -160.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -72.95 151.44 41.85 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.497 -1.002 . . . . 0.0 110.0 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -139.63 161.04 38.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.835 0.826 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.0 t -78.39 122.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 125.547 1.539 . . . . 0.0 107.88 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -71.59 -55.93 6.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.608 162.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -162.24 146.13 12.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.244 0.474 . . . . 0.0 110.476 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.85 93.72 2.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.3 mt -70.57 -28.08 64.62 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.286 1.034 . . . . 0.0 109.945 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -136.78 91.09 2.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.214 1.406 . . . . 0.0 109.674 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.62 -41.57 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 123.67 0.788 . . . . 0.0 110.322 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -71.46 -5.16 30.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.128 -0.983 . . . . 0.0 113.13 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -23.47 28.04 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.636 1.107 . . . . 0.0 111.471 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.2 m -136.14 67.47 62.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 109.857 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 136.38 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.326 2.017 . . . . 0.0 111.75 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.82 -9.25 3.82 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.266 -1.296 . . . . 0.0 115.295 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.56 145.49 51.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.216 1.508 . . . . 0.0 108.956 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.9 m -110.94 147.24 35.07 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.93 0.892 . . . . 0.0 111.527 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.76 151.0 42.33 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.92 44.84 7.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.388 0.994 . . . . 0.0 111.805 -170.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.15 -174.99 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.65 1.98 . . . . 0.0 109.615 159.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.45 104.03 4.34 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 119.801 -1.812 . . . . 0.0 106.665 163.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.13 131.47 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.24 -50.37 4.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.129 1.372 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -136.53 143.79 43.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.86 125.28 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.509 -2.775 . . . . 0.0 103.509 168.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 44.8 51.91 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.21 1.404 . . . . 0.0 111.258 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 65.64 -24.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.978 2.511 . . . . 0.0 115.094 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -69.31 135.79 50.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.55 118.65 36.8 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.429 -157.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.05 2.14 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.516 -156.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -14.98 0.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.543 1.137 . . . . 0.0 113.156 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.96 6.81 6.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.061 2.544 . . . . 0.0 112.828 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.8 mt -90.28 160.57 16.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.174 1.352 . . . . 0.0 110.101 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -83.87 162.77 20.42 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.95 0.5 . . . . 0.0 110.831 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -49.21 -51.43 33.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -59.05 -35.63 73.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.381 0.673 . . . . 0.0 111.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -74.49 -39.99 62.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.85 -41.85 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.41 -46.4 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.79 1.236 . . . . 0.0 110.37 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -38.78 70.37 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.595 0.56 . . . . 0.0 111.732 -171.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.26 -44.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.226 1.01 . . . . 0.0 109.315 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.59 -32.75 74.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.757 -0.59 . . . . 0.0 110.761 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -64.2 -42.11 96.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.049 1.295 . . . . 0.0 109.847 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.63 -20.25 65.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.526 1.53 . . . . 0.0 112.678 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.55 143.31 93.62 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 124.797 1.239 . . . . 0.0 110.578 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 142.45 49.05 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 124.447 3.431 . . . . 0.0 111.049 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.37 144.69 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.9 -1.08 64.0 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.892 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.45 158.09 16.71 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 119.703 1.751 . . . . 0.0 107.474 173.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.21 153.73 37.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.978 0.911 . . . . 0.0 111.034 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 m -126.21 128.26 46.95 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.737 1.615 . . . . 0.0 106.795 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -80.06 126.32 30.91 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.25 152.19 40.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.04 128.6 59.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.3 pp -125.83 164.56 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.33 1.052 . . . . 0.0 110.546 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 118.7 36.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.651 0.78 . . . . 0.0 110.887 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 0.0 109.399 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.232 0.174 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtm -128.16 146.07 50.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.074 0.95 . . . . 0.0 108.954 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -122.56 112.21 17.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -117.69 168.3 10.57 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.215 2.206 . . . . 0.0 108.464 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.8 m -133.66 150.03 51.56 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.837 -0.539 . . . . 0.0 109.601 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.4 pt -140.13 145.7 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.651 1.18 . . . . 0.0 110.258 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.91 118.5 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 9.6 tttt -56.08 129.92 41.95 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.166 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.05 -81.99 0.63 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.91 143.69 20.75 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.659 1.184 . . . . 0.0 108.522 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 55.71 -3.31 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.294 3.038 . . . . 0.0 115.557 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 163.26 -177.3 39.29 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -92.66 3.81 54.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.236 1.014 . . . . 0.0 111.088 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.11 -52.85 3.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.751 -1.218 . . . . 0.0 112.066 -172.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -61.67 166.75 4.01 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 123.165 1.459 . . . . 0.0 111.886 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 p -126.9 151.33 48.58 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.235 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.9 171.45 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.65 161.52 36.27 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.181 1.393 . . . . 0.0 109.207 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 143.49 45.64 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 p -130.17 176.68 2.66 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.28 -19.1 62.1 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.319 2.013 . . . . 0.0 112.166 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p -109.47 3.27 21.16 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.529 1.132 . . . . 0.0 112.496 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.11 -163.17 12.4 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -82.3 145.57 29.9 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.835 0.817 . . . . 0.0 109.986 -167.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -131.69 156.65 45.52 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.265 0.626 . . . . 0.0 109.369 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.17 140.67 17.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 171.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -106.09 -64.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.036 1.335 . . . . 0.0 108.581 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -142.84 134.45 26.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.74 136.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.742 1.617 . . . . 0.0 107.298 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -122.26 -50.57 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.955 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -93.23 95.26 9.26 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.9 mt -65.53 -54.28 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.256 1.822 . . . . 0.0 109.975 -171.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -60.0 -28.32 67.62 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.702 0.683 . . . . 0.0 111.067 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.15 -25.62 72.28 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 118.024 -1.431 . . . . 0.0 112.277 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.7 m -140.31 75.9 27.07 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 119.686 1.743 . . . . 0.0 112.42 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.77 154.8 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.135 2.557 . . . . 0.0 110.218 170.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.82 -45.1 2.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.753 1.168 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.57 132.05 30.01 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.093 2.157 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.44 -173.3 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.076 1.351 . . . . 0.0 109.038 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.17 104.72 14.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.49 -15.67 3.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.946 1.736 . . . . 0.0 111.653 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.51 105.53 0.11 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 128.416 2.686 . . . . 0.0 110.659 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.2 101.34 4.59 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.084 1.354 . . . . 0.0 109.102 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.65 129.95 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.438 1.895 . . . . 0.0 109.944 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.79 -43.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.57 1.548 . . . . 0.0 110.435 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.44 149.42 51.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.937 0.895 . . . . 0.0 109.53 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.1 mt -130.67 127.2 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 163.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 42.45 58.33 3.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 112.223 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 67.06 -18.78 0.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.598 2.359 . . . . 0.0 114.886 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -76.89 132.42 39.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.05 126.84 32.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.31 8.29 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -59.56 -13.61 9.94 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -129.63 38.62 3.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.055 1.342 . . . . 0.0 109.107 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.5 mt -121.5 146.04 47.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 126.5 1.92 . . . . 0.0 108.662 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.53 155.98 33.27 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 116.993 -1.479 . . . . 0.0 109.413 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.602 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 7.6 t60 -49.21 -28.72 4.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.739 175.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.5 m -74.32 -31.2 62.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.117 1.326 . . . . 0.0 111.945 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.82 -47.87 15.83 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 125.004 1.322 . . . . 0.0 110.554 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.602 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 2.7 m -54.56 -37.84 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 130.591 3.556 . . . . 0.0 111.726 168.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.98 -47.18 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.279 0.632 . . . . 0.0 109.843 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.59 -42.55 99.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.433 1.093 . . . . 0.0 111.759 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.86 -58.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 126.288 1.835 . . . . 0.0 108.879 169.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.45 -33.44 71.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.118 0.417 . . . . 0.0 111.406 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -64.66 -46.78 80.98 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.434 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.07 -28.89 69.18 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.174 0.99 . . . . 0.0 112.493 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.1 m -50.81 135.98 26.82 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 112.39 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.84 150.31 83.85 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.254 3.303 . . . . 0.0 110.615 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 75.7 mt -91.89 148.78 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.29 13.78 55.04 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.47 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -109.23 136.02 49.37 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.78 140.5 58.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.6 m -134.53 124.18 25.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.183 1.793 . . . . 0.0 106.997 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.0 m -91.45 127.94 37.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mp -124.89 125.04 43.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.38 129.23 58.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.44 150.37 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.37 1.068 . . . . 0.0 108.833 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -84.74 107.8 17.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 119.468 1.031 . . . . 0.0 110.299 179.083 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.54 0.559 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.5 mtm -128.02 136.34 51.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.6 m -134.82 104.97 6.22 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 -168.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.37 168.43 9.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.116 1.767 . . . . 0.0 108.53 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.26 144.88 50.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.7 pt -137.94 131.94 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.111 0.965 . . . . 0.0 111.148 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.1 t -90.4 114.59 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 122.292 1.044 . . . . 0.0 109.063 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 34.7 tttm -65.11 126.43 28.07 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 170.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.04 -71.85 1.3 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 119.43 1.013 . . . . 0.0 111.719 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.55 -52.87 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.866 1.266 . . . . 0.0 109.893 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . 0.256 5.8 pt20 -74.28 58.22 0.72 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.966 1.365 . . . . 0.0 110.555 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 56.72 -150.59 26.85 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.739 -161.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -81.95 157.89 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 160.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.36 -45.36 30.54 Favored Glycine 0 C--O 1.223 -0.586 0 C-N-CA 119.403 -1.38 . . . . 0.0 112.05 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -52.07 155.94 1.73 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.667 1.233 . . . . 0.0 111.225 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.2 p -120.39 161.15 21.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.193 1.397 . . . . 0.0 108.04 -172.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.31 159.41 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.525 -0.735 . . . . 0.0 110.079 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 149.0 52.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.091 1.756 . . . . 0.0 107.527 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -76.5 141.08 41.38 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.277 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.08 165.36 29.77 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.646 1.179 . . . . 0.0 108.578 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.04 -2.86 8.67 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.791 2.994 . . . . 0.0 116.084 -164.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -136.81 2.53 2.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.468 1.031 . . . . 0.0 112.723 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.32 -176.63 28.85 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -77.93 148.62 34.43 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.15 -0.618 . . . . 0.0 110.332 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -131.63 162.64 29.9 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.814 0.845 . . . . 0.0 109.633 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.16 127.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -76.57 -69.05 0.54 Allowed 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.097 1.359 . . . . 0.0 107.625 172.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -152.33 141.1 20.98 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.5 0.591 . . . . 0.0 109.915 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -85.57 114.76 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -104.35 -9.8 18.24 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.968 0.907 . . . . 0.0 110.888 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -140.23 81.28 1.8 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.561 1.944 . . . . 0.0 105.952 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.51 -45.2 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.169 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.22 -34.44 59.25 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.514 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.94 87.03 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.783 0.719 . . . . 0.0 111.889 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.4 m -126.21 67.44 63.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 118.755 1.278 . . . . 0.0 110.748 170.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 48' ' ' LEU . 22.7 Cg_exo -58.53 158.69 22.47 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.656 2.237 . . . . 0.0 112.393 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.18 -20.72 0.41 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.598 1.57 . . . . 0.0 114.314 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 46' ' ' PRO . 2.8 tp -63.52 133.61 54.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.258 1.823 . . . . 0.0 107.902 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.2 t -125.37 10.9 8.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.904 0.881 . . . . 0.0 112.438 -167.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.29 150.96 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 130.502 3.521 . . . . 0.0 114.849 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 8.06 32.8 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 113.542 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.46 113.07 2.46 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.603 1.561 . . . . 0.0 109.623 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.43 106.32 4.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.703 1.201 . . . . 0.0 109.79 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.49 142.29 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.336 1.054 . . . . 0.0 110.229 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.49 -55.74 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.338 1.455 . . . . 0.0 110.504 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.27 155.22 46.67 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.892 0.877 . . . . 0.0 109.463 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.2 mt -133.59 132.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 163.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 42.04 44.22 2.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.581 1.952 . . . . 0.0 113.654 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 59.06 42.52 18.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.636 1.175 . . . . 0.0 112.815 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -128.55 136.48 50.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.421 1.888 . . . . 0.0 107.12 160.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.16 120.59 23.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.411 1.084 . . . . 0.0 109.67 175.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 m -115.89 16.94 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 128.046 2.538 . . . . 0.0 107.86 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -42.45 97.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 119.714 -1.866 . . . . 0.0 111.223 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.9 -25.53 58.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.347 0.976 . . . . 0.0 111.285 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.11 138.69 57.84 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.966 1.706 . . . . 0.0 112.887 -163.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 m -63.58 165.33 8.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.43 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.47 -53.61 35.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.199 0.599 . . . . 0.0 110.624 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.4 m -62.52 -34.36 76.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.803 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -62.94 -47.04 84.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.24 0.927 . . . . 0.0 108.814 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.7 -44.5 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.704 1.202 . . . . 0.0 110.275 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.28 -43.11 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 O-C-N 121.64 -0.662 . . . . 0.0 109.987 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -44.6 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.96 0.904 . . . . 0.0 110.5 -172.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.49 -51.47 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.453 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 50.7 mt -68.24 -13.58 62.35 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.537 -0.727 . . . . 0.0 112.646 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -83.44 -33.64 25.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.397 1.453 . . . . 0.0 110.657 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -72.3 -36.01 68.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.912 0.778 . . . . 0.0 109.409 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -47.84 137.65 10.13 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.875 1.27 . . . . 0.0 112.208 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.63 127.33 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.503 3.469 . . . . 0.0 111.873 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 53.4 mt -66.88 134.7 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 10.94 85.93 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.236 0.922 . . . . 0.0 112.391 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -113.89 158.96 20.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.307 1.443 . . . . 0.0 108.54 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.19 150.32 43.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 162.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.6 m -131.46 146.25 52.16 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 127.803 2.441 . . . . 0.0 106.36 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.87 122.7 45.71 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -168.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -123.65 157.3 34.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.563 1.074 . . . . 0.0 109.308 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.62 140.54 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 167.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.52 156.06 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.543 1.137 . . . . 0.0 109.939 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.96 84.96 5.41 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.178 -0.951 . . . . 0.0 110.824 -168.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 162.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.3 mtp -89.69 135.77 33.42 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 162.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.8 m -112.92 142.72 45.28 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -133.54 167.83 19.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.159 1.784 . . . . 0.0 109.24 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -135.5 153.08 51.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 108.687 168.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.18 161.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.252 1.421 . . . . 0.0 110.071 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.52 115.15 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 122.363 1.077 . . . . 0.0 108.418 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -67.77 115.17 7.02 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.425 1.49 . . . . 0.0 109.824 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.86 -81.98 0.4 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.174 -171.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.35 139.77 18.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.512 1.656 . . . . 0.0 111.071 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 61.64 -35.68 0.11 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.014 2.126 . . . . 0.0 112.45 -166.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.52 -141.48 3.37 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.634 1.588 . . . . 0.0 109.472 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -94.04 153.48 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.12 -42.33 58.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.194 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -62.96 166.96 5.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.419 1.104 . . . . 0.0 111.786 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.0 p -125.79 153.34 44.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.593 1.157 . . . . 0.0 109.514 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.22 170.58 11.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.079 0.952 . . . . 0.0 109.823 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.1 149.71 41.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.95 2.1 . . . . 0.0 108.674 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.95 148.47 47.66 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 32' ' ' THR . 5.5 p -147.29 163.05 30.12 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.575 1.95 . . . . 0.0 106.726 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.96 12.73 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.961 1 C-N-CA 125.521 4.148 . . . . 0.0 113.884 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.449 ' H ' ' C ' ' A' ' 30' ' ' SER . 3.0 p -144.17 -3.72 0.84 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.887 2.075 . . . . 0.0 111.134 -162.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.86 -164.4 17.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -82.91 146.98 28.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.094 1.447 . . . . 0.0 110.369 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -127.57 163.66 23.69 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 126.018 1.727 . . . . 0.0 109.298 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.52 117.43 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -70.16 -61.63 1.7 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.052 1.341 . . . . 0.0 108.502 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -151.13 154.29 36.65 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.097 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.8 mt -106.18 110.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.795 2.438 . . . . 0.0 106.811 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.52 -5.58 22.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.918 1.287 . . . . 0.0 111.723 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.68 69.58 0.75 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.765 1.626 . . . . 0.0 109.192 -161.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.45 -62.56 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 125.186 1.395 . . . . 0.0 110.579 -159.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.92 -12.38 60.58 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.703 0.683 . . . . 0.0 112.658 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.02 -25.09 62.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.87 0.748 . . . . 0.0 111.856 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 34.9 m -128.35 76.88 77.79 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.199 1.0 . . . . 0.0 109.095 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -62.82 159.54 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.413 2.075 . . . . 0.0 110.833 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.27 -48.46 0.71 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.179 1.847 . . . . 0.0 114.238 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.9 tp -44.9 140.21 2.72 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 129.176 2.99 . . . . 0.0 112.357 -170.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.8 m -132.37 159.63 38.66 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.346 1.459 . . . . 0.0 110.255 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -60.09 146.46 42.92 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 165.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 2.44 59.75 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.444 -0.642 . . . . 0.0 113.673 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -62.8 112.6 2.61 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 163.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tp -80.52 129.52 34.56 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 mt -95.04 130.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -167.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.99 -51.02 6.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.633 1.573 . . . . 0.0 109.8 -170.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -138.6 150.43 46.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.935 0.894 . . . . 0.0 108.764 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -131.72 124.96 54.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 38.92 54.92 2.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.801 1.641 . . . . 0.0 111.244 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 61.66 -6.89 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.769 2.828 . . . . 0.0 116.437 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.14 125.06 26.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.378 1.444 . . . . 0.0 108.052 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.1 129.68 41.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.5 m -127.75 4.03 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.647 0.779 . . . . 0.0 111.833 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -50.67 -38.9 49.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.627 1.171 . . . . 0.0 110.861 165.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -105.36 21.31 17.38 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 mt -117.67 150.33 39.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.913 1.233 . . . . 0.0 113.821 -171.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.92 154.16 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.507 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.18 -52.07 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.145 0.578 . . . . 0.0 111.951 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 m -63.93 -24.71 67.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.711 -0.662 . . . . 0.0 111.898 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.54 -42.12 62.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.628 1.104 . . . . 0.0 109.546 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.84 -40.66 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.548 0.739 . . . . 0.0 109.48 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -46.25 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.497 0.719 . . . . 0.0 109.492 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.42 -41.91 99.05 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.621 1.169 . . . . 0.0 110.909 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -66.62 -44.54 89.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.31 -31.91 72.58 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.902 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 121.651 2.023 . . . . 0.0 110.82 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.85 -36.87 77.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.359 1.063 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.3 m -55.67 136.86 71.21 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.37 144.16 90.4 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.146 3.231 . . . . 0.0 111.575 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -76.89 134.07 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 168.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.05 28.43 68.5 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.63 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -129.83 159.89 35.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.13 134.96 41.16 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -105.36 129.8 53.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 m -87.59 135.58 33.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.57 167.65 20.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.692 0.678 . . . . 0.0 109.303 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -132.7 141.55 44.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.35 150.89 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.405 1.082 . . . . 0.0 110.404 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.7 97.14 8.95 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 107.911 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.25 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtp -88.57 135.81 33.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.3 m -134.45 103.82 5.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 168.36 9.45 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 126.085 1.754 . . . . 0.0 108.748 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.3 m -126.94 142.91 51.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.9 pt -127.62 167.85 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.764 1.626 . . . . 0.0 108.943 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.0 t -129.22 149.7 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.253 1.821 . . . . 0.0 106.963 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -113.24 99.82 8.1 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.822 1.249 . . . . 0.0 111.359 -164.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 54.23 4.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.744 1.64 . . . . 0.0 114.183 -172.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.07 -42.43 0.53 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.583 . . . . 0.0 116.53 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -80.21 -11.52 59.73 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.001 1.728 . . . . 0.0 113.106 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 65.91 149.92 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.015 2.526 . . . . 0.0 110.32 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.62 -53.77 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.23 153.24 2.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.044 1.337 . . . . 0.0 111.831 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.3 p -116.96 148.47 41.38 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.465 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 pt -110.34 153.78 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.88 156.67 45.68 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.128 1.371 . . . . 0.0 108.757 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.79 139.52 39.35 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.16 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.02 175.91 2.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.847 1.659 . . . . 0.0 108.831 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.39 -21.42 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.963 3.109 . . . . 0.0 113.373 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -104.27 -4.31 23.15 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -162.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.1 177.26 14.81 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -162.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -71.35 148.43 47.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.351 1.075 . . . . 0.0 108.855 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -133.63 154.74 50.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.57 116.92 27.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -64.32 -58.96 5.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.603 169.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -153.74 144.34 22.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.0 mt -91.39 124.57 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -119.06 -3.24 10.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.512 1.125 . . . . 0.0 112.336 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -136.0 91.54 2.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.58 -55.38 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -63.58 -29.83 71.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.692 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.67 -16.98 61.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.642 1.11 . . . . 0.0 112.869 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.3 m -136.7 66.92 57.67 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 120.0 1.9 . . . . 0.0 111.124 -171.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.68 117.8 4.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.684 2.923 . . . . 0.0 112.581 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -7.49 81.85 Favored Glycine 0 C--N 1.335 0.493 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.213 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.07 153.27 42.73 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 82.6 m -124.46 159.8 29.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.517 1.127 . . . . 0.0 111.036 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.64 145.95 24.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.84 43.69 23.53 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -167.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.9 -170.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.494 1.117 . . . . 0.0 108.766 161.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.96 119.0 9.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.2 mt -89.63 127.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -171.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.05 -48.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.861 -163.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -134.74 132.6 38.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -115.62 129.41 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 167.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.86 16.77 7.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.48 1.912 . . . . 0.0 114.809 164.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 58.87 50.3 8.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.19 1.359 . . . . 0.0 112.019 -165.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.56 -15.38 10.85 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.95 133.19 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 130.712 3.605 . . . . 0.0 113.53 -165.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.29 7.34 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.001 0.921 . . . . 0.0 112.882 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.46 -18.22 64.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 113.597 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -110.37 -21.85 11.99 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.891 0.877 . . . . 0.0 110.047 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.23 139.47 58.49 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.916 0.865 . . . . 0.0 111.735 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.8 m -65.54 158.18 27.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.238 1.415 . . . . 0.0 110.553 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -50.61 -54.07 25.73 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 124.353 1.061 . . . . 0.0 110.154 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.04 -17.78 63.69 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.819 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.44 -36.81 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.433 1.093 . . . . 0.0 108.996 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -74.21 -43.45 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.662 1.185 . . . . 0.0 109.286 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.9 t -51.54 -43.73 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.039 0 C-N-CA 123.875 0.87 . . . . 0.0 108.894 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.481 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -65.02 -42.97 93.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.2 mt -60.44 -44.36 96.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -65.35 -31.28 72.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.465 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.481 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 47.8 mtmt -62.37 -43.4 98.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.219 1.827 . . . . 0.0 111.298 165.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.66 -32.78 71.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.984 1.314 . . . . 0.0 112.547 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -53.67 139.33 50.57 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.053 1.341 . . . . 0.0 111.811 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.19 122.33 9.38 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.727 2.951 . . . . 0.0 110.048 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 mt -61.1 147.66 10.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.27 9.8 13.25 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.36 -1.244 . . . . 0.0 114.144 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 m -121.29 173.59 7.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.667 1.587 . . . . 0.0 108.192 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.3 153.19 25.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.687 0.756 . . . . 0.0 111.425 -175.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.2 m -142.22 144.34 33.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.415 1.486 . . . . 0.0 108.834 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -110.93 107.62 17.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.049 2.14 . . . . 0.0 109.144 -157.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.3 112.53 16.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.159 1.8 . . . . 0.0 111.615 -170.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -87.23 130.12 37.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.595 1.558 . . . . 0.0 108.608 171.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.25 150.21 30.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.011 1.324 . . . . 0.0 111.187 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -78.11 77.34 4.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 0.0 111.329 -168.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 . . . . . 0 CA--C 1.54 0.562 0 C-N-CA 126.487 1.915 . . . . 0.0 108.216 174.266 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.7 mt . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.78 137.09 41.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.825 1.25 . . . . 0.0 107.913 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.8 m -125.45 120.03 29.87 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -168.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 mt -137.19 167.07 22.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.804 1.242 . . . . 0.0 107.943 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.58 143.83 51.09 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.9 pt -137.91 161.85 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.779 1.232 . . . . 0.0 109.733 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.1 t -117.46 147.5 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -97.12 86.7 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 71.87 0.68 Allowed Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.614 -160.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . 60.52 154.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.823 2.849 . . . . 0.0 115.043 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 47.78 -0.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.211 2.204 . . . . 0.0 115.58 -158.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 133.98 -129.97 5.46 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 104.453 -3.459 . . . . 0.0 104.453 -172.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -97.79 168.06 10.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 166.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.17 -45.12 57.52 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 121.706 -0.621 . . . . 0.0 111.895 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -64.47 -179.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.052 2.141 . . . . 0.0 113.388 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 p -132.81 147.04 52.31 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.834 1.254 . . . . 0.0 109.76 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 pt -110.7 167.68 4.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.286 1.035 . . . . 0.0 109.28 166.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.35 161.96 35.61 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.433 1.893 . . . . 0.0 107.217 168.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.33 148.73 41.07 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.687 1.195 . . . . 0.0 108.11 163.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.07 163.6 23.04 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.163 0.985 . . . . 0.0 108.41 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.16 -1.34 2.85 Favored 'Trans proline' 0 C--N 1.345 0.371 1 C-N-CA 126.166 4.577 . . . . 0.0 116.993 -170.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -132.62 -13.34 2.95 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.337 1.055 . . . . 0.0 111.848 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.08 172.32 17.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -164.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -68.03 124.87 24.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.856 1.262 . . . . 0.0 109.15 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -102.71 163.48 12.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 122.188 0.994 . . . . 0.0 109.625 171.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.8 t -72.03 128.03 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 163.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -71.62 -69.26 0.39 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -154.22 141.33 19.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.987 0.915 . . . . 0.0 108.592 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 mt -89.72 135.35 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.15 -31.0 4.22 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.445 0.698 . . . . 0.0 110.778 -171.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -130.65 95.92 3.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.57 -40.71 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.548 0.739 . . . . 0.0 110.513 -171.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.06 -19.21 61.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.915 -1.116 . . . . 0.0 111.656 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.38 -23.16 75.05 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.135 -0.978 . . . . 0.0 111.562 166.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 90.2 m -147.51 74.48 11.51 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 119.559 1.68 . . . . 0.0 110.067 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.29 158.94 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.54 1.493 . . . . 0.0 112.531 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.46 -46.51 1.64 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.824 -0.987 . . . . 0.0 113.251 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 tt -52.74 146.12 10.99 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.253 2.221 . . . . 0.0 109.993 -166.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.54 162.02 31.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.045 0.926 . . . . 0.0 111.71 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -69.32 148.39 49.78 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.453 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.56 7.13 25.85 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.007 -1.441 . . . . 0.0 114.176 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -51.53 126.53 17.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.576 1.688 . . . . 0.0 106.542 166.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -96.11 110.94 23.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.6 mt -70.91 141.58 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.321 1.419 . . . . 0.0 109.254 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.81 -43.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.061 1.344 . . . . 0.0 110.261 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -135.87 156.74 48.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.272 0.558 . . . . 0.0 109.53 171.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.34 125.67 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 164.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 45.87 37.83 3.91 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.237 1.415 . . . . 0.0 114.819 169.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 54.59 60.55 3.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.187 1.795 . . . . 0.0 112.629 -169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -134.79 133.93 40.36 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 151.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.24 122.51 34.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.293 1.037 . . . . 0.0 108.595 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.45 -1.35 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -162.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -24.29 40.11 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.869 1.668 . . . . 0.0 113.447 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -91.25 1.13 57.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.723 1.609 . . . . 0.0 112.126 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.54 173.48 6.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.287 1.435 . . . . 0.0 111.255 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.2 m -109.27 159.98 16.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.208 1.803 . . . . 0.0 108.814 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -50.21 -50.73 48.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.367 0.667 . . . . 0.0 111.922 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.5 m -64.57 -31.33 72.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.562 0.745 . . . . 0.0 111.068 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.24 -45.49 84.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.725 0.693 . . . . 0.0 109.273 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.87 -37.35 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.566 1.147 . . . . 0.0 108.942 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.2 -45.62 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.057 0.943 . . . . 0.0 109.152 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -34.25 71.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.329 0.585 . . . . 0.0 112.345 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.24 -56.08 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.775 1.63 . . . . 0.0 107.654 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.6 mt -61.53 -27.39 68.57 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.603 -0.686 . . . . 0.0 111.933 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -66.25 -41.07 90.47 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 109.889 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.66 -40.77 88.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.582 1.153 . . . . 0.0 110.736 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.9 m -49.41 139.65 14.23 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.747 1.219 . . . . 0.0 112.173 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -67.15 118.74 5.8 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.299 3.333 . . . . 0.0 110.995 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.36 137.25 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.09 18.86 71.42 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.223 1.392 . . . . 0.0 113.372 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 t -113.72 163.87 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.391 1.477 . . . . 0.0 107.403 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -62.99 153.92 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.43 1.109 . . . . 0.0 110.309 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -133.15 140.94 47.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.167 2.587 . . . . 0.0 105.166 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.3 m -89.32 135.77 33.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.237 1.815 . . . . 0.0 106.259 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.28 164.31 15.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 162.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.9 mt -132.26 137.49 54.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 164.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -134.47 157.25 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.932 1.693 . . . . 0.0 109.112 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.92 98.62 11.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.311 1.044 . . . . 0.0 109.144 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 . . . . . 0 N--CA 1.466 0.354 0 O-C-N 121.56 -0.713 . . . . 0.0 110.01 168.127 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--O 1.234 0.255 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.2 mtm -105.32 114.97 29.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 m -76.74 140.9 40.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 157.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -140.57 168.51 19.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.01 2.124 . . . . 0.0 106.955 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.8 m -125.07 147.7 48.86 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.142 -0.974 . . . . 0.0 108.487 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.97 163.47 37.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.524 1.129 . . . . 0.0 109.216 171.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 t -136.04 137.68 48.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 72.7 tttt -108.38 81.9 1.54 Allowed 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.177 -0.952 . . . . 0.0 113.452 -153.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.69 -78.7 0.08 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.514 1.054 . . . . 0.0 115.236 -165.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.82 -60.34 0.26 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.362 1.581 . . . . 0.0 112.392 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -82.74 44.73 0.93 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.892 0.853 . . . . 0.0 111.046 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.419 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 64.48 74.94 0.41 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.64 1.114 . . . . 0.0 111.896 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.09 -86.85 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 125.774 1.63 . . . . 0.0 108.737 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.48 -31.61 0.58 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.643 1.592 . . . . 0.0 111.159 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.437 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 34.0 p90 -61.44 165.72 4.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.046 1.339 . . . . 0.0 110.353 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -119.8 147.46 44.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.771 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 pt -113.32 162.66 11.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.353 0.661 . . . . 0.0 109.332 167.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.51 157.8 41.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.521 2.329 . . . . 0.0 106.713 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -74.53 148.07 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.6 p -137.52 162.73 53.23 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.17 1.45 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.319 3.346 . . . . 0.0 114.567 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -131.73 -0.87 3.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.014 1.326 . . . . 0.0 112.453 -166.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.63 179.26 15.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -168.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -77.06 154.84 32.96 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 118.541 1.171 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -148.37 159.83 43.62 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 112.579 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.41 115.4 22.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 125.554 1.541 . . . . 0.0 107.56 -173.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -72.93 -44.2 61.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.598 171.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.25 160.4 23.88 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -171.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' A' ' 25' ' ' PHE . 1.4 mm? -105.2 -4.25 21.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.061 1.745 . . . . 0.0 112.466 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -143.42 96.38 2.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 157.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.23 -42.49 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 109.403 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.93 -33.53 75.8 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.368 -0.833 . . . . 0.0 111.144 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.19 -21.41 79.26 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.109 -0.828 . . . . 0.0 112.371 171.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.4 m -129.47 68.62 80.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 118.891 1.345 . . . . 0.0 110.123 -174.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.03 149.77 88.89 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.143 1.895 . . . . 0.0 110.246 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.02 -21.44 0.37 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.077 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.29 136.15 57.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.357 1.578 . . . . 0.0 110.004 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -127.72 160.62 31.13 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.969 1.308 . . . . 0.0 109.633 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -71.97 139.85 48.85 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.193 0.997 . . . . 0.0 109.418 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.02 66.32 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.57 -167.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.575 1.95 . . . . 0.0 110.105 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.73 115.86 6.96 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 mm -70.74 125.58 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.353 1.461 . . . . 0.0 110.546 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.68 -56.9 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.67 1.188 . . . . 0.0 111.381 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -133.96 145.84 49.91 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.5 mt -134.36 123.81 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 50.85 33.62 8.95 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.871 1.268 . . . . 0.0 112.543 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.7 11.48 8.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.635 2.774 . . . . 0.0 115.162 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.24 132.26 34.96 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.187 1.395 . . . . 0.0 107.451 163.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -80.13 138.81 36.99 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.99 13.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.403 1.481 . . . . 0.0 111.659 -172.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.852 -1.155 . . . . 0.0 113.383 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -120.37 30.09 7.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.978 0.808 . . . . 0.0 109.698 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -98.04 164.88 12.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.194 0.998 . . . . 0.0 110.606 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -84.91 162.5 19.43 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.076 1.35 . . . . 0.0 109.984 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -45.69 -58.46 3.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 126.608 1.963 . . . . 0.0 110.551 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.4 m -58.53 -40.36 82.74 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.284 1.033 . . . . 0.0 110.694 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -65.68 -44.48 86.09 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.851 1.26 . . . . 0.0 109.962 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.63 -39.75 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.957 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.15 -40.48 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 O-C-N 121.617 -0.677 . . . . 0.0 109.579 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -48.63 78.87 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.551 1.54 . . . . 0.0 110.199 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.4 mt -60.09 -43.75 93.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.979 1.312 . . . . 0.0 109.24 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -69.05 -27.11 65.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.783 175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -65.57 -44.39 86.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 121.15 1.795 . . . . 0.0 108.268 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.47 -26.14 68.31 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.711 0.632 . . . . 0.0 112.374 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.6 m -53.51 134.13 53.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.045 0.538 . . . . 0.0 110.67 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -68.0 135.13 34.01 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.217 3.278 . . . . 0.0 110.698 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -71.27 127.69 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.534 1.534 . . . . 0.0 107.983 -175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.96 11.87 59.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.935 2.207 . . . . 0.0 113.134 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -92.2 167.36 12.09 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 149.17 34.45 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -131.44 126.35 34.84 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.3 m -101.23 113.63 26.86 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -167.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.55 153.84 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.198 0.908 . . . . 0.0 109.733 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -129.55 136.36 59.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.06 153.27 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.845 1.258 . . . . 0.0 110.869 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 105.95 17.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.641 1.977 . . . . 0.0 107.316 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 126.221 1.809 . . . . 0.0 109.872 170.22 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.2 mtm -113.38 146.47 39.43 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.8 m -135.22 98.8 4.07 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.028 1.331 . . . . 0.0 107.996 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.86 167.6 9.61 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.352 1.461 . . . . 0.0 109.82 -172.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.27 145.81 47.87 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.906 0.883 . . . . 0.0 110.537 -177.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.4 pt -139.65 134.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 125.562 1.545 . . . . 0.0 108.832 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.45 121.76 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 73.6 tttt -69.93 116.85 10.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.282 1.033 . . . . 0.0 109.58 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.73 -68.86 1.43 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.861 -169.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.21 -73.5 0.13 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.809 1.304 . . . . 0.0 112.01 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -76.41 36.22 0.15 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.112 0.965 . . . . 0.0 111.164 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 87.85 -126.68 8.16 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 -158.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -113.71 166.8 11.18 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.72 25.62 3.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.087 1.803 . . . . 0.0 113.611 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -151.07 167.64 27.09 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.892 1.346 . . . . 0.0 108.472 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 p -129.37 159.84 34.95 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.241 0.617 . . . . 0.0 109.797 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 pt -125.21 152.4 31.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.09 0.556 . . . . 0.0 110.502 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.22 145.42 30.41 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.446 1.099 . . . . 0.0 108.202 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.48 148.45 48.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.057 0.932 . . . . 0.0 110.809 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p -137.44 166.57 25.72 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.389 1.875 . . . . 0.0 105.985 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -70.75 -5.33 16.57 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.406 2.737 . . . . 0.0 112.871 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -129.33 -6.91 4.77 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.074 0.852 . . . . 0.0 112.804 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.89 -177.7 35.37 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.848 1.213 . . . . 0.0 110.587 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -94.12 92.62 7.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.57 -0.959 . . . . 0.0 110.601 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -86.88 161.56 18.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 119.629 1.104 . . . . 0.0 111.791 -162.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.54 115.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -71.63 -61.63 1.71 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 170.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -150.29 143.57 25.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.4 mt -96.11 110.51 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.2 mt -78.27 -36.28 47.01 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.798 0.839 . . . . 0.0 109.022 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -132.02 93.36 3.27 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.153 1.781 . . . . 0.0 109.083 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.8 mt -56.81 -44.06 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 110.154 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -68.07 -12.28 60.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.1 -14.01 52.87 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 119.509 1.05 . . . . 0.0 111.349 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.52 54.96 15.22 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.709 1.204 . . . . 0.0 109.67 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.07 124.3 10.83 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.922 1.748 . . . . 0.0 111.233 -164.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -16.24 61.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.971 1.272 . . . . 0.0 113.411 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.94 152.69 39.26 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.8 p -124.84 151.79 44.81 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.724 0.81 . . . . 0.0 108.901 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -76.4 138.57 40.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.06 96.32 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -168.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.63 -177.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.852 0.826 . . . . 0.0 111.554 163.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.59 91.19 2.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.84 135.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.559 1.544 . . . . 0.0 109.196 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.17 -45.98 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.166 1.387 . . . . 0.0 110.367 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -128.79 148.84 50.9 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.75 138.75 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 152.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 67.82 -54.42 0.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 128.979 2.911 . . . . 0.0 116.203 167.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 165.27 13.85 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 130.793 3.637 . . . . 0.0 113.584 -156.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -131.76 141.9 49.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.909 1.686 . . . . 0.0 109.194 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -69.55 128.83 37.87 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.8 m -133.75 22.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 125.402 1.481 . . . . 0.0 107.563 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -60.43 3.69 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 119.977 -1.702 . . . . 0.0 110.719 176.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.22 -21.15 62.17 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.456 0.169 . . . . 0.0 111.193 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.89 134.58 37.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.867 1.667 . . . . 0.0 111.61 -167.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -56.63 162.33 2.31 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.674 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -49.28 -51.38 34.07 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.69 0.796 . . . . 0.0 109.311 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -52.07 17.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.036 2.534 . . . . 0.0 111.495 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.31 -46.71 82.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.516 1.126 . . . . 0.0 108.531 -170.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.37 -46.46 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.471 1.509 . . . . 0.0 110.443 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.57 -45.17 78.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -40.55 77.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.126 0.97 . . . . 0.0 111.473 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.59 -48.95 85.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 123.996 0.919 . . . . 0.0 109.109 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.12 -26.96 68.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.737 0.415 . . . . 0.0 111.58 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -71.51 -41.47 69.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.808 1.186 . . . . 0.0 110.382 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.51 -27.65 67.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.447 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.9 m -49.72 127.17 19.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 123.275 0.63 . . . . 0.0 110.739 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.04 132.84 46.73 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.937 3.092 . . . . 0.0 110.773 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 mm -64.01 127.75 25.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 166.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.44 17.71 75.36 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.323 0.963 . . . . 0.0 112.294 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -115.24 159.45 20.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 123.313 1.53 . . . . 0.0 108.823 159.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.05 153.58 40.32 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.876 168.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.6 m -137.77 149.11 46.14 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 126.936 2.094 . . . . 0.0 107.869 165.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 126.1 54.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.627 2.371 . . . . 0.0 105.941 -168.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.46 115.69 18.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.996 1.271 . . . . 0.0 109.171 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mt -97.62 125.59 50.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.06 155.11 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.607 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -108.81 74.86 0.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.041 2.136 . . . . 0.0 109.693 -170.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 171.29 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.1 mtm -89.72 125.1 35.15 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -96.66 142.94 28.1 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.16 145.4 51.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.789 1.636 . . . . 0.0 108.06 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 m -103.06 135.15 45.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.179 0.592 . . . . 0.0 109.882 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.9 pt -143.98 137.59 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.285 1.034 . . . . 0.0 111.595 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.254 0.2 OUTLIER -110.35 136.03 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.598 1.189 . . . . 0.0 112.338 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 66.3 tttt -79.06 117.6 20.26 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.813 1.645 . . . . 0.0 111.924 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.461 ' H ' ' HA ' ' A' ' 23' ' ' PHE . . . -81.73 171.98 52.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 166.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.55 -59.64 3.59 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.686 1.994 . . . . 0.0 113.882 -168.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -82.16 10.83 6.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.695 -0.628 . . . . 0.0 111.096 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 82.23 1.64 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 126.298 1.904 . . . . 0.0 108.364 169.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.461 ' HA ' ' H ' ' A' ' 19' ' ' GLY . 43.9 m-85 61.13 -175.97 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.995 1.318 . . . . 0.0 111.049 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.2 -63.61 1.5 Allowed Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -60.17 170.92 1.12 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.536 1.135 . . . . 0.0 113.775 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -131.43 158.38 40.98 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.026 1.33 . . . . 0.0 109.541 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.3 pt -123.68 162.01 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 124.732 1.213 . . . . 0.0 108.717 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.21 158.17 43.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.89 114.82 9.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.849 1.259 . . . . 0.0 107.962 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -99.31 168.36 9.75 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -66.35 -8.83 21.76 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.308 2.005 . . . . 0.0 114.568 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -129.12 -4.43 5.0 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 120.104 1.32 . . . . 0.0 114.022 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.59 -172.94 33.73 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -162.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -84.82 143.32 29.16 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 121.526 -0.985 . . . . 0.0 108.655 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -134.48 154.24 51.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.588 171.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.09 126.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.597 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -81.07 -57.05 3.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.739 1.216 . . . . 0.0 108.526 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -157.32 149.53 22.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.1 mt -122.54 132.77 70.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.67 -58.2 1.6 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.204 1.002 . . . . 0.0 109.45 -164.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -88.04 87.98 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.8 1.24 . . . . 0.0 110.107 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.02 -38.55 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.062 0.945 . . . . 0.0 112.116 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.85 -36.17 67.38 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.772 -0.58 . . . . 0.0 111.123 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.19 -9.74 81.59 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.183 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.27 64.59 73.97 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 119.454 1.627 . . . . 0.0 108.614 172.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.41 125.41 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.201 1.934 . . . . 0.0 112.057 -165.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.62 0.38 84.09 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.125 -0.819 . . . . 0.0 112.696 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.99 140.95 56.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.781 1.291 . . . . 0.0 108.387 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 151.29 43.12 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 122.177 0.989 . . . . 0.0 110.464 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -77.78 148.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.14 56.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 117.4 -1.778 . . . . 0.0 114.383 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -63.63 126.75 28.57 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.926 1.863 . . . . 0.0 109.424 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 123.05 25.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.784 1.633 . . . . 0.0 108.363 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.83 146.23 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.2 -53.62 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.708 0.803 . . . . 0.0 110.916 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.5 131.61 24.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -116.95 124.3 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 170.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 46.1 46.35 12.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.791 1.636 . . . . 0.0 113.002 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.266 0.2 OUTLIER 61.15 31.7 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.271 1.829 . . . . 0.0 115.22 -177.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.15 132.11 55.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.121 1.768 . . . . 0.0 106.752 165.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -83.4 120.76 26.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.33 1.452 . . . . 0.0 110.85 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 m -121.98 7.01 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.679 1.992 . . . . 0.0 109.412 -171.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -37.97 39.82 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.029 1.286 . . . . 0.0 112.085 -173.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -115.71 7.75 14.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mp -62.06 143.37 56.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.382 1.873 . . . . 0.0 109.991 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -54.77 159.16 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.939 0.774 . . . . 0.0 110.069 165.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -50.38 -49.65 53.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 168.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -55.57 -44.73 77.13 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.873 1.269 . . . . 0.0 112.725 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.77 -39.89 95.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.398 1.079 . . . . 0.0 109.715 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.2 -49.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.497 0.719 . . . . 0.0 109.814 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.5 -38.12 54.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.472 1.509 . . . . 0.0 109.888 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.68 -46.11 80.3 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.771 0.828 . . . . 0.0 111.024 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mt -59.16 -46.14 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.604 1.161 . . . . 0.0 109.52 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.494 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 98.0 mt -61.09 -17.41 52.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.222 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -86.19 -33.64 20.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.379 1.445 . . . . 0.0 111.523 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -42.57 69.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.473 1.109 . . . . 0.0 109.406 165.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 91.9 m -51.35 135.55 31.9 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 111.776 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -67.56 112.67 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 1 C-N-CA 125.636 4.224 . . . . 0.0 112.098 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -51.32 117.76 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.382 1.473 . . . . 0.0 107.548 170.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.49 8.75 57.21 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.862 1.22 . . . . 0.0 113.249 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.85 151.74 51.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.972 1.386 . . . . 0.0 110.339 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -72.38 153.37 41.49 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.329 1.452 . . . . 0.0 112.123 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -131.23 143.82 50.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 130.083 3.353 . . . . 0.0 105.905 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.4 m -109.02 116.62 32.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -116.56 115.62 26.09 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.572 1.149 . . . . 0.0 108.549 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.37 134.47 28.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.43 152.61 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 110.723 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -88.01 67.69 9.01 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.185 -0.947 . . . . 0.0 110.768 -170.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.239 0.538 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.7 mtm -111.09 153.69 25.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.601 0.637 . . . . 0.0 109.543 165.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.9 m -132.17 120.25 22.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.4 mt -126.85 168.41 14.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.532 1.533 . . . . 0.0 107.936 -175.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 m -134.67 141.97 46.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.6 pt -138.46 151.31 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 110.981 -176.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.5 153.19 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.625 1.97 . . . . 0.0 108.942 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -113.23 105.69 13.73 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.341 1.456 . . . . 0.0 109.022 -145.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.69 61.39 3.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.662 1.601 . . . . 0.0 112.577 -165.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.23 152.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.975 2.51 . . . . 0.0 112.459 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 65.42 -25.42 0.09 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.336 2.255 . . . . 0.0 115.56 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -164.16 31.13 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.681 -2.568 . . . . 0.0 106.681 -159.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -102.29 12.89 35.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -174.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.34 -66.15 1.28 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.609 1.1 . . . . 0.0 110.879 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -54.05 158.04 2.31 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 122.143 0.973 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -114.56 159.88 19.9 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.586 1.154 . . . . 0.0 109.418 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.7 pt -118.31 154.33 20.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.548 0.69 . . . . 0.0 110.432 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.91 170.26 9.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.263 2.225 . . . . 0.0 108.286 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.08 122.04 46.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 107.512 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.4 p -126.03 171.51 7.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.959 1.303 . . . . 0.0 109.734 -167.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.15 -14.69 45.17 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.164 1.909 . . . . 0.0 112.64 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -104.67 -11.83 16.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.019 1.328 . . . . 0.0 111.72 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.28 -162.25 23.63 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -73.34 147.58 44.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -139.73 165.09 28.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.306 0.574 . . . . 0.0 109.465 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.19 117.1 16.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.6 -74.18 0.15 Allowed 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -140.12 153.61 46.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -99.54 106.86 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.095 1.758 . . . . 0.0 108.168 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -101.82 -0.0 34.94 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.267 1.427 . . . . 0.0 110.957 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -149.83 114.06 5.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.037 1.735 . . . . 0.0 108.596 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.09 -58.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.484 1.513 . . . . 0.0 109.216 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.69 -37.1 75.34 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.037 1.335 . . . . 0.0 111.636 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.25 -25.75 72.3 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.3 m -126.94 67.61 69.72 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 118.947 1.373 . . . . 0.0 111.198 -172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.8 128.16 20.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.718 2.279 . . . . 0.0 111.224 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.12 76.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 124.401 1.001 . . . . 0.0 114.297 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.84 153.12 44.23 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.444 1.122 . . . . 0.0 108.754 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.5 m -135.78 0.76 2.72 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 62.6 151.22 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.641 2.376 . . . . 0.0 112.205 -166.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.99 6.52 25.5 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.683 -1.065 . . . . 0.0 113.73 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.38 128.88 38.12 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.429 1.492 . . . . 0.0 107.817 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -81.28 109.96 16.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.843 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.99 124.66 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.94 -57.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.128 1.371 . . . . 0.0 108.893 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -128.56 150.47 50.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.284 1.034 . . . . 0.0 109.229 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.2 mt -127.86 126.65 67.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 164.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 43.64 52.84 6.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 111.046 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 59.94 -7.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.973 2.509 . . . . 0.0 116.371 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -69.63 117.08 10.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -58.11 115.9 3.2 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 163.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 0.8 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 O-C-N 124.057 0.848 . . . . 0.0 112.397 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -54.49 -21.9 11.34 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -170.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -112.03 -2.86 14.93 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 121.319 1.872 . . . . 0.0 112.663 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.55 160.25 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.321 -0.862 . . . . 0.0 109.198 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -89.53 157.11 18.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.209 1.004 . . . . 0.0 109.793 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -40.83 -56.8 2.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.984 1.714 . . . . 0.0 112.132 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.7 m -67.0 -26.26 66.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.896 0.878 . . . . 0.0 111.038 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.29 -44.96 67.3 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.243 0.928 . . . . 0.0 109.364 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.6 -40.57 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.384 1.073 . . . . 0.0 109.646 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.68 -53.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 123.715 0.806 . . . . 0.0 109.029 169.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.519 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 12.9 t70 -57.22 -46.39 82.98 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.352 0.661 . . . . 0.0 111.722 -172.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.4 mt -55.27 -45.52 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.649 1.18 . . . . 0.0 109.494 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -67.74 -35.72 79.24 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.716 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 72' ' ' ASP . 9.0 mtmp? -55.01 -47.9 74.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.266 1.848 . . . . 0.0 109.589 167.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -34.73 75.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.218 1.007 . . . . 0.0 112.478 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.76 138.04 43.4 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.157 0.983 . . . . 0.0 109.689 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -54.29 144.27 61.04 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.347 2.698 . . . . 0.0 110.119 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.5 mt -80.43 131.43 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 161.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.91 35.79 72.86 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.268 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.7 m -146.43 131.79 18.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.746 1.273 . . . . 0.0 108.831 161.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -61.45 152.7 29.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.616 1.198 . . . . 0.0 111.094 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -137.55 135.57 36.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.966 2.906 . . . . 0.0 105.116 -168.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -112.49 110.85 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.822 1.249 . . . . 0.0 108.29 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.96 112.63 18.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.514 0.597 . . . . 0.0 110.84 -169.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -89.17 141.72 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.37 146.58 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.851 0.834 . . . . 0.0 111.819 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.0 96.61 5.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.205 1.002 . . . . 0.0 109.327 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 . . . . . 0 CA--C 1.519 -0.215 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.398 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -87.35 145.8 26.17 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.2 m -123.45 139.17 54.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.3 mt -142.81 167.88 21.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.444 2.297 . . . . 0.0 106.837 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.8 m -128.95 154.61 46.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.3 -0.875 . . . . 0.0 108.694 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 pt -145.66 166.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 126.054 1.741 . . . . 0.0 109.907 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.82 143.37 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.636 1.575 . . . . 0.0 107.582 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -88.62 145.68 25.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.26 1.024 . . . . 0.0 111.232 -175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.32 82.8 0.35 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.264 1.411 . . . . 0.0 113.899 -168.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.97 -84.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.035 2.134 . . . . 0.0 115.697 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.25 -15.4 46.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.934 1.243 . . . . 0.0 112.862 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.39 28.73 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -66.36 146.0 55.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 118.869 1.334 . . . . 0.0 108.173 170.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.24 -51.84 53.79 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -61.82 164.02 6.81 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.368 1.08 . . . . 0.0 110.198 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.43 ' HG1' ' CD2' ' A' ' 40' ' ' LEU . 12.0 p -117.37 156.78 27.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.973 0.909 . . . . 0.0 109.25 -174.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.02 158.32 18.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 167.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.12 163.1 25.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 165.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.83 147.13 47.48 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 159.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.3 p -139.7 161.9 53.92 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 163.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.32 -42.66 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.016 2.477 . . . . 0.0 113.256 -174.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.487 ' HG1' ' CD1' ' A' ' 53' ' ' LEU . 33.8 p -73.29 -23.84 60.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 111.159 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.75 178.86 26.9 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -172.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -62.42 145.74 53.26 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -134.17 161.11 35.8 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 123.134 0.574 . . . . 0.0 111.134 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.86 107.27 7.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 -58.2 9.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.112 0.965 . . . . 0.0 109.553 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -151.69 148.14 27.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.788 1.635 . . . . 0.0 106.778 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.6 mt -91.2 97.14 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' CD2' ' HG1' ' A' ' 26' ' ' THR . 2.6 mm? -72.7 -26.15 61.49 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.219 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -142.71 95.57 2.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.446 1.898 . . . . 0.0 108.998 -158.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.4 -57.06 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.76 1.224 . . . . 0.0 109.105 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.15 -25.32 66.92 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.802 0.728 . . . . 0.0 111.608 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 -32.35 66.77 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.213 170.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.3 p -130.08 70.36 82.13 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 120.058 1.929 . . . . 0.0 112.774 -171.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.39 111.59 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.748 2.299 . . . . 0.0 111.636 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.04 85.34 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.407 1.479 . . . . 0.0 114.844 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 152.97 43.15 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.03 1.415 . . . . 0.0 108.089 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.7 m -129.12 156.0 44.58 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.303 1.041 . . . . 0.0 110.023 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.24 137.48 53.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.14 12.41 79.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.494 -1.725 . . . . 0.0 114.182 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -58.43 129.53 42.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.093 1.946 . . . . 0.0 110.117 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.487 ' CD1' ' HG1' ' A' ' 32' ' ' THR . 3.1 tp -78.5 144.42 35.71 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 172.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.2 mt -108.0 135.9 45.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 125.359 1.464 . . . . 0.0 108.206 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -122.45 -57.04 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.274 1.03 . . . . 0.0 110.085 -170.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 64.0 mt-10 -129.89 149.7 51.5 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.3 mt -135.93 129.39 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 168.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 41.13 45.33 2.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.392 2.277 . . . . 0.0 111.573 -173.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 57.51 4.54 0.24 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.391 2.276 . . . . 0.0 115.795 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.1 126.04 29.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 160.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.421 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 21.8 t-20 -73.02 132.22 43.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 168.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.84 -2.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.516 1.126 . . . . 0.0 110.844 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -6.69 1.27 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -121.03 -2.28 9.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.022 1.329 . . . . 0.0 111.659 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.5 mt -77.42 167.97 20.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.581 1.082 . . . . 0.0 110.517 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.5 m -88.66 155.53 19.55 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -47.76 -50.65 24.9 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.839 1.256 . . . . 0.0 112.341 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 m -65.73 -29.43 69.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.251 1.02 . . . . 0.0 111.266 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.37 -44.46 83.09 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.44 -39.95 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 121.172 -0.955 . . . . 0.0 110.564 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.53 -50.68 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 124.493 1.117 . . . . 0.0 108.893 171.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -66.25 -37.38 85.34 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.23 0.956 . . . . 0.0 112.011 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.88 -44.23 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.469 -0.769 . . . . 0.0 109.308 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.06 -17.59 64.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.946 -1.096 . . . . 0.0 112.29 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.03 -46.58 42.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.776 1.625 . . . . 0.0 108.993 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.07 -27.22 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.039 0.836 . . . . 0.0 112.85 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.95 123.82 61.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 118.849 0.75 . . . . 0.0 109.432 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -68.69 157.71 60.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.921 3.08 . . . . 0.0 113.276 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mm -90.08 124.56 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.575 1.55 . . . . 0.0 106.953 -170.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.41 73.77 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.571 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 m -110.64 157.75 19.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 162.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 153.83 41.07 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.797 1.284 . . . . 0.0 109.756 166.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -140.78 131.37 25.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.512 1.925 . . . . 0.0 105.961 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -97.17 121.12 38.71 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.923 1.689 . . . . 0.0 106.537 -171.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.68 149.87 42.6 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.815 1.189 . . . . 0.0 110.017 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.03 125.24 66.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.72 177.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.966 1.306 . . . . 0.0 109.549 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -107.21 124.32 49.57 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.077 0.853 . . . . 0.0 111.683 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 130.539 3.536 . . . . 0.0 106.344 -170.401 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.7 mt . . . . . 0 C--O 1.236 0.389 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.57 129.87 50.55 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.467 1.107 . . . . 0.0 108.413 171.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 m -95.33 136.2 35.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.57 168.45 20.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.369 1.867 . . . . 0.0 108.509 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 m -135.64 131.17 35.43 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.322 -0.861 . . . . 0.0 108.909 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 pt -120.67 166.39 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.262 1.025 . . . . 0.0 110.11 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.72 132.9 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.12 106.51 17.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.632 -0.668 . . . . 0.0 109.735 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.31 171.73 6.36 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 121.876 0.709 . . . . 0.0 112.408 171.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -59.48 -52.78 64.13 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.581 1.152 . . . . 0.0 111.009 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -80.3 29.52 0.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.511 1.124 . . . . 0.0 110.31 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 75.58 -171.43 54.27 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 125.439 1.495 . . . . 0.0 109.512 -166.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.15 -0.79 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.423 1.889 . . . . 0.0 114.715 -172.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.54 -61.03 3.24 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 119.819 -1.801 . . . . 0.0 111.198 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -54.09 152.35 6.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 118.659 1.229 . . . . 0.0 111.232 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.4 p -118.84 159.17 24.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.199 1.4 . . . . 0.0 108.151 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 pt -123.56 166.72 18.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.639 0.733 . . . . 0.0 109.996 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.09 170.04 16.77 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.547 2.739 . . . . 0.0 108.168 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.25 115.93 31.27 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.37 2.268 . . . . 0.0 106.834 169.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 52.4 p -111.27 169.28 6.47 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.064 1.346 . . . . 0.0 108.251 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 23.4 Cg_endo -64.09 10.52 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 125.14 3.893 . . . . 0.0 115.065 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.445 ' HG1' ' CD1' ' A' ' 53' ' ' LEU . 36.3 p -131.33 -11.76 3.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 111.632 -171.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.61 -165.09 24.27 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -169.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -66.48 141.36 57.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -130.57 162.82 28.47 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.544 0.688 . . . . 0.0 109.643 166.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.6 t -71.11 138.3 22.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 168.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -93.19 -48.42 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.434 1.094 . . . . 0.0 109.418 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -161.81 159.13 26.61 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.091 1.756 . . . . 0.0 106.88 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.2 139.99 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 46.3 mt -123.13 -54.52 1.8 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -87.57 77.7 8.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.9 mt -61.82 -51.37 73.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 125.472 1.509 . . . . 0.0 108.666 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -57.5 -35.29 70.04 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.047 0.939 . . . . 0.0 112.41 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.34 -23.48 70.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.172 0.897 . . . . 0.0 112.115 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.5 m -118.84 60.5 4.64 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 119.007 1.404 . . . . 0.0 110.824 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.4 138.58 51.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.678 2.252 . . . . 0.0 110.722 -167.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 -9.16 27.88 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.893 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.54 146.19 44.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.152 1.476 . . . . 0.0 108.728 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.73 162.12 27.34 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.734 1.214 . . . . 0.0 112.155 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.69 149.58 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.476 -0.765 . . . . 0.0 109.845 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 14.13 58.06 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.363 -0.836 . . . . 0.0 113.916 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.3 129.68 36.18 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.169 1.484 . . . . 0.0 108.37 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.445 ' CD1' ' HG1' ' A' ' 32' ' ' THR . 4.4 tp -76.64 133.4 39.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 mt -95.18 125.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.529 1.132 . . . . 0.0 109.293 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -112.71 -51.94 5.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.845 1.258 . . . . 0.0 110.713 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.28 153.32 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.416 0.686 . . . . 0.0 109.558 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.68 134.85 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 161.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 35.89 57.11 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.702 2.001 . . . . 0.0 113.774 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 59.0 24.47 12.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.483 1.113 . . . . 0.0 112.856 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -117.39 120.59 38.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.904 2.482 . . . . 0.0 106.323 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 126.31 28.17 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.22 -3.42 5.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -9.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 169.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.79 -8.27 14.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.303 1.41 . . . . 0.0 112.222 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.7 mt -77.57 158.6 29.76 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.534 0.734 . . . . 0.0 111.856 -172.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.75 148.69 46.09 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.644 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 3.1 t60 -54.86 -22.86 16.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.333 1.453 . . . . 0.0 112.241 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -79.45 -17.24 54.66 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.912 -1.743 . . . . 0.0 112.805 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -87.66 -51.4 5.91 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.325 -1.484 . . . . 0.0 108.105 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.644 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 2.5 m -49.24 -38.19 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 131.558 3.943 . . . . 0.0 112.776 166.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -63.56 -54.5 31.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.775 0.83 . . . . 0.0 109.53 170.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.84 -40.79 89.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.746 0.654 . . . . 0.0 111.095 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.15 -45.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 125.837 1.655 . . . . 0.0 110.996 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.75 -33.86 76.59 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.933 -0.479 . . . . 0.0 110.949 174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -68.24 -34.85 76.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.287 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -74.14 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 173.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.6 m -59.47 141.71 87.72 Favored Pre-proline 0 CA--C 1.536 0.438 0 O-C-N 120.444 -1.41 . . . . 0.0 109.342 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.19 125.79 14.64 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 123.536 2.824 . . . . 0.0 110.594 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.9 mt -58.98 135.59 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.91 85.25 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.823 1.202 . . . . 0.0 113.268 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 t -103.64 147.76 26.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -66.98 142.33 57.29 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 165.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.9 m -127.49 132.55 49.97 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.772 2.829 . . . . 0.0 105.591 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -88.04 130.26 35.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mp -130.6 149.53 52.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mt -128.82 123.5 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 172.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -111.49 152.71 13.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.037 1.335 . . . . 0.0 107.552 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -88.07 106.17 17.97 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--O 1.234 0.251 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.5 mtm -88.98 155.91 19.2 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.8 m -134.78 108.91 8.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.0 mt -98.77 169.23 9.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.547 2.339 . . . . 0.0 107.532 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -135.25 151.38 50.54 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.315 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.9 pt -144.35 128.28 12.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.17 1.388 . . . . 0.0 110.249 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 120.92 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 123.523 1.63 . . . . 0.0 109.291 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -57.66 118.23 5.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.034 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.36 -75.49 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.29 165.87 30.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.599 0.699 . . . . 0.0 109.47 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 60.87 -16.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 129.191 2.996 . . . . 0.0 116.809 172.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.61 138.03 5.1 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -167.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -52.08 131.49 31.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.64 84.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.09 145.04 21.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.26 1.03 . . . . 0.0 110.995 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 p -107.27 156.43 18.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.13 149.16 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.446 0.641 . . . . 0.0 110.535 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -124.95 143.28 50.96 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.076 2.15 . . . . 0.0 108.087 -177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -89.12 87.12 7.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -171.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -70.39 167.29 27.44 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 124.64 1.176 . . . . 0.0 109.09 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.03 9.36 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.387 2.724 . . . . 0.0 112.968 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.63 -2.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -152.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.64 -169.1 22.52 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -166.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -87.52 142.08 28.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.012 -1.287 . . . . 0.0 109.188 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -124.19 162.81 22.86 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 123.49 0.716 . . . . 0.0 110.995 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.28 116.57 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -69.51 -68.71 0.39 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.995 1.318 . . . . 0.0 108.519 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -148.41 154.87 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.441 1.496 . . . . 0.0 107.26 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.0 mt -120.53 107.84 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.005 1.322 . . . . 0.0 108.222 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.2 -53.49 3.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.918 0.866 . . . . 0.0 109.971 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.18 74.45 7.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.0 mt -50.36 -48.81 24.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.748 1.219 . . . . 0.0 109.516 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -63.62 -37.88 88.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.588 -172.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.85 -5.15 60.57 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.694 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 40.9 m -131.08 71.9 81.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 120.191 1.996 . . . . 0.0 109.528 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.2 129.13 23.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.009 2.473 . . . . 0.0 111.136 -174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.59 -7.77 52.15 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.04 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.69 147.07 47.17 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.988 1.394 . . . . 0.0 109.26 -176.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.4 m -138.14 141.5 40.13 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.312 1.445 . . . . 0.0 107.297 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.58 158.39 27.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.47 47.53 56.75 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.815 -0.553 . . . . 0.0 111.729 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.44 -159.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.225 2.21 . . . . 0.0 109.595 152.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -154.95 110.18 3.07 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 160.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.18 134.8 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 120.785 1.63 . . . . 0.0 109.106 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.55 -50.29 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.806 1.243 . . . . 0.0 110.347 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -133.85 151.04 51.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.393 0.677 . . . . 0.0 109.427 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.4 mt -124.45 127.34 72.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 65.68 -36.96 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 131.027 3.731 . . . . 0.0 115.741 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.26 19.7 pt20 162.31 -7.54 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.796 3.638 . . . . 0.0 112.592 -171.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -99.84 142.25 31.57 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.79 -1.194 . . . . 0.0 109.502 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -72.73 137.74 46.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.808 1.243 . . . . 0.0 110.381 171.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.73 19.63 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 126.966 2.107 . . . . 0.0 108.394 -175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.99 -58.47 4.07 Favored 'General case' 0 C--N 1.343 0.316 0 O-C-N 120.382 -1.449 . . . . 0.0 109.994 171.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -67.7 -19.96 65.22 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.341 0.657 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.09 137.44 51.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.216 2.206 . . . . 0.0 111.744 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -60.61 156.4 16.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.198 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -46.98 -51.14 17.82 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.0 0.92 . . . . 0.0 110.192 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -55.82 -35.59 66.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.198 2.599 . . . . 0.0 111.669 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.38 -50.06 49.58 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.848 1.259 . . . . 0.0 107.613 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.3 t -63.55 -39.31 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.593 0.757 . . . . 0.0 109.348 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.78 -51.96 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.457 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -66.86 -33.49 75.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.433 0.56 . . . . 0.0 112.1 -170.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.94 -52.28 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 124.043 0.937 . . . . 0.0 109.584 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.07 -35.75 81.29 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.008 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 43.9 mtmt -59.38 -48.56 81.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 121.189 1.813 . . . . 0.0 111.38 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.5 -33.28 74.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.618 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 97.0 m -46.7 125.29 8.01 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.06 0.944 . . . . 0.0 110.087 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -58.17 145.31 93.14 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.685 2.924 . . . . 0.0 109.991 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.7 mm -72.63 139.66 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.856 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.84 75.59 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.05 1.31 . . . . 0.0 113.352 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -99.27 128.19 45.37 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.784 1.292 . . . . 0.0 108.152 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.19 139.63 58.47 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.9 m -124.17 125.93 45.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 m -88.68 122.47 32.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.79 112.67 19.12 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.13 131.51 33.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 169.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.36 150.75 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 109.815 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -81.26 113.88 19.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.829 0.852 . . . . 0.0 109.685 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 . . . . . 0 C--O 1.235 0.317 0 C-N-CA 125.106 1.363 . . . . 0.0 107.709 171.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.9 mtm -142.18 148.17 37.78 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.484 1.514 . . . . 0.0 107.914 153.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -99.7 142.47 31.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 165.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -138.1 160.79 38.47 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.717 1.607 . . . . 0.0 106.791 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -130.8 144.8 51.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.5 pt -138.69 152.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 125.351 1.46 . . . . 0.0 110.442 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.91 98.34 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.236 1.014 . . . . 0.0 109.641 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 52.1 tttt -43.58 112.41 0.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.574 2.35 . . . . 0.0 111.1 177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -67.52 1.88 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.72 150.77 3.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.458 1.503 . . . . 0.0 108.557 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 40.9 57.49 2.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.105 1.362 . . . . 0.0 110.813 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.427 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 76.99 -144.16 29.57 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -112.46 160.17 18.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.516 1.526 . . . . 0.0 108.084 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.04 7.73 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 124.4 1.0 . . . . 0.0 110.615 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -58.56 170.25 0.79 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.346 1.069 . . . . 0.0 111.093 172.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -132.73 159.08 40.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.529 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 pt -118.78 141.83 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.268 1.032 . . . . 0.0 109.031 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.04 133.56 43.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 127.232 2.213 . . . . 0.0 105.77 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 141.85 50.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 163.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -128.9 169.84 12.09 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.47 1.508 . . . . 0.0 108.216 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.63 4.14 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.127 3.218 . . . . 0.0 113.452 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.1 p -131.55 -27.49 1.94 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.543 1.065 . . . . 0.0 112.115 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.26 -166.1 37.44 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -83.65 137.96 33.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -128.34 162.78 26.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 126.888 2.075 . . . . 0.0 107.466 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -77.91 123.38 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -75.36 -70.57 0.41 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -149.13 158.45 44.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.37 0.986 . . . . 0.0 109.049 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.0 mt -117.46 120.65 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.2 mt -105.21 -17.67 14.39 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.265 1.426 . . . . 0.0 111.008 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -142.22 82.78 1.8 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.702 2.001 . . . . 0.0 106.548 -162.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.59 -36.56 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.931 1.292 . . . . 0.0 110.682 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.43 -26.11 65.36 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.034 -1.041 . . . . 0.0 113.11 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.2 -11.74 71.33 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.708 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.03 67.15 6.31 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.588 1.694 . . . . 0.0 110.678 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.7 130.15 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.838 2.359 . . . . 0.0 109.849 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.68 -5.96 72.01 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.202 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 tp -77.79 142.73 38.45 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.493 1.146 . . . . 0.0 109.091 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.4 m -132.21 159.36 39.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.811 1.245 . . . . 0.0 109.554 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.51 144.29 57.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 -1.0 84.22 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.585 -1.675 . . . . 0.0 114.446 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -63.62 106.33 0.94 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.44 1.62 . . . . 0.0 110.005 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.86 126.04 28.48 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.695 1.598 . . . . 0.0 109.571 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.57 144.58 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 109.208 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.42 -43.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 126.293 1.837 . . . . 0.0 108.847 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -136.12 153.59 51.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.579 0.752 . . . . 0.0 110.161 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.549 HG23 ' H ' ' A' ' 58' ' ' ASN . 6.8 mt -111.41 -157.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 167.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.549 ' H ' HG23 ' A' ' 57' ' ' ILE . 85.7 m-20 -53.25 76.56 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.268 2.227 . . . . 0.0 110.92 168.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 55.76 38.97 30.74 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.182 1.393 . . . . 0.0 111.989 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.75 125.82 38.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.834 1.654 . . . . 0.0 107.212 162.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.35 114.77 22.67 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.417 1.487 . . . . 0.0 108.141 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.2 m -117.47 6.61 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -163.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -53.48 -19.88 4.16 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -114.96 -10.09 12.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.064 1.346 . . . . 0.0 112.116 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.2 mt -68.11 147.15 52.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.977 0.894 . . . . 0.0 108.635 175.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.4 m -74.76 164.68 26.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.419 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -48.08 -56.3 8.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.644 0.777 . . . . 0.0 109.535 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.9 m -60.85 -28.76 69.08 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.958 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.68 -45.97 27.54 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.13 1.372 . . . . 0.0 110.73 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.25 -41.51 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.11 -43.0 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.137 0.975 . . . . 0.0 109.225 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.75 89.76 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.853 1.261 . . . . 0.0 110.722 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.81 -51.33 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.035 0.934 . . . . 0.0 108.76 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.438 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 29.9 mt -62.9 -26.4 68.77 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.757 -0.589 . . . . 0.0 111.729 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -68.92 -40.31 79.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.305 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.58 -33.88 75.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.527 1.058 . . . . 0.0 113.193 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.8 m -49.62 134.25 19.3 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.778 1.231 . . . . 0.0 111.563 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.13 121.47 8.63 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.234 3.289 . . . . 0.0 111.777 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.16 124.13 11.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.206 1.402 . . . . 0.0 107.742 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.19 14.92 70.59 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.24 -0.756 . . . . 0.0 113.208 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.4 m -115.62 147.94 40.22 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 118.655 1.227 . . . . 0.0 108.165 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.98 141.18 58.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.885 1.274 . . . . 0.0 108.487 171.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -128.89 124.9 36.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.081 1.753 . . . . 0.0 106.419 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -89.46 128.74 36.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 mp -133.46 158.28 43.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.1 130.83 73.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.0 148.25 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.715 1.206 . . . . 0.0 110.18 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -82.99 84.71 7.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.716 0.807 . . . . 0.0 109.502 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.518 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 C--O 1.239 0.501 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 31.6 mtm -92.53 113.84 26.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.742 0.701 . . . . 0.0 109.292 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -82.95 129.07 34.98 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -145.7 142.56 29.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.685 1.594 . . . . 0.0 107.641 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -125.08 140.18 53.13 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.965 . . . . 0.0 110.665 -166.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 pt -129.51 158.29 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.174 1.389 . . . . 0.0 111.03 -172.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -128.14 116.79 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.858 1.263 . . . . 0.0 108.516 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 55.6 tttt -75.26 104.81 5.98 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.571 1.148 . . . . 0.0 109.915 -174.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.76 -67.63 1.87 Allowed Glycine 0 CA--C 1.523 0.564 0 CA-C-O 119.703 -0.498 . . . . 0.0 112.599 -169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 -70.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.514 0.657 . . . . 0.0 111.243 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -78.11 72.0 4.62 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.023 1.329 . . . . 0.0 107.922 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 61.6 -149.75 45.84 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -83.51 1.41 42.03 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 167.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.53 -63.14 1.48 Allowed Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.761 -1.212 . . . . 0.0 111.623 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -52.58 155.14 2.3 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.028 1.414 . . . . 0.0 111.765 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -122.17 157.38 31.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.0 107.915 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.38 174.68 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 109.232 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.13 165.18 14.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.496 1.918 . . . . 0.0 107.513 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 141.01 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 151.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.64 154.92 60.16 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.58 16.06 1.5 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.292 2.661 . . . . 0.0 113.983 -160.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.469 ' HG1' HD22 ' A' ' 53' ' ' LEU . 2.4 p -144.63 4.04 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.768 1.627 . . . . 0.0 112.092 -160.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.76 169.48 21.72 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -156.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -77.08 160.77 28.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.995 0.897 . . . . 0.0 111.856 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -131.48 146.46 52.25 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.64 127.07 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -100.73 -52.54 3.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.376 1.07 . . . . 0.0 109.862 -173.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -150.39 133.9 16.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.05 128.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -118.43 9.29 12.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.409 1.083 . . . . 0.0 110.509 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.55 81.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 42' ' ' ILE . 3.5 mp -59.2 -60.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 124.834 1.253 . . . . 0.0 109.073 -166.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.81 -9.99 59.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.14 -38.15 94.94 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 164.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 80.4 m -123.31 67.07 34.87 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.47 0.708 . . . . 0.0 111.96 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.88 142.56 93.71 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.216 1.944 . . . . 0.0 109.641 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.22 -31.66 3.72 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 117.984 -1.453 . . . . 0.0 113.065 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -63.9 147.34 52.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.204 1.502 . . . . 0.0 110.387 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.6 m -137.08 168.95 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.342 1.857 . . . . 0.0 109.421 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.53 146.23 31.41 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.218 -0.926 . . . . 0.0 110.598 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.63 -3.16 80.17 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.132 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -55.59 115.83 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.403 1.481 . . . . 0.0 108.211 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' HG1' ' A' ' 32' ' ' THR . 2.8 tm? -75.26 98.13 3.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.56 119.73 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.525 1.53 . . . . 0.0 108.229 177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.18 -52.15 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.038 1.735 . . . . 0.0 109.123 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.03 143.65 44.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.879 1.272 . . . . 0.0 108.543 -169.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.7 mt -131.21 134.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.961 1.304 . . . . 0.0 107.574 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 39.95 47.99 2.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.787 2.035 . . . . 0.0 110.402 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 66.41 13.19 9.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.261 1.425 . . . . 0.0 112.79 171.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.01 130.18 46.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.884 1.673 . . . . 0.0 107.828 167.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -58.21 123.87 17.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.994 0.918 . . . . 0.0 110.476 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.29 -3.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 118.176 -0.916 . . . . 0.0 113.251 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -54.21 -37.03 64.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.48 1.491 . . . . 0.0 112.502 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -97.51 2.28 49.97 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.327 1.051 . . . . 0.0 111.649 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.7 mt -87.5 160.77 18.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.155 0.982 . . . . 0.0 108.894 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 152.26 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -41.14 -52.51 3.27 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.675 1.59 . . . . 0.0 111.715 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.5 m -56.97 -42.28 79.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.149 1.379 . . . . 0.0 112.224 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -64.19 -38.22 90.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -69.8 -51.47 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.567 0.747 . . . . 0.0 109.473 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.86 -38.03 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.172 1.389 . . . . 0.0 110.268 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.41 -34.47 70.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.048 0.842 . . . . 0.0 111.97 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -54.31 -60.3 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.5 -31.61 64.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 174.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.07 -50.94 68.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 121.109 1.777 . . . . 0.0 108.736 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.68 -35.28 75.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.14 0.976 . . . . 0.0 111.455 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 50.6 m -56.64 144.28 65.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.574 0.749 . . . . 0.0 112.704 -169.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.36 123.44 10.24 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.454 3.436 . . . . 0.0 112.311 -172.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mm -59.29 131.58 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.5 26.57 72.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.462 1.029 . . . . 0.0 112.988 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -103.84 157.44 17.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 154.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.83 152.69 30.92 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.196 152.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.2 m -139.97 125.68 19.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -89.36 119.44 29.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -166.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.27 154.94 35.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.04 129.81 54.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pp -119.69 167.39 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 108.122 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.29 -120.32 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 110.93 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 126.508 1.923 . . . . 0.0 110.791 175.659 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mtm -113.92 154.73 27.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.004 0.922 . . . . 0.0 109.309 168.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.9 m -131.06 134.58 46.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.31 167.73 22.15 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.035 1.734 . . . . 0.0 108.62 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -122.97 153.06 40.26 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -139.9 155.39 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.203 1.801 . . . . 0.0 110.013 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.26 99.31 4.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.011 1.725 . . . . 0.0 107.968 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 53.2 tttt -53.64 109.17 0.42 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.268 2.227 . . . . 0.0 111.617 -174.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.35 33.44 4.32 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.15 1.357 . . . . 0.0 115.862 -163.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . 59.56 162.41 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.387 2.275 . . . . 0.0 113.69 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 52.32 -10.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.249 1.82 . . . . 0.0 114.854 -153.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 147.39 -155.58 26.57 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.96 152.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 153.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.57 -56.0 26.83 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -54.75 159.94 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.488 1.137 . . . . 0.0 111.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.5 p -128.65 161.44 29.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.882 1.673 . . . . 0.0 108.368 -172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.2 162.97 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 122.066 0.936 . . . . 0.0 109.758 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.98 146.97 39.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.017 1.327 . . . . 0.0 107.864 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.57 136.01 47.26 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.253 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 p -133.74 165.72 34.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.61 -12.74 35.54 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.085 1.857 . . . . 0.0 112.574 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.435 ' HG1' ' CD1' ' A' ' 53' ' ' LEU . 7.5 p -109.36 5.63 23.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.44 1.496 . . . . 0.0 111.817 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.0 -159.47 15.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -165.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -87.44 152.58 22.12 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.274 -1.133 . . . . 0.0 110.274 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -120.51 158.93 26.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 109.552 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.33 119.09 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -69.06 -68.89 0.37 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 171.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -151.98 151.89 31.78 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -174.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.26 92.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.4 mt -82.78 -18.44 40.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.117 1.367 . . . . 0.0 112.162 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -124.06 91.58 3.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.04 -29.21 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.499 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -73.65 -60.25 2.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.631 0.772 . . . . 0.0 110.003 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -5.01 87.68 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 123.694 0.664 . . . . 0.0 112.663 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.0 m -120.02 66.18 10.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.976 1.388 . . . . 0.0 107.759 165.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.38 146.58 56.78 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.624 2.216 . . . . 0.0 110.404 -170.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.14 -7.89 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.941 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 tt -73.86 132.81 42.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.7 m -110.98 155.02 23.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 123.416 1.579 . . . . 0.0 110.415 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.35 148.38 51.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.579 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.18 8.83 12.77 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 117.841 -1.533 . . . . 0.0 116.098 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -59.98 139.45 57.42 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.8 1.8 . . . . 0.0 109.219 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.435 ' CD1' ' HG1' ' A' ' 32' ' ' THR . 4.3 tp -91.75 129.39 37.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.862 1.665 . . . . 0.0 110.34 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mt -81.66 130.1 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.844 0.858 . . . . 0.0 110.598 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -116.25 -55.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.265 1.826 . . . . 0.0 109.205 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -125.29 152.92 44.03 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.55 135.08 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 157.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 33.57 56.66 0.54 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.411 2.685 . . . . 0.0 113.351 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 61.29 25.92 15.83 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -121.51 129.49 52.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 170.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -72.46 126.62 30.3 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.277 0.631 . . . . 0.0 111.018 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 m -128.76 17.47 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.98 0.912 . . . . 0.0 112.272 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.8 -15.98 62.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.931 -1.106 . . . . 0.0 112.196 173.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.33 17.32 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.429 1.892 . . . . 0.0 110.664 -169.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.7 mt -110.66 147.19 34.83 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.095 -1.003 . . . . 0.0 111.173 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.1 m -75.12 147.5 40.47 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 117.173 -1.394 . . . . 0.0 108.115 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.587 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 70.1 t60 -42.99 -34.21 0.95 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.774 2.029 . . . . 0.0 113.943 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.69 -34.01 76.91 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 120.969 -1.082 . . . . 0.0 112.208 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.02 -49.09 16.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.248 2.219 . . . . 0.0 110.748 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -59.4 -42.62 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 1 C-N-CA 132.589 4.355 . . . . 0.0 111.896 172.518 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.6 -50.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 167.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.51 -40.97 93.34 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.603 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mt -59.34 -50.68 78.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.949 1.3 . . . . 0.0 109.918 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -60.94 -28.87 69.28 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.876 -0.515 . . . . 0.0 110.144 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -72.77 -42.19 64.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.672 -1.268 . . . . 0.0 109.632 174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -68.32 -16.49 63.97 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.39 1.45 . . . . 0.0 112.852 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -60.61 140.49 92.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 O-C-N 121.17 -0.956 . . . . 0.0 110.004 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -58.62 142.92 98.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.609 3.54 . . . . 0.0 111.501 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.07 136.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 159.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.22 51.47 54.71 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 123.293 0.37 . . . . 0.0 112.358 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.2 m -150.03 151.49 33.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -61.89 102.31 0.26 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.862 1.265 . . . . 0.0 109.461 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.6 m -83.04 146.11 28.91 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 160.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.6 m -120.56 131.2 54.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mp -127.04 149.93 49.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.87 126.11 73.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.58 154.48 27.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.004 0.907 . . . . 0.0 110.814 -175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -91.25 80.24 5.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.514 -170.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.941 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.102 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -123.19 -56.49 1.73 Allowed 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 118.914 1.357 . . . . 0.0 108.319 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m 44.3 -141.79 0.22 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.779 0.831 . . . . 0.0 111.287 -167.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.84 51.96 0.4 Allowed Glycine 0 C--N 1.332 0.336 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -158.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 p -140.83 169.68 17.18 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 158.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -130.7 165.09 23.62 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.29 126.22 0.94 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 104.656 -3.378 . . . . 0.0 104.656 -170.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.93 157.13 42.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 117.379 0.59 . . . . 0.0 110.096 -167.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.55 -176.21 5.31 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.846 1.658 . . . . 0.0 108.701 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -139.36 105.72 5.28 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -101.18 153.49 19.56 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.319 0.647 . . . . 0.0 109.568 -160.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtm -89.07 113.88 25.06 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.734 -169.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.5 m -78.1 137.31 38.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 159.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -131.42 161.77 31.71 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -119.81 144.89 47.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.7 pt -138.89 162.81 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.368 1.467 . . . . 0.0 109.333 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.4 t -132.14 137.28 55.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.894 0.854 . . . . 0.0 108.713 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -97.62 85.56 3.62 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 121.883 -0.511 . . . . 0.0 111.569 -166.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.32 -69.25 1.23 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.579 0.609 . . . . 0.0 114.445 -166.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.64 -62.41 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.247 1.419 . . . . 0.0 109.183 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -65.1 6.4 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.997 2.519 . . . . 0.0 114.653 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.63 71.6 1.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 63.54 173.06 0.17 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.499 1.919 . . . . 0.0 111.188 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.54 49.1 0.87 Allowed Glycine 0 C--O 1.222 -0.605 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -157.97 163.55 37.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.7 p -121.17 161.75 21.32 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.381 1.072 . . . . 0.0 108.805 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 pt -123.34 162.94 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.061 0.934 . . . . 0.0 110.132 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.77 140.31 40.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 107.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.75 121.04 18.22 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 p -110.2 168.47 7.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -64.97 -10.52 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.507 1.471 . . . . 0.0 112.224 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 p -114.58 7.2 16.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 112.758 -170.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.52 -172.5 15.76 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -171.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -77.07 149.98 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.666 -0.902 . . . . 0.0 108.751 174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -130.17 164.02 25.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.588 1.155 . . . . 0.0 108.498 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.52 122.39 22.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -73.99 -62.33 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -154.66 145.58 22.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.19 136.64 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.7 mt -119.63 -8.94 9.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 111.313 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -155.81 108.51 2.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.362 2.265 . . . . 0.0 106.842 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.97 -53.7 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.16 0.984 . . . . 0.0 110.07 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -72.86 -4.19 30.31 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.065 -1.022 . . . . 0.0 112.521 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.77 -16.17 79.31 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.15 -0.969 . . . . 0.0 111.797 163.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.7 p -150.23 57.99 2.9 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 118.956 1.378 . . . . 0.0 113.541 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.27 112.32 1.53 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.342 2.028 . . . . 0.0 111.534 -170.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.75 -5.96 37.57 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.514 1.53 . . . . 0.0 113.62 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.81 139.37 41.72 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.377 1.589 . . . . 0.0 109.795 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.8 m -123.82 9.84 8.88 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 66.2 152.3 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.056 2.142 . . . . 0.0 112.784 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.88 -3.0 0.17 Allowed Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.896 1.236 . . . . 0.0 115.31 -170.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.98 158.43 19.34 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.286 2.043 . . . . 0.0 109.718 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.86 114.11 26.85 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.626 1.57 . . . . 0.0 109.978 -161.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.1 mt -65.26 129.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.812 1.245 . . . . 0.0 109.298 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.78 -51.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.429 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.5 145.54 51.87 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.834 1.652 . . . . 0.0 109.873 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.6 mt -125.06 122.26 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 45.05 42.26 6.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.264 1.426 . . . . 0.0 111.656 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 65.76 8.39 5.22 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.177 1.391 . . . . 0.0 113.609 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -77.68 138.6 39.16 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.641 -1.287 . . . . 0.0 108.031 163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.67 116.86 22.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.672 2.389 . . . . 0.0 108.33 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.53 13.61 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 125.449 1.5 . . . . 0.0 112.016 -169.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.44 -55.41 35.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 118.319 -2.738 . . . . 0.0 112.562 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -81.45 -6.77 59.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.596 0.758 . . . . 0.0 111.095 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.46 135.17 55.81 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.28 1.832 . . . . 0.0 111.203 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -63.41 160.81 15.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.037 171.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -48.77 -49.57 38.01 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.25 0.62 . . . . 0.0 111.012 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -42.92 73.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.043 1.737 . . . . 0.0 112.227 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.442 1.497 . . . . 0.0 108.069 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.22 -43.76 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 110.617 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.33 -42.58 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 124.26 1.024 . . . . 0.0 109.926 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -44.47 91.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.183 0.993 . . . . 0.0 110.156 -176.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.04 -44.48 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.519 -0.738 . . . . 0.0 109.146 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.5 -23.73 66.96 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.57 -0.706 . . . . 0.0 111.571 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -72.95 -42.92 62.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.943 1.247 . . . . 0.0 109.977 171.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -55.55 -35.45 65.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.109 0.868 . . . . 0.0 110.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 81.9 m -54.67 138.8 61.38 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.3 141.14 55.52 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.827 3.685 . . . . 0.0 110.814 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mm -70.86 142.28 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.97 -2.08 28.16 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.446 1.974 . . . . 0.0 113.385 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.4 m -103.01 165.02 11.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.076 1.35 . . . . 0.0 107.862 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -69.21 153.35 43.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 123.128 1.442 . . . . 0.0 111.216 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -140.6 141.46 35.16 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.061 2.144 . . . . 0.0 105.653 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 m -112.62 115.9 29.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.04 153.01 28.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mt -126.55 122.41 60.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.72 164.14 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.708 0.803 . . . . 0.0 110.764 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -84.13 124.02 30.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.383 0.673 . . . . 0.0 111.13 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -153.95 175.59 13.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 108.471 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.24 82.37 0.07 OUTLIER Glycine 0 C--N 1.336 0.557 0 C-N-CA 126.542 2.02 . . . . 0.0 113.708 168.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -67.8 -54.17 21.19 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.983 0.892 . . . . 0.0 110.51 167.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.51 163.89 32.29 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.7 1.136 . . . . 0.0 111.789 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.27 128.33 9.66 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.319 2.013 . . . . 0.0 110.689 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.82 118.23 0.94 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 167.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.9 m 46.85 48.12 15.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.404 1.481 . . . . 0.0 112.017 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.273 0 CA-C-O 117.877 -1.513 . . . . 0.0 109.493 -177.12 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.519 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m 52.67 48.12 23.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.61 1.164 . . . . 0.0 112.685 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.1 t -60.69 164.66 4.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.395 1.078 . . . . 0.0 110.553 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.66 178.68 53.87 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 153.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m 66.19 117.68 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.239 1.816 . . . . 0.0 113.045 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 m -72.54 82.97 1.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 170.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.89 -72.99 0.72 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -165.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -67.24 145.64 54.99 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.411 0.624 . . . . 0.0 110.329 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.24 -8.71 0.2 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.673 1.189 . . . . 0.0 112.603 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.46 109.34 0.87 Allowed 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.905 2.882 . . . . 0.0 110.435 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.36 161.11 17.52 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.505 1.922 . . . . 0.0 109.124 165.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 mtm -88.78 150.06 23.12 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.9 m -116.04 148.29 40.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -145.46 168.3 20.88 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 128.62 2.768 . . . . 0.0 107.457 -172.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.12 153.97 51.03 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.247 -0.908 . . . . 0.0 108.591 170.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 pt -134.07 167.38 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 126.461 1.905 . . . . 0.0 109.227 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.7 139.67 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.24 152.56 40.98 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.09 74.72 0.28 Allowed Glycine 0 C--O 1.238 0.377 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.27 -166.92 0.08 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.051 1.34 . . . . 0.0 111.157 -167.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 40.47 9.7 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 131.579 3.952 . . . . 0.0 118.643 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.16 67.93 1.86 Allowed Glycine 0 N--CA 1.445 -0.736 0 O-C-N 120.65 -1.281 . . . . 0.0 110.553 -165.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 63.75 174.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.227 2.211 . . . . 0.0 111.544 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.81 34.96 4.95 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.545 1.545 . . . . 0.0 110.233 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -140.89 167.03 23.17 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 p -129.96 151.38 50.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.6 pt -114.22 144.96 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.77 131.36 46.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.09 144.41 50.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.6 p -138.57 167.0 21.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 127.676 2.391 . . . . 0.0 105.567 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.71 -36.45 97.13 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 p -79.0 -28.39 43.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.576 1.95 . . . . 0.0 111.684 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.99 -134.34 4.79 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -162.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -106.63 147.2 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.952 . . . . 0.0 110.094 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -146.78 161.13 41.28 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.234 1.014 . . . . 0.0 108.342 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -77.26 114.49 17.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -63.37 -61.36 2.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.105 1.362 . . . . 0.0 108.759 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -157.08 154.23 29.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.86 114.25 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.9 mt -87.63 -25.11 23.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.798 0.839 . . . . 0.0 110.106 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -150.1 96.15 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.011 1.724 . . . . 0.0 107.598 -169.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 mt -60.47 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 109.949 -166.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -64.12 -12.39 39.0 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.48 -34.96 63.22 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 119.232 0.924 . . . . 0.0 111.426 170.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.3 m -126.87 67.64 69.19 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.467 1.107 . . . . 0.0 108.703 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.55 132.92 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.38 2.053 . . . . 0.0 109.124 -172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.05 -3.4 71.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.259 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.94 135.08 49.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.22 1.51 . . . . 0.0 107.003 166.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.7 m -137.17 131.69 32.88 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.85 153.47 41.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.245 0.618 . . . . 0.0 111.89 -163.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.94 37.14 93.92 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -166.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.48 -173.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.081 1.352 . . . . 0.0 110.389 160.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.38 122.45 20.25 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 154.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.7 mt -69.52 129.51 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.28 -58.08 2.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.521 1.128 . . . . 0.0 111.425 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -136.61 131.67 34.05 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.19 127.24 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 45.55 38.56 4.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.105 1.762 . . . . 0.0 111.575 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 61.1 18.47 9.04 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.14 1.776 . . . . 0.0 114.056 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -92.49 135.52 33.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 156.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -80.83 138.62 36.22 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.227 0.536 . . . . 0.0 110.067 173.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.89 10.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 126.35 1.86 . . . . 0.0 108.347 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -24.51 66.99 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 119.265 -2.147 . . . . 0.0 112.477 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.55 -13.01 16.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.137 0.88 . . . . 0.0 110.598 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -59.38 127.73 33.57 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 126.366 1.866 . . . . 0.0 111.67 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.09 162.11 3.65 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.362 1.039 . . . . 0.0 110.316 176.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -49.85 -48.33 51.18 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.169 0.588 . . . . 0.0 109.989 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -58.38 -36.13 73.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.724 1.21 . . . . 0.0 111.848 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.45 -47.71 54.08 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.198 1.399 . . . . 0.0 107.818 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.03 -46.48 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.937 0.895 . . . . 0.0 109.462 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.07 -42.83 91.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.886 0.874 . . . . 0.0 110.851 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -30.73 70.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.42 0.688 . . . . 0.0 111.914 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.25 -40.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.6 mt -62.03 -27.59 68.99 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.001 -1.062 . . . . 0.0 110.773 172.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -69.6 -29.91 67.54 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.653 -1.279 . . . . 0.0 111.863 172.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.72 -22.45 53.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.213 0.915 . . . . 0.0 111.24 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.57 132.88 91.24 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 118.974 0.806 . . . . 0.0 110.476 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.19 132.45 46.95 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.526 2.818 . . . . 0.0 109.595 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -72.13 106.84 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.85 6.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.059 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -136.09 163.34 30.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 118.839 1.32 . . . . 0.0 109.736 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.31 143.65 57.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.28 1.038 . . . . 0.0 111.025 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -131.03 135.17 47.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.478 1.911 . . . . 0.0 105.929 171.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 m -111.5 128.38 55.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -164.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -129.23 137.09 50.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -112.15 129.94 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.81 145.61 35.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 109.711 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -76.04 99.84 4.73 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 109.679 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -152.53 148.74 27.74 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.58 -173.3 31.11 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 126.804 2.145 . . . . 0.0 108.436 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.17 114.35 7.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.74 0.77 . . . . 0.0 111.508 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.9 173.99 21.35 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 124.263 0.935 . . . . 0.0 113.369 163.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.6 116.76 4.11 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.689 2.259 . . . . 0.0 106.601 169.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.2 t -147.89 -63.17 0.26 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -167.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.2 m -80.35 160.08 25.54 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 153.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 CA-C-O 117.553 -1.693 . . . . 0.0 111.398 167.016 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.308 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -61.82 97.82 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.281 1.432 . . . . 0.0 108.471 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 t -66.66 154.32 40.89 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.79 90.45 0.55 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 m 72.77 -81.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.253 1.821 . . . . 0.0 110.101 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.1 t 62.52 150.3 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.393 2.277 . . . . 0.0 111.301 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.88 43.32 2.89 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.348 -0.845 . . . . 0.0 112.351 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -48.76 128.22 15.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.797 2.439 . . . . 0.0 110.56 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.98 173.75 16.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.451 1.901 . . . . 0.0 108.83 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -115.01 100.12 7.95 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.704 1.601 . . . . 0.0 106.825 171.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.91 161.9 23.01 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 mtm -106.7 118.03 35.61 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.771 0.796 . . . . 0.0 109.682 174.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.3 m -84.33 143.69 29.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.6 mt -143.87 168.08 20.8 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.089 2.156 . . . . 0.0 106.351 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.6 m -127.47 148.5 50.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.167 0.987 . . . . 0.0 109.169 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.7 pt -139.68 160.03 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.846 1.258 . . . . 0.0 111.126 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.1 t -129.06 113.69 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 123.011 1.386 . . . . 0.0 108.615 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.65 102.82 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.08 2.152 . . . . 0.0 108.643 168.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.83 -62.31 3.88 Favored Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.32 -62.44 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 109.225 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.0 51.35 0.5 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.42 2.288 . . . . 0.0 111.913 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.66 47.47 12.98 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.113 1.816 . . . . 0.0 113.597 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 84.9 -11.46 0.78 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 130.54 3.536 . . . . 0.0 113.72 174.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -60.6 1.95 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.86 1.209 . . . . 0.0 111.552 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -49.4 151.05 1.63 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.051 1.426 . . . . 0.0 110.38 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -125.18 159.48 31.43 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -171.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 pt -126.87 152.44 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.526 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.93 137.24 49.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.745 1.218 . . . . 0.0 109.453 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -71.65 124.46 24.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 126.064 1.745 . . . . 0.0 109.389 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 p -120.69 159.75 47.22 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -58.91 -28.87 88.74 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.388 2.725 . . . . 0.0 111.878 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 p -98.23 -5.63 32.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.238 2.615 . . . . 0.0 113.61 -168.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.59 173.72 17.11 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -76.72 145.52 38.62 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.411 -1.052 . . . . 0.0 109.461 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -129.15 151.07 50.23 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.25 108.44 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -66.72 -62.25 1.55 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -155.06 143.19 20.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -90.98 126.61 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 127.044 2.138 . . . . 0.0 106.211 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.7 mt -110.78 -17.95 13.24 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.319 0.648 . . . . 0.0 111.029 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -133.96 77.21 1.7 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.315 1.446 . . . . 0.0 108.165 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.53 -39.61 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.658 1.183 . . . . 0.0 111.222 -169.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -10.4 59.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.87 -15.9 66.61 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 119.27 0.941 . . . . 0.0 111.798 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 48.0 m -130.77 70.73 82.55 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 118.56 1.18 . . . . 0.0 109.91 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -60.42 121.56 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.758 2.972 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.85 71.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.687 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.58 144.81 56.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.325 1.562 . . . . 0.0 109.822 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.0 m -129.53 161.78 29.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.89 1.328 . . . . 0.0 110.444 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.56 136.17 57.76 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.449 1.5 . . . . 0.0 108.261 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.22 17.77 70.5 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.565 1.555 . . . . 0.0 115.044 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.76 101.42 0.64 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.16 1.98 . . . . 0.0 111.405 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.69 114.26 6.89 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.531 1.932 . . . . 0.0 111.09 -167.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.55 134.38 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.607 1.094 . . . . 0.0 110.545 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.9 t -119.55 -49.51 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.232 1.413 . . . . 0.0 110.062 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.89 146.11 49.97 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.545 0.688 . . . . 0.0 109.549 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -121.29 135.58 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 153.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 32.28 54.42 0.33 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.638 2.375 . . . . 0.0 113.306 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 47.78 4.49 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 130.421 3.488 . . . . 0.0 118.813 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -26.16 67.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.059 1.754 . . . . 0.0 113.055 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 65.88 126.42 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 130.299 3.44 . . . . 0.0 111.336 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.87 20.78 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.644 1.978 . . . . 0.0 108.49 -163.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -59.94 4.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 119.5 -2.0 . . . . 0.0 112.343 173.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -76.89 -12.17 59.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.159 0.583 . . . . 0.0 111.794 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -56.93 131.6 50.16 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 126.119 1.768 . . . . 0.0 110.396 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 160.14 15.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.474 174.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -43.24 -50.85 6.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.834 0.854 . . . . 0.0 110.53 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.1 m -60.39 -32.72 71.58 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.814 0.846 . . . . 0.0 112.016 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.39 -45.25 60.56 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.23 -38.22 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.402 0.681 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.9 -52.07 65.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.049 1.34 . . . . 0.0 109.743 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.23 -39.6 93.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.618 1.167 . . . . 0.0 109.942 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.2 mt -56.92 -55.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.65 1.18 . . . . 0.0 110.14 169.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.8 -21.98 66.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.411 0.551 . . . . 0.0 111.604 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -70.66 -40.82 72.79 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.543 -1.348 . . . . 0.0 110.226 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -74.31 -21.7 59.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.921 0.889 . . . . 0.0 113.272 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.8 m -55.09 128.79 66.34 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 168.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -61.89 140.07 83.18 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.761 2.974 . . . . 0.0 111.689 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.01 117.28 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.68 49.65 5.32 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -145.63 155.49 43.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.939 -1.33 . . . . 0.0 108.681 160.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -70.17 129.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 168.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -101.89 142.75 32.7 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.524 1.529 . . . . 0.0 107.414 165.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -104.89 126.8 52.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.15 156.99 47.33 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.83 135.11 63.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.42 159.34 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 110.17 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -81.84 122.59 27.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.162 0.585 . . . . 0.0 110.826 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -141.61 -45.76 0.36 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.876 0.87 . . . . 0.0 111.738 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -48.95 136.4 19.81 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.659 1.123 . . . . 0.0 111.898 -176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 175.51 -41.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.219 2.208 . . . . 0.0 109.58 -166.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.61 -174.52 2.15 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.371 0.986 . . . . 0.0 112.668 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -82.68 65.58 8.12 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.264 2.643 . . . . 0.0 110.924 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 t 84.34 102.11 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.408 2.283 . . . . 0.0 109.206 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.5 t 50.83 39.89 23.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.343 1.057 . . . . 0.0 110.681 -173.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 116.392 -2.338 . . . . 0.0 110.945 179.294 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.37 155.93 45.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.101 1.361 . . . . 0.0 110.108 -170.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m 48.5 38.35 10.8 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.643 1.577 . . . . 0.0 114.114 170.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.14 -173.18 42.06 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.055 0.836 . . . . 0.0 113.44 -168.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -119.26 174.1 6.55 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.291 2.237 . . . . 0.0 110.127 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m 53.7 -171.0 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.446 1.099 . . . . 0.0 113.112 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.7 -92.87 0.49 Allowed Glycine 0 C--N 1.334 0.455 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 164.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.73 172.53 17.78 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.088 1.355 . . . . 0.0 108.248 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.51 154.97 38.43 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.571 1.148 . . . . 0.0 110.657 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -116.35 96.72 5.66 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.646 1.578 . . . . 0.0 106.999 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.39 162.69 32.33 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.543 1.537 . . . . 0.0 108.293 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.8 mtm -111.11 114.82 28.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.201 1.0 . . . . 0.0 109.07 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.1 m -83.72 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 168.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.5 mt -138.99 168.67 19.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.136 2.174 . . . . 0.0 107.258 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.7 m -123.09 149.85 43.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.9 pt -130.82 154.37 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.898 1.679 . . . . 0.0 108.637 165.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 104.6 3.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -68.85 118.09 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.998 1.719 . . . . 0.0 109.629 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.84 -63.29 2.22 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.176 0.893 . . . . 0.0 111.007 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.34 -58.11 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.396 1.078 . . . . 0.0 110.87 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -76.69 56.54 1.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.879 2.072 . . . . 0.0 110.138 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.76 61.59 2.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.178 1.371 . . . . 0.0 111.796 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 69.69 -71.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 126.988 2.115 . . . . 0.0 109.418 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.21 -52.4 0.66 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.09 158.68 1.05 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.647 1.213 . . . . 0.0 111.76 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.3 p -115.51 151.92 33.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.252 -173.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.1 159.92 16.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.96 129.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.146 2.578 . . . . 0.0 106.603 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.77 128.35 35.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 p -122.99 168.4 12.17 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.509 1.124 . . . . 0.0 108.081 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.01 -35.56 92.66 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.238 2.625 . . . . 0.0 110.595 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -82.37 6.81 15.88 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.221 2.209 . . . . 0.0 113.367 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.47 -157.02 18.35 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -84.76 141.45 30.52 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.788 -0.83 . . . . 0.0 110.176 -169.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -132.02 165.56 23.69 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.639 1.176 . . . . 0.0 108.74 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -89.38 124.44 42.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -73.71 -68.4 0.51 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.114 1.366 . . . . 0.0 108.663 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -155.06 137.93 15.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.1 mt -85.09 129.21 38.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 mt -108.57 -8.11 15.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.576 0.75 . . . . 0.0 111.225 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -149.64 114.17 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.44 -55.93 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.571 1.148 . . . . 0.0 110.055 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -57.16 -32.73 66.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.931 0.787 . . . . 0.0 110.889 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.04 75.03 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 123.413 0.53 . . . . 0.0 113.287 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.7 m -132.94 73.34 75.74 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 119.132 1.466 . . . . 0.0 111.159 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.95 110.55 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.718 1 C-N-CA 125.971 4.447 . . . . 0.0 115.671 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.82 55.25 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.061 -1.025 . . . . 0.0 113.446 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -55.73 152.92 8.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.769 2.027 . . . . 0.0 109.768 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 57.2 m -144.69 151.12 38.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.108 1.363 . . . . 0.0 111.515 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -60.39 142.65 54.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.693 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.52 10.3 48.31 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.886 -2.063 . . . . 0.0 114.712 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -53.86 115.96 2.28 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.614 1.707 . . . . 0.0 106.405 166.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.54 103.62 8.6 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.85 143.59 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.514 1.052 . . . . 0.0 109.043 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.8 t -130.46 -52.24 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.294 1.038 . . . . 0.0 110.021 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -130.05 145.72 51.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -126.49 125.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.45 38.99 11.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.153 2.181 . . . . 0.0 110.551 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 72.77 -1.42 3.01 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.956 2.102 . . . . 0.0 113.263 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -78.85 135.47 37.04 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.744 -1.222 . . . . 0.0 108.066 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -71.8 121.53 19.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.977 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.88 6.37 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 111.913 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -59.97 -45.12 93.73 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.289 1.404 . . . . 0.0 110.097 172.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -88.27 24.86 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.574 1.549 . . . . 0.0 111.384 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.83 140.62 52.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.483 1.513 . . . . 0.0 110.133 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.8 m -67.93 158.23 33.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.596 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -47.57 -51.55 20.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.057 0.943 . . . . 0.0 110.996 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.6 m -67.1 -27.03 67.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.828 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.8 -43.53 71.93 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.471 1.032 . . . . 0.0 108.965 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.1 -36.97 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.154 -0.966 . . . . 0.0 110.325 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.8 t -57.74 -47.72 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.58 0.752 . . . . 0.0 109.411 169.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.9 -30.61 69.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.022 0.915 . . . . 0.0 112.575 -172.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.4 mt -67.88 -48.15 76.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.21 -25.26 67.7 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.959 -1.088 . . . . 0.0 111.893 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -74.39 -35.33 63.48 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.345 -1.472 . . . . 0.0 110.808 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.68 -49.72 56.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.974 0.806 . . . . 0.0 108.944 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.7 m -42.03 115.33 1.5 Allowed Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.696 1.599 . . . . 0.0 112.376 -170.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.88 127.61 25.79 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.913 3.075 . . . . 0.0 107.391 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.73 141.09 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.43 16.19 48.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.805 1.669 . . . . 0.0 114.019 -171.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.8 t -87.28 160.68 18.33 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.691 1.745 . . . . 0.0 106.975 164.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.29 135.45 36.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.9 m -120.52 109.8 15.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -87.05 104.28 16.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.904 2.482 . . . . 0.0 108.474 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.29 160.27 14.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.394 0.543 . . . . 0.0 109.565 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.74 130.76 68.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.32 150.56 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.5 1.12 . . . . 0.0 108.853 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 116.98 22.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.041 1.736 . . . . 0.0 108.55 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -160.67 113.94 2.05 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.37 -98.11 0.16 Allowed Glycine 0 C--O 1.228 -0.25 0 N-CA-C 107.027 -2.429 . . . . 0.0 107.027 172.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 74.17 152.31 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 110.553 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.46 -164.99 12.81 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -167.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.8 6.63 4.02 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.626 3.55 . . . . 0.0 113.903 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.8 t 132.95 107.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 130.956 3.702 . . . . 0.0 106.175 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 80.4 142.57 0.07 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 127.807 2.443 . . . . 0.0 109.35 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -172.414 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.046 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -59.92 -55.31 35.64 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 158.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m 51.87 73.45 0.32 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.707 1.603 . . . . 0.0 110.748 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.83 94.32 0.17 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 171.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 p 54.32 117.64 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 129.284 3.033 . . . . 0.0 114.946 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.7 m -154.49 85.53 1.13 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.475 1.11 . . . . 0.0 109.559 168.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.77 170.21 22.79 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 167.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -144.15 164.54 30.4 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.308 1.843 . . . . 0.0 108.866 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 50.59 86.08 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.692 2.397 . . . . 0.0 111.636 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -150.31 101.26 2.97 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.7 mt 51.05 167.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 130.971 3.708 . . . . 0.0 115.728 -171.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.9 mtp -131.48 114.71 15.25 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.739 1.216 . . . . 0.0 108.383 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 m -78.27 142.77 37.58 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 164.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.2 mt -142.84 168.48 19.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.78 2.432 . . . . 0.0 107.006 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.86 155.6 37.75 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.14 -0.975 . . . . 0.0 108.731 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.3 pt -132.83 169.85 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 166.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 t -115.65 151.14 17.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 162.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 56.9 tttt -70.02 165.4 21.91 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.809 -1.182 . . . . 0.0 110.091 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -136.62 165.61 24.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.07 -24.25 60.65 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -165.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -75.89 12.86 0.97 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.222 1.374 . . . . 0.0 111.004 165.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.426 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 72.71 69.71 1.35 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.729 1.633 . . . . 0.0 109.817 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 77.0 168.08 0.24 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.69 2.796 . . . . 0.0 111.236 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.86 28.16 9.11 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.152 1.834 . . . . 0.0 111.71 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -138.45 172.92 12.18 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.2 p -131.01 146.8 52.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.134 1.374 . . . . 0.0 108.039 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.48 152.17 19.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -126.48 154.16 44.11 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.53 1.932 . . . . 0.0 108.032 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.06 128.62 36.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.538 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 p -121.79 159.01 52.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 11.33 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.037 3.158 . . . . 0.0 114.332 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.4 p -127.18 -6.1 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.38 0.991 . . . . 0.0 112.863 -168.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.56 170.0 12.6 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -160.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -72.95 151.44 41.85 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.497 -1.002 . . . . 0.0 110.0 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -139.63 161.04 38.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.835 0.826 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.0 t -78.39 122.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 125.547 1.539 . . . . 0.0 107.88 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -71.59 -55.93 6.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.608 162.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -162.24 146.13 12.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.244 0.474 . . . . 0.0 110.476 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.85 93.72 2.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.3 mt -70.57 -28.08 64.62 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.286 1.034 . . . . 0.0 109.945 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -136.78 91.09 2.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.214 1.406 . . . . 0.0 109.674 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.62 -41.57 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 123.67 0.788 . . . . 0.0 110.322 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -71.46 -5.16 30.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.128 -0.983 . . . . 0.0 113.13 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -23.47 28.04 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.636 1.107 . . . . 0.0 111.471 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.2 m -136.14 67.47 62.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 109.857 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 136.38 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.326 2.017 . . . . 0.0 111.75 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.82 -9.25 3.82 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.266 -1.296 . . . . 0.0 115.295 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.56 145.49 51.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.216 1.508 . . . . 0.0 108.956 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.9 m -110.94 147.24 35.07 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.93 0.892 . . . . 0.0 111.527 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.76 151.0 42.33 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.92 44.84 7.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.388 0.994 . . . . 0.0 111.805 -170.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.15 -174.99 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.65 1.98 . . . . 0.0 109.615 159.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.45 104.03 4.34 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 119.801 -1.812 . . . . 0.0 106.665 163.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.13 131.47 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.24 -50.37 4.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.129 1.372 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -136.53 143.79 43.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.86 125.28 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.509 -2.775 . . . . 0.0 103.509 168.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 44.8 51.91 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.21 1.404 . . . . 0.0 111.258 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 65.64 -24.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.978 2.511 . . . . 0.0 115.094 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -69.31 135.79 50.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.55 118.65 36.8 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.429 -157.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.05 2.14 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.516 -156.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -14.98 0.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.543 1.137 . . . . 0.0 113.156 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.96 6.81 6.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.061 2.544 . . . . 0.0 112.828 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.8 mt -90.28 160.57 16.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.174 1.352 . . . . 0.0 110.101 171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -83.87 162.77 20.42 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.95 0.5 . . . . 0.0 110.831 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -49.21 -51.43 33.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -59.05 -35.63 73.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.381 0.673 . . . . 0.0 111.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -74.49 -39.99 62.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.85 -41.85 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.41 -46.4 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.79 1.236 . . . . 0.0 110.37 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -38.78 70.37 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.595 0.56 . . . . 0.0 111.732 -171.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.26 -44.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.226 1.01 . . . . 0.0 109.315 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.59 -32.75 74.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.757 -0.59 . . . . 0.0 110.761 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -64.2 -42.11 96.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.049 1.295 . . . . 0.0 109.847 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.63 -20.25 65.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.526 1.53 . . . . 0.0 112.678 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.55 143.31 93.62 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 124.797 1.239 . . . . 0.0 110.578 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 142.45 49.05 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 124.447 3.431 . . . . 0.0 111.049 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.37 144.69 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.9 -1.08 64.0 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.892 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.45 158.09 16.71 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 119.703 1.751 . . . . 0.0 107.474 173.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.21 153.73 37.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.978 0.911 . . . . 0.0 111.034 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 m -126.21 128.26 46.95 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.737 1.615 . . . . 0.0 106.795 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -80.06 126.32 30.91 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.25 152.19 40.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.04 128.6 59.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.3 pp -125.83 164.56 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.33 1.052 . . . . 0.0 110.546 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 118.7 36.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.651 0.78 . . . . 0.0 110.887 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.35 87.41 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 0.0 109.399 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.74 56.4 0.07 OUTLIER Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -126.54 20.72 7.24 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.624 1.169 . . . . 0.0 112.88 -160.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.92 -160.92 15.14 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -170.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.98 159.33 38.86 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.633 1.555 . . . . 0.0 110.18 171.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.3 m -133.45 117.13 16.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.1 m -143.71 175.82 9.69 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.541 1.537 . . . . 0.0 109.243 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.811 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 -170.49 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 CA-C-O 117.516 -1.713 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.9 m 73.11 93.43 0.08 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.121 1.769 . . . . 0.0 109.151 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.3 86.64 2.03 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.11 -73.84 0.44 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.2 m 56.0 -63.36 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.035 2.534 . . . . 0.0 113.069 -171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 t -60.25 114.4 2.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.439 1.096 . . . . 0.0 109.184 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.18 117.79 0.8 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.43 135.67 57.76 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -156.75 177.01 11.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.195 2.198 . . . . 0.0 107.847 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 54.83 58.66 4.62 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.275 1.43 . . . . 0.0 109.893 -166.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -116.88 157.32 25.85 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.398 1.479 . . . . 0.0 107.665 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtm -128.16 146.07 50.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.074 0.95 . . . . 0.0 108.954 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -122.56 112.21 17.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -117.69 168.3 10.57 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.215 2.206 . . . . 0.0 108.464 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.8 m -133.66 150.03 51.56 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.837 -0.539 . . . . 0.0 109.601 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.4 pt -140.13 145.7 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.651 1.18 . . . . 0.0 110.258 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.91 118.5 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 9.6 tttt -56.08 129.92 41.95 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.166 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.05 -81.99 0.63 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.91 143.69 20.75 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.659 1.184 . . . . 0.0 108.522 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 55.71 -3.31 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.294 3.038 . . . . 0.0 115.557 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 163.26 -177.3 39.29 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -92.66 3.81 54.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.236 1.014 . . . . 0.0 111.088 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.11 -52.85 3.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.751 -1.218 . . . . 0.0 112.066 -172.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -61.67 166.75 4.01 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 123.165 1.459 . . . . 0.0 111.886 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 p -126.9 151.33 48.58 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.235 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.9 171.45 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.65 161.52 36.27 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.181 1.393 . . . . 0.0 109.207 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 143.49 45.64 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 p -130.17 176.68 2.66 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.28 -19.1 62.1 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.319 2.013 . . . . 0.0 112.166 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p -109.47 3.27 21.16 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.529 1.132 . . . . 0.0 112.496 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.11 -163.17 12.4 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -82.3 145.57 29.9 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.835 0.817 . . . . 0.0 109.986 -167.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -131.69 156.65 45.52 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.265 0.626 . . . . 0.0 109.369 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.17 140.67 17.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 171.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -106.09 -64.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.036 1.335 . . . . 0.0 108.581 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -142.84 134.45 26.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.74 136.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.742 1.617 . . . . 0.0 107.298 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -122.26 -50.57 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.955 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -93.23 95.26 9.26 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.9 mt -65.53 -54.28 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.256 1.822 . . . . 0.0 109.975 -171.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -60.0 -28.32 67.62 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.702 0.683 . . . . 0.0 111.067 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.15 -25.62 72.28 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 118.024 -1.431 . . . . 0.0 112.277 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.7 m -140.31 75.9 27.07 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 119.686 1.743 . . . . 0.0 112.42 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.77 154.8 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.135 2.557 . . . . 0.0 110.218 170.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.82 -45.1 2.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.753 1.168 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.57 132.05 30.01 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.093 2.157 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.44 -173.3 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.076 1.351 . . . . 0.0 109.038 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.17 104.72 14.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.49 -15.67 3.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.946 1.736 . . . . 0.0 111.653 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.51 105.53 0.11 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 128.416 2.686 . . . . 0.0 110.659 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.2 101.34 4.59 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.084 1.354 . . . . 0.0 109.102 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.65 129.95 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.438 1.895 . . . . 0.0 109.944 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.79 -43.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.57 1.548 . . . . 0.0 110.435 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.44 149.42 51.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.937 0.895 . . . . 0.0 109.53 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.1 mt -130.67 127.2 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 163.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 42.45 58.33 3.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 112.223 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 67.06 -18.78 0.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.598 2.359 . . . . 0.0 114.886 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -76.89 132.42 39.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.05 126.84 32.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.8 m -124.31 8.29 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -59.56 -13.61 9.94 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -129.63 38.62 3.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.055 1.342 . . . . 0.0 109.107 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.5 mt -121.5 146.04 47.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 126.5 1.92 . . . . 0.0 108.662 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.53 155.98 33.27 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 116.993 -1.479 . . . . 0.0 109.413 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.602 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 7.6 t60 -49.21 -28.72 4.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.739 175.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.5 m -74.32 -31.2 62.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.117 1.326 . . . . 0.0 111.945 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.82 -47.87 15.83 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 125.004 1.322 . . . . 0.0 110.554 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.602 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 2.7 m -54.56 -37.84 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 130.591 3.556 . . . . 0.0 111.726 168.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.98 -47.18 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.279 0.632 . . . . 0.0 109.843 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.59 -42.55 99.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.433 1.093 . . . . 0.0 111.759 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.86 -58.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 126.288 1.835 . . . . 0.0 108.879 169.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.45 -33.44 71.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.118 0.417 . . . . 0.0 111.406 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -64.66 -46.78 80.98 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.434 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.07 -28.89 69.18 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.174 0.99 . . . . 0.0 112.493 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.1 m -50.81 135.98 26.82 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 112.39 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.84 150.31 83.85 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.254 3.303 . . . . 0.0 110.615 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 75.7 mt -91.89 148.78 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.29 13.78 55.04 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.47 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -109.23 136.02 49.37 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.78 140.5 58.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.6 m -134.53 124.18 25.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.183 1.793 . . . . 0.0 106.997 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.0 m -91.45 127.94 37.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mp -124.89 125.04 43.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.38 129.23 58.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.44 150.37 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.37 1.068 . . . . 0.0 108.833 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -84.74 107.8 17.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -159.86 138.99 10.94 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.468 1.031 . . . . 0.0 110.299 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.23 176.78 45.61 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 127.797 2.617 . . . . 0.0 107.467 166.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.9 t 51.8 89.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.171 1.788 . . . . 0.0 112.185 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.65 -164.39 26.29 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -80.6 -29.21 2.4 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.913 2.409 . . . . 0.0 115.048 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.6 m -158.57 120.92 3.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.968 1.258 . . . . 0.0 110.577 -156.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.8 m -56.88 -28.52 61.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.143 0.883 . . . . 0.0 112.378 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 N-CA-C 104.869 -3.293 . . . . 0.0 104.869 -170.961 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -156.42 177.58 11.3 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 170.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.22 12.04 3.11 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.811 1.645 . . . . 0.0 114.466 173.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.78 81.66 1.67 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 m -175.13 83.6 0.03 OUTLIER 'General case' 0 C--O 1.233 0.222 0 C-N-CA 127.354 2.262 . . . . 0.0 107.872 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.6 m -76.07 178.28 6.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 161.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.56 167.95 40.02 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.714 1.174 . . . . 0.0 113.897 -165.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -139.18 166.43 24.55 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.863 2.065 . . . . 0.0 107.78 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.75 67.53 1.21 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -92.05 100.89 13.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.83 -156.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.513 2.325 . . . . 0.0 108.803 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.5 mtm -128.02 136.34 51.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.6 m -134.82 104.97 6.22 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 -168.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.37 168.43 9.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.116 1.767 . . . . 0.0 108.53 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.26 144.88 50.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.7 pt -137.94 131.94 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.111 0.965 . . . . 0.0 111.148 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.1 t -90.4 114.59 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 122.292 1.044 . . . . 0.0 109.063 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 34.7 tttm -65.11 126.43 28.07 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 170.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.04 -71.85 1.3 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 119.43 1.013 . . . . 0.0 111.719 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.55 -52.87 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.866 1.266 . . . . 0.0 109.893 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . 0.256 5.8 pt20 -74.28 58.22 0.72 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.966 1.365 . . . . 0.0 110.555 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 56.72 -150.59 26.85 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.739 -161.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -81.95 157.89 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 160.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.36 -45.36 30.54 Favored Glycine 0 C--O 1.223 -0.586 0 C-N-CA 119.403 -1.38 . . . . 0.0 112.05 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -52.07 155.94 1.73 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.667 1.233 . . . . 0.0 111.225 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.2 p -120.39 161.15 21.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.193 1.397 . . . . 0.0 108.04 -172.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.31 159.41 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.525 -0.735 . . . . 0.0 110.079 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 149.0 52.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.091 1.756 . . . . 0.0 107.527 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -76.5 141.08 41.38 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.277 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.08 165.36 29.77 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.646 1.179 . . . . 0.0 108.578 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.04 -2.86 8.67 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.791 2.994 . . . . 0.0 116.084 -164.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -136.81 2.53 2.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.468 1.031 . . . . 0.0 112.723 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.32 -176.63 28.85 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -77.93 148.62 34.43 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.15 -0.618 . . . . 0.0 110.332 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -131.63 162.64 29.9 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.814 0.845 . . . . 0.0 109.633 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.16 127.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -76.57 -69.05 0.54 Allowed 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.097 1.359 . . . . 0.0 107.625 172.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -152.33 141.1 20.98 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.5 0.591 . . . . 0.0 109.915 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -85.57 114.76 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -104.35 -9.8 18.24 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.968 0.907 . . . . 0.0 110.888 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -140.23 81.28 1.8 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.561 1.944 . . . . 0.0 105.952 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.51 -45.2 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.169 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.22 -34.44 59.25 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.514 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.94 87.03 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.783 0.719 . . . . 0.0 111.889 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.4 m -126.21 67.44 63.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 118.755 1.278 . . . . 0.0 110.748 170.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 48' ' ' LEU . 22.7 Cg_exo -58.53 158.69 22.47 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.656 2.237 . . . . 0.0 112.393 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.18 -20.72 0.41 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.598 1.57 . . . . 0.0 114.314 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 46' ' ' PRO . 2.8 tp -63.52 133.61 54.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.258 1.823 . . . . 0.0 107.902 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.2 t -125.37 10.9 8.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.904 0.881 . . . . 0.0 112.438 -167.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.29 150.96 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 130.502 3.521 . . . . 0.0 114.849 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 8.06 32.8 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 113.542 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.46 113.07 2.46 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.603 1.561 . . . . 0.0 109.623 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.43 106.32 4.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.703 1.201 . . . . 0.0 109.79 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.49 142.29 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.336 1.054 . . . . 0.0 110.229 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.49 -55.74 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.338 1.455 . . . . 0.0 110.504 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.27 155.22 46.67 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.892 0.877 . . . . 0.0 109.463 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.2 mt -133.59 132.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 163.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 42.04 44.22 2.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.581 1.952 . . . . 0.0 113.654 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 59.06 42.52 18.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.636 1.175 . . . . 0.0 112.815 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -128.55 136.48 50.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.421 1.888 . . . . 0.0 107.12 160.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.16 120.59 23.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.411 1.084 . . . . 0.0 109.67 175.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 m -115.89 16.94 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 128.046 2.538 . . . . 0.0 107.86 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -42.45 97.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 119.714 -1.866 . . . . 0.0 111.223 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.9 -25.53 58.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.347 0.976 . . . . 0.0 111.285 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.11 138.69 57.84 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.966 1.706 . . . . 0.0 112.887 -163.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 m -63.58 165.33 8.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.43 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.47 -53.61 35.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.199 0.599 . . . . 0.0 110.624 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.4 m -62.52 -34.36 76.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.803 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -62.94 -47.04 84.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.24 0.927 . . . . 0.0 108.814 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.7 -44.5 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.704 1.202 . . . . 0.0 110.275 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.28 -43.11 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 O-C-N 121.64 -0.662 . . . . 0.0 109.987 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -44.6 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.96 0.904 . . . . 0.0 110.5 -172.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.49 -51.47 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.453 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 50.7 mt -68.24 -13.58 62.35 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.537 -0.727 . . . . 0.0 112.646 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -83.44 -33.64 25.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.397 1.453 . . . . 0.0 110.657 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -72.3 -36.01 68.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.912 0.778 . . . . 0.0 109.409 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -47.84 137.65 10.13 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.875 1.27 . . . . 0.0 112.208 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.63 127.33 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.503 3.469 . . . . 0.0 111.873 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 53.4 mt -66.88 134.7 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 10.94 85.93 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.236 0.922 . . . . 0.0 112.391 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -113.89 158.96 20.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.307 1.443 . . . . 0.0 108.54 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.19 150.32 43.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 162.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.6 m -131.46 146.25 52.16 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 127.803 2.441 . . . . 0.0 106.36 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.87 122.7 45.71 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -168.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -123.65 157.3 34.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.563 1.074 . . . . 0.0 109.308 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mt -129.62 140.54 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 167.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.52 156.06 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.543 1.137 . . . . 0.0 109.939 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.96 84.96 5.41 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.178 -0.951 . . . . 0.0 110.824 -168.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 -135.6 154.62 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 162.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.27 -98.25 1.99 Allowed Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 105.811 -2.916 . . . . 0.0 105.811 157.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.7 t -147.24 154.24 40.77 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.937 0.875 . . . . 0.0 109.469 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.59 167.08 35.26 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.69 98.13 0.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.366 2.71 . . . . 0.0 109.225 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.9 m -127.42 156.65 41.74 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.043 2.137 . . . . 0.0 107.273 163.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.82 105.0 0.07 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.482 1.913 . . . . 0.0 108.837 -172.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.265 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 175.196 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -64.53 88.29 0.06 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.771 0.785 . . . . 0.0 109.332 168.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 p -135.37 -4.09 2.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.372 1.069 . . . . 0.0 112.486 -174.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.69 -79.18 0.27 Allowed Glycine 0 C--N 1.337 0.589 0 N-CA-C 107.551 -2.22 . . . . 0.0 107.551 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -54.24 104.63 0.11 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.625 1.17 . . . . 0.0 109.026 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.2 m -159.3 170.29 22.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 127.651 2.38 . . . . 0.0 107.485 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.51 -66.43 2.67 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 124.844 1.212 . . . . 0.0 110.885 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -61.14 138.4 58.21 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.555 1.142 . . . . 0.0 110.589 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.45 -170.69 3.51 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.057 1.743 . . . . 0.0 107.951 166.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -73.23 107.86 5.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 154.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -68.53 -176.97 0.85 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.07 1.748 . . . . 0.0 108.932 164.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.3 mtp -89.69 135.77 33.42 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 162.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.8 m -112.92 142.72 45.28 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -133.54 167.83 19.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.159 1.784 . . . . 0.0 109.24 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -135.5 153.08 51.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 108.687 168.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.6 pt -144.18 161.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.252 1.421 . . . . 0.0 110.071 174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.52 115.15 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 122.363 1.077 . . . . 0.0 108.418 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -67.77 115.17 7.02 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.425 1.49 . . . . 0.0 109.824 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.86 -81.98 0.4 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.174 -171.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.35 139.77 18.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.512 1.656 . . . . 0.0 111.071 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 61.64 -35.68 0.11 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.014 2.126 . . . . 0.0 112.45 -166.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.52 -141.48 3.37 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.634 1.588 . . . . 0.0 109.472 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -94.04 153.48 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.12 -42.33 58.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.194 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -62.96 166.96 5.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.419 1.104 . . . . 0.0 111.786 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.0 p -125.79 153.34 44.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.593 1.157 . . . . 0.0 109.514 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.22 170.58 11.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.079 0.952 . . . . 0.0 109.823 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.1 149.71 41.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.95 2.1 . . . . 0.0 108.674 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.95 148.47 47.66 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 32' ' ' THR . 5.5 p -147.29 163.05 30.12 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.575 1.95 . . . . 0.0 106.726 -177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.96 12.73 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.961 1 C-N-CA 125.521 4.148 . . . . 0.0 113.884 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.449 ' H ' ' C ' ' A' ' 30' ' ' SER . 3.0 p -144.17 -3.72 0.84 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.887 2.075 . . . . 0.0 111.134 -162.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.86 -164.4 17.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -82.91 146.98 28.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.094 1.447 . . . . 0.0 110.369 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -127.57 163.66 23.69 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 126.018 1.727 . . . . 0.0 109.298 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.52 117.43 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -70.16 -61.63 1.7 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.052 1.341 . . . . 0.0 108.502 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -151.13 154.29 36.65 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.097 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.8 mt -106.18 110.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.795 2.438 . . . . 0.0 106.811 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.52 -5.58 22.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.918 1.287 . . . . 0.0 111.723 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.68 69.58 0.75 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.765 1.626 . . . . 0.0 109.192 -161.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.45 -62.56 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 125.186 1.395 . . . . 0.0 110.579 -159.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.92 -12.38 60.58 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.703 0.683 . . . . 0.0 112.658 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.02 -25.09 62.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.87 0.748 . . . . 0.0 111.856 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 34.9 m -128.35 76.88 77.79 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.199 1.0 . . . . 0.0 109.095 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -62.82 159.54 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.413 2.075 . . . . 0.0 110.833 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.27 -48.46 0.71 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.179 1.847 . . . . 0.0 114.238 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.9 tp -44.9 140.21 2.72 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 129.176 2.99 . . . . 0.0 112.357 -170.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.8 m -132.37 159.63 38.66 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.346 1.459 . . . . 0.0 110.255 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -60.09 146.46 42.92 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 165.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 2.44 59.75 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.444 -0.642 . . . . 0.0 113.673 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -62.8 112.6 2.61 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 163.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tp -80.52 129.52 34.56 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 mt -95.04 130.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -167.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.99 -51.02 6.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.633 1.573 . . . . 0.0 109.8 -170.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -138.6 150.43 46.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.935 0.894 . . . . 0.0 108.764 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -131.72 124.96 54.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 38.92 54.92 2.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.801 1.641 . . . . 0.0 111.244 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 61.66 -6.89 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.769 2.828 . . . . 0.0 116.437 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.14 125.06 26.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.378 1.444 . . . . 0.0 108.052 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.1 129.68 41.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.5 m -127.75 4.03 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.647 0.779 . . . . 0.0 111.833 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -50.67 -38.9 49.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.627 1.171 . . . . 0.0 110.861 165.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -105.36 21.31 17.38 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.3 mt -117.67 150.33 39.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.913 1.233 . . . . 0.0 113.821 -171.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.92 154.16 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.507 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.18 -52.07 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.145 0.578 . . . . 0.0 111.951 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 m -63.93 -24.71 67.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.711 -0.662 . . . . 0.0 111.898 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.54 -42.12 62.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.628 1.104 . . . . 0.0 109.546 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -64.84 -40.66 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.548 0.739 . . . . 0.0 109.48 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -46.25 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.497 0.719 . . . . 0.0 109.492 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.42 -41.91 99.05 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.621 1.169 . . . . 0.0 110.909 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -66.62 -44.54 89.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.31 -31.91 72.58 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.902 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 121.651 2.023 . . . . 0.0 110.82 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.85 -36.87 77.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.359 1.063 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.3 m -55.67 136.86 71.21 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.37 144.16 90.4 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.146 3.231 . . . . 0.0 111.575 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -76.89 134.07 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 168.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.05 28.43 68.5 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.63 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -129.83 159.89 35.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.13 134.96 41.16 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -105.36 129.8 53.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 m -87.59 135.58 33.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.57 167.65 20.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.692 0.678 . . . . 0.0 109.303 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -132.7 141.55 44.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.35 150.89 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.405 1.082 . . . . 0.0 110.404 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.7 97.14 8.95 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 107.911 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -151.51 -70.04 0.17 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.39 -167.41 23.68 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.84 124.11 22.04 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.544 1.138 . . . . 0.0 109.519 172.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.71 169.64 42.15 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.48 1.038 . . . . 0.0 110.713 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.98 136.39 37.96 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.79 2.326 . . . . 0.0 110.854 -170.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 m -62.81 145.36 55.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 158.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.4 m 46.74 78.87 0.06 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.78 1.276 . . . . 0.0 110.535 -156.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.136 -1.925 . . . . 0.0 110.605 169.031 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.776 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m -73.87 112.08 9.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -149.25 151.48 34.32 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 169.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.32 -153.58 35.4 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -162.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.7 m -143.0 86.16 1.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.304 -1.115 . . . . 0.0 108.404 168.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.7 m 61.46 121.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.643 1.977 . . . . 0.0 111.56 -161.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.16 67.29 0.13 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -161.98 86.2 0.62 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.359 1.064 . . . . 0.0 108.211 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.77 161.61 20.61 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.366 0.666 . . . . 0.0 111.984 159.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -128.88 102.21 6.43 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.18 2.192 . . . . 0.0 105.855 165.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.39 179.93 7.63 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtp -88.57 135.81 33.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.3 m -134.45 103.82 5.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 168.36 9.45 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 126.085 1.754 . . . . 0.0 108.748 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.3 m -126.94 142.91 51.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.9 pt -127.62 167.85 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.764 1.626 . . . . 0.0 108.943 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.0 t -129.22 149.7 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.253 1.821 . . . . 0.0 106.963 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -113.24 99.82 8.1 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.822 1.249 . . . . 0.0 111.359 -164.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 54.23 4.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.744 1.64 . . . . 0.0 114.183 -172.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.07 -42.43 0.53 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.583 . . . . 0.0 116.53 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -80.21 -11.52 59.73 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.001 1.728 . . . . 0.0 113.106 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 65.91 149.92 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.015 2.526 . . . . 0.0 110.32 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.62 -53.77 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.23 153.24 2.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.044 1.337 . . . . 0.0 111.831 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.3 p -116.96 148.47 41.38 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.465 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 pt -110.34 153.78 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.88 156.67 45.68 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.128 1.371 . . . . 0.0 108.757 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.79 139.52 39.35 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.16 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.02 175.91 2.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.847 1.659 . . . . 0.0 108.831 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.39 -21.42 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.963 3.109 . . . . 0.0 113.373 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -104.27 -4.31 23.15 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -162.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.1 177.26 14.81 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -162.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -71.35 148.43 47.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.351 1.075 . . . . 0.0 108.855 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -133.63 154.74 50.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.57 116.92 27.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -64.32 -58.96 5.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.603 169.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -153.74 144.34 22.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.0 mt -91.39 124.57 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -119.06 -3.24 10.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.512 1.125 . . . . 0.0 112.336 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -136.0 91.54 2.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.58 -55.38 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -63.58 -29.83 71.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.692 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.67 -16.98 61.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.642 1.11 . . . . 0.0 112.869 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.3 m -136.7 66.92 57.67 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 120.0 1.9 . . . . 0.0 111.124 -171.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.68 117.8 4.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.684 2.923 . . . . 0.0 112.581 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -7.49 81.85 Favored Glycine 0 C--N 1.335 0.493 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.213 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.07 153.27 42.73 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 82.6 m -124.46 159.8 29.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.517 1.127 . . . . 0.0 111.036 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.64 145.95 24.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.84 43.69 23.53 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -167.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.9 -170.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.494 1.117 . . . . 0.0 108.766 161.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.96 119.0 9.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.2 mt -89.63 127.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -171.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.05 -48.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.861 -163.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -134.74 132.6 38.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -115.62 129.41 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 167.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.86 16.77 7.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.48 1.912 . . . . 0.0 114.809 164.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 58.87 50.3 8.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.19 1.359 . . . . 0.0 112.019 -165.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.56 -15.38 10.85 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.95 133.19 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 130.712 3.605 . . . . 0.0 113.53 -165.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.29 7.34 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.001 0.921 . . . . 0.0 112.882 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.46 -18.22 64.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 113.597 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -110.37 -21.85 11.99 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.891 0.877 . . . . 0.0 110.047 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.23 139.47 58.49 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.916 0.865 . . . . 0.0 111.735 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.8 m -65.54 158.18 27.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.238 1.415 . . . . 0.0 110.553 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -50.61 -54.07 25.73 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 124.353 1.061 . . . . 0.0 110.154 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.04 -17.78 63.69 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.819 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.44 -36.81 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.433 1.093 . . . . 0.0 108.996 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -74.21 -43.45 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.662 1.185 . . . . 0.0 109.286 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.9 t -51.54 -43.73 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.039 0 C-N-CA 123.875 0.87 . . . . 0.0 108.894 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.481 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -65.02 -42.97 93.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.2 mt -60.44 -44.36 96.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -65.35 -31.28 72.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.465 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.481 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 47.8 mtmt -62.37 -43.4 98.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.219 1.827 . . . . 0.0 111.298 165.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.66 -32.78 71.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.984 1.314 . . . . 0.0 112.547 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -53.67 139.33 50.57 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.053 1.341 . . . . 0.0 111.811 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.19 122.33 9.38 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.727 2.951 . . . . 0.0 110.048 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 mt -61.1 147.66 10.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.27 9.8 13.25 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.36 -1.244 . . . . 0.0 114.144 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 m -121.29 173.59 7.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.667 1.587 . . . . 0.0 108.192 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.3 153.19 25.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.687 0.756 . . . . 0.0 111.425 -175.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.2 m -142.22 144.34 33.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.415 1.486 . . . . 0.0 108.834 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -110.93 107.62 17.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.049 2.14 . . . . 0.0 109.144 -157.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.3 112.53 16.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.159 1.8 . . . . 0.0 111.615 -170.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -87.23 130.12 37.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.595 1.558 . . . . 0.0 108.608 171.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.25 150.21 30.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.011 1.324 . . . . 0.0 111.187 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -78.11 77.34 4.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 0.0 111.329 -168.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -152.13 -177.87 6.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.487 1.915 . . . . 0.0 108.216 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.98 179.73 40.55 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 129.224 3.297 . . . . 0.0 106.887 171.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.3 m -54.07 156.82 2.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.637 1.718 . . . . 0.0 112.629 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.88 -176.51 41.52 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.96 -52.77 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.621 2.214 . . . . 0.0 110.729 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m 64.66 -178.37 0.17 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.028 1.331 . . . . 0.0 110.44 -160.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.1 m 55.11 47.91 20.8 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.069 1.347 . . . . 0.0 112.26 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 106.596 -2.602 . . . . 0.0 106.596 174.846 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.198 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 m 59.71 -174.22 0.11 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.849 0.86 . . . . 0.0 110.91 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -122.94 1.72 9.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.503 1.121 . . . . 0.0 110.011 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.39 166.68 33.29 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 126.893 2.187 . . . . 0.0 108.084 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.1 p -157.14 -59.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.215 1.406 . . . . 0.0 108.56 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -155.53 158.88 39.18 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.719 2.007 . . . . 0.0 108.018 172.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.85 171.28 14.86 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 159.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.69 169.11 3.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.127 0.571 . . . . 0.0 109.909 165.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.79 -4.36 4.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.693 0.797 . . . . 0.0 111.805 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -43.66 98.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.607 3.163 . . . . 0.0 113.134 -168.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.7 mt -124.9 169.58 11.93 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 127.236 2.214 . . . . 0.0 107.853 163.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.78 137.09 41.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.825 1.25 . . . . 0.0 107.913 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.8 m -125.45 120.03 29.87 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -168.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 mt -137.19 167.07 22.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.804 1.242 . . . . 0.0 107.943 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.58 143.83 51.09 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.9 pt -137.91 161.85 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.779 1.232 . . . . 0.0 109.733 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.1 t -117.46 147.5 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -97.12 86.7 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 71.87 0.68 Allowed Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.614 -160.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . 60.52 154.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.823 2.849 . . . . 0.0 115.043 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 47.78 -0.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.211 2.204 . . . . 0.0 115.58 -158.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 133.98 -129.97 5.46 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 104.453 -3.459 . . . . 0.0 104.453 -172.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -97.79 168.06 10.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 166.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.17 -45.12 57.52 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 121.706 -0.621 . . . . 0.0 111.895 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -64.47 -179.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.052 2.141 . . . . 0.0 113.388 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 p -132.81 147.04 52.31 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.834 1.254 . . . . 0.0 109.76 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 pt -110.7 167.68 4.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.286 1.035 . . . . 0.0 109.28 166.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.35 161.96 35.61 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.433 1.893 . . . . 0.0 107.217 168.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.33 148.73 41.07 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.687 1.195 . . . . 0.0 108.11 163.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.07 163.6 23.04 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.163 0.985 . . . . 0.0 108.41 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.16 -1.34 2.85 Favored 'Trans proline' 0 C--N 1.345 0.371 1 C-N-CA 126.166 4.577 . . . . 0.0 116.993 -170.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -132.62 -13.34 2.95 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.337 1.055 . . . . 0.0 111.848 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.08 172.32 17.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -164.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -68.03 124.87 24.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.856 1.262 . . . . 0.0 109.15 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -102.71 163.48 12.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 122.188 0.994 . . . . 0.0 109.625 171.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.8 t -72.03 128.03 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 163.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -71.62 -69.26 0.39 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -154.22 141.33 19.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.987 0.915 . . . . 0.0 108.592 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.8 mt -89.72 135.35 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.15 -31.0 4.22 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.445 0.698 . . . . 0.0 110.778 -171.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -130.65 95.92 3.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.57 -40.71 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.548 0.739 . . . . 0.0 110.513 -171.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.06 -19.21 61.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.915 -1.116 . . . . 0.0 111.656 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.38 -23.16 75.05 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.135 -0.978 . . . . 0.0 111.562 166.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 90.2 m -147.51 74.48 11.51 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 119.559 1.68 . . . . 0.0 110.067 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.29 158.94 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.54 1.493 . . . . 0.0 112.531 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.46 -46.51 1.64 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.824 -0.987 . . . . 0.0 113.251 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 tt -52.74 146.12 10.99 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.253 2.221 . . . . 0.0 109.993 -166.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.54 162.02 31.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.045 0.926 . . . . 0.0 111.71 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -69.32 148.39 49.78 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.453 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.56 7.13 25.85 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.007 -1.441 . . . . 0.0 114.176 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -51.53 126.53 17.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.576 1.688 . . . . 0.0 106.542 166.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -96.11 110.94 23.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.6 mt -70.91 141.58 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.321 1.419 . . . . 0.0 109.254 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.81 -43.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.061 1.344 . . . . 0.0 110.261 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -135.87 156.74 48.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.272 0.558 . . . . 0.0 109.53 171.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.34 125.67 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 164.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 45.87 37.83 3.91 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.237 1.415 . . . . 0.0 114.819 169.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 54.59 60.55 3.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.187 1.795 . . . . 0.0 112.629 -169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -134.79 133.93 40.36 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 151.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.24 122.51 34.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.293 1.037 . . . . 0.0 108.595 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.45 -1.35 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -162.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -24.29 40.11 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.869 1.668 . . . . 0.0 113.447 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -91.25 1.13 57.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.723 1.609 . . . . 0.0 112.126 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.54 173.48 6.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.287 1.435 . . . . 0.0 111.255 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.2 m -109.27 159.98 16.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.208 1.803 . . . . 0.0 108.814 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -50.21 -50.73 48.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.367 0.667 . . . . 0.0 111.922 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.5 m -64.57 -31.33 72.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.562 0.745 . . . . 0.0 111.068 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.24 -45.49 84.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.725 0.693 . . . . 0.0 109.273 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.87 -37.35 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.566 1.147 . . . . 0.0 108.942 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.2 -45.62 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.057 0.943 . . . . 0.0 109.152 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -34.25 71.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.329 0.585 . . . . 0.0 112.345 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.24 -56.08 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.775 1.63 . . . . 0.0 107.654 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.6 mt -61.53 -27.39 68.57 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.603 -0.686 . . . . 0.0 111.933 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -66.25 -41.07 90.47 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 109.889 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.66 -40.77 88.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.582 1.153 . . . . 0.0 110.736 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.9 m -49.41 139.65 14.23 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.747 1.219 . . . . 0.0 112.173 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -67.15 118.74 5.8 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.299 3.333 . . . . 0.0 110.995 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.36 137.25 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.09 18.86 71.42 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.223 1.392 . . . . 0.0 113.372 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 t -113.72 163.87 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.391 1.477 . . . . 0.0 107.403 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -62.99 153.92 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.43 1.109 . . . . 0.0 110.309 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -133.15 140.94 47.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.167 2.587 . . . . 0.0 105.166 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.3 m -89.32 135.77 33.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.237 1.815 . . . . 0.0 106.259 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.28 164.31 15.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 162.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.9 mt -132.26 137.49 54.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 164.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -134.47 157.25 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.932 1.693 . . . . 0.0 109.112 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.92 98.62 11.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.311 1.044 . . . . 0.0 109.144 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -155.22 162.98 40.79 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.56 -0.713 . . . . 0.0 110.01 168.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.29 -63.49 0.03 OUTLIER Glycine 0 C--N 1.332 0.334 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 t -149.09 -162.61 1.6 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 117.881 0.84 . . . . 0.0 110.451 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -108.91 177.06 20.24 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.793 1.663 . . . . 0.0 111.278 171.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.46 -34.15 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.976 2.45 . . . . 0.0 113.023 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.5 p -86.93 108.02 18.62 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.682 1.193 . . . . 0.0 111.213 -158.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.8 m 72.27 -176.35 0.18 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.816 2.046 . . . . 0.0 111.568 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 -174.622 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 p -157.92 170.23 22.79 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 117.985 0.893 . . . . 0.0 109.28 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m 51.09 -166.72 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.18 1.392 . . . . 0.0 110.299 -166.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 53.11 -153.6 7.12 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 123.933 0.778 . . . . 0.0 111.819 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -140.77 137.71 33.58 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.865 0.866 . . . . 0.0 109.312 173.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.32 153.98 33.2 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.673 0.789 . . . . 0.0 109.488 170.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.54 -160.81 7.69 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 167.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -32.36 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 128.055 2.542 . . . . 0.0 111.93 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.62 -17.14 64.67 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 43.56 76.6 0.08 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.147 2.179 . . . . 0.0 111.503 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.72 167.41 11.14 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.497 -0.752 . . . . 0.0 109.499 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.2 mtm -105.32 114.97 29.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 m -76.74 140.9 40.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 157.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -140.57 168.51 19.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.01 2.124 . . . . 0.0 106.955 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.8 m -125.07 147.7 48.86 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.142 -0.974 . . . . 0.0 108.487 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.0 pt -131.97 163.47 37.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.524 1.129 . . . . 0.0 109.216 171.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 t -136.04 137.68 48.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 72.7 tttt -108.38 81.9 1.54 Allowed 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.177 -0.952 . . . . 0.0 113.452 -153.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.69 -78.7 0.08 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.514 1.054 . . . . 0.0 115.236 -165.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.82 -60.34 0.26 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.362 1.581 . . . . 0.0 112.392 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -82.74 44.73 0.93 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.892 0.853 . . . . 0.0 111.046 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.419 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 64.48 74.94 0.41 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.64 1.114 . . . . 0.0 111.896 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.09 -86.85 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 125.774 1.63 . . . . 0.0 108.737 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.48 -31.61 0.58 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.643 1.592 . . . . 0.0 111.159 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.437 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 34.0 p90 -61.44 165.72 4.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.046 1.339 . . . . 0.0 110.353 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -119.8 147.46 44.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.771 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 pt -113.32 162.66 11.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.353 0.661 . . . . 0.0 109.332 167.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.51 157.8 41.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.521 2.329 . . . . 0.0 106.713 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -74.53 148.07 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.6 p -137.52 162.73 53.23 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.17 1.45 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.319 3.346 . . . . 0.0 114.567 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -131.73 -0.87 3.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.014 1.326 . . . . 0.0 112.453 -166.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.63 179.26 15.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -168.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -77.06 154.84 32.96 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 118.541 1.171 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -148.37 159.83 43.62 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 112.579 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.41 115.4 22.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 125.554 1.541 . . . . 0.0 107.56 -173.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -72.93 -44.2 61.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.598 171.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.25 160.4 23.88 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -171.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' A' ' 25' ' ' PHE . 1.4 mm? -105.2 -4.25 21.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.061 1.745 . . . . 0.0 112.466 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -143.42 96.38 2.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 157.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.23 -42.49 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 109.403 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.93 -33.53 75.8 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.368 -0.833 . . . . 0.0 111.144 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.19 -21.41 79.26 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.109 -0.828 . . . . 0.0 112.371 171.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.4 m -129.47 68.62 80.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 118.891 1.345 . . . . 0.0 110.123 -174.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.03 149.77 88.89 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.143 1.895 . . . . 0.0 110.246 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.02 -21.44 0.37 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.077 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.29 136.15 57.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.357 1.578 . . . . 0.0 110.004 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -127.72 160.62 31.13 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.969 1.308 . . . . 0.0 109.633 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -71.97 139.85 48.85 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.193 0.997 . . . . 0.0 109.418 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.02 66.32 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.57 -167.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.575 1.95 . . . . 0.0 110.105 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.73 115.86 6.96 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 mm -70.74 125.58 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.353 1.461 . . . . 0.0 110.546 -171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.68 -56.9 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.67 1.188 . . . . 0.0 111.381 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -133.96 145.84 49.91 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.5 mt -134.36 123.81 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 50.85 33.62 8.95 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.871 1.268 . . . . 0.0 112.543 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.7 11.48 8.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.635 2.774 . . . . 0.0 115.162 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.24 132.26 34.96 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.187 1.395 . . . . 0.0 107.451 163.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -80.13 138.81 36.99 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.99 13.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.403 1.481 . . . . 0.0 111.659 -172.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.852 -1.155 . . . . 0.0 113.383 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -120.37 30.09 7.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.978 0.808 . . . . 0.0 109.698 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -98.04 164.88 12.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.194 0.998 . . . . 0.0 110.606 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -84.91 162.5 19.43 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.076 1.35 . . . . 0.0 109.984 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -45.69 -58.46 3.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 126.608 1.963 . . . . 0.0 110.551 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.4 m -58.53 -40.36 82.74 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.284 1.033 . . . . 0.0 110.694 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -65.68 -44.48 86.09 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.851 1.26 . . . . 0.0 109.962 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.63 -39.75 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.957 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.15 -40.48 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 O-C-N 121.617 -0.677 . . . . 0.0 109.579 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -48.63 78.87 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.551 1.54 . . . . 0.0 110.199 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.4 mt -60.09 -43.75 93.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.979 1.312 . . . . 0.0 109.24 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -69.05 -27.11 65.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.783 175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -65.57 -44.39 86.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 121.15 1.795 . . . . 0.0 108.268 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.47 -26.14 68.31 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.711 0.632 . . . . 0.0 112.374 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.6 m -53.51 134.13 53.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.045 0.538 . . . . 0.0 110.67 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -68.0 135.13 34.01 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.217 3.278 . . . . 0.0 110.698 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -71.27 127.69 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.534 1.534 . . . . 0.0 107.983 -175.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.96 11.87 59.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.935 2.207 . . . . 0.0 113.134 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -92.2 167.36 12.09 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 149.17 34.45 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -131.44 126.35 34.84 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.3 m -101.23 113.63 26.86 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -167.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.55 153.84 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.198 0.908 . . . . 0.0 109.733 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -129.55 136.36 59.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.06 153.27 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.845 1.258 . . . . 0.0 110.869 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 105.95 17.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.641 1.977 . . . . 0.0 107.316 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 -159.12 -51.56 0.06 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.221 1.809 . . . . 0.0 109.872 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.07 -148.64 44.74 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 m -69.69 -70.73 0.27 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.33 -167.66 12.72 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.72 59.63 7.34 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.638 3.559 . . . . 0.0 111.106 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.1 t -70.07 107.77 3.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.2 168.91 0.19 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.567 1.147 . . . . 0.0 111.698 -164.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -166.145 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.693 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -145.46 76.75 1.49 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 164.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.9 m 60.14 168.52 0.08 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 127.756 2.422 . . . . 0.0 113.568 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.85 -162.28 25.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.194 1.378 . . . . 0.0 110.131 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.9 t 74.97 125.03 0.04 OUTLIER 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.845 2.458 . . . . 0.0 112.452 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.7 t -89.99 173.23 8.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.594 1.958 . . . . 0.0 108.805 172.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.44 -146.08 15.23 Favored Glycine 0 C--O 1.238 0.393 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 66.8 -176.44 0.2 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.22 1.008 . . . . 0.0 109.76 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.43 144.96 49.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -87.55 89.23 7.92 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.44 149.82 24.07 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.07 0.948 . . . . 0.0 108.638 172.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.2 mtm -113.38 146.47 39.43 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.8 m -135.22 98.8 4.07 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.028 1.331 . . . . 0.0 107.996 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.86 167.6 9.61 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.352 1.461 . . . . 0.0 109.82 -172.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.27 145.81 47.87 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.906 0.883 . . . . 0.0 110.537 -177.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.4 pt -139.65 134.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 125.562 1.545 . . . . 0.0 108.832 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.45 121.76 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 73.6 tttt -69.93 116.85 10.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.282 1.033 . . . . 0.0 109.58 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.73 -68.86 1.43 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.861 -169.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.21 -73.5 0.13 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.809 1.304 . . . . 0.0 112.01 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -76.41 36.22 0.15 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.112 0.965 . . . . 0.0 111.164 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 87.85 -126.68 8.16 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 -158.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -113.71 166.8 11.18 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.72 25.62 3.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.087 1.803 . . . . 0.0 113.611 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -151.07 167.64 27.09 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.892 1.346 . . . . 0.0 108.472 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 p -129.37 159.84 34.95 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.241 0.617 . . . . 0.0 109.797 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 pt -125.21 152.4 31.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.09 0.556 . . . . 0.0 110.502 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.22 145.42 30.41 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.446 1.099 . . . . 0.0 108.202 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.48 148.45 48.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.057 0.932 . . . . 0.0 110.809 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p -137.44 166.57 25.72 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.389 1.875 . . . . 0.0 105.985 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -70.75 -5.33 16.57 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.406 2.737 . . . . 0.0 112.871 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -129.33 -6.91 4.77 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.074 0.852 . . . . 0.0 112.804 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.89 -177.7 35.37 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.848 1.213 . . . . 0.0 110.587 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -94.12 92.62 7.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.57 -0.959 . . . . 0.0 110.601 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -86.88 161.56 18.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 119.629 1.104 . . . . 0.0 111.791 -162.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.54 115.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -71.63 -61.63 1.71 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 170.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -150.29 143.57 25.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.4 mt -96.11 110.51 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.2 mt -78.27 -36.28 47.01 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.798 0.839 . . . . 0.0 109.022 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -132.02 93.36 3.27 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.153 1.781 . . . . 0.0 109.083 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.8 mt -56.81 -44.06 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 110.154 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -68.07 -12.28 60.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.1 -14.01 52.87 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 119.509 1.05 . . . . 0.0 111.349 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.52 54.96 15.22 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.709 1.204 . . . . 0.0 109.67 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.07 124.3 10.83 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.922 1.748 . . . . 0.0 111.233 -164.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -16.24 61.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.971 1.272 . . . . 0.0 113.411 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.94 152.69 39.26 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.8 p -124.84 151.79 44.81 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.724 0.81 . . . . 0.0 108.901 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -76.4 138.57 40.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.06 96.32 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -168.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.63 -177.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.852 0.826 . . . . 0.0 111.554 163.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.59 91.19 2.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.84 135.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.559 1.544 . . . . 0.0 109.196 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.17 -45.98 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.166 1.387 . . . . 0.0 110.367 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -128.79 148.84 50.9 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.75 138.75 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 152.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 67.82 -54.42 0.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 128.979 2.911 . . . . 0.0 116.203 167.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 165.27 13.85 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 130.793 3.637 . . . . 0.0 113.584 -156.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -131.76 141.9 49.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.909 1.686 . . . . 0.0 109.194 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -69.55 128.83 37.87 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.8 m -133.75 22.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 125.402 1.481 . . . . 0.0 107.563 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -60.43 3.69 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 119.977 -1.702 . . . . 0.0 110.719 176.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.22 -21.15 62.17 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.456 0.169 . . . . 0.0 111.193 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.89 134.58 37.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.867 1.667 . . . . 0.0 111.61 -167.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -56.63 162.33 2.31 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.674 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -49.28 -51.38 34.07 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.69 0.796 . . . . 0.0 109.311 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -52.07 17.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.036 2.534 . . . . 0.0 111.495 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.31 -46.71 82.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.516 1.126 . . . . 0.0 108.531 -170.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.37 -46.46 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.471 1.509 . . . . 0.0 110.443 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.57 -45.17 78.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -40.55 77.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.126 0.97 . . . . 0.0 111.473 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.59 -48.95 85.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 123.996 0.919 . . . . 0.0 109.109 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.12 -26.96 68.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.737 0.415 . . . . 0.0 111.58 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -71.51 -41.47 69.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.808 1.186 . . . . 0.0 110.382 174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.51 -27.65 67.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.447 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.9 m -49.72 127.17 19.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 123.275 0.63 . . . . 0.0 110.739 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.04 132.84 46.73 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.937 3.092 . . . . 0.0 110.773 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 mm -64.01 127.75 25.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 166.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.44 17.71 75.36 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.323 0.963 . . . . 0.0 112.294 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -115.24 159.45 20.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 123.313 1.53 . . . . 0.0 108.823 159.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.05 153.58 40.32 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.876 168.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.6 m -137.77 149.11 46.14 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 126.936 2.094 . . . . 0.0 107.869 165.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 126.1 54.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.627 2.371 . . . . 0.0 105.941 -168.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.46 115.69 18.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.996 1.271 . . . . 0.0 109.171 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.6 mt -97.62 125.59 50.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.06 155.11 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.607 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -108.81 74.86 0.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.041 2.136 . . . . 0.0 109.693 -170.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -108.45 68.7 0.7 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -161.71 92.06 0.11 Allowed Glycine 0 N--CA 1.454 -0.128 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 -170.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -141.16 -160.73 1.11 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.668 1.187 . . . . 0.0 108.729 -166.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.32 -163.2 13.83 Favored Glycine 0 CA--C 1.524 0.598 0 O-C-N 120.83 -1.169 . . . . 0.0 111.732 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.48 167.06 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.029 3.152 . . . . 0.0 113.381 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.2 p -152.13 147.8 26.88 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.643 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.1 m -145.88 92.35 2.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.909 1.684 . . . . 0.0 107.291 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -177.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.701 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t -145.53 -38.86 0.25 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 162.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.9 m -76.92 98.29 4.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 157.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.63 58.78 0.56 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 167.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m 60.92 174.6 0.1 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.213 1.805 . . . . 0.0 111.357 -158.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -158.68 -163.59 1.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.48 78.71 1.42 Allowed Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.09 157.87 44.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.445 1.898 . . . . 0.0 106.111 165.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.04 114.83 2.1 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.599 0.562 . . . . 0.0 110.956 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -82.83 50.95 1.8 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.482 1.513 . . . . 0.0 110.263 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.45 -162.69 0.17 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.122 2.169 . . . . 0.0 110.833 -176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.1 mtm -89.72 125.1 35.15 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -96.66 142.94 28.1 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.16 145.4 51.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.789 1.636 . . . . 0.0 108.06 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 m -103.06 135.15 45.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.179 0.592 . . . . 0.0 109.882 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.9 pt -143.98 137.59 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.285 1.034 . . . . 0.0 111.595 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.254 0.2 OUTLIER -110.35 136.03 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.598 1.189 . . . . 0.0 112.338 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 66.3 tttt -79.06 117.6 20.26 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.813 1.645 . . . . 0.0 111.924 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.461 ' H ' ' HA ' ' A' ' 23' ' ' PHE . . . -81.73 171.98 52.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 166.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.55 -59.64 3.59 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.686 1.994 . . . . 0.0 113.882 -168.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -82.16 10.83 6.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.695 -0.628 . . . . 0.0 111.096 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 82.23 1.64 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 126.298 1.904 . . . . 0.0 108.364 169.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.461 ' HA ' ' H ' ' A' ' 19' ' ' GLY . 43.9 m-85 61.13 -175.97 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.995 1.318 . . . . 0.0 111.049 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.2 -63.61 1.5 Allowed Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -60.17 170.92 1.12 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.536 1.135 . . . . 0.0 113.775 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -131.43 158.38 40.98 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.026 1.33 . . . . 0.0 109.541 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.3 pt -123.68 162.01 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 124.732 1.213 . . . . 0.0 108.717 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.21 158.17 43.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.89 114.82 9.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.849 1.259 . . . . 0.0 107.962 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -99.31 168.36 9.75 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -66.35 -8.83 21.76 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.308 2.005 . . . . 0.0 114.568 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -129.12 -4.43 5.0 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 120.104 1.32 . . . . 0.0 114.022 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.59 -172.94 33.73 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -162.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -84.82 143.32 29.16 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 121.526 -0.985 . . . . 0.0 108.655 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -134.48 154.24 51.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.588 171.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.09 126.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.597 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -81.07 -57.05 3.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.739 1.216 . . . . 0.0 108.526 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -157.32 149.53 22.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.1 mt -122.54 132.77 70.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.67 -58.2 1.6 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.204 1.002 . . . . 0.0 109.45 -164.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -88.04 87.98 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.8 1.24 . . . . 0.0 110.107 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.02 -38.55 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.062 0.945 . . . . 0.0 112.116 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.85 -36.17 67.38 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.772 -0.58 . . . . 0.0 111.123 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.19 -9.74 81.59 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.183 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -131.27 64.59 73.97 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 119.454 1.627 . . . . 0.0 108.614 172.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.41 125.41 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.201 1.934 . . . . 0.0 112.057 -165.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.62 0.38 84.09 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.125 -0.819 . . . . 0.0 112.696 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.99 140.95 56.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.781 1.291 . . . . 0.0 108.387 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 151.29 43.12 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 122.177 0.989 . . . . 0.0 110.464 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -77.78 148.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.14 56.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 117.4 -1.778 . . . . 0.0 114.383 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -63.63 126.75 28.57 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.926 1.863 . . . . 0.0 109.424 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 123.05 25.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.784 1.633 . . . . 0.0 108.363 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.83 146.23 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.2 -53.62 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.708 0.803 . . . . 0.0 110.916 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.5 131.61 24.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -116.95 124.3 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 170.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 46.1 46.35 12.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.791 1.636 . . . . 0.0 113.002 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.266 0.2 OUTLIER 61.15 31.7 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.271 1.829 . . . . 0.0 115.22 -177.554 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.15 132.11 55.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.121 1.768 . . . . 0.0 106.752 165.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -83.4 120.76 26.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.33 1.452 . . . . 0.0 110.85 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 m -121.98 7.01 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.679 1.992 . . . . 0.0 109.412 -171.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -37.97 39.82 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.029 1.286 . . . . 0.0 112.085 -173.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -115.71 7.75 14.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mp -62.06 143.37 56.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.382 1.873 . . . . 0.0 109.991 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -54.77 159.16 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.939 0.774 . . . . 0.0 110.069 165.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -50.38 -49.65 53.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 168.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -55.57 -44.73 77.13 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.873 1.269 . . . . 0.0 112.725 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.77 -39.89 95.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.398 1.079 . . . . 0.0 109.715 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.2 -49.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.497 0.719 . . . . 0.0 109.814 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.5 -38.12 54.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.472 1.509 . . . . 0.0 109.888 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.68 -46.11 80.3 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.771 0.828 . . . . 0.0 111.024 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mt -59.16 -46.14 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.604 1.161 . . . . 0.0 109.52 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.494 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 98.0 mt -61.09 -17.41 52.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.222 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -86.19 -33.64 20.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.379 1.445 . . . . 0.0 111.523 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -42.57 69.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.473 1.109 . . . . 0.0 109.406 165.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 91.9 m -51.35 135.55 31.9 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 111.776 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -67.56 112.67 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 1 C-N-CA 125.636 4.224 . . . . 0.0 112.098 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -51.32 117.76 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.382 1.473 . . . . 0.0 107.548 170.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.49 8.75 57.21 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.862 1.22 . . . . 0.0 113.249 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.85 151.74 51.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.972 1.386 . . . . 0.0 110.339 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -72.38 153.37 41.49 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.329 1.452 . . . . 0.0 112.123 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -131.23 143.82 50.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 130.083 3.353 . . . . 0.0 105.905 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.4 m -109.02 116.62 32.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -116.56 115.62 26.09 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.572 1.149 . . . . 0.0 108.549 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.37 134.47 28.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.43 152.61 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 110.723 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -88.01 67.69 9.01 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.185 -0.947 . . . . 0.0 110.768 -170.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -51.24 69.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.8 -96.69 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.7 t -143.58 157.05 44.71 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.608 1.204 . . . . 0.0 108.595 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.7 168.89 33.88 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -83.96 144.14 10.72 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.681 2.921 . . . . 0.0 110.019 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.4 m -123.95 -21.45 5.1 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.333 0.653 . . . . 0.0 112.072 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.0 t -142.68 148.42 37.31 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 153.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 150.959 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 m 52.32 -178.52 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.47 0.747 . . . . 0.0 110.538 -138.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 t -142.72 -23.3 0.65 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.287 1.035 . . . . 0.0 111.073 171.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.3 -168.82 23.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -104.38 137.84 41.67 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.884 0.874 . . . . 0.0 110.178 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.3 p -77.62 108.55 10.89 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.425 1.09 . . . . 0.0 108.299 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.29 -163.24 7.84 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.219 0.914 . . . . 0.0 112.242 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -125.8 -172.01 2.51 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.059 1.343 . . . . 0.0 109.481 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.71 151.53 48.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -160.58 115.23 2.19 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.013 1.325 . . . . 0.0 107.571 -175.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp -134.3 171.84 13.71 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.359 2.264 . . . . 0.0 106.713 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.7 mtm -111.09 153.69 25.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.601 0.637 . . . . 0.0 109.543 165.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.9 m -132.17 120.25 22.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.4 mt -126.85 168.41 14.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.532 1.533 . . . . 0.0 107.936 -175.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 m -134.67 141.97 46.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.6 pt -138.46 151.31 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 110.981 -176.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.5 153.19 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.625 1.97 . . . . 0.0 108.942 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -113.23 105.69 13.73 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.341 1.456 . . . . 0.0 109.022 -145.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.69 61.39 3.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.662 1.601 . . . . 0.0 112.577 -165.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.23 152.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.975 2.51 . . . . 0.0 112.459 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 65.42 -25.42 0.09 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.336 2.255 . . . . 0.0 115.56 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -164.16 31.13 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.681 -2.568 . . . . 0.0 106.681 -159.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -102.29 12.89 35.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -174.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.34 -66.15 1.28 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.609 1.1 . . . . 0.0 110.879 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -54.05 158.04 2.31 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 122.143 0.973 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -114.56 159.88 19.9 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.586 1.154 . . . . 0.0 109.418 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.7 pt -118.31 154.33 20.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.548 0.69 . . . . 0.0 110.432 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.91 170.26 9.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.263 2.225 . . . . 0.0 108.286 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.08 122.04 46.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 107.512 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.4 p -126.03 171.51 7.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.959 1.303 . . . . 0.0 109.734 -167.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.15 -14.69 45.17 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.164 1.909 . . . . 0.0 112.64 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -104.67 -11.83 16.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.019 1.328 . . . . 0.0 111.72 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.28 -162.25 23.63 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -73.34 147.58 44.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -139.73 165.09 28.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.306 0.574 . . . . 0.0 109.465 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.19 117.1 16.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.6 -74.18 0.15 Allowed 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -140.12 153.61 46.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -99.54 106.86 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.095 1.758 . . . . 0.0 108.168 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -101.82 -0.0 34.94 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.267 1.427 . . . . 0.0 110.957 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -149.83 114.06 5.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.037 1.735 . . . . 0.0 108.596 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.09 -58.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.484 1.513 . . . . 0.0 109.216 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.69 -37.1 75.34 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.037 1.335 . . . . 0.0 111.636 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.25 -25.75 72.3 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.3 m -126.94 67.61 69.72 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 118.947 1.373 . . . . 0.0 111.198 -172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.8 128.16 20.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.718 2.279 . . . . 0.0 111.224 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.12 76.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 124.401 1.001 . . . . 0.0 114.297 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.84 153.12 44.23 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.444 1.122 . . . . 0.0 108.754 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.5 m -135.78 0.76 2.72 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 62.6 151.22 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.641 2.376 . . . . 0.0 112.205 -166.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.99 6.52 25.5 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.683 -1.065 . . . . 0.0 113.73 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.38 128.88 38.12 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.429 1.492 . . . . 0.0 107.817 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -81.28 109.96 16.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.843 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.99 124.66 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.94 -57.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.128 1.371 . . . . 0.0 108.893 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -128.56 150.47 50.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.284 1.034 . . . . 0.0 109.229 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.2 mt -127.86 126.65 67.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 164.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 43.64 52.84 6.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 111.046 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 59.94 -7.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.973 2.509 . . . . 0.0 116.371 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -69.63 117.08 10.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -58.11 115.9 3.2 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 163.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 0.8 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 O-C-N 124.057 0.848 . . . . 0.0 112.397 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -54.49 -21.9 11.34 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -170.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -112.03 -2.86 14.93 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 121.319 1.872 . . . . 0.0 112.663 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.55 160.25 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.321 -0.862 . . . . 0.0 109.198 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -89.53 157.11 18.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.209 1.004 . . . . 0.0 109.793 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -40.83 -56.8 2.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.984 1.714 . . . . 0.0 112.132 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.7 m -67.0 -26.26 66.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.896 0.878 . . . . 0.0 111.038 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.29 -44.96 67.3 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.243 0.928 . . . . 0.0 109.364 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.6 -40.57 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.384 1.073 . . . . 0.0 109.646 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.68 -53.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 123.715 0.806 . . . . 0.0 109.029 169.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.519 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 12.9 t70 -57.22 -46.39 82.98 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.352 0.661 . . . . 0.0 111.722 -172.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.4 mt -55.27 -45.52 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.649 1.18 . . . . 0.0 109.494 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -67.74 -35.72 79.24 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.716 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 72' ' ' ASP . 9.0 mtmp? -55.01 -47.9 74.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.266 1.848 . . . . 0.0 109.589 167.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -34.73 75.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.218 1.007 . . . . 0.0 112.478 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.76 138.04 43.4 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.157 0.983 . . . . 0.0 109.689 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -54.29 144.27 61.04 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.347 2.698 . . . . 0.0 110.119 174.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.5 mt -80.43 131.43 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 161.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.91 35.79 72.86 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.268 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.7 m -146.43 131.79 18.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.746 1.273 . . . . 0.0 108.831 161.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -61.45 152.7 29.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.616 1.198 . . . . 0.0 111.094 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -137.55 135.57 36.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.966 2.906 . . . . 0.0 105.116 -168.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -112.49 110.85 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.822 1.249 . . . . 0.0 108.29 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.96 112.63 18.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.514 0.597 . . . . 0.0 110.84 -169.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -89.17 141.72 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.37 146.58 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.851 0.834 . . . . 0.0 111.819 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.0 96.61 5.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.205 1.002 . . . . 0.0 109.327 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -150.49 124.25 9.18 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -176.75 95.28 0.1 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -169.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -145.02 -105.88 0.11 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 169.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.29 179.83 31.86 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 156.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -80.08 102.17 1.42 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.419 2.746 . . . . 0.0 108.715 171.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.9 p -138.21 142.84 39.96 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.912 0.885 . . . . 0.0 109.606 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 m -111.57 103.56 11.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 169.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.821 0 CA-C-O 115.272 -2.96 . . . . 0.0 111.246 -177.79 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.941 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -168.9 162.72 11.41 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -172.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -125.2 166.25 16.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.549 0.74 . . . . 0.0 109.877 -175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.52 166.95 33.8 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 155.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.82 148.52 27.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.049 0.939 . . . . 0.0 108.498 176.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -111.77 12.1 20.97 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.344 1.858 . . . . 0.0 110.7 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.97 -111.45 4.11 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -162.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 tm0? 64.09 136.62 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.802 2.041 . . . . 0.0 111.201 -170.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.04 -178.3 5.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.093 1.757 . . . . 0.0 108.332 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.47 104.65 11.65 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.01 155.72 32.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -87.35 145.8 26.17 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.2 m -123.45 139.17 54.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.3 mt -142.81 167.88 21.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.444 2.297 . . . . 0.0 106.837 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.8 m -128.95 154.61 46.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.3 -0.875 . . . . 0.0 108.694 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 pt -145.66 166.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 126.054 1.741 . . . . 0.0 109.907 176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.82 143.37 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.636 1.575 . . . . 0.0 107.582 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -88.62 145.68 25.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.26 1.024 . . . . 0.0 111.232 -175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.32 82.8 0.35 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.264 1.411 . . . . 0.0 113.899 -168.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.97 -84.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.035 2.134 . . . . 0.0 115.697 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.25 -15.4 46.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.934 1.243 . . . . 0.0 112.862 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.39 28.73 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -66.36 146.0 55.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 118.869 1.334 . . . . 0.0 108.173 170.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.24 -51.84 53.79 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -61.82 164.02 6.81 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.368 1.08 . . . . 0.0 110.198 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.43 ' HG1' ' CD2' ' A' ' 40' ' ' LEU . 12.0 p -117.37 156.78 27.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.973 0.909 . . . . 0.0 109.25 -174.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.02 158.32 18.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 167.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.12 163.1 25.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 165.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.83 147.13 47.48 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 159.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.3 p -139.7 161.9 53.92 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 163.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.32 -42.66 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.016 2.477 . . . . 0.0 113.256 -174.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.487 ' HG1' ' CD1' ' A' ' 53' ' ' LEU . 33.8 p -73.29 -23.84 60.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 111.159 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.75 178.86 26.9 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -172.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -62.42 145.74 53.26 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -134.17 161.11 35.8 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 123.134 0.574 . . . . 0.0 111.134 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.86 107.27 7.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 -58.2 9.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.112 0.965 . . . . 0.0 109.553 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -151.69 148.14 27.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.788 1.635 . . . . 0.0 106.778 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.6 mt -91.2 97.14 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' CD2' ' HG1' ' A' ' 26' ' ' THR . 2.6 mm? -72.7 -26.15 61.49 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.219 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -142.71 95.57 2.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.446 1.898 . . . . 0.0 108.998 -158.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.4 -57.06 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.76 1.224 . . . . 0.0 109.105 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.15 -25.32 66.92 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.802 0.728 . . . . 0.0 111.608 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 -32.35 66.77 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.213 170.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.3 p -130.08 70.36 82.13 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 120.058 1.929 . . . . 0.0 112.774 -171.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.39 111.59 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.748 2.299 . . . . 0.0 111.636 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.04 85.34 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.407 1.479 . . . . 0.0 114.844 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 152.97 43.15 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.03 1.415 . . . . 0.0 108.089 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.7 m -129.12 156.0 44.58 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.303 1.041 . . . . 0.0 110.023 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.24 137.48 53.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.14 12.41 79.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.494 -1.725 . . . . 0.0 114.182 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -58.43 129.53 42.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.093 1.946 . . . . 0.0 110.117 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.487 ' CD1' ' HG1' ' A' ' 32' ' ' THR . 3.1 tp -78.5 144.42 35.71 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 172.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.2 mt -108.0 135.9 45.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 125.359 1.464 . . . . 0.0 108.206 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -122.45 -57.04 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.274 1.03 . . . . 0.0 110.085 -170.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 64.0 mt-10 -129.89 149.7 51.5 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.3 mt -135.93 129.39 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 168.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 41.13 45.33 2.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.392 2.277 . . . . 0.0 111.573 -173.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 57.51 4.54 0.24 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.391 2.276 . . . . 0.0 115.795 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.1 126.04 29.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 160.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.421 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 21.8 t-20 -73.02 132.22 43.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 168.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.84 -2.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.516 1.126 . . . . 0.0 110.844 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -6.69 1.27 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -121.03 -2.28 9.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.022 1.329 . . . . 0.0 111.659 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.5 mt -77.42 167.97 20.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.581 1.082 . . . . 0.0 110.517 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.5 m -88.66 155.53 19.55 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -47.76 -50.65 24.9 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.839 1.256 . . . . 0.0 112.341 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 m -65.73 -29.43 69.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.251 1.02 . . . . 0.0 111.266 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.37 -44.46 83.09 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.44 -39.95 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 121.172 -0.955 . . . . 0.0 110.564 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.53 -50.68 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 124.493 1.117 . . . . 0.0 108.893 171.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -66.25 -37.38 85.34 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.23 0.956 . . . . 0.0 112.011 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.88 -44.23 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.469 -0.769 . . . . 0.0 109.308 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.06 -17.59 64.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.946 -1.096 . . . . 0.0 112.29 172.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.03 -46.58 42.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.776 1.625 . . . . 0.0 108.993 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.07 -27.22 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.039 0.836 . . . . 0.0 112.85 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.95 123.82 61.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 118.849 0.75 . . . . 0.0 109.432 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -68.69 157.71 60.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.921 3.08 . . . . 0.0 113.276 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mm -90.08 124.56 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.575 1.55 . . . . 0.0 106.953 -170.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.41 73.77 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.571 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 m -110.64 157.75 19.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 162.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 153.83 41.07 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.797 1.284 . . . . 0.0 109.756 166.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -140.78 131.37 25.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.512 1.925 . . . . 0.0 105.961 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -97.17 121.12 38.71 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.923 1.689 . . . . 0.0 106.537 -171.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.68 149.87 42.6 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.815 1.189 . . . . 0.0 110.017 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.03 125.24 66.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.72 177.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.966 1.306 . . . . 0.0 109.549 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -107.21 124.32 49.57 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.077 0.853 . . . . 0.0 111.683 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.424 ' CG ' ' H ' ' A' ' 90' ' ' GLY . 4.0 tpm_? -159.63 -145.67 0.13 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 130.539 3.536 . . . . 0.0 106.344 -170.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 89' ' ' ARG . . . 131.38 161.15 10.1 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 128.57 2.986 . . . . 0.0 110.455 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 72.2 m -138.4 172.59 12.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.088 1.355 . . . . 0.0 109.971 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.96 162.42 9.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.011 1.767 . . . . 0.0 110.466 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.16 160.41 42.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 N-CA-C 108.203 -1.499 . . . . 0.0 108.203 156.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 t -65.74 -29.39 69.9 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.114 -0.991 . . . . 0.0 109.98 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.8 m -161.37 152.04 17.98 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 128.13 2.572 . . . . 0.0 105.872 157.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.218 0 N-CA-C 105.124 -3.19 . . . . 0.0 105.124 173.586 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.873 0 N-CA-C 107.438 -2.265 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -66.77 141.39 57.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.818 1.309 . . . . 0.0 108.166 166.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.18 170.44 21.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.045 1.338 . . . . 0.0 108.503 166.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.58 120.78 0.77 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 t -155.69 162.66 40.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 m 59.76 174.73 0.08 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.147 1.379 . . . . 0.0 111.231 -165.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.97 -37.2 4.48 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.659 -1.079 . . . . 0.0 111.472 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.37 164.67 18.38 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.579 1.19 . . . . 0.0 110.101 163.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.57 -174.75 4.69 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.73 2.012 . . . . 0.0 108.381 168.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 65.41 97.78 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.234 1.813 . . . . 0.0 110.424 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.7 mt -102.27 172.94 6.6 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.337 2.255 . . . . 0.0 108.594 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.57 129.87 50.55 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.467 1.107 . . . . 0.0 108.413 171.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 m -95.33 136.2 35.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.57 168.45 20.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.369 1.867 . . . . 0.0 108.509 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 m -135.64 131.17 35.43 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.322 -0.861 . . . . 0.0 108.909 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.5 pt -120.67 166.39 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.262 1.025 . . . . 0.0 110.11 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.72 132.9 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.12 106.51 17.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.632 -0.668 . . . . 0.0 109.735 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.31 171.73 6.36 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 121.876 0.709 . . . . 0.0 112.408 171.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -59.48 -52.78 64.13 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.581 1.152 . . . . 0.0 111.009 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -80.3 29.52 0.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.511 1.124 . . . . 0.0 110.31 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 75.58 -171.43 54.27 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 125.439 1.495 . . . . 0.0 109.512 -166.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.15 -0.79 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.423 1.889 . . . . 0.0 114.715 -172.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.54 -61.03 3.24 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 119.819 -1.801 . . . . 0.0 111.198 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -54.09 152.35 6.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 118.659 1.229 . . . . 0.0 111.232 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.4 p -118.84 159.17 24.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.199 1.4 . . . . 0.0 108.151 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.9 pt -123.56 166.72 18.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.639 0.733 . . . . 0.0 109.996 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.09 170.04 16.77 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.547 2.739 . . . . 0.0 108.168 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.25 115.93 31.27 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.37 2.268 . . . . 0.0 106.834 169.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 52.4 p -111.27 169.28 6.47 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.064 1.346 . . . . 0.0 108.251 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 23.4 Cg_endo -64.09 10.52 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 125.14 3.893 . . . . 0.0 115.065 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.445 ' HG1' ' CD1' ' A' ' 53' ' ' LEU . 36.3 p -131.33 -11.76 3.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 111.632 -171.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.61 -165.09 24.27 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -169.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -66.48 141.36 57.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -130.57 162.82 28.47 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.544 0.688 . . . . 0.0 109.643 166.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.6 t -71.11 138.3 22.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 168.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -93.19 -48.42 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.434 1.094 . . . . 0.0 109.418 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -161.81 159.13 26.61 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.091 1.756 . . . . 0.0 106.88 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.2 139.99 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 46.3 mt -123.13 -54.52 1.8 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -87.57 77.7 8.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.9 mt -61.82 -51.37 73.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 125.472 1.509 . . . . 0.0 108.666 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -57.5 -35.29 70.04 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.047 0.939 . . . . 0.0 112.41 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.34 -23.48 70.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.172 0.897 . . . . 0.0 112.115 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 75.5 m -118.84 60.5 4.64 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 119.007 1.404 . . . . 0.0 110.824 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.4 138.58 51.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.678 2.252 . . . . 0.0 110.722 -167.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 -9.16 27.88 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.893 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tt -73.54 146.19 44.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.152 1.476 . . . . 0.0 108.728 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.73 162.12 27.34 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.734 1.214 . . . . 0.0 112.155 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.69 149.58 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.476 -0.765 . . . . 0.0 109.845 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 14.13 58.06 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.363 -0.836 . . . . 0.0 113.916 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.3 129.68 36.18 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.169 1.484 . . . . 0.0 108.37 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.445 ' CD1' ' HG1' ' A' ' 32' ' ' THR . 4.4 tp -76.64 133.4 39.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 mt -95.18 125.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.529 1.132 . . . . 0.0 109.293 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -112.71 -51.94 5.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.845 1.258 . . . . 0.0 110.713 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.28 153.32 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.416 0.686 . . . . 0.0 109.558 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.68 134.85 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 161.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 35.89 57.11 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.702 2.001 . . . . 0.0 113.774 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 59.0 24.47 12.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.483 1.113 . . . . 0.0 112.856 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -117.39 120.59 38.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.904 2.482 . . . . 0.0 106.323 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 126.31 28.17 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.22 -3.42 5.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -9.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 169.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.79 -8.27 14.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.303 1.41 . . . . 0.0 112.222 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.7 mt -77.57 158.6 29.76 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.534 0.734 . . . . 0.0 111.856 -172.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.75 148.69 46.09 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.644 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 3.1 t60 -54.86 -22.86 16.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.333 1.453 . . . . 0.0 112.241 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -79.45 -17.24 54.66 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.912 -1.743 . . . . 0.0 112.805 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -87.66 -51.4 5.91 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.325 -1.484 . . . . 0.0 108.105 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.644 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 2.5 m -49.24 -38.19 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 131.558 3.943 . . . . 0.0 112.776 166.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -63.56 -54.5 31.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.775 0.83 . . . . 0.0 109.53 170.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.84 -40.79 89.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.746 0.654 . . . . 0.0 111.095 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.15 -45.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 125.837 1.655 . . . . 0.0 110.996 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.75 -33.86 76.59 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.933 -0.479 . . . . 0.0 110.949 174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -68.24 -34.85 76.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.287 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -74.14 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 173.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.6 m -59.47 141.71 87.72 Favored Pre-proline 0 CA--C 1.536 0.438 0 O-C-N 120.444 -1.41 . . . . 0.0 109.342 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.19 125.79 14.64 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 123.536 2.824 . . . . 0.0 110.594 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.9 mt -58.98 135.59 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.91 85.25 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.823 1.202 . . . . 0.0 113.268 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 t -103.64 147.76 26.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -66.98 142.33 57.29 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 165.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.9 m -127.49 132.55 49.97 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.772 2.829 . . . . 0.0 105.591 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -88.04 130.26 35.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mp -130.6 149.53 52.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mt -128.82 123.5 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 172.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -111.49 152.71 13.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.037 1.335 . . . . 0.0 107.552 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -88.07 106.17 17.97 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.94 123.59 9.81 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.82 115.69 0.54 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.0 m 50.93 51.71 16.49 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.685 1.594 . . . . 0.0 112.542 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.1 169.19 28.01 Favored Glycine 0 CA--C 1.54 1.65 0 C-N-CA 123.933 0.778 . . . . 0.0 114.543 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -78.32 -164.17 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.017 1 C-N-CA 126.158 4.572 . . . . 0.0 113.05 -175.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 m -107.02 177.56 4.82 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.765 1.626 . . . . 0.0 111.452 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.8 m -67.34 -175.69 0.5 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.551 1.54 . . . . 0.0 110.019 167.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 CA-C-O 116.736 -2.147 . . . . 0.0 108.073 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.219 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 m -145.02 162.8 36.04 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 p -134.44 165.0 26.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.559 1.143 . . . . 0.0 108.62 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.41 -174.8 41.47 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t 109.83 159.93 0.0 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 130.617 3.567 . . . . 0.0 106.471 -172.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.56 -23.79 63.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.079 0.952 . . . . 0.0 112.856 -170.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.34 -136.98 39.89 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -142.06 163.04 33.95 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.499 1.519 . . . . 0.0 107.855 173.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.05 83.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -160.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.83 98.34 7.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.208 1.403 . . . . 0.0 108.078 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.86 133.31 42.73 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.654 1.581 . . . . 0.0 108.611 169.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.5 mtm -88.98 155.91 19.2 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.8 m -134.78 108.91 8.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.0 mt -98.77 169.23 9.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.547 2.339 . . . . 0.0 107.532 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -135.25 151.38 50.54 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.315 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.9 pt -144.35 128.28 12.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.17 1.388 . . . . 0.0 110.249 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 120.92 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 123.523 1.63 . . . . 0.0 109.291 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -57.66 118.23 5.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.034 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.36 -75.49 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.29 165.87 30.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.599 0.699 . . . . 0.0 109.47 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 60.87 -16.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 129.191 2.996 . . . . 0.0 116.809 172.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.61 138.03 5.1 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -167.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -52.08 131.49 31.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.64 84.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.09 145.04 21.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.26 1.03 . . . . 0.0 110.995 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 p -107.27 156.43 18.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.13 149.16 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.446 0.641 . . . . 0.0 110.535 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -124.95 143.28 50.96 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.076 2.15 . . . . 0.0 108.087 -177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -89.12 87.12 7.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -171.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -70.39 167.29 27.44 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 124.64 1.176 . . . . 0.0 109.09 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.03 9.36 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.387 2.724 . . . . 0.0 112.968 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.63 -2.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -152.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.64 -169.1 22.52 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -166.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -87.52 142.08 28.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.012 -1.287 . . . . 0.0 109.188 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -124.19 162.81 22.86 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 123.49 0.716 . . . . 0.0 110.995 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.28 116.57 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -69.51 -68.71 0.39 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.995 1.318 . . . . 0.0 108.519 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -148.41 154.87 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.441 1.496 . . . . 0.0 107.26 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.0 mt -120.53 107.84 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.005 1.322 . . . . 0.0 108.222 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.2 -53.49 3.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.918 0.866 . . . . 0.0 109.971 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.18 74.45 7.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.0 mt -50.36 -48.81 24.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.748 1.219 . . . . 0.0 109.516 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -63.62 -37.88 88.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.588 -172.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.85 -5.15 60.57 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.694 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 40.9 m -131.08 71.9 81.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 120.191 1.996 . . . . 0.0 109.528 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.2 129.13 23.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.009 2.473 . . . . 0.0 111.136 -174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.59 -7.77 52.15 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.04 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.69 147.07 47.17 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.988 1.394 . . . . 0.0 109.26 -176.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.4 m -138.14 141.5 40.13 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.312 1.445 . . . . 0.0 107.297 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.58 158.39 27.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.47 47.53 56.75 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.815 -0.553 . . . . 0.0 111.729 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.44 -159.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.225 2.21 . . . . 0.0 109.595 152.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -154.95 110.18 3.07 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 160.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.18 134.8 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 120.785 1.63 . . . . 0.0 109.106 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.55 -50.29 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.806 1.243 . . . . 0.0 110.347 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -133.85 151.04 51.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.393 0.677 . . . . 0.0 109.427 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.4 mt -124.45 127.34 72.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 65.68 -36.96 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 131.027 3.731 . . . . 0.0 115.741 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.26 19.7 pt20 162.31 -7.54 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.796 3.638 . . . . 0.0 112.592 -171.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -99.84 142.25 31.57 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.79 -1.194 . . . . 0.0 109.502 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -72.73 137.74 46.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.808 1.243 . . . . 0.0 110.381 171.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.3 m -139.73 19.63 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 126.966 2.107 . . . . 0.0 108.394 -175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.99 -58.47 4.07 Favored 'General case' 0 C--N 1.343 0.316 0 O-C-N 120.382 -1.449 . . . . 0.0 109.994 171.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -67.7 -19.96 65.22 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.341 0.657 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 mp -56.09 137.44 51.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.216 2.206 . . . . 0.0 111.744 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -60.61 156.4 16.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.198 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -46.98 -51.14 17.82 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.0 0.92 . . . . 0.0 110.192 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -55.82 -35.59 66.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.198 2.599 . . . . 0.0 111.669 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.38 -50.06 49.58 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.848 1.259 . . . . 0.0 107.613 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.3 t -63.55 -39.31 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.593 0.757 . . . . 0.0 109.348 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.78 -51.96 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.457 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -66.86 -33.49 75.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.433 0.56 . . . . 0.0 112.1 -170.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.94 -52.28 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 124.043 0.937 . . . . 0.0 109.584 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.07 -35.75 81.29 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.008 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 43.9 mtmt -59.38 -48.56 81.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 121.189 1.813 . . . . 0.0 111.38 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.5 -33.28 74.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.618 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 97.0 m -46.7 125.29 8.01 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.06 0.944 . . . . 0.0 110.087 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -58.17 145.31 93.14 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.685 2.924 . . . . 0.0 109.991 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.7 mm -72.63 139.66 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.856 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.84 75.59 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.05 1.31 . . . . 0.0 113.352 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -99.27 128.19 45.37 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.784 1.292 . . . . 0.0 108.152 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.19 139.63 58.47 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.9 m -124.17 125.93 45.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 m -88.68 122.47 32.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.79 112.67 19.12 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.13 131.51 33.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 169.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.36 150.75 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 109.815 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -81.26 113.88 19.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.829 0.852 . . . . 0.0 109.685 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -144.81 179.3 7.41 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.106 1.363 . . . . 0.0 107.709 171.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.13 64.54 0.53 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 123.557 0.598 . . . . 0.0 111.61 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.2 t -153.27 158.46 41.67 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.47 164.01 30.76 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -92.57 -26.3 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.704 2.936 . . . . 0.0 114.295 -170.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 m -178.3 149.34 0.52 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.99 2.916 . . . . 0.0 107.625 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.42 177.99 0.16 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.954 1.702 . . . . 0.0 113.585 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.753 0 N-CA-C 106.368 -2.693 . . . . 0.0 106.368 177.732 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -148.78 127.24 12.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.024 2.13 . . . . 0.0 106.448 163.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.9 p 55.01 173.63 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.802 2.441 . . . . 0.0 113.314 -162.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.97 -175.24 50.77 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.202 0.906 . . . . 0.0 112.231 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m -81.95 -51.0 8.5 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.801 -0.823 . . . . 0.0 111.914 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 t 57.16 85.66 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.265 1.426 . . . . 0.0 111.101 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.66 117.06 4.51 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.774 0.702 . . . . 0.0 112.145 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -144.58 174.66 10.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.094 1.358 . . . . 0.0 109.542 162.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.62 135.51 36.6 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.343 0.657 . . . . 0.0 110.853 -174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -140.42 147.25 39.43 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 166.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 49.5 -160.75 0.05 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.049 2.139 . . . . 0.0 111.943 173.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.9 mtm -142.18 148.17 37.78 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.484 1.514 . . . . 0.0 107.914 153.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -99.7 142.47 31.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 165.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -138.1 160.79 38.47 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.717 1.607 . . . . 0.0 106.791 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -130.8 144.8 51.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.5 pt -138.69 152.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 125.351 1.46 . . . . 0.0 110.442 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.91 98.34 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.236 1.014 . . . . 0.0 109.641 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 52.1 tttt -43.58 112.41 0.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.574 2.35 . . . . 0.0 111.1 177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -67.52 1.88 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.72 150.77 3.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.458 1.503 . . . . 0.0 108.557 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 40.9 57.49 2.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.105 1.362 . . . . 0.0 110.813 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.427 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 76.99 -144.16 29.57 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -112.46 160.17 18.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.516 1.526 . . . . 0.0 108.084 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.04 7.73 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 124.4 1.0 . . . . 0.0 110.615 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -58.56 170.25 0.79 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.346 1.069 . . . . 0.0 111.093 172.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -132.73 159.08 40.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.529 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 pt -118.78 141.83 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.268 1.032 . . . . 0.0 109.031 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.04 133.56 43.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 127.232 2.213 . . . . 0.0 105.77 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 141.85 50.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 163.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -128.9 169.84 12.09 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.47 1.508 . . . . 0.0 108.216 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.63 4.14 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.127 3.218 . . . . 0.0 113.452 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.1 p -131.55 -27.49 1.94 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.543 1.065 . . . . 0.0 112.115 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.26 -166.1 37.44 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -83.65 137.96 33.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -128.34 162.78 26.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 126.888 2.075 . . . . 0.0 107.466 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -77.91 123.38 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -75.36 -70.57 0.41 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -149.13 158.45 44.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.37 0.986 . . . . 0.0 109.049 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.0 mt -117.46 120.65 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.2 mt -105.21 -17.67 14.39 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.265 1.426 . . . . 0.0 111.008 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -142.22 82.78 1.8 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.702 2.001 . . . . 0.0 106.548 -162.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.59 -36.56 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.931 1.292 . . . . 0.0 110.682 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.43 -26.11 65.36 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.034 -1.041 . . . . 0.0 113.11 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.2 -11.74 71.33 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.708 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.03 67.15 6.31 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.588 1.694 . . . . 0.0 110.678 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.7 130.15 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.838 2.359 . . . . 0.0 109.849 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.68 -5.96 72.01 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.202 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 tp -77.79 142.73 38.45 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.493 1.146 . . . . 0.0 109.091 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.4 m -132.21 159.36 39.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.811 1.245 . . . . 0.0 109.554 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.51 144.29 57.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 -1.0 84.22 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.585 -1.675 . . . . 0.0 114.446 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -63.62 106.33 0.94 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.44 1.62 . . . . 0.0 110.005 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.86 126.04 28.48 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.695 1.598 . . . . 0.0 109.571 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.57 144.58 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 109.208 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.42 -43.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 126.293 1.837 . . . . 0.0 108.847 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -136.12 153.59 51.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.579 0.752 . . . . 0.0 110.161 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.549 HG23 ' H ' ' A' ' 58' ' ' ASN . 6.8 mt -111.41 -157.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 167.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.549 ' H ' HG23 ' A' ' 57' ' ' ILE . 85.7 m-20 -53.25 76.56 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.268 2.227 . . . . 0.0 110.92 168.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 55.76 38.97 30.74 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.182 1.393 . . . . 0.0 111.989 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.75 125.82 38.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.834 1.654 . . . . 0.0 107.212 162.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.35 114.77 22.67 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.417 1.487 . . . . 0.0 108.141 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 28.2 m -117.47 6.61 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -163.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -53.48 -19.88 4.16 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -114.96 -10.09 12.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.064 1.346 . . . . 0.0 112.116 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 15.2 mt -68.11 147.15 52.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.977 0.894 . . . . 0.0 108.635 175.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.4 m -74.76 164.68 26.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.419 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -48.08 -56.3 8.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.644 0.777 . . . . 0.0 109.535 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.9 m -60.85 -28.76 69.08 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.958 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.68 -45.97 27.54 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.13 1.372 . . . . 0.0 110.73 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.25 -41.51 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.11 -43.0 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.137 0.975 . . . . 0.0 109.225 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.75 89.76 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.853 1.261 . . . . 0.0 110.722 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.81 -51.33 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.035 0.934 . . . . 0.0 108.76 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.438 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 29.9 mt -62.9 -26.4 68.77 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.757 -0.589 . . . . 0.0 111.729 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -68.92 -40.31 79.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.305 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.58 -33.88 75.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.527 1.058 . . . . 0.0 113.193 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.8 m -49.62 134.25 19.3 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.778 1.231 . . . . 0.0 111.563 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.13 121.47 8.63 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.234 3.289 . . . . 0.0 111.777 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.16 124.13 11.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.206 1.402 . . . . 0.0 107.742 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.19 14.92 70.59 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.24 -0.756 . . . . 0.0 113.208 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.4 m -115.62 147.94 40.22 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 118.655 1.227 . . . . 0.0 108.165 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.98 141.18 58.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.885 1.274 . . . . 0.0 108.487 171.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -128.89 124.9 36.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.081 1.753 . . . . 0.0 106.419 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -89.46 128.74 36.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 mp -133.46 158.28 43.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.1 130.83 73.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.0 148.25 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.715 1.206 . . . . 0.0 110.18 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -82.99 84.71 7.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.716 0.807 . . . . 0.0 109.502 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -85.93 158.99 19.77 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.63 -59.87 0.08 OUTLIER Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.5 m -150.2 -172.93 4.3 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 162.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -141.96 153.33 24.2 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 164.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.94 -42.91 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.482 2.122 . . . . 0.0 110.968 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 p -71.23 128.89 37.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.3 1.44 . . . . 0.0 109.591 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.0 m -57.45 -39.15 75.67 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.824 0.449 . . . . 0.0 111.414 169.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -153.259 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.823 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -130.16 118.94 22.21 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.354 1.461 . . . . 0.0 107.709 -173.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -171.47 100.61 0.19 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.39 -150.14 14.68 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.171 1.367 . . . . 0.0 110.795 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.61 115.06 2.12 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.057 1.343 . . . . 0.0 109.895 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -73.1 167.94 20.11 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 168.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.75 136.47 4.03 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 169.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.83 77.8 6.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.726 0.763 . . . . 0.0 109.536 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.91 165.84 12.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.77 0.828 . . . . 0.0 109.948 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -103.77 111.12 23.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 155.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.79 155.43 37.61 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 166.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 31.6 mtm -92.53 113.84 26.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.742 0.701 . . . . 0.0 109.292 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -82.95 129.07 34.98 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -145.7 142.56 29.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.685 1.594 . . . . 0.0 107.641 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -125.08 140.18 53.13 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.965 . . . . 0.0 110.665 -166.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.0 pt -129.51 158.29 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.174 1.389 . . . . 0.0 111.03 -172.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -128.14 116.79 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.858 1.263 . . . . 0.0 108.516 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 55.6 tttt -75.26 104.81 5.98 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.571 1.148 . . . . 0.0 109.915 -174.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.76 -67.63 1.87 Allowed Glycine 0 CA--C 1.523 0.564 0 CA-C-O 119.703 -0.498 . . . . 0.0 112.599 -169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 -70.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.514 0.657 . . . . 0.0 111.243 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -78.11 72.0 4.62 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.023 1.329 . . . . 0.0 107.922 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 61.6 -149.75 45.84 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -83.51 1.41 42.03 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 167.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.53 -63.14 1.48 Allowed Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.761 -1.212 . . . . 0.0 111.623 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -52.58 155.14 2.3 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.028 1.414 . . . . 0.0 111.765 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -122.17 157.38 31.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.0 107.915 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.38 174.68 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 109.232 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.13 165.18 14.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.496 1.918 . . . . 0.0 107.513 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 141.01 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 151.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.64 154.92 60.16 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.58 16.06 1.5 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.292 2.661 . . . . 0.0 113.983 -160.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.469 ' HG1' HD22 ' A' ' 53' ' ' LEU . 2.4 p -144.63 4.04 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.768 1.627 . . . . 0.0 112.092 -160.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.76 169.48 21.72 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -156.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -77.08 160.77 28.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.995 0.897 . . . . 0.0 111.856 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -131.48 146.46 52.25 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.64 127.07 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -100.73 -52.54 3.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.376 1.07 . . . . 0.0 109.862 -173.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -150.39 133.9 16.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.05 128.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -118.43 9.29 12.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.409 1.083 . . . . 0.0 110.509 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.55 81.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 42' ' ' ILE . 3.5 mp -59.2 -60.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 124.834 1.253 . . . . 0.0 109.073 -166.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.81 -9.99 59.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.14 -38.15 94.94 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 164.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 80.4 m -123.31 67.07 34.87 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.47 0.708 . . . . 0.0 111.96 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.88 142.56 93.71 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.216 1.944 . . . . 0.0 109.641 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.22 -31.66 3.72 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 117.984 -1.453 . . . . 0.0 113.065 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -63.9 147.34 52.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.204 1.502 . . . . 0.0 110.387 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.6 m -137.08 168.95 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.342 1.857 . . . . 0.0 109.421 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.53 146.23 31.41 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.218 -0.926 . . . . 0.0 110.598 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.63 -3.16 80.17 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.132 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -55.59 115.83 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.403 1.481 . . . . 0.0 108.211 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' HG1' ' A' ' 32' ' ' THR . 2.8 tm? -75.26 98.13 3.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.56 119.73 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.525 1.53 . . . . 0.0 108.229 177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.18 -52.15 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.038 1.735 . . . . 0.0 109.123 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.03 143.65 44.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.879 1.272 . . . . 0.0 108.543 -169.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.7 mt -131.21 134.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.961 1.304 . . . . 0.0 107.574 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 39.95 47.99 2.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.787 2.035 . . . . 0.0 110.402 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 66.41 13.19 9.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.261 1.425 . . . . 0.0 112.79 171.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.01 130.18 46.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.884 1.673 . . . . 0.0 107.828 167.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -58.21 123.87 17.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.994 0.918 . . . . 0.0 110.476 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.29 -3.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 118.176 -0.916 . . . . 0.0 113.251 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -54.21 -37.03 64.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.48 1.491 . . . . 0.0 112.502 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -97.51 2.28 49.97 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.327 1.051 . . . . 0.0 111.649 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.7 mt -87.5 160.77 18.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.155 0.982 . . . . 0.0 108.894 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 152.26 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -41.14 -52.51 3.27 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.675 1.59 . . . . 0.0 111.715 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.5 m -56.97 -42.28 79.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.149 1.379 . . . . 0.0 112.224 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -64.19 -38.22 90.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -69.8 -51.47 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.567 0.747 . . . . 0.0 109.473 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.86 -38.03 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.172 1.389 . . . . 0.0 110.268 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.41 -34.47 70.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.048 0.842 . . . . 0.0 111.97 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -54.31 -60.3 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.5 -31.61 64.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 174.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.07 -50.94 68.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 121.109 1.777 . . . . 0.0 108.736 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.68 -35.28 75.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.14 0.976 . . . . 0.0 111.455 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 50.6 m -56.64 144.28 65.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.574 0.749 . . . . 0.0 112.704 -169.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.36 123.44 10.24 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.454 3.436 . . . . 0.0 112.311 -172.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mm -59.29 131.58 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.5 26.57 72.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.462 1.029 . . . . 0.0 112.988 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -103.84 157.44 17.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 154.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.83 152.69 30.92 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.196 152.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.2 m -139.97 125.68 19.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -89.36 119.44 29.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -166.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.27 154.94 35.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.7 mt -134.04 129.81 54.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pp -119.69 167.39 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 108.122 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.29 -120.32 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 110.93 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 59.28 -107.22 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.508 1.923 . . . . 0.0 110.791 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.89 60.71 8.39 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.832 1.206 . . . . 0.0 112.024 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m -137.36 -25.94 1.02 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.16 174.24 0.27 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.159 1.361 . . . . 0.0 113.593 -167.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -84.53 -179.29 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.644 2.896 . . . . 0.0 109.597 166.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m 51.19 67.03 1.01 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.387 1.475 . . . . 0.0 111.308 -174.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.3 t -77.8 177.87 7.84 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 151.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.785 0 C-N-CA 126.204 1.859 . . . . 0.0 108.774 -174.902 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m 67.72 173.12 0.27 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.58 1.952 . . . . 0.0 111.398 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.0 p -150.3 159.17 44.64 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.828 -0.545 . . . . 0.0 111.569 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.31 128.87 1.42 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.237 1.398 . . . . 0.0 112.435 173.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 m 45.08 -81.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 128.274 2.63 . . . . 0.0 114.484 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -56.45 144.58 30.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.229 1.377 . . . . 0.0 108.263 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.66 -178.71 48.58 Favored Glycine 0 N--CA 1.449 -0.453 0 O-C-N 120.573 -1.329 . . . . 0.0 110.094 -168.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -156.16 147.93 22.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -168.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.06 161.66 0.13 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.478 2.711 . . . . 0.0 111.731 -164.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.55 100.83 2.89 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -170.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -132.29 178.0 7.15 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.737 1.615 . . . . 0.0 109.175 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mtm -113.92 154.73 27.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.004 0.922 . . . . 0.0 109.309 168.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.9 m -131.06 134.58 46.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.31 167.73 22.15 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.035 1.734 . . . . 0.0 108.62 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -122.97 153.06 40.26 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 pt -139.9 155.39 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.203 1.801 . . . . 0.0 110.013 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.26 99.31 4.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.011 1.725 . . . . 0.0 107.968 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 53.2 tttt -53.64 109.17 0.42 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.268 2.227 . . . . 0.0 111.617 -174.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.35 33.44 4.32 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.15 1.357 . . . . 0.0 115.862 -163.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . 59.56 162.41 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.387 2.275 . . . . 0.0 113.69 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 52.32 -10.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.249 1.82 . . . . 0.0 114.854 -153.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 147.39 -155.58 26.57 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -83.96 152.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 153.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.57 -56.0 26.83 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -54.75 159.94 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.488 1.137 . . . . 0.0 111.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.5 p -128.65 161.44 29.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.882 1.673 . . . . 0.0 108.368 -172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.2 162.97 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 122.066 0.936 . . . . 0.0 109.758 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.98 146.97 39.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.017 1.327 . . . . 0.0 107.864 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.57 136.01 47.26 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.253 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 p -133.74 165.72 34.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.61 -12.74 35.54 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.085 1.857 . . . . 0.0 112.574 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.435 ' HG1' ' CD1' ' A' ' 53' ' ' LEU . 7.5 p -109.36 5.63 23.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.44 1.496 . . . . 0.0 111.817 -168.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.0 -159.47 15.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -165.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -87.44 152.58 22.12 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.274 -1.133 . . . . 0.0 110.274 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -120.51 158.93 26.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 109.552 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.33 119.09 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -69.06 -68.89 0.37 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 171.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -151.98 151.89 31.78 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -174.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.26 92.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.4 mt -82.78 -18.44 40.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.117 1.367 . . . . 0.0 112.162 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -124.06 91.58 3.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.04 -29.21 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.499 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -73.65 -60.25 2.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.631 0.772 . . . . 0.0 110.003 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -5.01 87.68 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 123.694 0.664 . . . . 0.0 112.663 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 12.0 m -120.02 66.18 10.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.976 1.388 . . . . 0.0 107.759 165.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.38 146.58 56.78 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.624 2.216 . . . . 0.0 110.404 -170.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.14 -7.89 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.941 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 tt -73.86 132.81 42.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.7 m -110.98 155.02 23.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 123.416 1.579 . . . . 0.0 110.415 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.35 148.38 51.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.579 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.18 8.83 12.77 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 117.841 -1.533 . . . . 0.0 116.098 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -59.98 139.45 57.42 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.8 1.8 . . . . 0.0 109.219 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.435 ' CD1' ' HG1' ' A' ' 32' ' ' THR . 4.3 tp -91.75 129.39 37.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.862 1.665 . . . . 0.0 110.34 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mt -81.66 130.1 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.844 0.858 . . . . 0.0 110.598 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -116.25 -55.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.265 1.826 . . . . 0.0 109.205 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -125.29 152.92 44.03 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.55 135.08 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 157.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 33.57 56.66 0.54 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.411 2.685 . . . . 0.0 113.351 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 61.29 25.92 15.83 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -121.51 129.49 52.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 170.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -72.46 126.62 30.3 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.277 0.631 . . . . 0.0 111.018 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.2 m -128.76 17.47 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.98 0.912 . . . . 0.0 112.272 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.8 -15.98 62.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.931 -1.106 . . . . 0.0 112.196 173.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.33 17.32 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.429 1.892 . . . . 0.0 110.664 -169.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.7 mt -110.66 147.19 34.83 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.095 -1.003 . . . . 0.0 111.173 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.1 m -75.12 147.5 40.47 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 117.173 -1.394 . . . . 0.0 108.115 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.587 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 70.1 t60 -42.99 -34.21 0.95 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.774 2.029 . . . . 0.0 113.943 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.69 -34.01 76.91 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 120.969 -1.082 . . . . 0.0 112.208 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.02 -49.09 16.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.248 2.219 . . . . 0.0 110.748 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -59.4 -42.62 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 1 C-N-CA 132.589 4.355 . . . . 0.0 111.896 172.518 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.6 -50.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 167.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.51 -40.97 93.34 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.603 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mt -59.34 -50.68 78.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.949 1.3 . . . . 0.0 109.918 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -60.94 -28.87 69.28 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.876 -0.515 . . . . 0.0 110.144 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -72.77 -42.19 64.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.672 -1.268 . . . . 0.0 109.632 174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -68.32 -16.49 63.97 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.39 1.45 . . . . 0.0 112.852 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -60.61 140.49 92.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 O-C-N 121.17 -0.956 . . . . 0.0 110.004 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -58.62 142.92 98.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.609 3.54 . . . . 0.0 111.501 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.07 136.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 159.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.22 51.47 54.71 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 123.293 0.37 . . . . 0.0 112.358 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.2 m -150.03 151.49 33.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -61.89 102.31 0.26 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.862 1.265 . . . . 0.0 109.461 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.6 m -83.04 146.11 28.91 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 160.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.6 m -120.56 131.2 54.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mp -127.04 149.93 49.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.87 126.11 73.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.58 154.48 27.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.004 0.907 . . . . 0.0 110.814 -175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -91.25 80.24 5.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.514 -170.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.88 -155.67 0.19 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.941 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.75 -6.11 4.46 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 119.678 1.126 . . . . 0.0 114.774 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -115.96 -65.18 1.22 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.109 1.454 . . . . 0.0 110.773 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.11 -160.02 26.21 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 118.863 0.756 . . . . 0.0 111.634 -174.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.7 166.92 25.91 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.677 1.585 . . . . 0.0 111.416 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 46.99 59.57 3.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.421 1.888 . . . . 0.0 112.81 165.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 m -89.17 -30.96 18.19 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.586 0.755 . . . . 0.0 112.335 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.463 0 C-N-CA 126.058 1.789 . . . . 0.0 110.054 178.13 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.235 0.316 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtm -89.07 113.88 25.06 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.734 -169.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.5 m -78.1 137.31 38.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 159.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -131.42 161.77 31.71 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -119.81 144.89 47.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.819 HG22 ' HA ' ' A' ' 45' ' ' CYS . 21.7 pt -138.89 162.81 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.368 1.467 . . . . 0.0 109.333 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.4 t -132.14 137.28 55.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.894 0.854 . . . . 0.0 108.713 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -97.62 85.56 3.62 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 121.883 -0.511 . . . . 0.0 111.569 -166.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.32 -69.25 1.23 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.579 0.609 . . . . 0.0 114.445 -166.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.64 -62.41 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.247 1.419 . . . . 0.0 109.183 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -65.1 6.4 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.997 2.519 . . . . 0.0 114.653 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.63 71.6 1.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 63.54 173.06 0.17 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.499 1.919 . . . . 0.0 111.188 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.54 49.1 0.87 Allowed Glycine 0 C--O 1.222 -0.605 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -157.97 163.55 37.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.7 p -121.17 161.75 21.32 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.381 1.072 . . . . 0.0 108.805 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 pt -123.34 162.94 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.061 0.934 . . . . 0.0 110.132 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.77 140.31 40.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 107.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.75 121.04 18.22 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 p -110.2 168.47 7.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -64.97 -10.52 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.507 1.471 . . . . 0.0 112.224 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 p -114.58 7.2 16.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 112.758 -170.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.52 -172.5 15.76 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -171.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.437 ' HG2' HG21 ' A' ' 70' ' ' VAL . 43.3 mm-40 -77.07 149.98 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.666 -0.902 . . . . 0.0 108.751 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -130.17 164.02 25.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.588 1.155 . . . . 0.0 108.498 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.52 122.39 22.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -73.99 -62.33 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -154.66 145.58 22.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.19 136.64 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.7 mt -119.63 -8.94 9.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 111.313 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -155.81 108.51 2.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.362 2.265 . . . . 0.0 106.842 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.97 -53.7 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.16 0.984 . . . . 0.0 110.07 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -72.86 -4.19 30.31 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.065 -1.022 . . . . 0.0 112.521 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.77 -16.17 79.31 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.15 -0.969 . . . . 0.0 111.797 163.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.819 ' HA ' HG22 ' A' ' 16' ' ' ILE . 25.7 p -150.23 57.99 2.9 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 118.956 1.378 . . . . 0.0 113.541 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.27 112.32 1.53 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.342 2.028 . . . . 0.0 111.534 -170.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.75 -5.96 37.57 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.514 1.53 . . . . 0.0 113.62 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.81 139.37 41.72 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.377 1.589 . . . . 0.0 109.795 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.8 m -123.82 9.84 8.88 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 66.2 152.3 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.056 2.142 . . . . 0.0 112.784 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.88 -3.0 0.17 Allowed Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.896 1.236 . . . . 0.0 115.31 -170.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.98 158.43 19.34 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.286 2.043 . . . . 0.0 109.718 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.86 114.11 26.85 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.626 1.57 . . . . 0.0 109.978 -161.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 62' ' ' VAL . 53.1 mt -65.26 129.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.812 1.245 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 62' ' ' VAL . 59.8 t -124.78 -51.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.429 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.5 145.54 51.87 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.834 1.652 . . . . 0.0 109.873 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.6 mt -125.06 122.26 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 45.05 42.26 6.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.264 1.426 . . . . 0.0 111.656 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 65.76 8.39 5.22 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.177 1.391 . . . . 0.0 113.609 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -77.68 138.6 39.16 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.641 -1.287 . . . . 0.0 108.031 163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.67 116.86 22.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.672 2.389 . . . . 0.0 108.33 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG12 HD22 ' A' ' 65' ' ' LEU . 7.2 m -135.53 13.61 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 125.449 1.5 . . . . 0.0 112.016 -169.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -57.44 -55.41 35.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 118.319 -2.738 . . . . 0.0 112.562 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -81.45 -6.77 59.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.596 0.758 . . . . 0.0 111.095 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.679 HD22 HG12 ' A' ' 62' ' ' VAL . 6.4 mp -64.46 135.17 55.81 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.28 1.832 . . . . 0.0 111.203 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -63.41 160.81 15.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.037 171.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -48.77 -49.57 38.01 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.25 0.62 . . . . 0.0 111.012 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -42.92 73.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.043 1.737 . . . . 0.0 112.227 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.442 1.497 . . . . 0.0 108.069 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 34' ' ' GLN . 62.6 t -68.22 -43.76 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 110.617 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.33 -42.58 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 124.26 1.024 . . . . 0.0 109.926 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -44.47 91.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.183 0.993 . . . . 0.0 110.156 -176.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.04 -44.48 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.519 -0.738 . . . . 0.0 109.146 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.5 -23.73 66.96 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.57 -0.706 . . . . 0.0 111.571 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -72.95 -42.92 62.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.943 1.247 . . . . 0.0 109.977 171.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -55.55 -35.45 65.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.109 0.868 . . . . 0.0 110.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 81.9 m -54.67 138.8 61.38 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.3 141.14 55.52 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.827 3.685 . . . . 0.0 110.814 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mm -70.86 142.28 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.97 -2.08 28.16 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.446 1.974 . . . . 0.0 113.385 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.4 m -103.01 165.02 11.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.076 1.35 . . . . 0.0 107.862 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -69.21 153.35 43.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 123.128 1.442 . . . . 0.0 111.216 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -140.6 141.46 35.16 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.061 2.144 . . . . 0.0 105.653 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 m -112.62 115.9 29.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.406 HD13 HD11 ' A' ' 16' ' ' ILE . 6.1 mp -113.04 153.01 28.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mt -126.55 122.41 60.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.72 164.14 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.708 0.803 . . . . 0.0 110.764 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -84.13 124.02 30.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.383 0.673 . . . . 0.0 111.13 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 108.471 176.29 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 mtm -88.78 150.06 23.12 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.9 m -116.04 148.29 40.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -145.46 168.3 20.88 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 128.62 2.768 . . . . 0.0 107.457 -172.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.12 153.97 51.03 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.247 -0.908 . . . . 0.0 108.591 170.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.0 pt -134.07 167.38 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 126.461 1.905 . . . . 0.0 109.227 173.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.7 139.67 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HG2' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.24 152.56 40.98 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 176.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.09 74.72 0.28 Allowed Glycine 0 C--O 1.238 0.377 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.27 -166.92 0.08 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.051 1.34 . . . . 0.0 111.157 -167.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 40.47 9.7 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 131.579 3.952 . . . . 0.0 118.643 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.16 67.93 1.86 Allowed Glycine 0 N--CA 1.445 -0.736 0 O-C-N 120.65 -1.281 . . . . 0.0 110.553 -165.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CE1' HD22 ' A' ' 74' ' ' LEU . 23.1 m-85 63.75 174.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.227 2.211 . . . . 0.0 111.544 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.81 34.96 4.95 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.545 1.545 . . . . 0.0 110.233 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -140.89 167.03 23.17 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 p -129.96 151.38 50.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.6 pt -114.22 144.96 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.77 131.36 46.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.09 144.41 50.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.6 p -138.57 167.0 21.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 127.676 2.391 . . . . 0.0 105.567 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.71 -36.45 97.13 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 p -79.0 -28.39 43.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.576 1.95 . . . . 0.0 111.684 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.99 -134.34 4.79 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -162.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -106.63 147.2 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.952 . . . . 0.0 110.094 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -146.78 161.13 41.28 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.234 1.014 . . . . 0.0 108.342 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -77.26 114.49 17.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -63.37 -61.36 2.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.105 1.362 . . . . 0.0 108.759 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -157.08 154.23 29.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.86 114.25 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.9 mt -87.63 -25.11 23.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.798 0.839 . . . . 0.0 110.106 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -150.1 96.15 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.011 1.724 . . . . 0.0 107.598 -169.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 mt -60.47 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 109.949 -166.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -64.12 -12.39 39.0 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.48 -34.96 63.22 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 119.232 0.924 . . . . 0.0 111.426 170.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.493 ' HA ' HG22 ' A' ' 16' ' ' ILE . 79.3 m -126.87 67.64 69.19 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.467 1.107 . . . . 0.0 108.703 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.55 132.92 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.38 2.053 . . . . 0.0 109.124 -172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.05 -3.4 71.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.259 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.94 135.08 49.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.22 1.51 . . . . 0.0 107.003 166.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.7 m -137.17 131.69 32.88 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.85 153.47 41.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.245 0.618 . . . . 0.0 111.89 -163.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.94 37.14 93.92 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -166.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.48 -173.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.081 1.352 . . . . 0.0 110.389 160.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.38 122.45 20.25 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 154.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.7 mt -69.52 129.51 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.28 -58.08 2.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.521 1.128 . . . . 0.0 111.425 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 22.1 mt-10 -136.61 131.67 34.05 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.19 127.24 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 45.55 38.56 4.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.105 1.762 . . . . 0.0 111.575 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 61.1 18.47 9.04 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.14 1.776 . . . . 0.0 114.056 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -92.49 135.52 33.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 156.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 23.1 t-20 -80.83 138.62 36.22 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.227 0.536 . . . . 0.0 110.067 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.798 HG12 HD22 ' A' ' 65' ' ' LEU . 16.6 m -137.89 10.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 126.35 1.86 . . . . 0.0 108.347 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -24.51 66.99 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 119.265 -2.147 . . . . 0.0 112.477 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.55 -13.01 16.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.137 0.88 . . . . 0.0 110.598 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.798 HD22 HG12 ' A' ' 62' ' ' VAL . 5.6 mp -59.38 127.73 33.57 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 126.366 1.866 . . . . 0.0 111.67 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.09 162.11 3.65 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.362 1.039 . . . . 0.0 110.316 176.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -49.85 -48.33 51.18 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.169 0.588 . . . . 0.0 109.989 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -58.38 -36.13 73.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.724 1.21 . . . . 0.0 111.848 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.45 -47.71 54.08 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.198 1.399 . . . . 0.0 107.818 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.03 -46.48 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.937 0.895 . . . . 0.0 109.462 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.07 -42.83 91.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.886 0.874 . . . . 0.0 110.851 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -67.59 -30.73 70.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.42 0.688 . . . . 0.0 111.914 -177.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.25 -40.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 23' ' ' PHE . 35.6 mt -62.03 -27.59 68.99 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.001 -1.062 . . . . 0.0 110.773 172.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 8.6 mtpm? -69.6 -29.91 67.54 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.653 -1.279 . . . . 0.0 111.863 172.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.72 -22.45 53.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.213 0.915 . . . . 0.0 111.24 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.57 132.88 91.24 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 118.974 0.806 . . . . 0.0 110.476 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.19 132.45 46.95 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.526 2.818 . . . . 0.0 109.595 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.43 HD13 ' HG2' ' A' ' 18' ' ' LYS . 3.2 mm -72.13 106.84 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.85 6.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.059 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -136.09 163.34 30.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 118.839 1.32 . . . . 0.0 109.736 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.31 143.65 57.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.28 1.038 . . . . 0.0 111.025 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -131.03 135.17 47.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.478 1.911 . . . . 0.0 105.929 171.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 m -111.5 128.38 55.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -164.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -129.23 137.09 50.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -112.15 129.94 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.81 145.61 35.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 109.711 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.04 99.84 4.73 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 109.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 . . . . . 0 C--O 1.232 0.161 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 172.746 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 mtm -106.7 118.03 35.61 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.771 0.796 . . . . 0.0 109.682 174.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.3 m -84.33 143.69 29.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.6 mt -143.87 168.08 20.8 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.089 2.156 . . . . 0.0 106.351 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.6 m -127.47 148.5 50.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.167 0.987 . . . . 0.0 109.169 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 45' ' ' CYS . 15.7 pt -139.68 160.03 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.846 1.258 . . . . 0.0 111.126 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.1 t -129.06 113.69 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 123.011 1.386 . . . . 0.0 108.615 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.65 102.82 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.08 2.152 . . . . 0.0 108.643 168.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.83 -62.31 3.88 Favored Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.32 -62.44 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 109.225 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.0 51.35 0.5 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.42 2.288 . . . . 0.0 111.913 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.66 47.47 12.98 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.113 1.816 . . . . 0.0 113.597 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 84.9 -11.46 0.78 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 130.54 3.536 . . . . 0.0 113.72 174.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -60.6 1.95 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.86 1.209 . . . . 0.0 111.552 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -49.4 151.05 1.63 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.051 1.426 . . . . 0.0 110.38 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -125.18 159.48 31.43 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -171.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 pt -126.87 152.44 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.526 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.93 137.24 49.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.745 1.218 . . . . 0.0 109.453 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -71.65 124.46 24.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 126.064 1.745 . . . . 0.0 109.389 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 p -120.69 159.75 47.22 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -58.91 -28.87 88.74 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.388 2.725 . . . . 0.0 111.878 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 p -98.23 -5.63 32.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.238 2.615 . . . . 0.0 113.61 -168.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.59 173.72 17.11 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -76.72 145.52 38.62 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.411 -1.052 . . . . 0.0 109.461 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -129.15 151.07 50.23 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.25 108.44 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -66.72 -62.25 1.55 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -155.06 143.19 20.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -90.98 126.61 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 127.044 2.138 . . . . 0.0 106.211 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.7 mt -110.78 -17.95 13.24 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.319 0.648 . . . . 0.0 111.029 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -133.96 77.21 1.7 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.315 1.446 . . . . 0.0 108.165 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.53 -39.61 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.658 1.183 . . . . 0.0 111.222 -169.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -10.4 59.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.87 -15.9 66.61 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 119.27 0.941 . . . . 0.0 111.798 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.631 ' HA ' HG22 ' A' ' 16' ' ' ILE . 48.0 m -130.77 70.73 82.55 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 118.56 1.18 . . . . 0.0 109.91 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -60.42 121.56 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.758 2.972 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.85 71.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.687 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.58 144.81 56.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.325 1.562 . . . . 0.0 109.822 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.0 m -129.53 161.78 29.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.89 1.328 . . . . 0.0 110.444 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.56 136.17 57.76 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.449 1.5 . . . . 0.0 108.261 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.22 17.77 70.5 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.565 1.555 . . . . 0.0 115.044 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.76 101.42 0.64 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.16 1.98 . . . . 0.0 111.405 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.69 114.26 6.89 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.531 1.932 . . . . 0.0 111.09 -167.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.55 134.38 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.607 1.094 . . . . 0.0 110.545 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HG2' ' A' ' 63' ' ' GLN . 73.9 t -119.55 -49.51 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.232 1.413 . . . . 0.0 110.062 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.89 146.11 49.97 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.545 0.688 . . . . 0.0 109.549 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -121.29 135.58 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 153.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 32.28 54.42 0.33 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.638 2.375 . . . . 0.0 113.306 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 47.78 4.49 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 130.421 3.488 . . . . 0.0 118.813 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -26.16 67.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.059 1.754 . . . . 0.0 113.055 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 65.88 126.42 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 130.299 3.44 . . . . 0.0 111.336 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.607 HG12 HD22 ' A' ' 65' ' ' LEU . 12.5 m -134.87 20.78 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.644 1.978 . . . . 0.0 108.49 -163.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -62.99 -59.94 4.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 119.5 -2.0 . . . . 0.0 112.343 173.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -76.89 -12.17 59.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.159 0.583 . . . . 0.0 111.794 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.607 HD22 HG12 ' A' ' 62' ' ' VAL . 6.0 mp -56.93 131.6 50.16 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 126.119 1.768 . . . . 0.0 110.396 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 160.14 15.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.474 174.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -43.24 -50.85 6.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.834 0.854 . . . . 0.0 110.53 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.1 m -60.39 -32.72 71.58 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.814 0.846 . . . . 0.0 112.016 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.39 -45.25 60.56 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.23 -38.22 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.402 0.681 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.9 -52.07 65.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.049 1.34 . . . . 0.0 109.743 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.23 -39.6 93.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.618 1.167 . . . . 0.0 109.942 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.2 mt -56.92 -55.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.65 1.18 . . . . 0.0 110.14 169.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.8 -21.98 66.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.411 0.551 . . . . 0.0 111.604 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -70.66 -40.82 72.79 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.543 -1.348 . . . . 0.0 110.226 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -74.31 -21.7 59.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.921 0.889 . . . . 0.0 113.272 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.8 m -55.09 128.79 66.34 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 168.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -61.89 140.07 83.18 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.761 2.974 . . . . 0.0 111.689 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.01 117.28 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.68 49.65 5.32 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -145.63 155.49 43.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.939 -1.33 . . . . 0.0 108.681 160.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -70.17 129.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 168.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -101.89 142.75 32.7 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.524 1.529 . . . . 0.0 107.414 165.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -104.89 126.8 52.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.15 156.99 47.33 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.83 135.11 63.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.42 159.34 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 110.17 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -81.84 122.59 27.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.162 0.585 . . . . 0.0 110.826 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 N--CA 1.461 0.115 0 C-N-CA 123.876 0.87 . . . . 0.0 111.738 173.72 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.238 0.469 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.8 mtm -111.11 114.82 28.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.201 1.0 . . . . 0.0 109.07 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.1 m -83.72 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 168.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.5 mt -138.99 168.67 19.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.136 2.174 . . . . 0.0 107.258 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 82' ' ' GLU . 11.7 m -123.09 149.85 43.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 45' ' ' CYS . 24.9 pt -130.82 154.37 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.898 1.679 . . . . 0.0 108.637 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 104.6 3.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -68.85 118.09 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.998 1.719 . . . . 0.0 109.629 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.84 -63.29 2.22 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.176 0.893 . . . . 0.0 111.007 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.34 -58.11 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.396 1.078 . . . . 0.0 110.87 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -76.69 56.54 1.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.879 2.072 . . . . 0.0 110.138 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.76 61.59 2.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.178 1.371 . . . . 0.0 111.796 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 69.69 -71.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 126.988 2.115 . . . . 0.0 109.418 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.21 -52.4 0.66 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.09 158.68 1.05 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.647 1.213 . . . . 0.0 111.76 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.3 p -115.51 151.92 33.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.252 -173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.1 159.92 16.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.96 129.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.146 2.578 . . . . 0.0 106.603 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.77 128.35 35.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 p -122.99 168.4 12.17 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.509 1.124 . . . . 0.0 108.081 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.01 -35.56 92.66 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.238 2.625 . . . . 0.0 110.595 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -82.37 6.81 15.88 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.221 2.209 . . . . 0.0 113.367 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.47 -157.02 18.35 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -84.76 141.45 30.52 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.788 -0.83 . . . . 0.0 110.176 -169.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -132.02 165.56 23.69 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.639 1.176 . . . . 0.0 108.74 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -89.38 124.44 42.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -73.71 -68.4 0.51 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.114 1.366 . . . . 0.0 108.663 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -155.06 137.93 15.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.1 mt -85.09 129.21 38.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 mt -108.57 -8.11 15.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.576 0.75 . . . . 0.0 111.225 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -149.64 114.17 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.44 -55.93 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.571 1.148 . . . . 0.0 110.055 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -57.16 -32.73 66.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.931 0.787 . . . . 0.0 110.889 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.04 75.03 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 123.413 0.53 . . . . 0.0 113.287 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.567 ' HA ' HG22 ' A' ' 16' ' ' ILE . 59.7 m -132.94 73.34 75.74 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 119.132 1.466 . . . . 0.0 111.159 -175.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.95 110.55 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.718 1 C-N-CA 125.971 4.447 . . . . 0.0 115.671 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.82 55.25 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.061 -1.025 . . . . 0.0 113.446 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 49' ' ' CYS . 1.7 tm? -55.73 152.92 8.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.769 2.027 . . . . 0.0 109.768 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.552 ' N ' HD13 ' A' ' 48' ' ' LEU . 57.2 m -144.69 151.12 38.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.108 1.363 . . . . 0.0 111.515 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -60.39 142.65 54.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.693 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.52 10.3 48.31 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.886 -2.063 . . . . 0.0 114.712 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -53.86 115.96 2.28 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.614 1.707 . . . . 0.0 106.405 166.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.54 103.62 8.6 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.85 143.59 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.514 1.052 . . . . 0.0 109.043 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 63' ' ' GLN . 57.8 t -130.46 -52.24 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.294 1.038 . . . . 0.0 110.021 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -130.05 145.72 51.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -126.49 125.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.45 38.99 11.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.153 2.181 . . . . 0.0 110.551 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 72.77 -1.42 3.01 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.956 2.102 . . . . 0.0 113.263 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -78.85 135.47 37.04 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.744 -1.222 . . . . 0.0 108.066 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -71.8 121.53 19.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.977 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.411 ' HB ' HG22 ' A' ' 70' ' ' VAL . 32.6 m -121.88 6.37 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 111.913 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.429 ' HG3' HG13 ' A' ' 55' ' ' VAL . 19.1 mt-30 -59.97 -45.12 93.73 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.289 1.404 . . . . 0.0 110.097 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -88.27 24.86 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.574 1.549 . . . . 0.0 111.384 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.83 140.62 52.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.483 1.513 . . . . 0.0 110.133 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.8 m -67.93 158.23 33.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.596 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -47.57 -51.55 20.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.057 0.943 . . . . 0.0 110.996 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.6 m -67.1 -27.03 67.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.828 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.8 -43.53 71.93 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.471 1.032 . . . . 0.0 108.965 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -66.1 -36.97 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.154 -0.966 . . . . 0.0 110.325 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.8 t -57.74 -47.72 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.58 0.752 . . . . 0.0 109.411 169.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.9 -30.61 69.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.022 0.915 . . . . 0.0 112.575 -172.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.4 mt -67.88 -48.15 76.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.21 -25.26 67.7 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.959 -1.088 . . . . 0.0 111.893 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -74.39 -35.33 63.48 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.345 -1.472 . . . . 0.0 110.808 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.68 -49.72 56.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.974 0.806 . . . . 0.0 108.944 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.7 m -42.03 115.33 1.5 Allowed Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.696 1.599 . . . . 0.0 112.376 -170.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.88 127.61 25.79 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.913 3.075 . . . . 0.0 107.391 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.73 141.09 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.43 16.19 48.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.805 1.669 . . . . 0.0 114.019 -171.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.8 t -87.28 160.68 18.33 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.691 1.745 . . . . 0.0 106.975 164.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 15' ' ' THR . 0.0 OUTLIER -80.29 135.45 36.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.419 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.9 m -120.52 109.8 15.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -87.05 104.28 16.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.904 2.482 . . . . 0.0 108.474 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.29 160.27 14.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.394 0.543 . . . . 0.0 109.565 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.74 130.76 68.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.32 150.56 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.5 1.12 . . . . 0.0 108.853 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 116.98 22.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.041 1.736 . . . . 0.0 108.55 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.41 ' CE ' HD11 ' A' ' 87' ' ' ILE . 3.9 mtp -131.48 114.71 15.25 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.739 1.216 . . . . 0.0 108.383 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 m -78.27 142.77 37.58 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 164.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.2 mt -142.84 168.48 19.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.78 2.432 . . . . 0.0 107.006 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.86 155.6 37.75 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.14 -0.975 . . . . 0.0 108.731 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 45' ' ' CYS . 15.3 pt -132.83 169.85 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 t -115.65 151.14 17.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 162.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 56.9 tttt -70.02 165.4 21.91 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.809 -1.182 . . . . 0.0 110.091 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -136.62 165.61 24.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.07 -24.25 60.65 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -165.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -75.89 12.86 0.97 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.222 1.374 . . . . 0.0 111.004 165.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 72.71 69.71 1.35 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.729 1.633 . . . . 0.0 109.817 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 77.0 168.08 0.24 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.69 2.796 . . . . 0.0 111.236 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.86 28.16 9.11 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.152 1.834 . . . . 0.0 111.71 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -138.45 172.92 12.18 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.2 p -131.01 146.8 52.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.134 1.374 . . . . 0.0 108.039 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.48 152.17 19.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -126.48 154.16 44.11 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.53 1.932 . . . . 0.0 108.032 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.06 128.62 36.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.538 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 p -121.79 159.01 52.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 11.33 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.037 3.158 . . . . 0.0 114.332 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.4 p -127.18 -6.1 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.38 0.991 . . . . 0.0 112.863 -168.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.56 170.0 12.6 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -160.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -72.95 151.44 41.85 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.497 -1.002 . . . . 0.0 110.0 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -139.63 161.04 38.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.835 0.826 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 48' ' ' LEU . 51.0 t -78.39 122.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 125.547 1.539 . . . . 0.0 107.88 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -71.59 -55.93 6.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.608 162.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -162.24 146.13 12.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.244 0.474 . . . . 0.0 110.476 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.85 93.72 2.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.3 mt -70.57 -28.08 64.62 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.286 1.034 . . . . 0.0 109.945 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -136.78 91.09 2.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.214 1.406 . . . . 0.0 109.674 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.62 -41.57 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 123.67 0.788 . . . . 0.0 110.322 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -71.46 -5.16 30.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.128 -0.983 . . . . 0.0 113.13 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -23.47 28.04 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.636 1.107 . . . . 0.0 111.471 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.442 ' HA ' HG22 ' A' ' 16' ' ' ILE . 84.2 m -136.14 67.47 62.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 109.857 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 136.38 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.326 2.017 . . . . 0.0 111.75 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.82 -9.25 3.82 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.266 -1.296 . . . . 0.0 115.295 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' CD2' HG21 ' A' ' 36' ' ' VAL . 5.6 tt -61.56 145.49 51.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.216 1.508 . . . . 0.0 108.956 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.9 m -110.94 147.24 35.07 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.93 0.892 . . . . 0.0 111.527 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.76 151.0 42.33 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.92 44.84 7.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.388 0.994 . . . . 0.0 111.805 -170.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.15 -174.99 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.65 1.98 . . . . 0.0 109.615 159.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.45 104.03 4.34 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 119.801 -1.812 . . . . 0.0 106.665 163.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.13 131.47 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.24 -50.37 4.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.129 1.372 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -136.53 143.79 43.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.86 125.28 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.509 -2.775 . . . . 0.0 103.509 168.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 44.8 51.91 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.21 1.404 . . . . 0.0 111.258 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 65.64 -24.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.978 2.511 . . . . 0.0 115.094 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -69.31 135.79 50.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.55 118.65 36.8 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.429 -157.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.484 HG12 HD12 ' A' ' 65' ' ' LEU . 34.6 m -125.05 2.14 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.516 -156.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -14.98 0.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.543 1.137 . . . . 0.0 113.156 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.96 6.81 6.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.061 2.544 . . . . 0.0 112.828 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.484 HD12 HG12 ' A' ' 62' ' ' VAL . 23.8 mt -90.28 160.57 16.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.174 1.352 . . . . 0.0 110.101 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -83.87 162.77 20.42 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.95 0.5 . . . . 0.0 110.831 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -49.21 -51.43 33.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -59.05 -35.63 73.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.381 0.673 . . . . 0.0 111.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -74.49 -39.99 62.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.85 -41.85 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.41 -46.4 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.79 1.236 . . . . 0.0 110.37 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -38.78 70.37 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.595 0.56 . . . . 0.0 111.732 -171.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.26 -44.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.226 1.01 . . . . 0.0 109.315 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.59 -32.75 74.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.757 -0.59 . . . . 0.0 110.761 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -64.2 -42.11 96.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.049 1.295 . . . . 0.0 109.847 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.63 -20.25 65.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.526 1.53 . . . . 0.0 112.678 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.55 143.31 93.62 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 124.797 1.239 . . . . 0.0 110.578 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 142.45 49.05 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 124.447 3.431 . . . . 0.0 111.049 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.37 144.69 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.9 -1.08 64.0 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.892 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.45 158.09 16.71 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 119.703 1.751 . . . . 0.0 107.474 173.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.21 153.73 37.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.978 0.911 . . . . 0.0 111.034 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 m -126.21 128.26 46.95 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.737 1.615 . . . . 0.0 106.795 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -80.06 126.32 30.91 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.25 152.19 40.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.04 128.6 59.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 ' CE ' ' A' ' 12' ' ' MET . 1.3 pp -125.83 164.56 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.33 1.052 . . . . 0.0 110.546 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 118.7 36.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.651 0.78 . . . . 0.0 110.887 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 0.0 109.399 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.232 0.174 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtm -128.16 146.07 50.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.074 0.95 . . . . 0.0 108.954 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -122.56 112.21 17.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -117.69 168.3 10.57 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.215 2.206 . . . . 0.0 108.464 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.8 m -133.66 150.03 51.56 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.837 -0.539 . . . . 0.0 109.601 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.657 HG22 ' HA ' ' A' ' 45' ' ' CYS . 5.4 pt -140.13 145.7 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.651 1.18 . . . . 0.0 110.258 173.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.91 118.5 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 9.6 tttt -56.08 129.92 41.95 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.166 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.05 -81.99 0.63 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.91 143.69 20.75 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.659 1.184 . . . . 0.0 108.522 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 55.71 -3.31 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.294 3.038 . . . . 0.0 115.557 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 163.26 -177.3 39.29 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -92.66 3.81 54.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.236 1.014 . . . . 0.0 111.088 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.11 -52.85 3.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.751 -1.218 . . . . 0.0 112.066 -172.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -61.67 166.75 4.01 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 123.165 1.459 . . . . 0.0 111.886 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 p -126.9 151.33 48.58 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.235 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.9 171.45 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.65 161.52 36.27 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.181 1.393 . . . . 0.0 109.207 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 143.49 45.64 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 p -130.17 176.68 2.66 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.28 -19.1 62.1 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.319 2.013 . . . . 0.0 112.166 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p -109.47 3.27 21.16 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.529 1.132 . . . . 0.0 112.496 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.11 -163.17 12.4 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.722 ' HG3' HG21 ' A' ' 70' ' ' VAL . 4.1 mm100 -82.3 145.57 29.9 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.835 0.817 . . . . 0.0 109.986 -167.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -131.69 156.65 45.52 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.265 0.626 . . . . 0.0 109.369 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.17 140.67 17.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 171.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -106.09 -64.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.036 1.335 . . . . 0.0 108.581 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -142.84 134.45 26.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.74 136.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.742 1.617 . . . . 0.0 107.298 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -122.26 -50.57 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.955 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -93.23 95.26 9.26 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.9 mt -65.53 -54.28 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.256 1.822 . . . . 0.0 109.975 -171.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -60.0 -28.32 67.62 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.702 0.683 . . . . 0.0 111.067 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.15 -25.62 72.28 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 118.024 -1.431 . . . . 0.0 112.277 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.657 ' HA ' HG22 ' A' ' 16' ' ' ILE . 4.7 m -140.31 75.9 27.07 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 119.686 1.743 . . . . 0.0 112.42 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.77 154.8 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.135 2.557 . . . . 0.0 110.218 170.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.82 -45.1 2.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.753 1.168 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.57 132.05 30.01 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.093 2.157 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.44 -173.3 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.076 1.351 . . . . 0.0 109.038 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.17 104.72 14.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.49 -15.67 3.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.946 1.736 . . . . 0.0 111.653 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.51 105.53 0.11 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 128.416 2.686 . . . . 0.0 110.659 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.2 101.34 4.59 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.084 1.354 . . . . 0.0 109.102 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.65 129.95 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.438 1.895 . . . . 0.0 109.944 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.79 -43.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.57 1.548 . . . . 0.0 110.435 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.44 149.42 51.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.937 0.895 . . . . 0.0 109.53 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.1 mt -130.67 127.2 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 163.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 42.45 58.33 3.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 112.223 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 67.06 -18.78 0.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.598 2.359 . . . . 0.0 114.886 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -76.89 132.42 39.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.05 126.84 32.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 65' ' ' LEU . 27.8 m -124.31 8.29 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -59.56 -13.61 9.94 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -129.63 38.62 3.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.055 1.342 . . . . 0.0 109.107 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.434 HD12 HG12 ' A' ' 62' ' ' VAL . 17.5 mt -121.5 146.04 47.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 126.5 1.92 . . . . 0.0 108.662 171.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -76.53 155.98 33.27 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 116.993 -1.479 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.609 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 13.6 t-80 -49.21 -28.72 4.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.739 175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.5 m -74.32 -31.2 62.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.117 1.326 . . . . 0.0 111.945 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.82 -47.87 15.83 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 125.004 1.322 . . . . 0.0 110.554 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.722 HG21 ' HG3' ' A' ' 34' ' ' GLN . 2.7 m -54.56 -37.84 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 130.591 3.556 . . . . 0.0 111.726 168.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.98 -47.18 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.279 0.632 . . . . 0.0 109.843 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.59 -42.55 99.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.433 1.093 . . . . 0.0 111.759 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.86 -58.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 126.288 1.835 . . . . 0.0 108.879 169.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.45 -33.44 71.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.118 0.417 . . . . 0.0 111.406 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -64.66 -46.78 80.98 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.434 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.07 -28.89 69.18 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.174 0.99 . . . . 0.0 112.493 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.1 m -50.81 135.98 26.82 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 112.39 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.84 150.31 83.85 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.254 3.303 . . . . 0.0 110.615 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 75.7 mt -91.89 148.78 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.29 13.78 55.04 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.47 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -109.23 136.02 49.37 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.78 140.5 58.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.6 m -134.53 124.18 25.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.183 1.793 . . . . 0.0 106.997 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.0 m -91.45 127.94 37.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mp -124.89 125.04 43.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.38 129.23 58.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.44 150.37 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.37 1.068 . . . . 0.0 108.833 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -84.74 107.8 17.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 119.468 1.031 . . . . 0.0 110.299 179.083 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.54 0.559 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.5 mtm -128.02 136.34 51.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.424 HG23 HG12 ' A' ' 86' ' ' ILE . 76.6 m -134.82 104.97 6.22 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 -168.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.37 168.43 9.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.116 1.767 . . . . 0.0 108.53 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.26 144.88 50.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.7 pt -137.94 131.94 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.111 0.965 . . . . 0.0 111.148 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.1 t -90.4 114.59 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 122.292 1.044 . . . . 0.0 109.063 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 34.7 tttm -65.11 126.43 28.07 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 170.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.04 -71.85 1.3 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 119.43 1.013 . . . . 0.0 111.719 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.55 -52.87 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.866 1.266 . . . . 0.0 109.893 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . 0.256 5.8 pt20 -74.28 58.22 0.72 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.966 1.365 . . . . 0.0 110.555 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 56.72 -150.59 26.85 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.739 -161.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -81.95 157.89 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 160.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.36 -45.36 30.54 Favored Glycine 0 C--O 1.223 -0.586 0 C-N-CA 119.403 -1.38 . . . . 0.0 112.05 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -52.07 155.94 1.73 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.667 1.233 . . . . 0.0 111.225 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.2 p -120.39 161.15 21.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.193 1.397 . . . . 0.0 108.04 -172.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.31 159.41 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.525 -0.735 . . . . 0.0 110.079 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 149.0 52.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.091 1.756 . . . . 0.0 107.527 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -76.5 141.08 41.38 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.277 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.08 165.36 29.77 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.646 1.179 . . . . 0.0 108.578 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.04 -2.86 8.67 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.791 2.994 . . . . 0.0 116.084 -164.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -136.81 2.53 2.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.468 1.031 . . . . 0.0 112.723 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.32 -176.63 28.85 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -77.93 148.62 34.43 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.15 -0.618 . . . . 0.0 110.332 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -131.63 162.64 29.9 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.814 0.845 . . . . 0.0 109.633 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.16 127.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -76.57 -69.05 0.54 Allowed 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.097 1.359 . . . . 0.0 107.625 172.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -152.33 141.1 20.98 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.5 0.591 . . . . 0.0 109.915 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -85.57 114.76 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -104.35 -9.8 18.24 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.968 0.907 . . . . 0.0 110.888 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -140.23 81.28 1.8 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.561 1.944 . . . . 0.0 105.952 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.51 -45.2 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.169 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.22 -34.44 59.25 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.514 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.94 87.03 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.783 0.719 . . . . 0.0 111.889 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.705 ' HA ' HG22 ' A' ' 16' ' ' ILE . 12.4 m -126.21 67.44 63.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 118.755 1.278 . . . . 0.0 110.748 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -58.53 158.69 22.47 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.656 2.237 . . . . 0.0 112.393 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.18 -20.72 0.41 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.598 1.57 . . . . 0.0 114.314 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 tp -63.52 133.61 54.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.258 1.823 . . . . 0.0 107.902 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.2 t -125.37 10.9 8.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.904 0.881 . . . . 0.0 112.438 -167.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.29 150.96 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 130.502 3.521 . . . . 0.0 114.849 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 8.06 32.8 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 113.542 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.46 113.07 2.46 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.603 1.561 . . . . 0.0 109.623 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.43 106.32 4.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.703 1.201 . . . . 0.0 109.79 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.49 142.29 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.336 1.054 . . . . 0.0 110.229 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.49 -55.74 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.338 1.455 . . . . 0.0 110.504 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.27 155.22 46.67 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.892 0.877 . . . . 0.0 109.463 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.2 mt -133.59 132.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 163.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 42.04 44.22 2.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.581 1.952 . . . . 0.0 113.654 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 59.06 42.52 18.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.636 1.175 . . . . 0.0 112.815 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -128.55 136.48 50.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.421 1.888 . . . . 0.0 107.12 160.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.16 120.59 23.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.411 1.084 . . . . 0.0 109.67 175.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.694 HG12 HD22 ' A' ' 65' ' ' LEU . 10.4 m -115.89 16.94 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 128.046 2.538 . . . . 0.0 107.86 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -42.45 97.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 119.714 -1.866 . . . . 0.0 111.223 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.9 -25.53 58.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.347 0.976 . . . . 0.0 111.285 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 HG12 ' A' ' 62' ' ' VAL . 5.6 mp -60.11 138.69 57.84 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.966 1.706 . . . . 0.0 112.887 -163.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 m -63.58 165.33 8.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.43 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.47 -53.61 35.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.199 0.599 . . . . 0.0 110.624 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.4 m -62.52 -34.36 76.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.803 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -62.94 -47.04 84.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.24 0.927 . . . . 0.0 108.814 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.7 -44.5 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.704 1.202 . . . . 0.0 110.275 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.28 -43.11 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 O-C-N 121.64 -0.662 . . . . 0.0 109.987 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -44.6 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.96 0.904 . . . . 0.0 110.5 -172.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.49 -51.47 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.474 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 50.7 mt -68.24 -13.58 62.35 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.537 -0.727 . . . . 0.0 112.646 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -83.44 -33.64 25.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.397 1.453 . . . . 0.0 110.657 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -72.3 -36.01 68.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.912 0.778 . . . . 0.0 109.409 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -47.84 137.65 10.13 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.875 1.27 . . . . 0.0 112.208 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.63 127.33 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.503 3.469 . . . . 0.0 111.873 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 53.4 mt -66.88 134.7 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 10.94 85.93 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.236 0.922 . . . . 0.0 112.391 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -113.89 158.96 20.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.307 1.443 . . . . 0.0 108.54 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.19 150.32 43.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 162.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.6 m -131.46 146.25 52.16 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 127.803 2.441 . . . . 0.0 106.36 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.87 122.7 45.71 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -168.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -123.65 157.3 34.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.563 1.074 . . . . 0.0 109.308 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 13' ' ' THR . 4.1 mt -129.62 140.54 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 167.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.52 156.06 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.543 1.137 . . . . 0.0 109.939 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.96 84.96 5.41 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.178 -0.951 . . . . 0.0 110.824 -168.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 162.898 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.3 mtp -89.69 135.77 33.42 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 162.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.8 m -112.92 142.72 45.28 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -133.54 167.83 19.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.159 1.784 . . . . 0.0 109.24 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -135.5 153.08 51.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 108.687 168.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 45' ' ' CYS . 13.6 pt -144.18 161.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.252 1.421 . . . . 0.0 110.071 174.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.52 115.15 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 122.363 1.077 . . . . 0.0 108.418 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -67.77 115.17 7.02 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.425 1.49 . . . . 0.0 109.824 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.86 -81.98 0.4 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.174 -171.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.35 139.77 18.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.512 1.656 . . . . 0.0 111.071 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 61.64 -35.68 0.11 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.014 2.126 . . . . 0.0 112.45 -166.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.52 -141.48 3.37 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.634 1.588 . . . . 0.0 109.472 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -94.04 153.48 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.12 -42.33 58.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.194 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.479 ' HD1' ' HG ' ' A' ' 45' ' ' CYS . 12.8 p90 -62.96 166.96 5.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.419 1.104 . . . . 0.0 111.786 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.0 p -125.79 153.34 44.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.593 1.157 . . . . 0.0 109.514 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.22 170.58 11.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.079 0.952 . . . . 0.0 109.823 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.1 149.71 41.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.95 2.1 . . . . 0.0 108.674 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.95 148.47 47.66 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -147.29 163.05 30.12 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.575 1.95 . . . . 0.0 106.726 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.96 12.73 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.961 1 C-N-CA 125.521 4.148 . . . . 0.0 113.884 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -144.17 -3.72 0.84 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.887 2.075 . . . . 0.0 111.134 -162.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.86 -164.4 17.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -82.91 146.98 28.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.094 1.447 . . . . 0.0 110.369 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -127.57 163.66 23.69 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 126.018 1.727 . . . . 0.0 109.298 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.52 117.43 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -70.16 -61.63 1.7 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.052 1.341 . . . . 0.0 108.502 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -151.13 154.29 36.65 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.097 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.8 mt -106.18 110.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.795 2.438 . . . . 0.0 106.811 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.52 -5.58 22.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.918 1.287 . . . . 0.0 111.723 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.68 69.58 0.75 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.765 1.626 . . . . 0.0 109.192 -161.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.45 -62.56 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 125.186 1.395 . . . . 0.0 110.579 -159.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.92 -12.38 60.58 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.703 0.683 . . . . 0.0 112.658 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.02 -25.09 62.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.87 0.748 . . . . 0.0 111.856 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.581 ' HA ' HG22 ' A' ' 16' ' ' ILE . 34.9 m -128.35 76.88 77.79 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.199 1.0 . . . . 0.0 109.095 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -62.82 159.54 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.413 2.075 . . . . 0.0 110.833 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.27 -48.46 0.71 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.179 1.847 . . . . 0.0 114.238 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.9 tp -44.9 140.21 2.72 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 129.176 2.99 . . . . 0.0 112.357 -170.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.8 m -132.37 159.63 38.66 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.346 1.459 . . . . 0.0 110.255 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -60.09 146.46 42.92 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 165.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 2.44 59.75 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.444 -0.642 . . . . 0.0 113.673 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -62.8 112.6 2.61 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 163.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tp -80.52 129.52 34.56 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 mt -95.04 130.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -167.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.99 -51.02 6.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.633 1.573 . . . . 0.0 109.8 -170.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -138.6 150.43 46.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.935 0.894 . . . . 0.0 108.764 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -131.72 124.96 54.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 38.92 54.92 2.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.801 1.641 . . . . 0.0 111.244 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 61.66 -6.89 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.769 2.828 . . . . 0.0 116.437 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.14 125.06 26.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.378 1.444 . . . . 0.0 108.052 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.1 129.68 41.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.648 HG12 HD12 ' A' ' 65' ' ' LEU . 22.5 m -127.75 4.03 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.647 0.779 . . . . 0.0 111.833 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -50.67 -38.9 49.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.627 1.171 . . . . 0.0 110.861 165.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -105.36 21.31 17.38 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.648 HD12 HG12 ' A' ' 62' ' ' VAL . 17.3 mt -117.67 150.33 39.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.913 1.233 . . . . 0.0 113.821 -171.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.92 154.16 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.507 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.18 -52.07 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.145 0.578 . . . . 0.0 111.951 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 m -63.93 -24.71 67.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.711 -0.662 . . . . 0.0 111.898 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.54 -42.12 62.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.628 1.104 . . . . 0.0 109.546 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 62' ' ' VAL . 57.8 t -64.84 -40.66 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.548 0.739 . . . . 0.0 109.48 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -46.25 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.497 0.719 . . . . 0.0 109.492 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.42 -41.91 99.05 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.621 1.169 . . . . 0.0 110.909 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -66.62 -44.54 89.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.31 -31.91 72.58 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.902 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 121.651 2.023 . . . . 0.0 110.82 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.85 -36.87 77.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.359 1.063 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.3 m -55.67 136.86 71.21 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.37 144.16 90.4 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.146 3.231 . . . . 0.0 111.575 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -76.89 134.07 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 168.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.05 28.43 68.5 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.63 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -129.83 159.89 35.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.13 134.96 41.16 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -105.36 129.8 53.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 m -87.59 135.58 33.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.57 167.65 20.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.692 0.678 . . . . 0.0 109.303 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -132.7 141.55 44.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.35 150.89 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.405 1.082 . . . . 0.0 110.404 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.7 97.14 8.95 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 107.911 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.25 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 88' ' ' HIS . 2.8 mm? . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtp -88.57 135.81 33.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.406 HG23 HG12 ' A' ' 86' ' ' ILE . 85.3 m -134.45 103.82 5.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -172.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 168.36 9.45 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 126.085 1.754 . . . . 0.0 108.748 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.3 m -126.94 142.91 51.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' A' ' 45' ' ' CYS . 26.9 pt -127.62 167.85 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.764 1.626 . . . . 0.0 108.943 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.0 t -129.22 149.7 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.253 1.821 . . . . 0.0 106.963 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -113.24 99.82 8.1 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.822 1.249 . . . . 0.0 111.359 -164.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 54.23 4.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.744 1.64 . . . . 0.0 114.183 -172.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.07 -42.43 0.53 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.583 . . . . 0.0 116.53 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -80.21 -11.52 59.73 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.001 1.728 . . . . 0.0 113.106 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 16' ' ' ILE . 19.1 m-85 65.91 149.92 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.015 2.526 . . . . 0.0 110.32 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.62 -53.77 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.23 153.24 2.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.044 1.337 . . . . 0.0 111.831 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.3 p -116.96 148.47 41.38 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.465 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 pt -110.34 153.78 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.88 156.67 45.68 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.128 1.371 . . . . 0.0 108.757 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.79 139.52 39.35 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.16 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.02 175.91 2.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.847 1.659 . . . . 0.0 108.831 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.39 -21.42 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.963 3.109 . . . . 0.0 113.373 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -104.27 -4.31 23.15 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -162.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.1 177.26 14.81 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -162.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -71.35 148.43 47.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.351 1.075 . . . . 0.0 108.855 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -133.63 154.74 50.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG21 HD21 ' A' ' 48' ' ' LEU . 53.4 t -82.57 116.92 27.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -64.32 -58.96 5.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.603 169.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -153.74 144.34 22.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.0 mt -91.39 124.57 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -119.06 -3.24 10.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.512 1.125 . . . . 0.0 112.336 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -136.0 91.54 2.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.58 -55.38 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -63.58 -29.83 71.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.692 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.67 -16.98 61.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.642 1.11 . . . . 0.0 112.869 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.634 ' HA ' HG22 ' A' ' 16' ' ' ILE . 98.3 m -136.7 66.92 57.67 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 120.0 1.9 . . . . 0.0 111.124 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.68 117.8 4.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.684 2.923 . . . . 0.0 112.581 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -7.49 81.85 Favored Glycine 0 C--N 1.335 0.493 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.213 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.556 HD21 HG21 ' A' ' 36' ' ' VAL . 2.1 tt -66.07 153.27 42.73 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 82.6 m -124.46 159.8 29.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.517 1.127 . . . . 0.0 111.036 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.64 145.95 24.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.84 43.69 23.53 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -167.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.9 -170.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.494 1.117 . . . . 0.0 108.766 161.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.96 119.0 9.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.2 mt -89.63 127.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -171.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.05 -48.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.861 -163.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -134.74 132.6 38.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -115.62 129.41 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 167.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.86 16.77 7.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.48 1.912 . . . . 0.0 114.809 164.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 58.87 50.3 8.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.19 1.359 . . . . 0.0 112.019 -165.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.56 -15.38 10.85 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.95 133.19 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 130.712 3.605 . . . . 0.0 113.53 -165.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.29 7.34 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.001 0.921 . . . . 0.0 112.882 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.46 -18.22 64.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 113.597 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -110.37 -21.85 11.99 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.891 0.877 . . . . 0.0 110.047 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.23 139.47 58.49 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.916 0.865 . . . . 0.0 111.735 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.8 m -65.54 158.18 27.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.238 1.415 . . . . 0.0 110.553 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -50.61 -54.07 25.73 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 124.353 1.061 . . . . 0.0 110.154 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.04 -17.78 63.69 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.819 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.44 -36.81 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.433 1.093 . . . . 0.0 108.996 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -74.21 -43.45 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.662 1.185 . . . . 0.0 109.286 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.9 t -51.54 -43.73 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.039 0 C-N-CA 123.875 0.87 . . . . 0.0 108.894 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.506 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -65.02 -42.97 93.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.2 mt -60.44 -44.36 96.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -65.35 -31.28 72.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.465 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.506 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 47.8 mtmt -62.37 -43.4 98.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.219 1.827 . . . . 0.0 111.298 165.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.66 -32.78 71.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.984 1.314 . . . . 0.0 112.547 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -53.67 139.33 50.57 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.053 1.341 . . . . 0.0 111.811 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.19 122.33 9.38 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.727 2.951 . . . . 0.0 110.048 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 mt -61.1 147.66 10.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.27 9.8 13.25 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.36 -1.244 . . . . 0.0 114.144 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 m -121.29 173.59 7.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.667 1.587 . . . . 0.0 108.192 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.3 153.19 25.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.687 0.756 . . . . 0.0 111.425 -175.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.2 m -142.22 144.34 33.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.415 1.486 . . . . 0.0 108.834 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -110.93 107.62 17.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.049 2.14 . . . . 0.0 109.144 -157.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.3 112.53 16.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.159 1.8 . . . . 0.0 111.615 -170.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 13' ' ' THR . 3.4 mt -87.23 130.12 37.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.595 1.558 . . . . 0.0 108.608 171.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.25 150.21 30.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.011 1.324 . . . . 0.0 111.187 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.76 ' HA ' HD12 ' A' ' 11' ' ' LEU . 6.1 t-160 -78.11 77.34 4.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 0.0 111.329 -168.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 . . . . . 0 CA--C 1.54 0.562 0 C-N-CA 126.487 1.915 . . . . 0.0 108.216 174.266 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.7 mt . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.78 137.09 41.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.825 1.25 . . . . 0.0 107.913 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.8 m -125.45 120.03 29.87 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -168.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 mt -137.19 167.07 22.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.804 1.242 . . . . 0.0 107.943 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.58 143.83 51.09 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.545 HG21 HD12 ' A' ' 48' ' ' LEU . 20.9 pt -137.91 161.85 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.779 1.232 . . . . 0.0 109.733 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.1 t -117.46 147.5 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HG2' HD13 ' A' ' 79' ' ' ILE . 75.3 tttt -97.12 86.7 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -171.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 71.87 0.68 Allowed Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.614 -160.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.52 154.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.823 2.849 . . . . 0.0 115.043 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 47.78 -0.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.211 2.204 . . . . 0.0 115.58 -158.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.98 -129.97 5.46 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 104.453 -3.459 . . . . 0.0 104.453 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE2' HD12 ' A' ' 16' ' ' ILE . 48.7 m-85 -97.79 168.06 10.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 166.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.17 -45.12 57.52 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 121.706 -0.621 . . . . 0.0 111.895 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -64.47 -179.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.052 2.141 . . . . 0.0 113.388 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 p -132.81 147.04 52.31 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.834 1.254 . . . . 0.0 109.76 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 pt -110.7 167.68 4.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.286 1.035 . . . . 0.0 109.28 166.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.35 161.96 35.61 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.433 1.893 . . . . 0.0 107.217 168.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.33 148.73 41.07 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.687 1.195 . . . . 0.0 108.11 163.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.07 163.6 23.04 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.163 0.985 . . . . 0.0 108.41 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.16 -1.34 2.85 Favored 'Trans proline' 0 C--N 1.345 0.371 1 C-N-CA 126.166 4.577 . . . . 0.0 116.993 -170.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -132.62 -13.34 2.95 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.337 1.055 . . . . 0.0 111.848 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.08 172.32 17.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -164.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -68.03 124.87 24.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.856 1.262 . . . . 0.0 109.15 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -102.71 163.48 12.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 122.188 0.994 . . . . 0.0 109.625 171.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.48 HG21 HD21 ' A' ' 48' ' ' LEU . 92.8 t -72.03 128.03 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 163.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -71.62 -69.26 0.39 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -154.22 141.33 19.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.987 0.915 . . . . 0.0 108.592 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.487 HD11 HD23 ' A' ' 48' ' ' LEU . 30.8 mt -89.72 135.35 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.15 -31.0 4.22 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.445 0.698 . . . . 0.0 110.778 -171.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -130.65 95.92 3.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.57 -40.71 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.548 0.739 . . . . 0.0 110.513 -171.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.06 -19.21 61.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.915 -1.116 . . . . 0.0 111.656 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.38 -23.16 75.05 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.135 -0.978 . . . . 0.0 111.562 166.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 16' ' ' ILE . 90.2 m -147.51 74.48 11.51 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 119.559 1.68 . . . . 0.0 110.067 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.29 158.94 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.54 1.493 . . . . 0.0 112.531 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.46 -46.51 1.64 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.824 -0.987 . . . . 0.0 113.251 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 16' ' ' ILE . 3.0 tt -52.74 146.12 10.99 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.253 2.221 . . . . 0.0 109.993 -166.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.54 162.02 31.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.045 0.926 . . . . 0.0 111.71 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -69.32 148.39 49.78 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.453 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.56 7.13 25.85 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.007 -1.441 . . . . 0.0 114.176 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -51.53 126.53 17.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.576 1.688 . . . . 0.0 106.542 166.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -96.11 110.94 23.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.6 mt -70.91 141.58 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.321 1.419 . . . . 0.0 109.254 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.81 -43.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.061 1.344 . . . . 0.0 110.261 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -135.87 156.74 48.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.272 0.558 . . . . 0.0 109.53 171.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.34 125.67 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 164.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 45.87 37.83 3.91 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.237 1.415 . . . . 0.0 114.819 169.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 54.59 60.55 3.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.187 1.795 . . . . 0.0 112.629 -169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -134.79 133.93 40.36 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 151.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.24 122.51 34.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.293 1.037 . . . . 0.0 108.595 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.45 -1.35 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -162.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -24.29 40.11 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.869 1.668 . . . . 0.0 113.447 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -91.25 1.13 57.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.723 1.609 . . . . 0.0 112.126 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.54 173.48 6.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.287 1.435 . . . . 0.0 111.255 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.2 m -109.27 159.98 16.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.208 1.803 . . . . 0.0 108.814 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -50.21 -50.73 48.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.367 0.667 . . . . 0.0 111.922 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.5 m -64.57 -31.33 72.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.562 0.745 . . . . 0.0 111.068 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.24 -45.49 84.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.725 0.693 . . . . 0.0 109.273 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.87 -37.35 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.566 1.147 . . . . 0.0 108.942 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.2 -45.62 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.057 0.943 . . . . 0.0 109.152 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -34.25 71.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.329 0.585 . . . . 0.0 112.345 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.24 -56.08 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.775 1.63 . . . . 0.0 107.654 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.6 mt -61.53 -27.39 68.57 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.603 -0.686 . . . . 0.0 111.933 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -66.25 -41.07 90.47 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 109.889 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.66 -40.77 88.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.582 1.153 . . . . 0.0 110.736 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.9 m -49.41 139.65 14.23 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.747 1.219 . . . . 0.0 112.173 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -67.15 118.74 5.8 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.299 3.333 . . . . 0.0 110.995 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.437 HD13 ' HG2' ' A' ' 18' ' ' LYS . 4.4 mm -56.36 137.25 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.09 18.86 71.42 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.223 1.392 . . . . 0.0 113.372 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 t -113.72 163.87 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.391 1.477 . . . . 0.0 107.403 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -62.99 153.92 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.43 1.109 . . . . 0.0 110.309 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -133.15 140.94 47.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.167 2.587 . . . . 0.0 105.166 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.3 m -89.32 135.77 33.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.237 1.815 . . . . 0.0 106.259 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 16' ' ' ILE . 3.9 mp -117.28 164.31 15.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 162.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.9 mt -132.26 137.49 54.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 164.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -134.47 157.25 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.932 1.693 . . . . 0.0 109.112 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.92 98.62 11.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.311 1.044 . . . . 0.0 109.144 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 . . . . . 0 N--CA 1.466 0.354 0 O-C-N 121.56 -0.713 . . . . 0.0 110.01 168.127 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--O 1.234 0.255 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.2 mtm -105.32 114.97 29.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 m -76.74 140.9 40.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 157.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -140.57 168.51 19.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.01 2.124 . . . . 0.0 106.955 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.8 m -125.07 147.7 48.86 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.142 -0.974 . . . . 0.0 108.487 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 45' ' ' CYS . 30.0 pt -131.97 163.47 37.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.524 1.129 . . . . 0.0 109.216 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 t -136.04 137.68 48.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 72.7 tttt -108.38 81.9 1.54 Allowed 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.177 -0.952 . . . . 0.0 113.452 -153.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.69 -78.7 0.08 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.514 1.054 . . . . 0.0 115.236 -165.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.82 -60.34 0.26 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.362 1.581 . . . . 0.0 112.392 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -82.74 44.73 0.93 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.892 0.853 . . . . 0.0 111.046 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 64.48 74.94 0.41 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.64 1.114 . . . . 0.0 111.896 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.09 -86.85 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 125.774 1.63 . . . . 0.0 108.737 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.48 -31.61 0.58 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.643 1.592 . . . . 0.0 111.159 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 34.0 p90 -61.44 165.72 4.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.046 1.339 . . . . 0.0 110.353 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.412 HG23 HD23 ' A' ' 40' ' ' LEU . 17.3 p -119.8 147.46 44.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.771 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 pt -113.32 162.66 11.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.353 0.661 . . . . 0.0 109.332 167.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.51 157.8 41.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.521 2.329 . . . . 0.0 106.713 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -74.53 148.07 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.6 p -137.52 162.73 53.23 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.17 1.45 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.319 3.346 . . . . 0.0 114.567 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -131.73 -0.87 3.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.014 1.326 . . . . 0.0 112.453 -166.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.63 179.26 15.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -168.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -77.06 154.84 32.96 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 118.541 1.171 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -148.37 159.83 43.62 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 112.579 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.41 115.4 22.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 125.554 1.541 . . . . 0.0 107.56 -173.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -72.93 -44.2 61.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.598 171.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HB3' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -163.25 160.4 23.88 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -171.308 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 38' ' ' GLN . 1.4 mm? -105.2 -4.25 21.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.061 1.745 . . . . 0.0 112.466 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -143.42 96.38 2.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 157.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.23 -42.49 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 109.403 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.93 -33.53 75.8 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.368 -0.833 . . . . 0.0 111.144 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.19 -21.41 79.26 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.109 -0.828 . . . . 0.0 112.371 171.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.675 ' HA ' HG22 ' A' ' 16' ' ' ILE . 4.4 m -129.47 68.62 80.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 118.891 1.345 . . . . 0.0 110.123 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.03 149.77 88.89 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.143 1.895 . . . . 0.0 110.246 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.02 -21.44 0.37 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.077 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.29 136.15 57.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.357 1.578 . . . . 0.0 110.004 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -127.72 160.62 31.13 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.969 1.308 . . . . 0.0 109.633 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -71.97 139.85 48.85 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.193 0.997 . . . . 0.0 109.418 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.02 66.32 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.57 -167.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.575 1.95 . . . . 0.0 110.105 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.73 115.86 6.96 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.411 HG22 HG23 ' A' ' 62' ' ' VAL . 2.7 mm -70.74 125.58 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.353 1.461 . . . . 0.0 110.546 -171.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.68 -56.9 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.67 1.188 . . . . 0.0 111.381 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -133.96 145.84 49.91 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.5 mt -134.36 123.81 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 50.85 33.62 8.95 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.871 1.268 . . . . 0.0 112.543 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.7 11.48 8.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.635 2.774 . . . . 0.0 115.162 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.24 132.26 34.96 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.187 1.395 . . . . 0.0 107.451 163.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -80.13 138.81 36.99 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 54' ' ' ILE . 35.3 m -135.99 13.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.403 1.481 . . . . 0.0 111.659 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.852 -1.155 . . . . 0.0 113.383 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -120.37 30.09 7.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.978 0.808 . . . . 0.0 109.698 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -98.04 164.88 12.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.194 0.998 . . . . 0.0 110.606 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -84.91 162.5 19.43 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.076 1.35 . . . . 0.0 109.984 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -45.69 -58.46 3.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 126.608 1.963 . . . . 0.0 110.551 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.4 m -58.53 -40.36 82.74 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.284 1.033 . . . . 0.0 110.694 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -65.68 -44.48 86.09 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.851 1.26 . . . . 0.0 109.962 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.63 -39.75 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.957 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.15 -40.48 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 O-C-N 121.617 -0.677 . . . . 0.0 109.579 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -48.63 78.87 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.551 1.54 . . . . 0.0 110.199 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.4 mt -60.09 -43.75 93.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.979 1.312 . . . . 0.0 109.24 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -69.05 -27.11 65.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.783 175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -65.57 -44.39 86.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 121.15 1.795 . . . . 0.0 108.268 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.47 -26.14 68.31 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.711 0.632 . . . . 0.0 112.374 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.6 m -53.51 134.13 53.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.045 0.538 . . . . 0.0 110.67 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -68.0 135.13 34.01 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.217 3.278 . . . . 0.0 110.698 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -71.27 127.69 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.534 1.534 . . . . 0.0 107.983 -175.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.96 11.87 59.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.935 2.207 . . . . 0.0 113.134 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -92.2 167.36 12.09 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 149.17 34.45 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -131.44 126.35 34.84 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.3 m -101.23 113.63 26.86 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -167.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.55 153.84 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.198 0.908 . . . . 0.0 109.733 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -129.55 136.36 59.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.06 153.27 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.845 1.258 . . . . 0.0 110.869 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 105.95 17.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.641 1.977 . . . . 0.0 107.316 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 126.221 1.809 . . . . 0.0 109.872 170.22 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.2 mtm -113.38 146.47 39.43 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.459 HG23 HG12 ' A' ' 86' ' ' ILE . 44.8 m -135.22 98.8 4.07 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.028 1.331 . . . . 0.0 107.996 -173.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.86 167.6 9.61 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.352 1.461 . . . . 0.0 109.82 -172.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -122.27 145.81 47.87 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.906 0.883 . . . . 0.0 110.537 -177.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 45' ' ' CYS . 13.4 pt -139.65 134.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 125.562 1.545 . . . . 0.0 108.832 173.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.45 121.76 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 73.6 tttt -69.93 116.85 10.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.282 1.033 . . . . 0.0 109.58 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.73 -68.86 1.43 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.861 -169.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.21 -73.5 0.13 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.809 1.304 . . . . 0.0 112.01 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -76.41 36.22 0.15 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.112 0.965 . . . . 0.0 111.164 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 87.85 -126.68 8.16 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 -158.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CD2' HD12 ' A' ' 16' ' ' ILE . 97.9 m-85 -113.71 166.8 11.18 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.72 25.62 3.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.087 1.803 . . . . 0.0 113.611 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -151.07 167.64 27.09 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.892 1.346 . . . . 0.0 108.472 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 p -129.37 159.84 34.95 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.241 0.617 . . . . 0.0 109.797 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 pt -125.21 152.4 31.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.09 0.556 . . . . 0.0 110.502 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.22 145.42 30.41 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.446 1.099 . . . . 0.0 108.202 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.48 148.45 48.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.057 0.932 . . . . 0.0 110.809 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p -137.44 166.57 25.72 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.389 1.875 . . . . 0.0 105.985 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -70.75 -5.33 16.57 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.406 2.737 . . . . 0.0 112.871 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -129.33 -6.91 4.77 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.074 0.852 . . . . 0.0 112.804 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.89 -177.7 35.37 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.848 1.213 . . . . 0.0 110.587 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -94.12 92.62 7.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.57 -0.959 . . . . 0.0 110.601 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -86.88 161.56 18.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 119.629 1.104 . . . . 0.0 111.791 -162.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.54 115.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -71.63 -61.63 1.71 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 170.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -150.29 143.57 25.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.4 mt -96.11 110.51 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.2 mt -78.27 -36.28 47.01 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.798 0.839 . . . . 0.0 109.022 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -132.02 93.36 3.27 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.153 1.781 . . . . 0.0 109.083 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.8 mt -56.81 -44.06 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 110.154 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -68.07 -12.28 60.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.1 -14.01 52.87 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 119.509 1.05 . . . . 0.0 111.349 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.668 ' HA ' HG22 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -132.52 54.96 15.22 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.709 1.204 . . . . 0.0 109.67 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.07 124.3 10.83 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.922 1.748 . . . . 0.0 111.233 -164.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -16.24 61.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.971 1.272 . . . . 0.0 113.411 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.94 152.69 39.26 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.8 p -124.84 151.79 44.81 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.724 0.81 . . . . 0.0 108.901 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -76.4 138.57 40.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.06 96.32 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -168.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.63 -177.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.852 0.826 . . . . 0.0 111.554 163.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -140.59 91.19 2.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.495 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 62' ' ' VAL . 37.2 mt -55.84 135.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.559 1.544 . . . . 0.0 109.196 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.17 -45.98 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.166 1.387 . . . . 0.0 110.367 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -128.79 148.84 50.9 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.75 138.75 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 152.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 67.82 -54.42 0.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 128.979 2.911 . . . . 0.0 116.203 167.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 165.27 13.85 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 130.793 3.637 . . . . 0.0 113.584 -156.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -131.76 141.9 49.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.909 1.686 . . . . 0.0 109.194 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -69.55 128.83 37.87 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.592 HG12 HD22 ' A' ' 65' ' ' LEU . 10.8 m -133.75 22.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 125.402 1.481 . . . . 0.0 107.563 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -60.43 3.69 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 119.977 -1.702 . . . . 0.0 110.719 176.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.22 -21.15 62.17 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.456 0.169 . . . . 0.0 111.193 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.592 HD22 HG12 ' A' ' 62' ' ' VAL . 6.8 mp -52.89 134.58 37.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.867 1.667 . . . . 0.0 111.61 -167.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -56.63 162.33 2.31 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.674 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -49.28 -51.38 34.07 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.69 0.796 . . . . 0.0 109.311 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -52.07 17.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.036 2.534 . . . . 0.0 111.495 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.31 -46.71 82.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.516 1.126 . . . . 0.0 108.531 -170.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.37 -46.46 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.471 1.509 . . . . 0.0 110.443 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.413 HG12 ' HD3' ' A' ' 75' ' ' LYS . 54.2 t -55.57 -45.17 78.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -40.55 77.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.126 0.97 . . . . 0.0 111.473 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.59 -48.95 85.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 123.996 0.919 . . . . 0.0 109.109 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.12 -26.96 68.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.737 0.415 . . . . 0.0 111.58 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HD3' HG12 ' A' ' 71' ' ' VAL . 39.1 mtpt -71.51 -41.47 69.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.808 1.186 . . . . 0.0 110.382 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.51 -27.65 67.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.447 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.9 m -49.72 127.17 19.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 123.275 0.63 . . . . 0.0 110.739 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.04 132.84 46.73 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.937 3.092 . . . . 0.0 110.773 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 mm -64.01 127.75 25.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 166.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.44 17.71 75.36 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.323 0.963 . . . . 0.0 112.294 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -115.24 159.45 20.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 123.313 1.53 . . . . 0.0 108.823 159.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HG2' HG22 ' A' ' 15' ' ' THR . 3.8 tm-20 -65.05 153.58 40.32 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.876 168.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.6 m -137.77 149.11 46.14 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 126.936 2.094 . . . . 0.0 107.869 165.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 126.1 54.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.627 2.371 . . . . 0.0 105.941 -168.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.405 HD13 HD11 ' A' ' 16' ' ' ILE . 4.9 mp -128.46 115.69 18.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.996 1.271 . . . . 0.0 109.171 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.459 HG12 HG23 ' A' ' 13' ' ' THR . 3.6 mt -97.62 125.59 50.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.06 155.11 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.607 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -108.81 74.86 0.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.041 2.136 . . . . 0.0 109.693 -170.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 171.29 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.471 ' HE2' HD11 ' A' ' 87' ' ' ILE . 23.1 mtm -89.72 125.1 35.15 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 175.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -96.66 142.94 28.1 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.16 145.4 51.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.789 1.636 . . . . 0.0 108.06 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 m -103.06 135.15 45.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.179 0.592 . . . . 0.0 109.882 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.9 pt -143.98 137.59 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.285 1.034 . . . . 0.0 111.595 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 82' ' ' GLU 0.254 0.2 OUTLIER -110.35 136.03 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.598 1.189 . . . . 0.0 112.338 178.654 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 66.3 tttt -79.06 117.6 20.26 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.813 1.645 . . . . 0.0 111.924 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 23' ' ' PHE . . . -81.73 171.98 52.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 166.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.55 -59.64 3.59 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.686 1.994 . . . . 0.0 113.882 -168.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -82.16 10.83 6.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.695 -0.628 . . . . 0.0 111.096 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 82.23 1.64 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 126.298 1.904 . . . . 0.0 108.364 169.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HA ' ' H ' ' A' ' 19' ' ' GLY . 43.9 m-85 61.13 -175.97 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.995 1.318 . . . . 0.0 111.049 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.2 -63.61 1.5 Allowed Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -60.17 170.92 1.12 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.536 1.135 . . . . 0.0 113.775 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -131.43 158.38 40.98 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.026 1.33 . . . . 0.0 109.541 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.3 pt -123.68 162.01 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 124.732 1.213 . . . . 0.0 108.717 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.21 158.17 43.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.89 114.82 9.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.849 1.259 . . . . 0.0 107.962 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -99.31 168.36 9.75 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -66.35 -8.83 21.76 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.308 2.005 . . . . 0.0 114.568 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -129.12 -4.43 5.0 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 120.104 1.32 . . . . 0.0 114.022 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.59 -172.94 33.73 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -162.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -84.82 143.32 29.16 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 121.526 -0.985 . . . . 0.0 108.655 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -134.48 154.24 51.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.588 171.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.09 126.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.597 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -81.07 -57.05 3.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.739 1.216 . . . . 0.0 108.526 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -157.32 149.53 22.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 48' ' ' LEU . 22.1 mt -122.54 132.77 70.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.67 -58.2 1.6 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.204 1.002 . . . . 0.0 109.45 -164.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -88.04 87.98 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.8 1.24 . . . . 0.0 110.107 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.02 -38.55 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.062 0.945 . . . . 0.0 112.116 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.85 -36.17 67.38 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.772 -0.58 . . . . 0.0 111.123 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.19 -9.74 81.59 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.183 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.801 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.27 64.59 73.97 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 119.454 1.627 . . . . 0.0 108.614 172.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.41 125.41 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.201 1.934 . . . . 0.0 112.057 -165.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.62 0.38 84.09 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.125 -0.819 . . . . 0.0 112.696 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -67.99 140.95 56.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.781 1.291 . . . . 0.0 108.387 178.016 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 151.29 43.12 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 122.177 0.989 . . . . 0.0 110.464 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -77.78 148.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.14 56.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 117.4 -1.778 . . . . 0.0 114.383 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -63.63 126.75 28.57 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.926 1.863 . . . . 0.0 109.424 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 123.05 25.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.784 1.633 . . . . 0.0 108.363 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.83 146.23 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.2 -53.62 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.708 0.803 . . . . 0.0 110.916 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.5 131.61 24.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG13 HG21 ' A' ' 62' ' ' VAL . 3.2 mt -116.95 124.3 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 170.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.591 HD21 HG23 ' A' ' 83' ' ' THR . 77.5 m-20 46.1 46.35 12.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.791 1.636 . . . . 0.0 113.002 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.266 0.2 OUTLIER 61.15 31.7 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.271 1.829 . . . . 0.0 115.22 -177.554 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.15 132.11 55.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.121 1.768 . . . . 0.0 106.752 165.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -83.4 120.76 26.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.33 1.452 . . . . 0.0 110.85 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.45 HG21 HG13 ' A' ' 57' ' ' ILE . 21.3 m -121.98 7.01 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.679 1.992 . . . . 0.0 109.412 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -37.97 39.82 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.029 1.286 . . . . 0.0 112.085 -173.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -115.71 7.75 14.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD22 HG12 ' A' ' 62' ' ' VAL . 3.4 mp -62.06 143.37 56.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.382 1.873 . . . . 0.0 109.991 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -54.77 159.16 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.939 0.774 . . . . 0.0 110.069 165.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -50.38 -49.65 53.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 168.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -55.57 -44.73 77.13 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.873 1.269 . . . . 0.0 112.725 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.77 -39.89 95.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.398 1.079 . . . . 0.0 109.715 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.2 -49.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.497 0.719 . . . . 0.0 109.814 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.5 -38.12 54.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.472 1.509 . . . . 0.0 109.888 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.68 -46.11 80.3 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.771 0.828 . . . . 0.0 111.024 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mt -59.16 -46.14 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.604 1.161 . . . . 0.0 109.52 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 98.0 mt -61.09 -17.41 52.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.222 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -86.19 -33.64 20.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.379 1.445 . . . . 0.0 111.523 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -42.57 69.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.473 1.109 . . . . 0.0 109.406 165.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 91.9 m -51.35 135.55 31.9 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 111.776 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -67.56 112.67 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 1 C-N-CA 125.636 4.224 . . . . 0.0 112.098 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -51.32 117.76 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.382 1.473 . . . . 0.0 107.548 170.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.49 8.75 57.21 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.862 1.22 . . . . 0.0 113.249 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.85 151.74 51.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.972 1.386 . . . . 0.0 110.339 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' HG3' HG12 ' A' ' 17' ' ' VAL . 50.4 mp0 -72.38 153.37 41.49 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.329 1.452 . . . . 0.0 112.123 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.591 HG23 HD21 ' A' ' 58' ' ' ASN . 1.4 m -131.23 143.82 50.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 130.083 3.353 . . . . 0.0 105.905 -176.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.4 m -109.02 116.62 32.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -116.56 115.62 26.09 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.572 1.149 . . . . 0.0 108.549 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.37 134.47 28.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' A' ' 12' ' ' MET . 1.8 pp -129.43 152.61 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 110.723 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.539 ' HA ' HD12 ' A' ' 11' ' ' LEU . 1.6 t-80 -88.01 67.69 9.01 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.185 -0.947 . . . . 0.0 110.768 -170.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.239 0.538 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.7 mtm -111.09 153.69 25.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.601 0.637 . . . . 0.0 109.543 165.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.9 m -132.17 120.25 22.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.4 mt -126.85 168.41 14.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.532 1.533 . . . . 0.0 107.936 -175.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 m -134.67 141.97 46.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 45' ' ' CYS . 44.6 pt -138.46 151.31 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 110.981 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.5 153.19 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.625 1.97 . . . . 0.0 108.942 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -113.23 105.69 13.73 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.341 1.456 . . . . 0.0 109.022 -145.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.69 61.39 3.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.662 1.601 . . . . 0.0 112.577 -165.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.23 152.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.975 2.51 . . . . 0.0 112.459 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 65.42 -25.42 0.09 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.336 2.255 . . . . 0.0 115.56 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -164.16 31.13 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.681 -2.568 . . . . 0.0 106.681 -159.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -102.29 12.89 35.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -174.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.34 -66.15 1.28 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.609 1.1 . . . . 0.0 110.879 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -54.05 158.04 2.31 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 122.143 0.973 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -114.56 159.88 19.9 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.586 1.154 . . . . 0.0 109.418 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.7 pt -118.31 154.33 20.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.548 0.69 . . . . 0.0 110.432 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.91 170.26 9.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.263 2.225 . . . . 0.0 108.286 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.08 122.04 46.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 107.512 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.4 p -126.03 171.51 7.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.959 1.303 . . . . 0.0 109.734 -167.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.15 -14.69 45.17 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.164 1.909 . . . . 0.0 112.64 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -104.67 -11.83 16.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.019 1.328 . . . . 0.0 111.72 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.28 -162.25 23.63 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -73.34 147.58 44.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -139.73 165.09 28.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.306 0.574 . . . . 0.0 109.465 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.19 117.1 16.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.6 -74.18 0.15 Allowed 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -140.12 153.61 46.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -99.54 106.86 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.095 1.758 . . . . 0.0 108.168 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -101.82 -0.0 34.94 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.267 1.427 . . . . 0.0 110.957 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -149.83 114.06 5.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.037 1.735 . . . . 0.0 108.596 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.09 -58.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.484 1.513 . . . . 0.0 109.216 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.69 -37.1 75.34 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.037 1.335 . . . . 0.0 111.636 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.25 -25.75 72.3 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.68 ' HA ' HG22 ' A' ' 16' ' ' ILE . 46.3 m -126.94 67.61 69.72 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 118.947 1.373 . . . . 0.0 111.198 -172.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.8 128.16 20.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.718 2.279 . . . . 0.0 111.224 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.12 76.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 124.401 1.001 . . . . 0.0 114.297 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 48' ' ' LEU . 11.1 tp -66.84 153.12 44.23 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.444 1.122 . . . . 0.0 108.754 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.5 m -135.78 0.76 2.72 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 62.6 151.22 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.641 2.376 . . . . 0.0 112.205 -166.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.99 6.52 25.5 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.683 -1.065 . . . . 0.0 113.73 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.38 128.88 38.12 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.429 1.492 . . . . 0.0 107.817 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -81.28 109.96 16.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.843 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.99 124.66 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.94 -57.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.128 1.371 . . . . 0.0 108.893 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -128.56 150.47 50.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.284 1.034 . . . . 0.0 109.229 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.2 mt -127.86 126.65 67.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 164.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 43.64 52.84 6.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 111.046 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 59.94 -7.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.973 2.509 . . . . 0.0 116.371 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -69.63 117.08 10.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -58.11 115.9 3.2 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 163.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 0.8 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 O-C-N 124.057 0.848 . . . . 0.0 112.397 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -54.49 -21.9 11.34 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -170.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -112.03 -2.86 14.93 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 121.319 1.872 . . . . 0.0 112.663 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.55 160.25 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.321 -0.862 . . . . 0.0 109.198 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -89.53 157.11 18.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.209 1.004 . . . . 0.0 109.793 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -40.83 -56.8 2.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.984 1.714 . . . . 0.0 112.132 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.7 m -67.0 -26.26 66.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.896 0.878 . . . . 0.0 111.038 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.29 -44.96 67.3 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.243 0.928 . . . . 0.0 109.364 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.6 -40.57 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.384 1.073 . . . . 0.0 109.646 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.68 -53.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 123.715 0.806 . . . . 0.0 109.029 169.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.559 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 12.9 t70 -57.22 -46.39 82.98 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.352 0.661 . . . . 0.0 111.722 -172.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.4 mt -55.27 -45.52 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.649 1.18 . . . . 0.0 109.494 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -67.74 -35.72 79.24 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.716 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' A' ' 72' ' ' ASP . 9.0 mtmp? -55.01 -47.9 74.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.266 1.848 . . . . 0.0 109.589 167.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -34.73 75.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.218 1.007 . . . . 0.0 112.478 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 84.8 m -52.76 138.04 43.4 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.157 0.983 . . . . 0.0 109.689 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 77' ' ' CYS . 33.8 Cg_exo -54.29 144.27 61.04 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.347 2.698 . . . . 0.0 110.119 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.5 mt -80.43 131.43 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 161.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.91 35.79 72.86 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.268 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.7 m -146.43 131.79 18.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.746 1.273 . . . . 0.0 108.831 161.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -61.45 152.7 29.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.616 1.198 . . . . 0.0 111.094 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -137.55 135.57 36.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.966 2.906 . . . . 0.0 105.116 -168.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -112.49 110.85 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.822 1.249 . . . . 0.0 108.29 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.96 112.63 18.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.514 0.597 . . . . 0.0 110.84 -169.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -89.17 141.72 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.37 146.58 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.851 0.834 . . . . 0.0 111.819 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.0 96.61 5.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.205 1.002 . . . . 0.0 109.327 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 . . . . . 0 CA--C 1.519 -0.215 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.398 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -87.35 145.8 26.17 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.2 m -123.45 139.17 54.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.3 mt -142.81 167.88 21.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.444 2.297 . . . . 0.0 106.837 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.8 m -128.95 154.61 46.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.3 -0.875 . . . . 0.0 108.694 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.693 HG22 ' HA ' ' A' ' 45' ' ' CYS . 11.1 pt -145.66 166.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 126.054 1.741 . . . . 0.0 109.907 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.82 143.37 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.636 1.575 . . . . 0.0 107.582 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -88.62 145.68 25.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.26 1.024 . . . . 0.0 111.232 -175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.32 82.8 0.35 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.264 1.411 . . . . 0.0 113.899 -168.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.97 -84.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.035 2.134 . . . . 0.0 115.697 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.25 -15.4 46.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.934 1.243 . . . . 0.0 112.862 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.39 28.73 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.448 ' CE1' HD22 ' A' ' 74' ' ' LEU . 71.3 m-85 -66.36 146.0 55.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 118.869 1.334 . . . . 0.0 108.173 170.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.24 -51.84 53.79 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -61.82 164.02 6.81 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.368 1.08 . . . . 0.0 110.198 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.0 p -117.37 156.78 27.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.973 0.909 . . . . 0.0 109.25 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.02 158.32 18.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 167.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.12 163.1 25.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 165.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.83 147.13 47.48 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 159.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.3 p -139.7 161.9 53.92 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 163.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.32 -42.66 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.016 2.477 . . . . 0.0 113.256 -174.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -73.29 -23.84 60.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 111.159 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.75 178.86 26.9 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -172.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.421 ' CD ' HG21 ' A' ' 70' ' ' VAL . 24.0 mp0 -62.42 145.74 53.26 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -134.17 161.11 35.8 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 123.134 0.574 . . . . 0.0 111.134 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.86 107.27 7.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 -58.2 9.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.112 0.965 . . . . 0.0 109.553 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -151.69 148.14 27.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.788 1.635 . . . . 0.0 106.778 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.482 HG23 ' SG ' ' A' ' 45' ' ' CYS . 57.6 mt -91.2 97.14 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 166.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.7 -26.15 61.49 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.219 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -142.71 95.57 2.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.446 1.898 . . . . 0.0 108.998 -158.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.4 -57.06 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.76 1.224 . . . . 0.0 109.105 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.15 -25.32 66.92 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.802 0.728 . . . . 0.0 111.608 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 -32.35 66.77 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.213 170.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.693 ' HA ' HG22 ' A' ' 16' ' ' ILE . 29.3 p -130.08 70.36 82.13 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 120.058 1.929 . . . . 0.0 112.774 -171.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.39 111.59 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.748 2.299 . . . . 0.0 111.636 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.04 85.34 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.407 1.479 . . . . 0.0 114.844 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 152.97 43.15 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.03 1.415 . . . . 0.0 108.089 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.7 m -129.12 156.0 44.58 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.303 1.041 . . . . 0.0 110.023 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.24 137.48 53.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.14 12.41 79.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.494 -1.725 . . . . 0.0 114.182 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -58.43 129.53 42.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.093 1.946 . . . . 0.0 110.117 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 tp -78.5 144.42 35.71 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.2 mt -108.0 135.9 45.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 125.359 1.464 . . . . 0.0 108.206 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -122.45 -57.04 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.274 1.03 . . . . 0.0 110.085 -170.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 64.0 mt-10 -129.89 149.7 51.5 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.3 mt -135.93 129.39 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 168.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 41.13 45.33 2.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.392 2.277 . . . . 0.0 111.573 -173.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 57.51 4.54 0.24 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.391 2.276 . . . . 0.0 115.795 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.1 126.04 29.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 160.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.532 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 21.8 t-20 -73.02 132.22 43.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 168.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.84 -2.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.516 1.126 . . . . 0.0 110.844 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -6.69 1.27 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -121.03 -2.28 9.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.022 1.329 . . . . 0.0 111.659 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.5 mt -77.42 167.97 20.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.581 1.082 . . . . 0.0 110.517 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.5 m -88.66 155.53 19.55 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -47.76 -50.65 24.9 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.839 1.256 . . . . 0.0 112.341 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 m -65.73 -29.43 69.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.251 1.02 . . . . 0.0 111.266 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.37 -44.46 83.09 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 34' ' ' GLN . 21.6 t -67.44 -39.95 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 121.172 -0.955 . . . . 0.0 110.564 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.53 -50.68 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 124.493 1.117 . . . . 0.0 108.893 171.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -66.25 -37.38 85.34 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.23 0.956 . . . . 0.0 112.011 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.88 -44.23 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.469 -0.769 . . . . 0.0 109.308 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.448 HD22 ' CE1' ' A' ' 23' ' ' PHE . 85.8 mt -65.06 -17.59 64.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.946 -1.096 . . . . 0.0 112.29 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.03 -46.58 42.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.776 1.625 . . . . 0.0 108.993 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.07 -27.22 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.039 0.836 . . . . 0.0 112.85 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.95 123.82 61.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 118.849 0.75 . . . . 0.0 109.432 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -68.69 157.71 60.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.921 3.08 . . . . 0.0 113.276 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mm -90.08 124.56 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.575 1.55 . . . . 0.0 106.953 -170.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.41 73.77 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.571 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 m -110.64 157.75 19.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 162.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 153.83 41.07 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.797 1.284 . . . . 0.0 109.756 166.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -140.78 131.37 25.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.512 1.925 . . . . 0.0 105.961 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -97.17 121.12 38.71 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.923 1.689 . . . . 0.0 106.537 -171.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.68 149.87 42.6 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.815 1.189 . . . . 0.0 110.017 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.03 125.24 66.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.72 177.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.966 1.306 . . . . 0.0 109.549 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -107.21 124.32 49.57 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.077 0.853 . . . . 0.0 111.683 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 130.539 3.536 . . . . 0.0 106.344 -170.401 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.7 mt . . . . . 0 C--O 1.236 0.389 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.57 129.87 50.55 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.467 1.107 . . . . 0.0 108.413 171.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 m -95.33 136.2 35.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.57 168.45 20.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.369 1.867 . . . . 0.0 108.509 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 m -135.64 131.17 35.43 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.322 -0.861 . . . . 0.0 108.909 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.5 pt -120.67 166.39 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.262 1.025 . . . . 0.0 110.11 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.72 132.9 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.12 106.51 17.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.632 -0.668 . . . . 0.0 109.735 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.31 171.73 6.36 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 121.876 0.709 . . . . 0.0 112.408 171.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.78 64.13 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.581 1.152 . . . . 0.0 111.009 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -80.3 29.52 0.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.511 1.124 . . . . 0.0 110.31 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.58 -171.43 54.27 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 125.439 1.495 . . . . 0.0 109.512 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.444 ' CD2' HD12 ' A' ' 16' ' ' ILE . 94.3 m-85 -67.15 -0.79 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.423 1.889 . . . . 0.0 114.715 -172.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.54 -61.03 3.24 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 119.819 -1.801 . . . . 0.0 111.198 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -54.09 152.35 6.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 118.659 1.229 . . . . 0.0 111.232 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.4 p -118.84 159.17 24.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.199 1.4 . . . . 0.0 108.151 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 71' ' ' VAL . 35.9 pt -123.56 166.72 18.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.639 0.733 . . . . 0.0 109.996 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.09 170.04 16.77 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.547 2.739 . . . . 0.0 108.168 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.25 115.93 31.27 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.37 2.268 . . . . 0.0 106.834 169.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 52.4 p -111.27 169.28 6.47 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.064 1.346 . . . . 0.0 108.251 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 23.4 Cg_endo -64.09 10.52 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 125.14 3.893 . . . . 0.0 115.065 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.3 p -131.33 -11.76 3.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 111.632 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.61 -165.09 24.27 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -169.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.508 ' CG ' HG21 ' A' ' 70' ' ' VAL . 12.8 mp0 -66.48 141.36 57.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -130.57 162.82 28.47 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.544 0.688 . . . . 0.0 109.643 166.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 48' ' ' LEU . 86.6 t -71.11 138.3 22.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 168.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -93.19 -48.42 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.434 1.094 . . . . 0.0 109.418 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -161.81 159.13 26.61 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.091 1.756 . . . . 0.0 106.88 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.2 139.99 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 46.3 mt -123.13 -54.52 1.8 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -87.57 77.7 8.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.9 mt -61.82 -51.37 73.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 125.472 1.509 . . . . 0.0 108.666 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -57.5 -35.29 70.04 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.047 0.939 . . . . 0.0 112.41 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.34 -23.48 70.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.172 0.897 . . . . 0.0 112.115 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.497 ' HA ' HG22 ' A' ' 16' ' ' ILE . 75.5 m -118.84 60.5 4.64 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 119.007 1.404 . . . . 0.0 110.824 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.4 138.58 51.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.678 2.252 . . . . 0.0 110.722 -167.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 -9.16 27.88 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.893 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 36' ' ' VAL . 2.4 tt -73.54 146.19 44.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.152 1.476 . . . . 0.0 108.728 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.73 162.12 27.34 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.734 1.214 . . . . 0.0 112.155 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.69 149.58 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.476 -0.765 . . . . 0.0 109.845 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 14.13 58.06 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.363 -0.836 . . . . 0.0 113.916 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.3 129.68 36.18 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.169 1.484 . . . . 0.0 108.37 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tp -76.64 133.4 39.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 mt -95.18 125.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.529 1.132 . . . . 0.0 109.293 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -112.71 -51.94 5.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.845 1.258 . . . . 0.0 110.713 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.3 mt-10 -123.28 153.32 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.416 0.686 . . . . 0.0 109.558 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.68 134.85 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 161.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 35.89 57.11 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.702 2.001 . . . . 0.0 113.774 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 59.0 24.47 12.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.483 1.113 . . . . 0.0 112.856 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -117.39 120.59 38.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.904 2.482 . . . . 0.0 106.323 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 126.31 28.17 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG12 HD12 ' A' ' 65' ' ' LEU . 34.2 m -126.22 -3.42 5.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -9.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 169.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.79 -8.27 14.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.303 1.41 . . . . 0.0 112.222 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 62' ' ' VAL . 15.7 mt -77.57 158.6 29.76 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.534 0.734 . . . . 0.0 111.856 -172.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.669 ' O ' HG22 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -71.75 148.69 46.09 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.581 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.656 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 1.7 t-80 -54.86 -22.86 16.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.333 1.453 . . . . 0.0 112.241 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -79.45 -17.24 54.66 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.912 -1.743 . . . . 0.0 112.805 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -87.66 -51.4 5.91 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.325 -1.484 . . . . 0.0 108.105 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 66' ' ' SER . 2.5 m -49.24 -38.19 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 131.558 3.943 . . . . 0.0 112.776 166.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 27' ' ' ILE . 10.9 t -63.56 -54.5 31.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.775 0.83 . . . . 0.0 109.53 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.84 -40.79 89.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.746 0.654 . . . . 0.0 111.095 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.15 -45.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 125.837 1.655 . . . . 0.0 110.996 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.75 -33.86 76.59 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.933 -0.479 . . . . 0.0 110.949 174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -68.24 -34.85 76.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.287 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -74.14 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 173.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.6 m -59.47 141.71 87.72 Favored Pre-proline 0 CA--C 1.536 0.438 0 O-C-N 120.444 -1.41 . . . . 0.0 109.342 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.19 125.79 14.64 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 123.536 2.824 . . . . 0.0 110.594 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.9 mt -58.98 135.59 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.91 85.25 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.823 1.202 . . . . 0.0 113.268 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 t -103.64 147.76 26.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -66.98 142.33 57.29 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 165.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.9 m -127.49 132.55 49.97 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.772 2.829 . . . . 0.0 105.591 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -88.04 130.26 35.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mp -130.6 149.53 52.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 56' ' ' GLU . 6.1 mt -128.82 123.5 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 172.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -111.49 152.71 13.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.037 1.335 . . . . 0.0 107.552 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -88.07 106.17 17.97 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 88' ' ' HIS . 2.4 mm? . . . . . 0 C--O 1.234 0.251 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.5 mtm -88.98 155.91 19.2 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.42 HG23 HG12 ' A' ' 86' ' ' ILE . 35.8 m -134.78 108.91 8.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.0 mt -98.77 169.23 9.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.547 2.339 . . . . 0.0 107.532 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -135.25 151.38 50.54 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.315 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.577 HG22 ' HA ' ' A' ' 45' ' ' CYS . 28.9 pt -144.35 128.28 12.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.17 1.388 . . . . 0.0 110.249 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 120.92 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 123.523 1.63 . . . . 0.0 109.291 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 7.1 mttt -57.66 118.23 5.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.034 174.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.36 -75.49 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.29 165.87 30.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.599 0.699 . . . . 0.0 109.47 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 60.87 -16.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 129.191 2.996 . . . . 0.0 116.809 172.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 123.61 138.03 5.1 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -167.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -52.08 131.49 31.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.64 84.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.09 145.04 21.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.26 1.03 . . . . 0.0 110.995 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 p -107.27 156.43 18.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.13 149.16 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.446 0.641 . . . . 0.0 110.535 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -124.95 143.28 50.96 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.076 2.15 . . . . 0.0 108.087 -177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -89.12 87.12 7.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -171.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -70.39 167.29 27.44 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 124.64 1.176 . . . . 0.0 109.09 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.03 9.36 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.387 2.724 . . . . 0.0 112.968 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.63 -2.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -152.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.64 -169.1 22.52 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -166.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.637 ' HG2' HG21 ' A' ' 70' ' ' VAL . 2.5 mm100 -87.52 142.08 28.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.012 -1.287 . . . . 0.0 109.188 174.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -124.19 162.81 22.86 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 123.49 0.716 . . . . 0.0 110.995 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 48' ' ' LEU . 54.9 t -88.28 116.57 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -69.51 -68.71 0.39 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.995 1.318 . . . . 0.0 108.519 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -148.41 154.87 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.441 1.496 . . . . 0.0 107.26 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.402 ' CD1' HD13 ' A' ' 48' ' ' LEU . 65.0 mt -120.53 107.84 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.005 1.322 . . . . 0.0 108.222 -173.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.2 -53.49 3.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.918 0.866 . . . . 0.0 109.971 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.18 74.45 7.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.0 mt -50.36 -48.81 24.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.748 1.219 . . . . 0.0 109.516 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -63.62 -37.88 88.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.588 -172.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.85 -5.15 60.57 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.694 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HA ' HG22 ' A' ' 16' ' ' ILE . 40.9 m -131.08 71.9 81.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 120.191 1.996 . . . . 0.0 109.528 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.2 129.13 23.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.009 2.473 . . . . 0.0 111.136 -174.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.59 -7.77 52.15 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.04 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.566 HD12 ' CB ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -61.69 147.07 47.17 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.988 1.394 . . . . 0.0 109.26 -176.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.4 m -138.14 141.5 40.13 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.312 1.445 . . . . 0.0 107.297 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.58 158.39 27.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.47 47.53 56.75 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.815 -0.553 . . . . 0.0 111.729 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.44 -159.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.225 2.21 . . . . 0.0 109.595 152.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -154.95 110.18 3.07 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 160.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.18 134.8 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 120.785 1.63 . . . . 0.0 109.106 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.55 -50.29 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.806 1.243 . . . . 0.0 110.347 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 40.4 mt-10 -133.85 151.04 51.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.393 0.677 . . . . 0.0 109.427 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.4 mt -124.45 127.34 72.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 65.68 -36.96 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 131.027 3.731 . . . . 0.0 115.741 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.26 19.7 pt20 162.31 -7.54 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.796 3.638 . . . . 0.0 112.592 -171.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -99.84 142.25 31.57 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.79 -1.194 . . . . 0.0 109.502 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 19.4 t-20 -72.73 137.74 46.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.808 1.243 . . . . 0.0 110.381 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.587 HG12 HD22 ' A' ' 65' ' ' LEU . 6.3 m -139.73 19.63 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 126.966 2.107 . . . . 0.0 108.394 -175.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.99 -58.47 4.07 Favored 'General case' 0 C--N 1.343 0.316 0 O-C-N 120.382 -1.449 . . . . 0.0 109.994 171.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -67.7 -19.96 65.22 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.341 0.657 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.587 HD22 HG12 ' A' ' 62' ' ' VAL . 6.7 mp -56.09 137.44 51.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.216 2.206 . . . . 0.0 111.744 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -60.61 156.4 16.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.198 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -46.98 -51.14 17.82 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.0 0.92 . . . . 0.0 110.192 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -55.82 -35.59 66.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.198 2.599 . . . . 0.0 111.669 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.38 -50.06 49.58 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.848 1.259 . . . . 0.0 107.613 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.637 HG21 ' HG2' ' A' ' 34' ' ' GLN . 97.3 t -63.55 -39.31 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.593 0.757 . . . . 0.0 109.348 -176.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.78 -51.96 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -66.86 -33.49 75.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.433 0.56 . . . . 0.0 112.1 -170.469 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.94 -52.28 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 124.043 0.937 . . . . 0.0 109.584 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.07 -35.75 81.29 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.008 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 43.9 mtmt -59.38 -48.56 81.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 121.189 1.813 . . . . 0.0 111.38 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.5 -33.28 74.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.618 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 97.0 m -46.7 125.29 8.01 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.06 0.944 . . . . 0.0 110.087 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' CYS . 7.1 Cg_exo -58.17 145.31 93.14 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.685 2.924 . . . . 0.0 109.991 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 17.7 mm -72.63 139.66 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.856 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.84 75.59 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.05 1.31 . . . . 0.0 113.352 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -99.27 128.19 45.37 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.784 1.292 . . . . 0.0 108.152 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.19 139.63 58.47 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.9 m -124.17 125.93 45.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 m -88.68 122.47 32.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.79 112.67 19.12 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 13' ' ' THR . 6.5 mt -80.13 131.51 33.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 169.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.36 150.75 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 109.815 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.466 ' HA ' HD13 ' A' ' 11' ' ' LEU . 1.6 t-160 -81.26 113.88 19.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.829 0.852 . . . . 0.0 109.685 -176.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 . . . . . 0 C--O 1.235 0.317 0 C-N-CA 125.106 1.363 . . . . 0.0 107.709 171.991 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.9 mtm -142.18 148.17 37.78 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.484 1.514 . . . . 0.0 107.914 153.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -99.7 142.47 31.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 165.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -138.1 160.79 38.47 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.717 1.607 . . . . 0.0 106.791 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -130.8 144.8 51.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 16' ' ' ILE . 11.5 pt -138.69 152.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 125.351 1.46 . . . . 0.0 110.442 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.91 98.34 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.236 1.014 . . . . 0.0 109.641 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 52.1 tttt -43.58 112.41 0.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.574 2.35 . . . . 0.0 111.1 177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -67.52 1.88 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.72 150.77 3.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.458 1.503 . . . . 0.0 108.557 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 40.9 57.49 2.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.105 1.362 . . . . 0.0 110.813 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 76.99 -144.16 29.57 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -112.46 160.17 18.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.516 1.526 . . . . 0.0 108.084 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.04 7.73 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 124.4 1.0 . . . . 0.0 110.615 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -58.56 170.25 0.79 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.346 1.069 . . . . 0.0 111.093 172.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -132.73 159.08 40.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.529 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 pt -118.78 141.83 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.268 1.032 . . . . 0.0 109.031 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.04 133.56 43.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 127.232 2.213 . . . . 0.0 105.77 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 141.85 50.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 163.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -128.9 169.84 12.09 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.47 1.508 . . . . 0.0 108.216 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.63 4.14 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.127 3.218 . . . . 0.0 113.452 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.1 p -131.55 -27.49 1.94 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.543 1.065 . . . . 0.0 112.115 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.26 -166.1 37.44 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -83.65 137.96 33.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -128.34 162.78 26.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 126.888 2.075 . . . . 0.0 107.466 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -77.91 123.38 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -75.36 -70.57 0.41 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -149.13 158.45 44.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.37 0.986 . . . . 0.0 109.049 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.432 HG23 ' SG ' ' A' ' 45' ' ' CYS . 69.0 mt -117.46 120.65 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.2 mt -105.21 -17.67 14.39 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.265 1.426 . . . . 0.0 111.008 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -142.22 82.78 1.8 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.702 2.001 . . . . 0.0 106.548 -162.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.59 -36.56 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.931 1.292 . . . . 0.0 110.682 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.43 -26.11 65.36 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.034 -1.041 . . . . 0.0 113.11 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.2 -11.74 71.33 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.708 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.432 ' SG ' HG23 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -153.03 67.15 6.31 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.588 1.694 . . . . 0.0 110.678 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.7 130.15 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.838 2.359 . . . . 0.0 109.849 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.68 -5.96 72.01 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.202 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 tp -77.79 142.73 38.45 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.493 1.146 . . . . 0.0 109.091 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.4 m -132.21 159.36 39.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.811 1.245 . . . . 0.0 109.554 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.51 144.29 57.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 -1.0 84.22 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.585 -1.675 . . . . 0.0 114.446 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -63.62 106.33 0.94 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.44 1.62 . . . . 0.0 110.005 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.86 126.04 28.48 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.695 1.598 . . . . 0.0 109.571 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.57 144.58 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 109.208 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.42 -43.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 126.293 1.837 . . . . 0.0 108.847 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -136.12 153.59 51.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.579 0.752 . . . . 0.0 110.161 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 58' ' ' ASN . 6.8 mt -111.41 -157.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 167.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.676 ' H ' HG22 ' A' ' 57' ' ' ILE . 85.7 m-20 -53.25 76.56 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.268 2.227 . . . . 0.0 110.92 168.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 55.76 38.97 30.74 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.182 1.393 . . . . 0.0 111.989 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.75 125.82 38.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.834 1.654 . . . . 0.0 107.212 162.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.35 114.77 22.67 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.417 1.487 . . . . 0.0 108.141 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.582 HG12 HD12 ' A' ' 65' ' ' LEU . 28.2 m -117.47 6.61 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -163.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -53.48 -19.88 4.16 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -114.96 -10.09 12.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.064 1.346 . . . . 0.0 112.116 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.582 HD12 HG12 ' A' ' 62' ' ' VAL . 15.2 mt -68.11 147.15 52.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.977 0.894 . . . . 0.0 108.635 175.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.4 m -74.76 164.68 26.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.419 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -48.08 -56.3 8.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.644 0.777 . . . . 0.0 109.535 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.9 m -60.85 -28.76 69.08 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.958 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.68 -45.97 27.54 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.13 1.372 . . . . 0.0 110.73 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.25 -41.51 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.11 -43.0 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.137 0.975 . . . . 0.0 109.225 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.75 89.76 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.853 1.261 . . . . 0.0 110.722 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.81 -51.33 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.035 0.934 . . . . 0.0 108.76 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.404 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 29.9 mt -62.9 -26.4 68.77 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.757 -0.589 . . . . 0.0 111.729 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -68.92 -40.31 79.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.305 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.58 -33.88 75.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.527 1.058 . . . . 0.0 113.193 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.8 m -49.62 134.25 19.3 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.778 1.231 . . . . 0.0 111.563 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.13 121.47 8.63 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.234 3.289 . . . . 0.0 111.777 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.16 124.13 11.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.206 1.402 . . . . 0.0 107.742 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.19 14.92 70.59 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.24 -0.756 . . . . 0.0 113.208 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.4 m -115.62 147.94 40.22 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 118.655 1.227 . . . . 0.0 108.165 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.98 141.18 58.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.885 1.274 . . . . 0.0 108.487 171.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -128.89 124.9 36.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.081 1.753 . . . . 0.0 106.419 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -89.46 128.74 36.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 mp -133.46 158.28 43.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.1 130.83 73.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.0 148.25 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.715 1.206 . . . . 0.0 110.18 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -82.99 84.71 7.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.716 0.807 . . . . 0.0 109.502 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.518 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 C--O 1.239 0.501 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.572 ' HE2' HD11 ' A' ' 87' ' ' ILE . 31.6 mtm -92.53 113.84 26.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.742 0.701 . . . . 0.0 109.292 174.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -82.95 129.07 34.98 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -145.7 142.56 29.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.685 1.594 . . . . 0.0 107.641 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -125.08 140.18 53.13 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.965 . . . . 0.0 110.665 -166.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.563 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.0 pt -129.51 158.29 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.174 1.389 . . . . 0.0 111.03 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -128.14 116.79 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.858 1.263 . . . . 0.0 108.516 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HG2' HD13 ' A' ' 79' ' ' ILE . 55.6 tttt -75.26 104.81 5.98 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.571 1.148 . . . . 0.0 109.915 -174.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.76 -67.63 1.87 Allowed Glycine 0 CA--C 1.523 0.564 0 CA-C-O 119.703 -0.498 . . . . 0.0 112.599 -169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 -70.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.514 0.657 . . . . 0.0 111.243 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -78.11 72.0 4.62 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.023 1.329 . . . . 0.0 107.922 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 61.6 -149.75 45.84 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD12 ' A' ' 16' ' ' ILE . 97.5 m-85 -83.51 1.41 42.03 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.53 -63.14 1.48 Allowed Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.761 -1.212 . . . . 0.0 111.623 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -52.58 155.14 2.3 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.028 1.414 . . . . 0.0 111.765 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -122.17 157.38 31.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.0 107.915 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.38 174.68 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 109.232 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.13 165.18 14.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.496 1.918 . . . . 0.0 107.513 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 141.01 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 151.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.64 154.92 60.16 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.58 16.06 1.5 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.292 2.661 . . . . 0.0 113.983 -160.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -144.63 4.04 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.768 1.627 . . . . 0.0 112.092 -160.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.76 169.48 21.72 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -156.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -77.08 160.77 28.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.995 0.897 . . . . 0.0 111.856 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -131.48 146.46 52.25 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.64 127.07 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -100.73 -52.54 3.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.376 1.07 . . . . 0.0 109.862 -173.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -150.39 133.9 16.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.05 128.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -118.43 9.29 12.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.409 1.083 . . . . 0.0 110.509 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.55 81.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.678 HD12 ' H ' ' A' ' 42' ' ' ILE . 3.5 mp -59.2 -60.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 124.834 1.253 . . . . 0.0 109.073 -166.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.81 -9.99 59.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.14 -38.15 94.94 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 164.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.563 ' HA ' HG22 ' A' ' 16' ' ' ILE . 80.4 m -123.31 67.07 34.87 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.47 0.708 . . . . 0.0 111.96 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.88 142.56 93.71 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.216 1.944 . . . . 0.0 109.641 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.22 -31.66 3.72 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 117.984 -1.453 . . . . 0.0 113.065 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -63.9 147.34 52.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.204 1.502 . . . . 0.0 110.387 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.6 m -137.08 168.95 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.342 1.857 . . . . 0.0 109.421 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.53 146.23 31.41 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.218 -0.926 . . . . 0.0 110.598 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.63 -3.16 80.17 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.132 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -55.59 115.83 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.403 1.481 . . . . 0.0 108.211 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.26 98.13 3.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.56 119.73 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.525 1.53 . . . . 0.0 108.229 177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.18 -52.15 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.038 1.735 . . . . 0.0 109.123 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -136.03 143.65 44.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.879 1.272 . . . . 0.0 108.543 -169.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 74' ' ' LEU . 97.7 mt -131.21 134.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.961 1.304 . . . . 0.0 107.574 170.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 39.95 47.99 2.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.787 2.035 . . . . 0.0 110.402 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 66.41 13.19 9.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.261 1.425 . . . . 0.0 112.79 171.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.01 130.18 46.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.884 1.673 . . . . 0.0 107.828 167.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -58.21 123.87 17.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.994 0.918 . . . . 0.0 110.476 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.29 -3.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 118.176 -0.916 . . . . 0.0 113.251 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -54.21 -37.03 64.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.48 1.491 . . . . 0.0 112.502 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -97.51 2.28 49.97 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.327 1.051 . . . . 0.0 111.649 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.7 mt -87.5 160.77 18.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.155 0.982 . . . . 0.0 108.894 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 152.26 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -41.14 -52.51 3.27 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.675 1.59 . . . . 0.0 111.715 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.5 m -56.97 -42.28 79.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.149 1.379 . . . . 0.0 112.224 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -64.19 -38.22 90.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.704 ' O ' HD22 ' A' ' 74' ' ' LEU . 19.4 t -69.8 -51.47 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.567 0.747 . . . . 0.0 109.473 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.86 -38.03 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.172 1.389 . . . . 0.0 110.268 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.41 -34.47 70.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.048 0.842 . . . . 0.0 111.97 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -54.31 -60.3 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -56.5 -31.61 64.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 174.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.07 -50.94 68.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 121.109 1.777 . . . . 0.0 108.736 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.68 -35.28 75.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.14 0.976 . . . . 0.0 111.455 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 50.6 m -56.64 144.28 65.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.574 0.749 . . . . 0.0 112.704 -169.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.36 123.44 10.24 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.454 3.436 . . . . 0.0 112.311 -172.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.463 HD13 ' HG2' ' A' ' 18' ' ' LYS . 5.5 mm -59.29 131.58 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.5 26.57 72.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.462 1.029 . . . . 0.0 112.988 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -103.84 157.44 17.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 154.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.83 152.69 30.92 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.196 152.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.2 m -139.97 125.68 19.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -89.36 119.44 29.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -166.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.27 154.94 35.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 56' ' ' GLU . 5.7 mt -134.04 129.81 54.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.572 HD11 ' HE2' ' A' ' 12' ' ' MET . 1.2 pp -119.69 167.39 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 108.122 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.29 -120.32 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 110.93 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 126.508 1.923 . . . . 0.0 110.791 175.659 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mtm -113.92 154.73 27.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.004 0.922 . . . . 0.0 109.309 168.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.9 m -131.06 134.58 46.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.31 167.73 22.15 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.035 1.734 . . . . 0.0 108.62 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -122.97 153.06 40.26 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 45' ' ' CYS . 23.1 pt -139.9 155.39 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.203 1.801 . . . . 0.0 110.013 174.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.26 99.31 4.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.011 1.725 . . . . 0.0 107.968 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 53.2 tttt -53.64 109.17 0.42 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.268 2.227 . . . . 0.0 111.617 -174.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.35 33.44 4.32 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.15 1.357 . . . . 0.0 115.862 -163.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . 59.56 162.41 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.387 2.275 . . . . 0.0 113.69 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 52.32 -10.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.249 1.82 . . . . 0.0 114.854 -153.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 147.39 -155.58 26.57 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' CD2' HD12 ' A' ' 16' ' ' ILE . 54.5 m-85 -83.96 152.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 153.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.57 -56.0 26.83 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -54.75 159.94 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.488 1.137 . . . . 0.0 111.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.5 p -128.65 161.44 29.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.882 1.673 . . . . 0.0 108.368 -172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.2 162.97 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 122.066 0.936 . . . . 0.0 109.758 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.98 146.97 39.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.017 1.327 . . . . 0.0 107.864 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.57 136.01 47.26 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.253 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 p -133.74 165.72 34.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.61 -12.74 35.54 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.085 1.857 . . . . 0.0 112.574 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -109.36 5.63 23.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.44 1.496 . . . . 0.0 111.817 -168.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.0 -159.47 15.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -165.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.537 ' CG ' HG21 ' A' ' 70' ' ' VAL . 93.6 mm-40 -87.44 152.58 22.12 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.274 -1.133 . . . . 0.0 110.274 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -120.51 158.93 26.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 109.552 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.33 119.09 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -69.06 -68.89 0.37 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 171.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -151.98 151.89 31.78 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -174.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.26 92.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.4 mt -82.78 -18.44 40.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.117 1.367 . . . . 0.0 112.162 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -124.06 91.58 3.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.04 -29.21 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.499 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -73.65 -60.25 2.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.631 0.772 . . . . 0.0 110.003 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -5.01 87.68 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 123.694 0.664 . . . . 0.0 112.663 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' HG22 ' A' ' 16' ' ' ILE . 12.0 m -120.02 66.18 10.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.976 1.388 . . . . 0.0 107.759 165.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.38 146.58 56.78 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.624 2.216 . . . . 0.0 110.404 -170.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.14 -7.89 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.941 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.433 HD12 ' CG2' ' A' ' 16' ' ' ILE . 2.8 tt -73.86 132.81 42.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.7 m -110.98 155.02 23.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 123.416 1.579 . . . . 0.0 110.415 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.35 148.38 51.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.579 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.18 8.83 12.77 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 117.841 -1.533 . . . . 0.0 116.098 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -59.98 139.45 57.42 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.8 1.8 . . . . 0.0 109.219 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.75 129.39 37.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.862 1.665 . . . . 0.0 110.34 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mt -81.66 130.1 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.844 0.858 . . . . 0.0 110.598 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -116.25 -55.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.265 1.826 . . . . 0.0 109.205 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -125.29 152.92 44.03 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.55 135.08 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 157.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 33.57 56.66 0.54 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.411 2.685 . . . . 0.0 113.351 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 61.29 25.92 15.83 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -121.51 129.49 52.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 170.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -72.46 126.62 30.3 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.277 0.631 . . . . 0.0 111.018 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.503 HG12 HD12 ' A' ' 65' ' ' LEU . 21.2 m -128.76 17.47 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.98 0.912 . . . . 0.0 112.272 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.8 -15.98 62.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.931 -1.106 . . . . 0.0 112.196 173.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.33 17.32 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.429 1.892 . . . . 0.0 110.664 -169.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 62' ' ' VAL . 17.7 mt -110.66 147.19 34.83 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.095 -1.003 . . . . 0.0 111.173 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.557 ' O ' HG22 ' A' ' 70' ' ' VAL . 14.1 m -75.12 147.5 40.47 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 117.173 -1.394 . . . . 0.0 108.115 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.596 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 70.1 t60 -42.99 -34.21 0.95 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.774 2.029 . . . . 0.0 113.943 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.69 -34.01 76.91 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 120.969 -1.082 . . . . 0.0 112.208 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.02 -49.09 16.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.248 2.219 . . . . 0.0 110.748 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.596 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -59.4 -42.62 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 1 C-N-CA 132.589 4.355 . . . . 0.0 111.896 172.518 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.6 -50.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 167.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.51 -40.97 93.34 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.603 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mt -59.34 -50.68 78.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.949 1.3 . . . . 0.0 109.918 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -60.94 -28.87 69.28 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.876 -0.515 . . . . 0.0 110.144 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -72.77 -42.19 64.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.672 -1.268 . . . . 0.0 109.632 174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -68.32 -16.49 63.97 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.39 1.45 . . . . 0.0 112.852 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -60.61 140.49 92.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 O-C-N 121.17 -0.956 . . . . 0.0 110.004 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -58.62 142.92 98.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.609 3.54 . . . . 0.0 111.501 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.07 136.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 159.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.22 51.47 54.71 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 123.293 0.37 . . . . 0.0 112.358 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.2 m -150.03 151.49 33.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -61.89 102.31 0.26 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.862 1.265 . . . . 0.0 109.461 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.6 m -83.04 146.11 28.91 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 160.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.6 m -120.56 131.2 54.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mp -127.04 149.93 49.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.87 126.11 73.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.58 154.48 27.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.004 0.907 . . . . 0.0 110.814 -175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -91.25 80.24 5.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.514 -170.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.941 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.102 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -123.19 -56.49 1.73 Allowed 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 118.914 1.357 . . . . 0.0 108.319 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m 44.3 -141.79 0.22 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.779 0.831 . . . . 0.0 111.287 -167.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.84 51.96 0.4 Allowed Glycine 0 C--N 1.332 0.336 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -158.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 p -140.83 169.68 17.18 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 158.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -130.7 165.09 23.62 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.29 126.22 0.94 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 104.656 -3.378 . . . . 0.0 104.656 -170.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.93 157.13 42.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 117.379 0.59 . . . . 0.0 110.096 -167.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.55 -176.21 5.31 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.846 1.658 . . . . 0.0 108.701 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -139.36 105.72 5.28 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -101.18 153.49 19.56 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.319 0.647 . . . . 0.0 109.568 -160.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtm -89.07 113.88 25.06 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.734 -169.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.5 m -78.1 137.31 38.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 159.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -131.42 161.77 31.71 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -119.81 144.89 47.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.819 HG22 ' HA ' ' A' ' 45' ' ' CYS . 21.7 pt -138.89 162.81 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.368 1.467 . . . . 0.0 109.333 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.4 t -132.14 137.28 55.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.894 0.854 . . . . 0.0 108.713 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -97.62 85.56 3.62 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 121.883 -0.511 . . . . 0.0 111.569 -166.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.32 -69.25 1.23 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.579 0.609 . . . . 0.0 114.445 -166.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.64 -62.41 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.247 1.419 . . . . 0.0 109.183 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -65.1 6.4 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.997 2.519 . . . . 0.0 114.653 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.63 71.6 1.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 63.54 173.06 0.17 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.499 1.919 . . . . 0.0 111.188 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.54 49.1 0.87 Allowed Glycine 0 C--O 1.222 -0.605 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -157.97 163.55 37.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.7 p -121.17 161.75 21.32 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.381 1.072 . . . . 0.0 108.805 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 pt -123.34 162.94 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.061 0.934 . . . . 0.0 110.132 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.77 140.31 40.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 107.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.75 121.04 18.22 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 p -110.2 168.47 7.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -64.97 -10.52 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.507 1.471 . . . . 0.0 112.224 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 p -114.58 7.2 16.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 112.758 -170.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.52 -172.5 15.76 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -171.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.437 ' HG2' HG21 ' A' ' 70' ' ' VAL . 43.3 mm-40 -77.07 149.98 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.666 -0.902 . . . . 0.0 108.751 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -130.17 164.02 25.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.588 1.155 . . . . 0.0 108.498 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.52 122.39 22.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -73.99 -62.33 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -154.66 145.58 22.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.19 136.64 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.7 mt -119.63 -8.94 9.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 111.313 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -155.81 108.51 2.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.362 2.265 . . . . 0.0 106.842 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.97 -53.7 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.16 0.984 . . . . 0.0 110.07 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -72.86 -4.19 30.31 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.065 -1.022 . . . . 0.0 112.521 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.77 -16.17 79.31 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.15 -0.969 . . . . 0.0 111.797 163.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.819 ' HA ' HG22 ' A' ' 16' ' ' ILE . 25.7 p -150.23 57.99 2.9 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 118.956 1.378 . . . . 0.0 113.541 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.27 112.32 1.53 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.342 2.028 . . . . 0.0 111.534 -170.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.75 -5.96 37.57 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.514 1.53 . . . . 0.0 113.62 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.81 139.37 41.72 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.377 1.589 . . . . 0.0 109.795 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.8 m -123.82 9.84 8.88 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 66.2 152.3 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.056 2.142 . . . . 0.0 112.784 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.88 -3.0 0.17 Allowed Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.896 1.236 . . . . 0.0 115.31 -170.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.98 158.43 19.34 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.286 2.043 . . . . 0.0 109.718 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.86 114.11 26.85 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.626 1.57 . . . . 0.0 109.978 -161.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 62' ' ' VAL . 53.1 mt -65.26 129.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.812 1.245 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 62' ' ' VAL . 59.8 t -124.78 -51.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.429 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.5 145.54 51.87 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.834 1.652 . . . . 0.0 109.873 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.6 mt -125.06 122.26 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 45.05 42.26 6.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.264 1.426 . . . . 0.0 111.656 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 65.76 8.39 5.22 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.177 1.391 . . . . 0.0 113.609 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -77.68 138.6 39.16 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.641 -1.287 . . . . 0.0 108.031 163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.67 116.86 22.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.672 2.389 . . . . 0.0 108.33 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG12 HD22 ' A' ' 65' ' ' LEU . 7.2 m -135.53 13.61 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 125.449 1.5 . . . . 0.0 112.016 -169.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -57.44 -55.41 35.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 118.319 -2.738 . . . . 0.0 112.562 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -81.45 -6.77 59.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.596 0.758 . . . . 0.0 111.095 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.679 HD22 HG12 ' A' ' 62' ' ' VAL . 6.4 mp -64.46 135.17 55.81 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.28 1.832 . . . . 0.0 111.203 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -63.41 160.81 15.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.037 171.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -48.77 -49.57 38.01 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.25 0.62 . . . . 0.0 111.012 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -42.92 73.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.043 1.737 . . . . 0.0 112.227 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.442 1.497 . . . . 0.0 108.069 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 34' ' ' GLN . 62.6 t -68.22 -43.76 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 110.617 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.33 -42.58 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 124.26 1.024 . . . . 0.0 109.926 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -44.47 91.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.183 0.993 . . . . 0.0 110.156 -176.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.04 -44.48 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.519 -0.738 . . . . 0.0 109.146 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.5 -23.73 66.96 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.57 -0.706 . . . . 0.0 111.571 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -72.95 -42.92 62.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.943 1.247 . . . . 0.0 109.977 171.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -55.55 -35.45 65.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.109 0.868 . . . . 0.0 110.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 81.9 m -54.67 138.8 61.38 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.3 141.14 55.52 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.827 3.685 . . . . 0.0 110.814 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mm -70.86 142.28 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.97 -2.08 28.16 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.446 1.974 . . . . 0.0 113.385 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.4 m -103.01 165.02 11.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.076 1.35 . . . . 0.0 107.862 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -69.21 153.35 43.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 123.128 1.442 . . . . 0.0 111.216 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -140.6 141.46 35.16 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.061 2.144 . . . . 0.0 105.653 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 m -112.62 115.9 29.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.406 HD13 HD11 ' A' ' 16' ' ' ILE . 6.1 mp -113.04 153.01 28.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mt -126.55 122.41 60.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.72 164.14 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.708 0.803 . . . . 0.0 110.764 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -84.13 124.02 30.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.383 0.673 . . . . 0.0 111.13 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -153.95 175.59 13.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 108.471 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.24 82.37 0.07 OUTLIER Glycine 0 C--N 1.336 0.557 0 C-N-CA 126.542 2.02 . . . . 0.0 113.708 168.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -67.8 -54.17 21.19 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.983 0.892 . . . . 0.0 110.51 167.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.51 163.89 32.29 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.7 1.136 . . . . 0.0 111.789 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.27 128.33 9.66 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.319 2.013 . . . . 0.0 110.689 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.82 118.23 0.94 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 167.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.9 m 46.85 48.12 15.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.404 1.481 . . . . 0.0 112.017 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.273 0 CA-C-O 117.877 -1.513 . . . . 0.0 109.493 -177.12 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.519 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m 52.67 48.12 23.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.61 1.164 . . . . 0.0 112.685 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.1 t -60.69 164.66 4.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.395 1.078 . . . . 0.0 110.553 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.66 178.68 53.87 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 153.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m 66.19 117.68 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.239 1.816 . . . . 0.0 113.045 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 m -72.54 82.97 1.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 170.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.89 -72.99 0.72 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -165.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -67.24 145.64 54.99 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.411 0.624 . . . . 0.0 110.329 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.24 -8.71 0.2 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.673 1.189 . . . . 0.0 112.603 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.46 109.34 0.87 Allowed 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.905 2.882 . . . . 0.0 110.435 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.36 161.11 17.52 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.505 1.922 . . . . 0.0 109.124 165.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 mtm -88.78 150.06 23.12 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.9 m -116.04 148.29 40.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -145.46 168.3 20.88 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 128.62 2.768 . . . . 0.0 107.457 -172.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.12 153.97 51.03 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.247 -0.908 . . . . 0.0 108.591 170.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.0 pt -134.07 167.38 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 126.461 1.905 . . . . 0.0 109.227 173.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.7 139.67 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HG2' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.24 152.56 40.98 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 176.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.09 74.72 0.28 Allowed Glycine 0 C--O 1.238 0.377 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.27 -166.92 0.08 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.051 1.34 . . . . 0.0 111.157 -167.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 40.47 9.7 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 131.579 3.952 . . . . 0.0 118.643 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.16 67.93 1.86 Allowed Glycine 0 N--CA 1.445 -0.736 0 O-C-N 120.65 -1.281 . . . . 0.0 110.553 -165.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CE1' HD22 ' A' ' 74' ' ' LEU . 23.1 m-85 63.75 174.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.227 2.211 . . . . 0.0 111.544 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.81 34.96 4.95 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.545 1.545 . . . . 0.0 110.233 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -140.89 167.03 23.17 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 p -129.96 151.38 50.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.6 pt -114.22 144.96 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.77 131.36 46.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.09 144.41 50.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.6 p -138.57 167.0 21.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 127.676 2.391 . . . . 0.0 105.567 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.71 -36.45 97.13 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 p -79.0 -28.39 43.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.576 1.95 . . . . 0.0 111.684 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.99 -134.34 4.79 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -162.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -106.63 147.2 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.952 . . . . 0.0 110.094 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -146.78 161.13 41.28 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.234 1.014 . . . . 0.0 108.342 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -77.26 114.49 17.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -63.37 -61.36 2.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.105 1.362 . . . . 0.0 108.759 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -157.08 154.23 29.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.86 114.25 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.9 mt -87.63 -25.11 23.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.798 0.839 . . . . 0.0 110.106 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -150.1 96.15 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.011 1.724 . . . . 0.0 107.598 -169.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 mt -60.47 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 109.949 -166.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -64.12 -12.39 39.0 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.48 -34.96 63.22 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 119.232 0.924 . . . . 0.0 111.426 170.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.493 ' HA ' HG22 ' A' ' 16' ' ' ILE . 79.3 m -126.87 67.64 69.19 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.467 1.107 . . . . 0.0 108.703 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.55 132.92 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.38 2.053 . . . . 0.0 109.124 -172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.05 -3.4 71.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.259 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.94 135.08 49.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.22 1.51 . . . . 0.0 107.003 166.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.7 m -137.17 131.69 32.88 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.85 153.47 41.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.245 0.618 . . . . 0.0 111.89 -163.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.94 37.14 93.92 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -166.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.48 -173.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.081 1.352 . . . . 0.0 110.389 160.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.38 122.45 20.25 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 154.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.7 mt -69.52 129.51 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.28 -58.08 2.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.521 1.128 . . . . 0.0 111.425 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 22.1 mt-10 -136.61 131.67 34.05 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.19 127.24 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 45.55 38.56 4.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.105 1.762 . . . . 0.0 111.575 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 61.1 18.47 9.04 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.14 1.776 . . . . 0.0 114.056 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -92.49 135.52 33.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 156.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 23.1 t-20 -80.83 138.62 36.22 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.227 0.536 . . . . 0.0 110.067 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.798 HG12 HD22 ' A' ' 65' ' ' LEU . 16.6 m -137.89 10.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 126.35 1.86 . . . . 0.0 108.347 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -24.51 66.99 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 119.265 -2.147 . . . . 0.0 112.477 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.55 -13.01 16.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.137 0.88 . . . . 0.0 110.598 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.798 HD22 HG12 ' A' ' 62' ' ' VAL . 5.6 mp -59.38 127.73 33.57 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 126.366 1.866 . . . . 0.0 111.67 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.09 162.11 3.65 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.362 1.039 . . . . 0.0 110.316 176.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -49.85 -48.33 51.18 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.169 0.588 . . . . 0.0 109.989 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -58.38 -36.13 73.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.724 1.21 . . . . 0.0 111.848 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.45 -47.71 54.08 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.198 1.399 . . . . 0.0 107.818 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.03 -46.48 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.937 0.895 . . . . 0.0 109.462 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.07 -42.83 91.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.886 0.874 . . . . 0.0 110.851 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -67.59 -30.73 70.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.42 0.688 . . . . 0.0 111.914 -177.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.25 -40.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 23' ' ' PHE . 35.6 mt -62.03 -27.59 68.99 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.001 -1.062 . . . . 0.0 110.773 172.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 8.6 mtpm? -69.6 -29.91 67.54 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.653 -1.279 . . . . 0.0 111.863 172.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.72 -22.45 53.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.213 0.915 . . . . 0.0 111.24 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.57 132.88 91.24 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 118.974 0.806 . . . . 0.0 110.476 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.19 132.45 46.95 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.526 2.818 . . . . 0.0 109.595 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.43 HD13 ' HG2' ' A' ' 18' ' ' LYS . 3.2 mm -72.13 106.84 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.85 6.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.059 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -136.09 163.34 30.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 118.839 1.32 . . . . 0.0 109.736 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.31 143.65 57.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.28 1.038 . . . . 0.0 111.025 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -131.03 135.17 47.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.478 1.911 . . . . 0.0 105.929 171.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 m -111.5 128.38 55.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -164.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -129.23 137.09 50.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -112.15 129.94 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.81 145.61 35.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 109.711 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.04 99.84 4.73 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 109.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -152.53 148.74 27.74 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.58 -173.3 31.11 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 126.804 2.145 . . . . 0.0 108.436 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.17 114.35 7.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.74 0.77 . . . . 0.0 111.508 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.9 173.99 21.35 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 124.263 0.935 . . . . 0.0 113.369 163.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.6 116.76 4.11 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.689 2.259 . . . . 0.0 106.601 169.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.2 t -147.89 -63.17 0.26 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -167.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.2 m -80.35 160.08 25.54 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 153.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 CA-C-O 117.553 -1.693 . . . . 0.0 111.398 167.016 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.308 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -61.82 97.82 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.281 1.432 . . . . 0.0 108.471 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 t -66.66 154.32 40.89 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.79 90.45 0.55 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 m 72.77 -81.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.253 1.821 . . . . 0.0 110.101 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.1 t 62.52 150.3 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.393 2.277 . . . . 0.0 111.301 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.88 43.32 2.89 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.348 -0.845 . . . . 0.0 112.351 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -48.76 128.22 15.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.797 2.439 . . . . 0.0 110.56 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.98 173.75 16.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.451 1.901 . . . . 0.0 108.83 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -115.01 100.12 7.95 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.704 1.601 . . . . 0.0 106.825 171.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.91 161.9 23.01 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 mtm -106.7 118.03 35.61 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.771 0.796 . . . . 0.0 109.682 174.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.3 m -84.33 143.69 29.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.6 mt -143.87 168.08 20.8 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.089 2.156 . . . . 0.0 106.351 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.6 m -127.47 148.5 50.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.167 0.987 . . . . 0.0 109.169 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 45' ' ' CYS . 15.7 pt -139.68 160.03 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.846 1.258 . . . . 0.0 111.126 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.1 t -129.06 113.69 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 123.011 1.386 . . . . 0.0 108.615 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.65 102.82 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.08 2.152 . . . . 0.0 108.643 168.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.83 -62.31 3.88 Favored Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.32 -62.44 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 109.225 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.0 51.35 0.5 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.42 2.288 . . . . 0.0 111.913 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.66 47.47 12.98 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.113 1.816 . . . . 0.0 113.597 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 84.9 -11.46 0.78 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 130.54 3.536 . . . . 0.0 113.72 174.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -60.6 1.95 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.86 1.209 . . . . 0.0 111.552 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -49.4 151.05 1.63 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.051 1.426 . . . . 0.0 110.38 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -125.18 159.48 31.43 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -171.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 pt -126.87 152.44 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.526 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.93 137.24 49.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.745 1.218 . . . . 0.0 109.453 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -71.65 124.46 24.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 126.064 1.745 . . . . 0.0 109.389 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 p -120.69 159.75 47.22 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -58.91 -28.87 88.74 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.388 2.725 . . . . 0.0 111.878 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 p -98.23 -5.63 32.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.238 2.615 . . . . 0.0 113.61 -168.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.59 173.72 17.11 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -76.72 145.52 38.62 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.411 -1.052 . . . . 0.0 109.461 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -129.15 151.07 50.23 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.25 108.44 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -66.72 -62.25 1.55 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -155.06 143.19 20.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -90.98 126.61 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 127.044 2.138 . . . . 0.0 106.211 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.7 mt -110.78 -17.95 13.24 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.319 0.648 . . . . 0.0 111.029 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -133.96 77.21 1.7 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.315 1.446 . . . . 0.0 108.165 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.53 -39.61 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.658 1.183 . . . . 0.0 111.222 -169.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -10.4 59.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.87 -15.9 66.61 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 119.27 0.941 . . . . 0.0 111.798 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.631 ' HA ' HG22 ' A' ' 16' ' ' ILE . 48.0 m -130.77 70.73 82.55 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 118.56 1.18 . . . . 0.0 109.91 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -60.42 121.56 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.758 2.972 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.85 71.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.687 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.58 144.81 56.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.325 1.562 . . . . 0.0 109.822 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.0 m -129.53 161.78 29.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.89 1.328 . . . . 0.0 110.444 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.56 136.17 57.76 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.449 1.5 . . . . 0.0 108.261 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.22 17.77 70.5 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.565 1.555 . . . . 0.0 115.044 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.76 101.42 0.64 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.16 1.98 . . . . 0.0 111.405 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.69 114.26 6.89 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.531 1.932 . . . . 0.0 111.09 -167.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.55 134.38 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.607 1.094 . . . . 0.0 110.545 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HG2' ' A' ' 63' ' ' GLN . 73.9 t -119.55 -49.51 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.232 1.413 . . . . 0.0 110.062 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.89 146.11 49.97 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.545 0.688 . . . . 0.0 109.549 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -121.29 135.58 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 153.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 32.28 54.42 0.33 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.638 2.375 . . . . 0.0 113.306 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 47.78 4.49 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 130.421 3.488 . . . . 0.0 118.813 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -26.16 67.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.059 1.754 . . . . 0.0 113.055 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 65.88 126.42 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 130.299 3.44 . . . . 0.0 111.336 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.607 HG12 HD22 ' A' ' 65' ' ' LEU . 12.5 m -134.87 20.78 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.644 1.978 . . . . 0.0 108.49 -163.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -62.99 -59.94 4.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 119.5 -2.0 . . . . 0.0 112.343 173.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -76.89 -12.17 59.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.159 0.583 . . . . 0.0 111.794 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.607 HD22 HG12 ' A' ' 62' ' ' VAL . 6.0 mp -56.93 131.6 50.16 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 126.119 1.768 . . . . 0.0 110.396 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 160.14 15.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.474 174.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -43.24 -50.85 6.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.834 0.854 . . . . 0.0 110.53 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.1 m -60.39 -32.72 71.58 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.814 0.846 . . . . 0.0 112.016 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.39 -45.25 60.56 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.23 -38.22 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.402 0.681 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.9 -52.07 65.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.049 1.34 . . . . 0.0 109.743 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.23 -39.6 93.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.618 1.167 . . . . 0.0 109.942 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.2 mt -56.92 -55.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.65 1.18 . . . . 0.0 110.14 169.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.8 -21.98 66.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.411 0.551 . . . . 0.0 111.604 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -70.66 -40.82 72.79 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.543 -1.348 . . . . 0.0 110.226 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -74.31 -21.7 59.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.921 0.889 . . . . 0.0 113.272 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.8 m -55.09 128.79 66.34 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 168.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -61.89 140.07 83.18 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.761 2.974 . . . . 0.0 111.689 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.01 117.28 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.68 49.65 5.32 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -145.63 155.49 43.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.939 -1.33 . . . . 0.0 108.681 160.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -70.17 129.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 168.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -101.89 142.75 32.7 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.524 1.529 . . . . 0.0 107.414 165.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -104.89 126.8 52.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.15 156.99 47.33 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.83 135.11 63.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.42 159.34 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 110.17 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -81.84 122.59 27.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.162 0.585 . . . . 0.0 110.826 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -141.61 -45.76 0.36 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.876 0.87 . . . . 0.0 111.738 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -48.95 136.4 19.81 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.659 1.123 . . . . 0.0 111.898 -176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 175.51 -41.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.219 2.208 . . . . 0.0 109.58 -166.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.61 -174.52 2.15 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.371 0.986 . . . . 0.0 112.668 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -82.68 65.58 8.12 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.264 2.643 . . . . 0.0 110.924 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 t 84.34 102.11 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.408 2.283 . . . . 0.0 109.206 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.5 t 50.83 39.89 23.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.343 1.057 . . . . 0.0 110.681 -173.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 116.392 -2.338 . . . . 0.0 110.945 179.294 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.37 155.93 45.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.101 1.361 . . . . 0.0 110.108 -170.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m 48.5 38.35 10.8 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.643 1.577 . . . . 0.0 114.114 170.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.14 -173.18 42.06 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.055 0.836 . . . . 0.0 113.44 -168.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -119.26 174.1 6.55 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.291 2.237 . . . . 0.0 110.127 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m 53.7 -171.0 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.446 1.099 . . . . 0.0 113.112 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.7 -92.87 0.49 Allowed Glycine 0 C--N 1.334 0.455 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 164.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.73 172.53 17.78 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.088 1.355 . . . . 0.0 108.248 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.51 154.97 38.43 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.571 1.148 . . . . 0.0 110.657 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -116.35 96.72 5.66 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.646 1.578 . . . . 0.0 106.999 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.39 162.69 32.33 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.543 1.537 . . . . 0.0 108.293 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.8 mtm -111.11 114.82 28.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.201 1.0 . . . . 0.0 109.07 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.1 m -83.72 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 168.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.5 mt -138.99 168.67 19.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.136 2.174 . . . . 0.0 107.258 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 82' ' ' GLU . 11.7 m -123.09 149.85 43.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 45' ' ' CYS . 24.9 pt -130.82 154.37 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.898 1.679 . . . . 0.0 108.637 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 104.6 3.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -68.85 118.09 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.998 1.719 . . . . 0.0 109.629 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.84 -63.29 2.22 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.176 0.893 . . . . 0.0 111.007 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.34 -58.11 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.396 1.078 . . . . 0.0 110.87 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -76.69 56.54 1.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.879 2.072 . . . . 0.0 110.138 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.76 61.59 2.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.178 1.371 . . . . 0.0 111.796 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 69.69 -71.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 126.988 2.115 . . . . 0.0 109.418 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.21 -52.4 0.66 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.09 158.68 1.05 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.647 1.213 . . . . 0.0 111.76 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.3 p -115.51 151.92 33.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.252 -173.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.1 159.92 16.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.96 129.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.146 2.578 . . . . 0.0 106.603 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.77 128.35 35.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 p -122.99 168.4 12.17 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.509 1.124 . . . . 0.0 108.081 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.01 -35.56 92.66 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.238 2.625 . . . . 0.0 110.595 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -82.37 6.81 15.88 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.221 2.209 . . . . 0.0 113.367 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.47 -157.02 18.35 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -84.76 141.45 30.52 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.788 -0.83 . . . . 0.0 110.176 -169.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -132.02 165.56 23.69 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.639 1.176 . . . . 0.0 108.74 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -89.38 124.44 42.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -73.71 -68.4 0.51 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.114 1.366 . . . . 0.0 108.663 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -155.06 137.93 15.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.1 mt -85.09 129.21 38.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 mt -108.57 -8.11 15.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.576 0.75 . . . . 0.0 111.225 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -149.64 114.17 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.44 -55.93 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.571 1.148 . . . . 0.0 110.055 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -57.16 -32.73 66.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.931 0.787 . . . . 0.0 110.889 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.04 75.03 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 123.413 0.53 . . . . 0.0 113.287 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.567 ' HA ' HG22 ' A' ' 16' ' ' ILE . 59.7 m -132.94 73.34 75.74 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 119.132 1.466 . . . . 0.0 111.159 -175.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.95 110.55 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.718 1 C-N-CA 125.971 4.447 . . . . 0.0 115.671 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.82 55.25 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.061 -1.025 . . . . 0.0 113.446 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 49' ' ' CYS . 1.7 tm? -55.73 152.92 8.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.769 2.027 . . . . 0.0 109.768 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.552 ' N ' HD13 ' A' ' 48' ' ' LEU . 57.2 m -144.69 151.12 38.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.108 1.363 . . . . 0.0 111.515 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -60.39 142.65 54.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.693 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.52 10.3 48.31 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.886 -2.063 . . . . 0.0 114.712 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -53.86 115.96 2.28 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.614 1.707 . . . . 0.0 106.405 166.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.54 103.62 8.6 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.85 143.59 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.514 1.052 . . . . 0.0 109.043 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 63' ' ' GLN . 57.8 t -130.46 -52.24 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.294 1.038 . . . . 0.0 110.021 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -130.05 145.72 51.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -126.49 125.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.45 38.99 11.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.153 2.181 . . . . 0.0 110.551 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 72.77 -1.42 3.01 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.956 2.102 . . . . 0.0 113.263 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -78.85 135.47 37.04 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.744 -1.222 . . . . 0.0 108.066 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -71.8 121.53 19.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.977 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.411 ' HB ' HG22 ' A' ' 70' ' ' VAL . 32.6 m -121.88 6.37 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 111.913 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.429 ' HG3' HG13 ' A' ' 55' ' ' VAL . 19.1 mt-30 -59.97 -45.12 93.73 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.289 1.404 . . . . 0.0 110.097 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -88.27 24.86 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.574 1.549 . . . . 0.0 111.384 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.83 140.62 52.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.483 1.513 . . . . 0.0 110.133 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.8 m -67.93 158.23 33.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.596 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -47.57 -51.55 20.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.057 0.943 . . . . 0.0 110.996 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.6 m -67.1 -27.03 67.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.828 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.8 -43.53 71.93 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.471 1.032 . . . . 0.0 108.965 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -66.1 -36.97 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.154 -0.966 . . . . 0.0 110.325 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.8 t -57.74 -47.72 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.58 0.752 . . . . 0.0 109.411 169.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.9 -30.61 69.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.022 0.915 . . . . 0.0 112.575 -172.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.4 mt -67.88 -48.15 76.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.21 -25.26 67.7 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.959 -1.088 . . . . 0.0 111.893 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -74.39 -35.33 63.48 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.345 -1.472 . . . . 0.0 110.808 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.68 -49.72 56.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.974 0.806 . . . . 0.0 108.944 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.7 m -42.03 115.33 1.5 Allowed Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.696 1.599 . . . . 0.0 112.376 -170.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.88 127.61 25.79 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.913 3.075 . . . . 0.0 107.391 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.73 141.09 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.43 16.19 48.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.805 1.669 . . . . 0.0 114.019 -171.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.8 t -87.28 160.68 18.33 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.691 1.745 . . . . 0.0 106.975 164.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 15' ' ' THR . 0.0 OUTLIER -80.29 135.45 36.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.9 m -120.52 109.8 15.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -87.05 104.28 16.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.904 2.482 . . . . 0.0 108.474 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.29 160.27 14.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.394 0.543 . . . . 0.0 109.565 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.74 130.76 68.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.32 150.56 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.5 1.12 . . . . 0.0 108.853 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 116.98 22.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.041 1.736 . . . . 0.0 108.55 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -160.67 113.94 2.05 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.37 -98.11 0.16 Allowed Glycine 0 C--O 1.228 -0.25 0 N-CA-C 107.027 -2.429 . . . . 0.0 107.027 172.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 74.17 152.31 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 110.553 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.46 -164.99 12.81 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -167.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.8 6.63 4.02 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.626 3.55 . . . . 0.0 113.903 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.8 t 132.95 107.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 130.956 3.702 . . . . 0.0 106.175 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 80.4 142.57 0.07 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 127.807 2.443 . . . . 0.0 109.35 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -172.414 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.046 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -59.92 -55.31 35.64 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 158.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m 51.87 73.45 0.32 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.707 1.603 . . . . 0.0 110.748 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.83 94.32 0.17 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 171.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 p 54.32 117.64 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 129.284 3.033 . . . . 0.0 114.946 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.7 m -154.49 85.53 1.13 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.475 1.11 . . . . 0.0 109.559 168.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.77 170.21 22.79 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 167.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -144.15 164.54 30.4 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.308 1.843 . . . . 0.0 108.866 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 50.59 86.08 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.692 2.397 . . . . 0.0 111.636 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -150.31 101.26 2.97 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.7 mt 51.05 167.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 130.971 3.708 . . . . 0.0 115.728 -171.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.41 ' CE ' HD11 ' A' ' 87' ' ' ILE . 3.9 mtp -131.48 114.71 15.25 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.739 1.216 . . . . 0.0 108.383 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 m -78.27 142.77 37.58 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 164.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.2 mt -142.84 168.48 19.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.78 2.432 . . . . 0.0 107.006 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.86 155.6 37.75 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.14 -0.975 . . . . 0.0 108.731 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 45' ' ' CYS . 15.3 pt -132.83 169.85 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 t -115.65 151.14 17.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 162.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 56.9 tttt -70.02 165.4 21.91 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.809 -1.182 . . . . 0.0 110.091 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -136.62 165.61 24.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.07 -24.25 60.65 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -165.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -75.89 12.86 0.97 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.222 1.374 . . . . 0.0 111.004 165.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 72.71 69.71 1.35 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.729 1.633 . . . . 0.0 109.817 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 77.0 168.08 0.24 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.69 2.796 . . . . 0.0 111.236 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.86 28.16 9.11 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.152 1.834 . . . . 0.0 111.71 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -138.45 172.92 12.18 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.2 p -131.01 146.8 52.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.134 1.374 . . . . 0.0 108.039 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.48 152.17 19.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -126.48 154.16 44.11 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.53 1.932 . . . . 0.0 108.032 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.06 128.62 36.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.538 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 p -121.79 159.01 52.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 11.33 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.037 3.158 . . . . 0.0 114.332 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.4 p -127.18 -6.1 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.38 0.991 . . . . 0.0 112.863 -168.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.56 170.0 12.6 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -160.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -72.95 151.44 41.85 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.497 -1.002 . . . . 0.0 110.0 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -139.63 161.04 38.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.835 0.826 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 48' ' ' LEU . 51.0 t -78.39 122.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 125.547 1.539 . . . . 0.0 107.88 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -71.59 -55.93 6.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.608 162.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -162.24 146.13 12.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.244 0.474 . . . . 0.0 110.476 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.85 93.72 2.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.3 mt -70.57 -28.08 64.62 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.286 1.034 . . . . 0.0 109.945 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -136.78 91.09 2.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.214 1.406 . . . . 0.0 109.674 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.62 -41.57 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 123.67 0.788 . . . . 0.0 110.322 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -71.46 -5.16 30.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.128 -0.983 . . . . 0.0 113.13 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -23.47 28.04 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.636 1.107 . . . . 0.0 111.471 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.442 ' HA ' HG22 ' A' ' 16' ' ' ILE . 84.2 m -136.14 67.47 62.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 109.857 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 136.38 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.326 2.017 . . . . 0.0 111.75 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.82 -9.25 3.82 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.266 -1.296 . . . . 0.0 115.295 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' CD2' HG21 ' A' ' 36' ' ' VAL . 5.6 tt -61.56 145.49 51.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.216 1.508 . . . . 0.0 108.956 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.9 m -110.94 147.24 35.07 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.93 0.892 . . . . 0.0 111.527 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.76 151.0 42.33 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.92 44.84 7.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.388 0.994 . . . . 0.0 111.805 -170.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.15 -174.99 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.65 1.98 . . . . 0.0 109.615 159.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.45 104.03 4.34 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 119.801 -1.812 . . . . 0.0 106.665 163.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.13 131.47 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.24 -50.37 4.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.129 1.372 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -136.53 143.79 43.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.86 125.28 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.509 -2.775 . . . . 0.0 103.509 168.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 44.8 51.91 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.21 1.404 . . . . 0.0 111.258 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 65.64 -24.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.978 2.511 . . . . 0.0 115.094 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -69.31 135.79 50.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.55 118.65 36.8 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.429 -157.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.484 HG12 HD12 ' A' ' 65' ' ' LEU . 34.6 m -125.05 2.14 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.516 -156.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -14.98 0.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.543 1.137 . . . . 0.0 113.156 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.96 6.81 6.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.061 2.544 . . . . 0.0 112.828 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.484 HD12 HG12 ' A' ' 62' ' ' VAL . 23.8 mt -90.28 160.57 16.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.174 1.352 . . . . 0.0 110.101 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -83.87 162.77 20.42 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.95 0.5 . . . . 0.0 110.831 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -49.21 -51.43 33.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -59.05 -35.63 73.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.381 0.673 . . . . 0.0 111.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -74.49 -39.99 62.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.85 -41.85 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.41 -46.4 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.79 1.236 . . . . 0.0 110.37 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -38.78 70.37 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.595 0.56 . . . . 0.0 111.732 -171.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.26 -44.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.226 1.01 . . . . 0.0 109.315 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.59 -32.75 74.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.757 -0.59 . . . . 0.0 110.761 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -64.2 -42.11 96.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.049 1.295 . . . . 0.0 109.847 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.63 -20.25 65.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.526 1.53 . . . . 0.0 112.678 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.55 143.31 93.62 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 124.797 1.239 . . . . 0.0 110.578 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 142.45 49.05 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 124.447 3.431 . . . . 0.0 111.049 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.37 144.69 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.9 -1.08 64.0 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.892 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.45 158.09 16.71 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 119.703 1.751 . . . . 0.0 107.474 173.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.21 153.73 37.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.978 0.911 . . . . 0.0 111.034 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 m -126.21 128.26 46.95 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.737 1.615 . . . . 0.0 106.795 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -80.06 126.32 30.91 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.25 152.19 40.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.04 128.6 59.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 ' CE ' ' A' ' 12' ' ' MET . 1.3 pp -125.83 164.56 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.33 1.052 . . . . 0.0 110.546 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 118.7 36.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.651 0.78 . . . . 0.0 110.887 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.35 87.41 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 0.0 109.399 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.74 56.4 0.07 OUTLIER Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -126.54 20.72 7.24 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.624 1.169 . . . . 0.0 112.88 -160.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.92 -160.92 15.14 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -170.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.98 159.33 38.86 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.633 1.555 . . . . 0.0 110.18 171.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.3 m -133.45 117.13 16.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.1 m -143.71 175.82 9.69 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.541 1.537 . . . . 0.0 109.243 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.811 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 -170.49 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 CA-C-O 117.516 -1.713 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.9 m 73.11 93.43 0.08 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.121 1.769 . . . . 0.0 109.151 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.3 86.64 2.03 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.11 -73.84 0.44 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.2 m 56.0 -63.36 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.035 2.534 . . . . 0.0 113.069 -171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 t -60.25 114.4 2.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.439 1.096 . . . . 0.0 109.184 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.18 117.79 0.8 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.43 135.67 57.76 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -156.75 177.01 11.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.195 2.198 . . . . 0.0 107.847 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 54.83 58.66 4.62 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.275 1.43 . . . . 0.0 109.893 -166.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -116.88 157.32 25.85 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.398 1.479 . . . . 0.0 107.665 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtm -128.16 146.07 50.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.074 0.95 . . . . 0.0 108.954 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -122.56 112.21 17.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -117.69 168.3 10.57 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.215 2.206 . . . . 0.0 108.464 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.8 m -133.66 150.03 51.56 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.837 -0.539 . . . . 0.0 109.601 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.657 HG22 ' HA ' ' A' ' 45' ' ' CYS . 5.4 pt -140.13 145.7 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.651 1.18 . . . . 0.0 110.258 173.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.91 118.5 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 9.6 tttt -56.08 129.92 41.95 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.166 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.05 -81.99 0.63 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.91 143.69 20.75 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.659 1.184 . . . . 0.0 108.522 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 55.71 -3.31 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.294 3.038 . . . . 0.0 115.557 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 163.26 -177.3 39.29 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -92.66 3.81 54.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.236 1.014 . . . . 0.0 111.088 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.11 -52.85 3.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.751 -1.218 . . . . 0.0 112.066 -172.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -61.67 166.75 4.01 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 123.165 1.459 . . . . 0.0 111.886 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 p -126.9 151.33 48.58 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.235 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.9 171.45 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.65 161.52 36.27 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.181 1.393 . . . . 0.0 109.207 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 143.49 45.64 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 p -130.17 176.68 2.66 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.28 -19.1 62.1 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.319 2.013 . . . . 0.0 112.166 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p -109.47 3.27 21.16 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.529 1.132 . . . . 0.0 112.496 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.11 -163.17 12.4 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.722 ' HG3' HG21 ' A' ' 70' ' ' VAL . 4.1 mm100 -82.3 145.57 29.9 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.835 0.817 . . . . 0.0 109.986 -167.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -131.69 156.65 45.52 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.265 0.626 . . . . 0.0 109.369 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.17 140.67 17.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 171.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -106.09 -64.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.036 1.335 . . . . 0.0 108.581 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -142.84 134.45 26.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.74 136.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.742 1.617 . . . . 0.0 107.298 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -122.26 -50.57 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.955 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -93.23 95.26 9.26 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.9 mt -65.53 -54.28 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.256 1.822 . . . . 0.0 109.975 -171.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -60.0 -28.32 67.62 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.702 0.683 . . . . 0.0 111.067 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.15 -25.62 72.28 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 118.024 -1.431 . . . . 0.0 112.277 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.657 ' HA ' HG22 ' A' ' 16' ' ' ILE . 4.7 m -140.31 75.9 27.07 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 119.686 1.743 . . . . 0.0 112.42 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.77 154.8 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.135 2.557 . . . . 0.0 110.218 170.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.82 -45.1 2.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.753 1.168 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.57 132.05 30.01 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.093 2.157 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.44 -173.3 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.076 1.351 . . . . 0.0 109.038 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.17 104.72 14.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.49 -15.67 3.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.946 1.736 . . . . 0.0 111.653 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.51 105.53 0.11 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 128.416 2.686 . . . . 0.0 110.659 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.2 101.34 4.59 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.084 1.354 . . . . 0.0 109.102 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.65 129.95 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.438 1.895 . . . . 0.0 109.944 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.79 -43.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.57 1.548 . . . . 0.0 110.435 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.44 149.42 51.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.937 0.895 . . . . 0.0 109.53 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.1 mt -130.67 127.2 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 163.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 42.45 58.33 3.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 112.223 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 67.06 -18.78 0.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.598 2.359 . . . . 0.0 114.886 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -76.89 132.42 39.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.05 126.84 32.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 65' ' ' LEU . 27.8 m -124.31 8.29 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -59.56 -13.61 9.94 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -129.63 38.62 3.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.055 1.342 . . . . 0.0 109.107 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.434 HD12 HG12 ' A' ' 62' ' ' VAL . 17.5 mt -121.5 146.04 47.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 126.5 1.92 . . . . 0.0 108.662 171.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -76.53 155.98 33.27 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 116.993 -1.479 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.609 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 13.6 t-80 -49.21 -28.72 4.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.739 175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.5 m -74.32 -31.2 62.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.117 1.326 . . . . 0.0 111.945 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.82 -47.87 15.83 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 125.004 1.322 . . . . 0.0 110.554 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.722 HG21 ' HG3' ' A' ' 34' ' ' GLN . 2.7 m -54.56 -37.84 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 130.591 3.556 . . . . 0.0 111.726 168.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.98 -47.18 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.279 0.632 . . . . 0.0 109.843 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.59 -42.55 99.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.433 1.093 . . . . 0.0 111.759 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.86 -58.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 126.288 1.835 . . . . 0.0 108.879 169.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.45 -33.44 71.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.118 0.417 . . . . 0.0 111.406 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -64.66 -46.78 80.98 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.434 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.07 -28.89 69.18 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.174 0.99 . . . . 0.0 112.493 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.1 m -50.81 135.98 26.82 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 112.39 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.84 150.31 83.85 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.254 3.303 . . . . 0.0 110.615 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 75.7 mt -91.89 148.78 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.29 13.78 55.04 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.47 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -109.23 136.02 49.37 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.78 140.5 58.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.6 m -134.53 124.18 25.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.183 1.793 . . . . 0.0 106.997 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.0 m -91.45 127.94 37.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mp -124.89 125.04 43.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.38 129.23 58.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.44 150.37 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.37 1.068 . . . . 0.0 108.833 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -84.74 107.8 17.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -159.86 138.99 10.94 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.468 1.031 . . . . 0.0 110.299 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.23 176.78 45.61 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 127.797 2.617 . . . . 0.0 107.467 166.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.9 t 51.8 89.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.171 1.788 . . . . 0.0 112.185 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.65 -164.39 26.29 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -80.6 -29.21 2.4 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.913 2.409 . . . . 0.0 115.048 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.6 m -158.57 120.92 3.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.968 1.258 . . . . 0.0 110.577 -156.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.8 m -56.88 -28.52 61.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.143 0.883 . . . . 0.0 112.378 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 N-CA-C 104.869 -3.293 . . . . 0.0 104.869 -170.961 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -156.42 177.58 11.3 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 170.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.22 12.04 3.11 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.811 1.645 . . . . 0.0 114.466 173.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.78 81.66 1.67 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 m -175.13 83.6 0.03 OUTLIER 'General case' 0 C--O 1.233 0.222 0 C-N-CA 127.354 2.262 . . . . 0.0 107.872 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.6 m -76.07 178.28 6.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 161.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.56 167.95 40.02 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.714 1.174 . . . . 0.0 113.897 -165.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -139.18 166.43 24.55 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.863 2.065 . . . . 0.0 107.78 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.75 67.53 1.21 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -92.05 100.89 13.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.83 -156.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.513 2.325 . . . . 0.0 108.803 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.5 mtm -128.02 136.34 51.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.424 HG23 HG12 ' A' ' 86' ' ' ILE . 76.6 m -134.82 104.97 6.22 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 -168.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.37 168.43 9.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.116 1.767 . . . . 0.0 108.53 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.26 144.88 50.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.7 pt -137.94 131.94 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.111 0.965 . . . . 0.0 111.148 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.1 t -90.4 114.59 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 122.292 1.044 . . . . 0.0 109.063 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 34.7 tttm -65.11 126.43 28.07 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 170.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.04 -71.85 1.3 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 119.43 1.013 . . . . 0.0 111.719 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.55 -52.87 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.866 1.266 . . . . 0.0 109.893 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . 0.256 5.8 pt20 -74.28 58.22 0.72 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.966 1.365 . . . . 0.0 110.555 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 56.72 -150.59 26.85 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.739 -161.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -81.95 157.89 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 160.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.36 -45.36 30.54 Favored Glycine 0 C--O 1.223 -0.586 0 C-N-CA 119.403 -1.38 . . . . 0.0 112.05 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -52.07 155.94 1.73 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.667 1.233 . . . . 0.0 111.225 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.2 p -120.39 161.15 21.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.193 1.397 . . . . 0.0 108.04 -172.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.31 159.41 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.525 -0.735 . . . . 0.0 110.079 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 149.0 52.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.091 1.756 . . . . 0.0 107.527 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -76.5 141.08 41.38 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.277 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.08 165.36 29.77 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.646 1.179 . . . . 0.0 108.578 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.04 -2.86 8.67 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.791 2.994 . . . . 0.0 116.084 -164.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -136.81 2.53 2.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.468 1.031 . . . . 0.0 112.723 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.32 -176.63 28.85 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -77.93 148.62 34.43 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.15 -0.618 . . . . 0.0 110.332 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -131.63 162.64 29.9 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.814 0.845 . . . . 0.0 109.633 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.16 127.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -76.57 -69.05 0.54 Allowed 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.097 1.359 . . . . 0.0 107.625 172.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -152.33 141.1 20.98 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.5 0.591 . . . . 0.0 109.915 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -85.57 114.76 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -104.35 -9.8 18.24 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.968 0.907 . . . . 0.0 110.888 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -140.23 81.28 1.8 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.561 1.944 . . . . 0.0 105.952 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.51 -45.2 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.169 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.22 -34.44 59.25 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.514 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.94 87.03 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.783 0.719 . . . . 0.0 111.889 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.705 ' HA ' HG22 ' A' ' 16' ' ' ILE . 12.4 m -126.21 67.44 63.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 118.755 1.278 . . . . 0.0 110.748 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -58.53 158.69 22.47 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.656 2.237 . . . . 0.0 112.393 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.18 -20.72 0.41 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.598 1.57 . . . . 0.0 114.314 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 tp -63.52 133.61 54.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.258 1.823 . . . . 0.0 107.902 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.2 t -125.37 10.9 8.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.904 0.881 . . . . 0.0 112.438 -167.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.29 150.96 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 130.502 3.521 . . . . 0.0 114.849 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 8.06 32.8 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 113.542 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.46 113.07 2.46 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.603 1.561 . . . . 0.0 109.623 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.43 106.32 4.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.703 1.201 . . . . 0.0 109.79 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.49 142.29 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.336 1.054 . . . . 0.0 110.229 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.49 -55.74 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.338 1.455 . . . . 0.0 110.504 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.27 155.22 46.67 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.892 0.877 . . . . 0.0 109.463 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.2 mt -133.59 132.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 163.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 42.04 44.22 2.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.581 1.952 . . . . 0.0 113.654 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 59.06 42.52 18.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.636 1.175 . . . . 0.0 112.815 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -128.55 136.48 50.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.421 1.888 . . . . 0.0 107.12 160.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.16 120.59 23.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.411 1.084 . . . . 0.0 109.67 175.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.694 HG12 HD22 ' A' ' 65' ' ' LEU . 10.4 m -115.89 16.94 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 128.046 2.538 . . . . 0.0 107.86 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -42.45 97.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 119.714 -1.866 . . . . 0.0 111.223 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.9 -25.53 58.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.347 0.976 . . . . 0.0 111.285 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 HG12 ' A' ' 62' ' ' VAL . 5.6 mp -60.11 138.69 57.84 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.966 1.706 . . . . 0.0 112.887 -163.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 m -63.58 165.33 8.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.43 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.47 -53.61 35.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.199 0.599 . . . . 0.0 110.624 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.4 m -62.52 -34.36 76.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.803 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -62.94 -47.04 84.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.24 0.927 . . . . 0.0 108.814 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.7 -44.5 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.704 1.202 . . . . 0.0 110.275 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.28 -43.11 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 O-C-N 121.64 -0.662 . . . . 0.0 109.987 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -44.6 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.96 0.904 . . . . 0.0 110.5 -172.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.49 -51.47 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.474 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 50.7 mt -68.24 -13.58 62.35 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.537 -0.727 . . . . 0.0 112.646 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -83.44 -33.64 25.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.397 1.453 . . . . 0.0 110.657 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -72.3 -36.01 68.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.912 0.778 . . . . 0.0 109.409 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -47.84 137.65 10.13 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.875 1.27 . . . . 0.0 112.208 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.63 127.33 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.503 3.469 . . . . 0.0 111.873 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 53.4 mt -66.88 134.7 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 10.94 85.93 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.236 0.922 . . . . 0.0 112.391 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -113.89 158.96 20.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.307 1.443 . . . . 0.0 108.54 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.19 150.32 43.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 162.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.6 m -131.46 146.25 52.16 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 127.803 2.441 . . . . 0.0 106.36 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.87 122.7 45.71 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -168.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -123.65 157.3 34.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.563 1.074 . . . . 0.0 109.308 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 13' ' ' THR . 4.1 mt -129.62 140.54 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 167.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.52 156.06 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.543 1.137 . . . . 0.0 109.939 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.96 84.96 5.41 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.178 -0.951 . . . . 0.0 110.824 -168.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 -135.6 154.62 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 162.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.27 -98.25 1.99 Allowed Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 105.811 -2.916 . . . . 0.0 105.811 157.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.7 t -147.24 154.24 40.77 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.937 0.875 . . . . 0.0 109.469 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.59 167.08 35.26 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.69 98.13 0.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.366 2.71 . . . . 0.0 109.225 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.9 m -127.42 156.65 41.74 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.043 2.137 . . . . 0.0 107.273 163.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.82 105.0 0.07 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.482 1.913 . . . . 0.0 108.837 -172.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.265 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 175.196 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -64.53 88.29 0.06 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.771 0.785 . . . . 0.0 109.332 168.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 p -135.37 -4.09 2.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.372 1.069 . . . . 0.0 112.486 -174.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.69 -79.18 0.27 Allowed Glycine 0 C--N 1.337 0.589 0 N-CA-C 107.551 -2.22 . . . . 0.0 107.551 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -54.24 104.63 0.11 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.625 1.17 . . . . 0.0 109.026 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.2 m -159.3 170.29 22.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 127.651 2.38 . . . . 0.0 107.485 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.51 -66.43 2.67 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 124.844 1.212 . . . . 0.0 110.885 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -61.14 138.4 58.21 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.555 1.142 . . . . 0.0 110.589 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.45 -170.69 3.51 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.057 1.743 . . . . 0.0 107.951 166.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -73.23 107.86 5.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 154.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -68.53 -176.97 0.85 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.07 1.748 . . . . 0.0 108.932 164.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.3 mtp -89.69 135.77 33.42 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 162.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.8 m -112.92 142.72 45.28 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -133.54 167.83 19.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.159 1.784 . . . . 0.0 109.24 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -135.5 153.08 51.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 108.687 168.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 45' ' ' CYS . 13.6 pt -144.18 161.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.252 1.421 . . . . 0.0 110.071 174.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.52 115.15 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 122.363 1.077 . . . . 0.0 108.418 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -67.77 115.17 7.02 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.425 1.49 . . . . 0.0 109.824 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.86 -81.98 0.4 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.174 -171.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.35 139.77 18.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.512 1.656 . . . . 0.0 111.071 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 61.64 -35.68 0.11 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.014 2.126 . . . . 0.0 112.45 -166.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.52 -141.48 3.37 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.634 1.588 . . . . 0.0 109.472 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -94.04 153.48 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.12 -42.33 58.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.194 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.479 ' HD1' ' HG ' ' A' ' 45' ' ' CYS . 12.8 p90 -62.96 166.96 5.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.419 1.104 . . . . 0.0 111.786 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.0 p -125.79 153.34 44.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.593 1.157 . . . . 0.0 109.514 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.22 170.58 11.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.079 0.952 . . . . 0.0 109.823 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.1 149.71 41.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.95 2.1 . . . . 0.0 108.674 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.95 148.47 47.66 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -147.29 163.05 30.12 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.575 1.95 . . . . 0.0 106.726 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.96 12.73 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.961 1 C-N-CA 125.521 4.148 . . . . 0.0 113.884 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -144.17 -3.72 0.84 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.887 2.075 . . . . 0.0 111.134 -162.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.86 -164.4 17.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -82.91 146.98 28.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.094 1.447 . . . . 0.0 110.369 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -127.57 163.66 23.69 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 126.018 1.727 . . . . 0.0 109.298 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.52 117.43 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -70.16 -61.63 1.7 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.052 1.341 . . . . 0.0 108.502 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -151.13 154.29 36.65 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.097 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.8 mt -106.18 110.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.795 2.438 . . . . 0.0 106.811 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.52 -5.58 22.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.918 1.287 . . . . 0.0 111.723 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.68 69.58 0.75 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.765 1.626 . . . . 0.0 109.192 -161.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.45 -62.56 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 125.186 1.395 . . . . 0.0 110.579 -159.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.92 -12.38 60.58 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.703 0.683 . . . . 0.0 112.658 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.02 -25.09 62.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.87 0.748 . . . . 0.0 111.856 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.581 ' HA ' HG22 ' A' ' 16' ' ' ILE . 34.9 m -128.35 76.88 77.79 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.199 1.0 . . . . 0.0 109.095 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -62.82 159.54 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.413 2.075 . . . . 0.0 110.833 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.27 -48.46 0.71 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.179 1.847 . . . . 0.0 114.238 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.9 tp -44.9 140.21 2.72 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 129.176 2.99 . . . . 0.0 112.357 -170.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.8 m -132.37 159.63 38.66 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.346 1.459 . . . . 0.0 110.255 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -60.09 146.46 42.92 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 165.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 2.44 59.75 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.444 -0.642 . . . . 0.0 113.673 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -62.8 112.6 2.61 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 163.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tp -80.52 129.52 34.56 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 mt -95.04 130.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -167.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.99 -51.02 6.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.633 1.573 . . . . 0.0 109.8 -170.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -138.6 150.43 46.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.935 0.894 . . . . 0.0 108.764 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -131.72 124.96 54.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 38.92 54.92 2.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.801 1.641 . . . . 0.0 111.244 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 61.66 -6.89 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.769 2.828 . . . . 0.0 116.437 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.14 125.06 26.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.378 1.444 . . . . 0.0 108.052 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.1 129.68 41.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.648 HG12 HD12 ' A' ' 65' ' ' LEU . 22.5 m -127.75 4.03 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.647 0.779 . . . . 0.0 111.833 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -50.67 -38.9 49.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.627 1.171 . . . . 0.0 110.861 165.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -105.36 21.31 17.38 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.648 HD12 HG12 ' A' ' 62' ' ' VAL . 17.3 mt -117.67 150.33 39.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.913 1.233 . . . . 0.0 113.821 -171.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.92 154.16 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.507 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.18 -52.07 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.145 0.578 . . . . 0.0 111.951 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 m -63.93 -24.71 67.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.711 -0.662 . . . . 0.0 111.898 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.54 -42.12 62.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.628 1.104 . . . . 0.0 109.546 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 62' ' ' VAL . 57.8 t -64.84 -40.66 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.548 0.739 . . . . 0.0 109.48 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -46.25 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.497 0.719 . . . . 0.0 109.492 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.42 -41.91 99.05 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.621 1.169 . . . . 0.0 110.909 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -66.62 -44.54 89.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.31 -31.91 72.58 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.902 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 121.651 2.023 . . . . 0.0 110.82 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.85 -36.87 77.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.359 1.063 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.3 m -55.67 136.86 71.21 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.37 144.16 90.4 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.146 3.231 . . . . 0.0 111.575 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -76.89 134.07 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 168.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.05 28.43 68.5 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.63 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -129.83 159.89 35.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.13 134.96 41.16 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -105.36 129.8 53.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 m -87.59 135.58 33.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.57 167.65 20.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.692 0.678 . . . . 0.0 109.303 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -132.7 141.55 44.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.35 150.89 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.405 1.082 . . . . 0.0 110.404 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.7 97.14 8.95 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 107.911 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -151.51 -70.04 0.17 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.39 -167.41 23.68 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.84 124.11 22.04 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.544 1.138 . . . . 0.0 109.519 172.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.71 169.64 42.15 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.48 1.038 . . . . 0.0 110.713 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.98 136.39 37.96 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.79 2.326 . . . . 0.0 110.854 -170.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 m -62.81 145.36 55.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 158.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.4 m 46.74 78.87 0.06 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.78 1.276 . . . . 0.0 110.535 -156.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.136 -1.925 . . . . 0.0 110.605 169.031 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.776 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m -73.87 112.08 9.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -149.25 151.48 34.32 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 169.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.32 -153.58 35.4 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -162.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.7 m -143.0 86.16 1.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.304 -1.115 . . . . 0.0 108.404 168.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.7 m 61.46 121.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.643 1.977 . . . . 0.0 111.56 -161.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.16 67.29 0.13 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -161.98 86.2 0.62 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.359 1.064 . . . . 0.0 108.211 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.77 161.61 20.61 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.366 0.666 . . . . 0.0 111.984 159.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -128.88 102.21 6.43 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.18 2.192 . . . . 0.0 105.855 165.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 88' ' ' HIS . 2.8 mm? -82.39 179.93 7.63 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtp -88.57 135.81 33.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.406 HG23 HG12 ' A' ' 86' ' ' ILE . 85.3 m -134.45 103.82 5.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -172.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 168.36 9.45 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 126.085 1.754 . . . . 0.0 108.748 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.3 m -126.94 142.91 51.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' A' ' 45' ' ' CYS . 26.9 pt -127.62 167.85 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.764 1.626 . . . . 0.0 108.943 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.0 t -129.22 149.7 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.253 1.821 . . . . 0.0 106.963 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -113.24 99.82 8.1 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.822 1.249 . . . . 0.0 111.359 -164.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 54.23 4.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.744 1.64 . . . . 0.0 114.183 -172.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.07 -42.43 0.53 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.583 . . . . 0.0 116.53 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -80.21 -11.52 59.73 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.001 1.728 . . . . 0.0 113.106 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 16' ' ' ILE . 19.1 m-85 65.91 149.92 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.015 2.526 . . . . 0.0 110.32 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.62 -53.77 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.23 153.24 2.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.044 1.337 . . . . 0.0 111.831 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.3 p -116.96 148.47 41.38 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.465 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 pt -110.34 153.78 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.88 156.67 45.68 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.128 1.371 . . . . 0.0 108.757 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.79 139.52 39.35 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.16 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.02 175.91 2.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.847 1.659 . . . . 0.0 108.831 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.39 -21.42 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.963 3.109 . . . . 0.0 113.373 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -104.27 -4.31 23.15 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -162.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.1 177.26 14.81 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -162.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -71.35 148.43 47.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.351 1.075 . . . . 0.0 108.855 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -133.63 154.74 50.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG21 HD21 ' A' ' 48' ' ' LEU . 53.4 t -82.57 116.92 27.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -64.32 -58.96 5.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.603 169.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -153.74 144.34 22.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.0 mt -91.39 124.57 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -119.06 -3.24 10.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.512 1.125 . . . . 0.0 112.336 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -136.0 91.54 2.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.58 -55.38 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -63.58 -29.83 71.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.692 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.67 -16.98 61.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.642 1.11 . . . . 0.0 112.869 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.634 ' HA ' HG22 ' A' ' 16' ' ' ILE . 98.3 m -136.7 66.92 57.67 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 120.0 1.9 . . . . 0.0 111.124 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.68 117.8 4.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.684 2.923 . . . . 0.0 112.581 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -7.49 81.85 Favored Glycine 0 C--N 1.335 0.493 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.213 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.556 HD21 HG21 ' A' ' 36' ' ' VAL . 2.1 tt -66.07 153.27 42.73 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 82.6 m -124.46 159.8 29.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.517 1.127 . . . . 0.0 111.036 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.64 145.95 24.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.84 43.69 23.53 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -167.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.9 -170.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.494 1.117 . . . . 0.0 108.766 161.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.96 119.0 9.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.2 mt -89.63 127.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -171.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.05 -48.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.861 -163.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -134.74 132.6 38.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -115.62 129.41 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 167.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.86 16.77 7.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.48 1.912 . . . . 0.0 114.809 164.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 58.87 50.3 8.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.19 1.359 . . . . 0.0 112.019 -165.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.56 -15.38 10.85 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.95 133.19 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 130.712 3.605 . . . . 0.0 113.53 -165.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.29 7.34 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.001 0.921 . . . . 0.0 112.882 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.46 -18.22 64.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 113.597 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -110.37 -21.85 11.99 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.891 0.877 . . . . 0.0 110.047 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.23 139.47 58.49 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.916 0.865 . . . . 0.0 111.735 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.8 m -65.54 158.18 27.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.238 1.415 . . . . 0.0 110.553 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -50.61 -54.07 25.73 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 124.353 1.061 . . . . 0.0 110.154 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.04 -17.78 63.69 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.819 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.44 -36.81 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.433 1.093 . . . . 0.0 108.996 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -74.21 -43.45 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.662 1.185 . . . . 0.0 109.286 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.9 t -51.54 -43.73 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.039 0 C-N-CA 123.875 0.87 . . . . 0.0 108.894 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.506 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -65.02 -42.97 93.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.2 mt -60.44 -44.36 96.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -65.35 -31.28 72.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.465 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 47.8 mtmt -62.37 -43.4 98.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.219 1.827 . . . . 0.0 111.298 165.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.66 -32.78 71.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.984 1.314 . . . . 0.0 112.547 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -53.67 139.33 50.57 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.053 1.341 . . . . 0.0 111.811 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.19 122.33 9.38 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.727 2.951 . . . . 0.0 110.048 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 mt -61.1 147.66 10.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.27 9.8 13.25 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.36 -1.244 . . . . 0.0 114.144 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 m -121.29 173.59 7.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.667 1.587 . . . . 0.0 108.192 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.3 153.19 25.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.687 0.756 . . . . 0.0 111.425 -175.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.2 m -142.22 144.34 33.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.415 1.486 . . . . 0.0 108.834 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -110.93 107.62 17.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.049 2.14 . . . . 0.0 109.144 -157.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.3 112.53 16.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.159 1.8 . . . . 0.0 111.615 -170.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 13' ' ' THR . 3.4 mt -87.23 130.12 37.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.595 1.558 . . . . 0.0 108.608 171.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.25 150.21 30.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.011 1.324 . . . . 0.0 111.187 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.76 ' HA ' HD12 ' A' ' 11' ' ' LEU . 6.1 t-160 -78.11 77.34 4.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 0.0 111.329 -168.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -152.13 -177.87 6.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.487 1.915 . . . . 0.0 108.216 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.98 179.73 40.55 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 129.224 3.297 . . . . 0.0 106.887 171.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.3 m -54.07 156.82 2.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.637 1.718 . . . . 0.0 112.629 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.88 -176.51 41.52 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.96 -52.77 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.621 2.214 . . . . 0.0 110.729 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m 64.66 -178.37 0.17 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.028 1.331 . . . . 0.0 110.44 -160.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.1 m 55.11 47.91 20.8 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.069 1.347 . . . . 0.0 112.26 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 106.596 -2.602 . . . . 0.0 106.596 174.846 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.198 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 m 59.71 -174.22 0.11 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.849 0.86 . . . . 0.0 110.91 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -122.94 1.72 9.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.503 1.121 . . . . 0.0 110.011 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.39 166.68 33.29 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 126.893 2.187 . . . . 0.0 108.084 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.1 p -157.14 -59.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.215 1.406 . . . . 0.0 108.56 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -155.53 158.88 39.18 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.719 2.007 . . . . 0.0 108.018 172.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.85 171.28 14.86 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 159.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.69 169.11 3.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.127 0.571 . . . . 0.0 109.909 165.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.79 -4.36 4.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.693 0.797 . . . . 0.0 111.805 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -43.66 98.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.607 3.163 . . . . 0.0 113.134 -168.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.7 mt -124.9 169.58 11.93 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 127.236 2.214 . . . . 0.0 107.853 163.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.78 137.09 41.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.825 1.25 . . . . 0.0 107.913 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.8 m -125.45 120.03 29.87 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -168.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 mt -137.19 167.07 22.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.804 1.242 . . . . 0.0 107.943 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.58 143.83 51.09 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.545 HG21 HD12 ' A' ' 48' ' ' LEU . 20.9 pt -137.91 161.85 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.779 1.232 . . . . 0.0 109.733 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.1 t -117.46 147.5 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HG2' HD13 ' A' ' 79' ' ' ILE . 75.3 tttt -97.12 86.7 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -171.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 71.87 0.68 Allowed Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.614 -160.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.52 154.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.823 2.849 . . . . 0.0 115.043 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 47.78 -0.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.211 2.204 . . . . 0.0 115.58 -158.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.98 -129.97 5.46 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 104.453 -3.459 . . . . 0.0 104.453 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE2' HD12 ' A' ' 16' ' ' ILE . 48.7 m-85 -97.79 168.06 10.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 166.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.17 -45.12 57.52 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 121.706 -0.621 . . . . 0.0 111.895 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -64.47 -179.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.052 2.141 . . . . 0.0 113.388 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 p -132.81 147.04 52.31 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.834 1.254 . . . . 0.0 109.76 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 pt -110.7 167.68 4.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.286 1.035 . . . . 0.0 109.28 166.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.35 161.96 35.61 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.433 1.893 . . . . 0.0 107.217 168.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.33 148.73 41.07 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.687 1.195 . . . . 0.0 108.11 163.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.07 163.6 23.04 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.163 0.985 . . . . 0.0 108.41 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.16 -1.34 2.85 Favored 'Trans proline' 0 C--N 1.345 0.371 1 C-N-CA 126.166 4.577 . . . . 0.0 116.993 -170.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -132.62 -13.34 2.95 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.337 1.055 . . . . 0.0 111.848 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.08 172.32 17.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -164.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -68.03 124.87 24.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.856 1.262 . . . . 0.0 109.15 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -102.71 163.48 12.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 122.188 0.994 . . . . 0.0 109.625 171.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.48 HG21 HD21 ' A' ' 48' ' ' LEU . 92.8 t -72.03 128.03 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 163.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -71.62 -69.26 0.39 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -154.22 141.33 19.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.987 0.915 . . . . 0.0 108.592 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.487 HD11 HD23 ' A' ' 48' ' ' LEU . 30.8 mt -89.72 135.35 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.15 -31.0 4.22 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.445 0.698 . . . . 0.0 110.778 -171.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -130.65 95.92 3.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.57 -40.71 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.548 0.739 . . . . 0.0 110.513 -171.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.06 -19.21 61.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.915 -1.116 . . . . 0.0 111.656 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.38 -23.16 75.05 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.135 -0.978 . . . . 0.0 111.562 166.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 16' ' ' ILE . 90.2 m -147.51 74.48 11.51 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 119.559 1.68 . . . . 0.0 110.067 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.29 158.94 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.54 1.493 . . . . 0.0 112.531 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.46 -46.51 1.64 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.824 -0.987 . . . . 0.0 113.251 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 16' ' ' ILE . 3.0 tt -52.74 146.12 10.99 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.253 2.221 . . . . 0.0 109.993 -166.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.54 162.02 31.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.045 0.926 . . . . 0.0 111.71 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -69.32 148.39 49.78 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.453 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.56 7.13 25.85 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.007 -1.441 . . . . 0.0 114.176 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -51.53 126.53 17.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.576 1.688 . . . . 0.0 106.542 166.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -96.11 110.94 23.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.6 mt -70.91 141.58 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.321 1.419 . . . . 0.0 109.254 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.81 -43.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.061 1.344 . . . . 0.0 110.261 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -135.87 156.74 48.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.272 0.558 . . . . 0.0 109.53 171.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.34 125.67 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 164.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 45.87 37.83 3.91 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.237 1.415 . . . . 0.0 114.819 169.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 54.59 60.55 3.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.187 1.795 . . . . 0.0 112.629 -169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -134.79 133.93 40.36 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 151.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.24 122.51 34.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.293 1.037 . . . . 0.0 108.595 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.45 -1.35 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -162.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -24.29 40.11 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.869 1.668 . . . . 0.0 113.447 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -91.25 1.13 57.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.723 1.609 . . . . 0.0 112.126 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.54 173.48 6.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.287 1.435 . . . . 0.0 111.255 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.2 m -109.27 159.98 16.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.208 1.803 . . . . 0.0 108.814 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -50.21 -50.73 48.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.367 0.667 . . . . 0.0 111.922 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.5 m -64.57 -31.33 72.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.562 0.745 . . . . 0.0 111.068 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.24 -45.49 84.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.725 0.693 . . . . 0.0 109.273 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.87 -37.35 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.566 1.147 . . . . 0.0 108.942 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.2 -45.62 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.057 0.943 . . . . 0.0 109.152 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -34.25 71.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.329 0.585 . . . . 0.0 112.345 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.24 -56.08 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.775 1.63 . . . . 0.0 107.654 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.6 mt -61.53 -27.39 68.57 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.603 -0.686 . . . . 0.0 111.933 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -66.25 -41.07 90.47 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 109.889 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.66 -40.77 88.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.582 1.153 . . . . 0.0 110.736 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.9 m -49.41 139.65 14.23 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.747 1.219 . . . . 0.0 112.173 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -67.15 118.74 5.8 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.299 3.333 . . . . 0.0 110.995 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.437 HD13 ' HG2' ' A' ' 18' ' ' LYS . 4.4 mm -56.36 137.25 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.09 18.86 71.42 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.223 1.392 . . . . 0.0 113.372 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 t -113.72 163.87 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.391 1.477 . . . . 0.0 107.403 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -62.99 153.92 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.43 1.109 . . . . 0.0 110.309 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -133.15 140.94 47.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.167 2.587 . . . . 0.0 105.166 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.3 m -89.32 135.77 33.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.237 1.815 . . . . 0.0 106.259 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 16' ' ' ILE . 3.9 mp -117.28 164.31 15.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 162.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.9 mt -132.26 137.49 54.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 164.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -134.47 157.25 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.932 1.693 . . . . 0.0 109.112 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.92 98.62 11.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.311 1.044 . . . . 0.0 109.144 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -155.22 162.98 40.79 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.56 -0.713 . . . . 0.0 110.01 168.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.29 -63.49 0.03 OUTLIER Glycine 0 C--N 1.332 0.334 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 t -149.09 -162.61 1.6 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 117.881 0.84 . . . . 0.0 110.451 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -108.91 177.06 20.24 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.793 1.663 . . . . 0.0 111.278 171.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.46 -34.15 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.976 2.45 . . . . 0.0 113.023 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.5 p -86.93 108.02 18.62 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.682 1.193 . . . . 0.0 111.213 -158.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.8 m 72.27 -176.35 0.18 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.816 2.046 . . . . 0.0 111.568 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 -174.622 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 p -157.92 170.23 22.79 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 117.985 0.893 . . . . 0.0 109.28 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m 51.09 -166.72 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.18 1.392 . . . . 0.0 110.299 -166.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 53.11 -153.6 7.12 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 123.933 0.778 . . . . 0.0 111.819 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -140.77 137.71 33.58 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.865 0.866 . . . . 0.0 109.312 173.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.32 153.98 33.2 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.673 0.789 . . . . 0.0 109.488 170.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.54 -160.81 7.69 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 167.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -32.36 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 128.055 2.542 . . . . 0.0 111.93 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.62 -17.14 64.67 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 43.56 76.6 0.08 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.147 2.179 . . . . 0.0 111.503 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.72 167.41 11.14 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.497 -0.752 . . . . 0.0 109.499 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.2 mtm -105.32 114.97 29.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 m -76.74 140.9 40.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 157.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -140.57 168.51 19.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.01 2.124 . . . . 0.0 106.955 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.8 m -125.07 147.7 48.86 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.142 -0.974 . . . . 0.0 108.487 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 45' ' ' CYS . 30.0 pt -131.97 163.47 37.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.524 1.129 . . . . 0.0 109.216 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 t -136.04 137.68 48.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 72.7 tttt -108.38 81.9 1.54 Allowed 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.177 -0.952 . . . . 0.0 113.452 -153.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.69 -78.7 0.08 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.514 1.054 . . . . 0.0 115.236 -165.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.82 -60.34 0.26 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.362 1.581 . . . . 0.0 112.392 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -82.74 44.73 0.93 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.892 0.853 . . . . 0.0 111.046 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 64.48 74.94 0.41 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.64 1.114 . . . . 0.0 111.896 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.09 -86.85 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 125.774 1.63 . . . . 0.0 108.737 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.48 -31.61 0.58 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.643 1.592 . . . . 0.0 111.159 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 34.0 p90 -61.44 165.72 4.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.046 1.339 . . . . 0.0 110.353 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.412 HG23 HD23 ' A' ' 40' ' ' LEU . 17.3 p -119.8 147.46 44.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.771 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 pt -113.32 162.66 11.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.353 0.661 . . . . 0.0 109.332 167.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.51 157.8 41.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.521 2.329 . . . . 0.0 106.713 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -74.53 148.07 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.6 p -137.52 162.73 53.23 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.17 1.45 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.319 3.346 . . . . 0.0 114.567 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -131.73 -0.87 3.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.014 1.326 . . . . 0.0 112.453 -166.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.63 179.26 15.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -168.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -77.06 154.84 32.96 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 118.541 1.171 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -148.37 159.83 43.62 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 112.579 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.41 115.4 22.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 125.554 1.541 . . . . 0.0 107.56 -173.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -72.93 -44.2 61.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.598 171.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HB3' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -163.25 160.4 23.88 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -171.308 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 38' ' ' GLN . 1.4 mm? -105.2 -4.25 21.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.061 1.745 . . . . 0.0 112.466 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -143.42 96.38 2.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 157.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.23 -42.49 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 109.403 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.93 -33.53 75.8 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.368 -0.833 . . . . 0.0 111.144 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.19 -21.41 79.26 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.109 -0.828 . . . . 0.0 112.371 171.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.675 ' HA ' HG22 ' A' ' 16' ' ' ILE . 4.4 m -129.47 68.62 80.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 118.891 1.345 . . . . 0.0 110.123 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.03 149.77 88.89 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.143 1.895 . . . . 0.0 110.246 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.02 -21.44 0.37 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.077 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.29 136.15 57.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.357 1.578 . . . . 0.0 110.004 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -127.72 160.62 31.13 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.969 1.308 . . . . 0.0 109.633 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -71.97 139.85 48.85 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.193 0.997 . . . . 0.0 109.418 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.02 66.32 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.57 -167.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.575 1.95 . . . . 0.0 110.105 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.73 115.86 6.96 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.411 HG22 HG23 ' A' ' 62' ' ' VAL . 2.7 mm -70.74 125.58 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.353 1.461 . . . . 0.0 110.546 -171.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.68 -56.9 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.67 1.188 . . . . 0.0 111.381 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -133.96 145.84 49.91 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.5 mt -134.36 123.81 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 50.85 33.62 8.95 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.871 1.268 . . . . 0.0 112.543 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.7 11.48 8.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.635 2.774 . . . . 0.0 115.162 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.24 132.26 34.96 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.187 1.395 . . . . 0.0 107.451 163.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -80.13 138.81 36.99 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 54' ' ' ILE . 35.3 m -135.99 13.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.403 1.481 . . . . 0.0 111.659 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.852 -1.155 . . . . 0.0 113.383 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -120.37 30.09 7.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.978 0.808 . . . . 0.0 109.698 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -98.04 164.88 12.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.194 0.998 . . . . 0.0 110.606 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -84.91 162.5 19.43 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.076 1.35 . . . . 0.0 109.984 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -45.69 -58.46 3.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 126.608 1.963 . . . . 0.0 110.551 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.4 m -58.53 -40.36 82.74 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.284 1.033 . . . . 0.0 110.694 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -65.68 -44.48 86.09 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.851 1.26 . . . . 0.0 109.962 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.63 -39.75 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.957 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.15 -40.48 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 O-C-N 121.617 -0.677 . . . . 0.0 109.579 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -48.63 78.87 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.551 1.54 . . . . 0.0 110.199 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.4 mt -60.09 -43.75 93.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.979 1.312 . . . . 0.0 109.24 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -69.05 -27.11 65.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.783 175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -65.57 -44.39 86.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 121.15 1.795 . . . . 0.0 108.268 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.47 -26.14 68.31 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.711 0.632 . . . . 0.0 112.374 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.6 m -53.51 134.13 53.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.045 0.538 . . . . 0.0 110.67 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -68.0 135.13 34.01 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.217 3.278 . . . . 0.0 110.698 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -71.27 127.69 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.534 1.534 . . . . 0.0 107.983 -175.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.96 11.87 59.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.935 2.207 . . . . 0.0 113.134 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -92.2 167.36 12.09 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 149.17 34.45 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -131.44 126.35 34.84 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.3 m -101.23 113.63 26.86 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -167.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.55 153.84 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.198 0.908 . . . . 0.0 109.733 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -129.55 136.36 59.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.06 153.27 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.845 1.258 . . . . 0.0 110.869 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 105.95 17.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.641 1.977 . . . . 0.0 107.316 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 -159.12 -51.56 0.06 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.221 1.809 . . . . 0.0 109.872 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.07 -148.64 44.74 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 m -69.69 -70.73 0.27 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.33 -167.66 12.72 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.72 59.63 7.34 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.638 3.559 . . . . 0.0 111.106 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.1 t -70.07 107.77 3.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.2 168.91 0.19 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.567 1.147 . . . . 0.0 111.698 -164.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -166.145 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.693 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -145.46 76.75 1.49 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 164.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.9 m 60.14 168.52 0.08 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 127.756 2.422 . . . . 0.0 113.568 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.85 -162.28 25.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.194 1.378 . . . . 0.0 110.131 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.9 t 74.97 125.03 0.04 OUTLIER 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.845 2.458 . . . . 0.0 112.452 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.7 t -89.99 173.23 8.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.594 1.958 . . . . 0.0 108.805 172.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.44 -146.08 15.23 Favored Glycine 0 C--O 1.238 0.393 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 66.8 -176.44 0.2 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.22 1.008 . . . . 0.0 109.76 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.43 144.96 49.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -87.55 89.23 7.92 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.44 149.82 24.07 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.07 0.948 . . . . 0.0 108.638 172.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.2 mtm -113.38 146.47 39.43 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.459 HG23 HG12 ' A' ' 86' ' ' ILE . 44.8 m -135.22 98.8 4.07 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.028 1.331 . . . . 0.0 107.996 -173.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.86 167.6 9.61 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.352 1.461 . . . . 0.0 109.82 -172.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -122.27 145.81 47.87 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.906 0.883 . . . . 0.0 110.537 -177.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 45' ' ' CYS . 13.4 pt -139.65 134.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 125.562 1.545 . . . . 0.0 108.832 173.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.45 121.76 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 73.6 tttt -69.93 116.85 10.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.282 1.033 . . . . 0.0 109.58 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.73 -68.86 1.43 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.861 -169.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.21 -73.5 0.13 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.809 1.304 . . . . 0.0 112.01 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -76.41 36.22 0.15 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.112 0.965 . . . . 0.0 111.164 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 87.85 -126.68 8.16 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 -158.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CD2' HD12 ' A' ' 16' ' ' ILE . 97.9 m-85 -113.71 166.8 11.18 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.72 25.62 3.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.087 1.803 . . . . 0.0 113.611 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -151.07 167.64 27.09 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.892 1.346 . . . . 0.0 108.472 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 p -129.37 159.84 34.95 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.241 0.617 . . . . 0.0 109.797 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 pt -125.21 152.4 31.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.09 0.556 . . . . 0.0 110.502 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.22 145.42 30.41 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.446 1.099 . . . . 0.0 108.202 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.48 148.45 48.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.057 0.932 . . . . 0.0 110.809 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p -137.44 166.57 25.72 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.389 1.875 . . . . 0.0 105.985 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -70.75 -5.33 16.57 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.406 2.737 . . . . 0.0 112.871 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -129.33 -6.91 4.77 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.074 0.852 . . . . 0.0 112.804 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.89 -177.7 35.37 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.848 1.213 . . . . 0.0 110.587 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -94.12 92.62 7.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.57 -0.959 . . . . 0.0 110.601 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -86.88 161.56 18.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 119.629 1.104 . . . . 0.0 111.791 -162.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.54 115.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -71.63 -61.63 1.71 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 170.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -150.29 143.57 25.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.4 mt -96.11 110.51 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.2 mt -78.27 -36.28 47.01 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.798 0.839 . . . . 0.0 109.022 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -132.02 93.36 3.27 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.153 1.781 . . . . 0.0 109.083 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.8 mt -56.81 -44.06 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 110.154 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -68.07 -12.28 60.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.1 -14.01 52.87 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 119.509 1.05 . . . . 0.0 111.349 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.668 ' HA ' HG22 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -132.52 54.96 15.22 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.709 1.204 . . . . 0.0 109.67 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.07 124.3 10.83 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.922 1.748 . . . . 0.0 111.233 -164.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -16.24 61.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.971 1.272 . . . . 0.0 113.411 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.94 152.69 39.26 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.8 p -124.84 151.79 44.81 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.724 0.81 . . . . 0.0 108.901 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -76.4 138.57 40.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.06 96.32 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -168.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.63 -177.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.852 0.826 . . . . 0.0 111.554 163.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -140.59 91.19 2.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.495 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 62' ' ' VAL . 37.2 mt -55.84 135.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.559 1.544 . . . . 0.0 109.196 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.17 -45.98 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.166 1.387 . . . . 0.0 110.367 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -128.79 148.84 50.9 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.75 138.75 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 152.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 67.82 -54.42 0.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 128.979 2.911 . . . . 0.0 116.203 167.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 165.27 13.85 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 130.793 3.637 . . . . 0.0 113.584 -156.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -131.76 141.9 49.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.909 1.686 . . . . 0.0 109.194 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -69.55 128.83 37.87 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.592 HG12 HD22 ' A' ' 65' ' ' LEU . 10.8 m -133.75 22.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 125.402 1.481 . . . . 0.0 107.563 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -60.43 3.69 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 119.977 -1.702 . . . . 0.0 110.719 176.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.22 -21.15 62.17 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.456 0.169 . . . . 0.0 111.193 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.592 HD22 HG12 ' A' ' 62' ' ' VAL . 6.8 mp -52.89 134.58 37.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.867 1.667 . . . . 0.0 111.61 -167.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -56.63 162.33 2.31 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.674 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -49.28 -51.38 34.07 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.69 0.796 . . . . 0.0 109.311 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -52.07 17.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.036 2.534 . . . . 0.0 111.495 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.31 -46.71 82.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.516 1.126 . . . . 0.0 108.531 -170.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.37 -46.46 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.471 1.509 . . . . 0.0 110.443 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.413 HG12 ' HD3' ' A' ' 75' ' ' LYS . 54.2 t -55.57 -45.17 78.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -40.55 77.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.126 0.97 . . . . 0.0 111.473 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.59 -48.95 85.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 123.996 0.919 . . . . 0.0 109.109 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.12 -26.96 68.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.737 0.415 . . . . 0.0 111.58 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HD3' HG12 ' A' ' 71' ' ' VAL . 39.1 mtpt -71.51 -41.47 69.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.808 1.186 . . . . 0.0 110.382 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.51 -27.65 67.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.447 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.9 m -49.72 127.17 19.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 123.275 0.63 . . . . 0.0 110.739 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.04 132.84 46.73 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.937 3.092 . . . . 0.0 110.773 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 mm -64.01 127.75 25.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 166.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.44 17.71 75.36 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.323 0.963 . . . . 0.0 112.294 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -115.24 159.45 20.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 123.313 1.53 . . . . 0.0 108.823 159.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HG2' HG22 ' A' ' 15' ' ' THR . 3.8 tm-20 -65.05 153.58 40.32 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.876 168.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.6 m -137.77 149.11 46.14 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 126.936 2.094 . . . . 0.0 107.869 165.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 126.1 54.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.627 2.371 . . . . 0.0 105.941 -168.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD13 HD11 ' A' ' 16' ' ' ILE . 4.9 mp -128.46 115.69 18.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.996 1.271 . . . . 0.0 109.171 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.459 HG12 HG23 ' A' ' 13' ' ' THR . 3.6 mt -97.62 125.59 50.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.06 155.11 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.607 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -108.81 74.86 0.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.041 2.136 . . . . 0.0 109.693 -170.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -108.45 68.7 0.7 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -161.71 92.06 0.11 Allowed Glycine 0 N--CA 1.454 -0.128 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 -170.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -141.16 -160.73 1.11 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.668 1.187 . . . . 0.0 108.729 -166.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.32 -163.2 13.83 Favored Glycine 0 CA--C 1.524 0.598 0 O-C-N 120.83 -1.169 . . . . 0.0 111.732 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.48 167.06 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.029 3.152 . . . . 0.0 113.381 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.2 p -152.13 147.8 26.88 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.643 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.1 m -145.88 92.35 2.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.909 1.684 . . . . 0.0 107.291 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -177.967 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.701 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t -145.53 -38.86 0.25 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 162.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.9 m -76.92 98.29 4.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 157.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.63 58.78 0.56 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 167.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m 60.92 174.6 0.1 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.213 1.805 . . . . 0.0 111.357 -158.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -158.68 -163.59 1.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.48 78.71 1.42 Allowed Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.09 157.87 44.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.445 1.898 . . . . 0.0 106.111 165.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.04 114.83 2.1 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.599 0.562 . . . . 0.0 110.956 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -82.83 50.95 1.8 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.482 1.513 . . . . 0.0 110.263 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 56.45 -162.69 0.17 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.122 2.169 . . . . 0.0 110.833 -176.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.471 ' HE2' HD11 ' A' ' 87' ' ' ILE . 23.1 mtm -89.72 125.1 35.15 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 175.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -96.66 142.94 28.1 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.16 145.4 51.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.789 1.636 . . . . 0.0 108.06 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 m -103.06 135.15 45.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.179 0.592 . . . . 0.0 109.882 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.9 pt -143.98 137.59 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.285 1.034 . . . . 0.0 111.595 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 82' ' ' GLU 0.254 0.2 OUTLIER -110.35 136.03 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.598 1.189 . . . . 0.0 112.338 178.654 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 66.3 tttt -79.06 117.6 20.26 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.813 1.645 . . . . 0.0 111.924 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 23' ' ' PHE . . . -81.73 171.98 52.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 166.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.55 -59.64 3.59 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.686 1.994 . . . . 0.0 113.882 -168.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -82.16 10.83 6.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.695 -0.628 . . . . 0.0 111.096 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 82.23 1.64 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 126.298 1.904 . . . . 0.0 108.364 169.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HA ' ' H ' ' A' ' 19' ' ' GLY . 43.9 m-85 61.13 -175.97 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.995 1.318 . . . . 0.0 111.049 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.2 -63.61 1.5 Allowed Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -60.17 170.92 1.12 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.536 1.135 . . . . 0.0 113.775 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -131.43 158.38 40.98 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.026 1.33 . . . . 0.0 109.541 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.3 pt -123.68 162.01 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 124.732 1.213 . . . . 0.0 108.717 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.21 158.17 43.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.89 114.82 9.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.849 1.259 . . . . 0.0 107.962 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -99.31 168.36 9.75 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -66.35 -8.83 21.76 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.308 2.005 . . . . 0.0 114.568 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -129.12 -4.43 5.0 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 120.104 1.32 . . . . 0.0 114.022 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.59 -172.94 33.73 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -162.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -84.82 143.32 29.16 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 121.526 -0.985 . . . . 0.0 108.655 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -134.48 154.24 51.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.588 171.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.09 126.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.597 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -81.07 -57.05 3.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.739 1.216 . . . . 0.0 108.526 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -157.32 149.53 22.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 48' ' ' LEU . 22.1 mt -122.54 132.77 70.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.67 -58.2 1.6 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.204 1.002 . . . . 0.0 109.45 -164.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -88.04 87.98 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.8 1.24 . . . . 0.0 110.107 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.02 -38.55 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.062 0.945 . . . . 0.0 112.116 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.85 -36.17 67.38 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.772 -0.58 . . . . 0.0 111.123 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.19 -9.74 81.59 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.183 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.801 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.27 64.59 73.97 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 119.454 1.627 . . . . 0.0 108.614 172.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.41 125.41 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.201 1.934 . . . . 0.0 112.057 -165.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.62 0.38 84.09 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.125 -0.819 . . . . 0.0 112.696 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -67.99 140.95 56.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.781 1.291 . . . . 0.0 108.387 178.016 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 151.29 43.12 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 122.177 0.989 . . . . 0.0 110.464 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -77.78 148.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.14 56.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 117.4 -1.778 . . . . 0.0 114.383 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -63.63 126.75 28.57 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.926 1.863 . . . . 0.0 109.424 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 123.05 25.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.784 1.633 . . . . 0.0 108.363 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.83 146.23 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.2 -53.62 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.708 0.803 . . . . 0.0 110.916 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.5 131.61 24.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG13 HG21 ' A' ' 62' ' ' VAL . 3.2 mt -116.95 124.3 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 170.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.591 HD21 HG23 ' A' ' 83' ' ' THR . 77.5 m-20 46.1 46.35 12.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.791 1.636 . . . . 0.0 113.002 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.266 0.2 OUTLIER 61.15 31.7 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.271 1.829 . . . . 0.0 115.22 -177.554 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.15 132.11 55.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.121 1.768 . . . . 0.0 106.752 165.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -83.4 120.76 26.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.33 1.452 . . . . 0.0 110.85 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.45 HG21 HG13 ' A' ' 57' ' ' ILE . 21.3 m -121.98 7.01 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.679 1.992 . . . . 0.0 109.412 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -37.97 39.82 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.029 1.286 . . . . 0.0 112.085 -173.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -115.71 7.75 14.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD22 HG12 ' A' ' 62' ' ' VAL . 3.4 mp -62.06 143.37 56.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.382 1.873 . . . . 0.0 109.991 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -54.77 159.16 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.939 0.774 . . . . 0.0 110.069 165.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -50.38 -49.65 53.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 168.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -55.57 -44.73 77.13 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.873 1.269 . . . . 0.0 112.725 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.77 -39.89 95.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.398 1.079 . . . . 0.0 109.715 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.2 -49.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.497 0.719 . . . . 0.0 109.814 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.5 -38.12 54.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.472 1.509 . . . . 0.0 109.888 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.68 -46.11 80.3 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.771 0.828 . . . . 0.0 111.024 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mt -59.16 -46.14 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.604 1.161 . . . . 0.0 109.52 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.469 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 98.0 mt -61.09 -17.41 52.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.222 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -86.19 -33.64 20.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.379 1.445 . . . . 0.0 111.523 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -42.57 69.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.473 1.109 . . . . 0.0 109.406 165.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 91.9 m -51.35 135.55 31.9 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 111.776 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -67.56 112.67 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 1 C-N-CA 125.636 4.224 . . . . 0.0 112.098 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -51.32 117.76 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.382 1.473 . . . . 0.0 107.548 170.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.49 8.75 57.21 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.862 1.22 . . . . 0.0 113.249 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.85 151.74 51.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.972 1.386 . . . . 0.0 110.339 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' HG3' HG12 ' A' ' 17' ' ' VAL . 50.4 mp0 -72.38 153.37 41.49 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.329 1.452 . . . . 0.0 112.123 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.591 HG23 HD21 ' A' ' 58' ' ' ASN . 1.4 m -131.23 143.82 50.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 130.083 3.353 . . . . 0.0 105.905 -176.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.4 m -109.02 116.62 32.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -116.56 115.62 26.09 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.572 1.149 . . . . 0.0 108.549 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.37 134.47 28.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' A' ' 12' ' ' MET . 1.8 pp -129.43 152.61 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 110.723 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.539 ' HA ' HD12 ' A' ' 11' ' ' LEU . 1.6 t-80 -88.01 67.69 9.01 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.185 -0.947 . . . . 0.0 110.768 -170.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -51.24 69.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.8 -96.69 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.7 t -143.58 157.05 44.71 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.608 1.204 . . . . 0.0 108.595 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.7 168.89 33.88 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -83.96 144.14 10.72 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.681 2.921 . . . . 0.0 110.019 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.4 m -123.95 -21.45 5.1 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.333 0.653 . . . . 0.0 112.072 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.0 t -142.68 148.42 37.31 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 153.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 150.959 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 m 52.32 -178.52 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.47 0.747 . . . . 0.0 110.538 -138.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 t -142.72 -23.3 0.65 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.287 1.035 . . . . 0.0 111.073 171.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.3 -168.82 23.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -104.38 137.84 41.67 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.884 0.874 . . . . 0.0 110.178 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.3 p -77.62 108.55 10.89 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.425 1.09 . . . . 0.0 108.299 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.29 -163.24 7.84 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.219 0.914 . . . . 0.0 112.242 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -125.8 -172.01 2.51 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.059 1.343 . . . . 0.0 109.481 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.71 151.53 48.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -160.58 115.23 2.19 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.013 1.325 . . . . 0.0 107.571 -175.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp -134.3 171.84 13.71 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.359 2.264 . . . . 0.0 106.713 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.7 mtm -111.09 153.69 25.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.601 0.637 . . . . 0.0 109.543 165.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.9 m -132.17 120.25 22.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.4 mt -126.85 168.41 14.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.532 1.533 . . . . 0.0 107.936 -175.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 m -134.67 141.97 46.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 45' ' ' CYS . 44.6 pt -138.46 151.31 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 110.981 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.5 153.19 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.625 1.97 . . . . 0.0 108.942 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -113.23 105.69 13.73 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.341 1.456 . . . . 0.0 109.022 -145.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.69 61.39 3.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.662 1.601 . . . . 0.0 112.577 -165.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.23 152.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.975 2.51 . . . . 0.0 112.459 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 65.42 -25.42 0.09 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.336 2.255 . . . . 0.0 115.56 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -164.16 31.13 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.681 -2.568 . . . . 0.0 106.681 -159.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -102.29 12.89 35.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -174.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.34 -66.15 1.28 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.609 1.1 . . . . 0.0 110.879 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -54.05 158.04 2.31 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 122.143 0.973 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -114.56 159.88 19.9 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.586 1.154 . . . . 0.0 109.418 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.7 pt -118.31 154.33 20.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.548 0.69 . . . . 0.0 110.432 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.91 170.26 9.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.263 2.225 . . . . 0.0 108.286 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.08 122.04 46.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 107.512 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.4 p -126.03 171.51 7.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.959 1.303 . . . . 0.0 109.734 -167.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.15 -14.69 45.17 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.164 1.909 . . . . 0.0 112.64 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -104.67 -11.83 16.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.019 1.328 . . . . 0.0 111.72 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.28 -162.25 23.63 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -73.34 147.58 44.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -139.73 165.09 28.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.306 0.574 . . . . 0.0 109.465 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.19 117.1 16.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.6 -74.18 0.15 Allowed 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -140.12 153.61 46.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -99.54 106.86 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.095 1.758 . . . . 0.0 108.168 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -101.82 -0.0 34.94 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.267 1.427 . . . . 0.0 110.957 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -149.83 114.06 5.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.037 1.735 . . . . 0.0 108.596 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.09 -58.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.484 1.513 . . . . 0.0 109.216 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.69 -37.1 75.34 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.037 1.335 . . . . 0.0 111.636 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.25 -25.75 72.3 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.68 ' HA ' HG22 ' A' ' 16' ' ' ILE . 46.3 m -126.94 67.61 69.72 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 118.947 1.373 . . . . 0.0 111.198 -172.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.8 128.16 20.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.718 2.279 . . . . 0.0 111.224 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.12 76.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 124.401 1.001 . . . . 0.0 114.297 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 48' ' ' LEU . 11.1 tp -66.84 153.12 44.23 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.444 1.122 . . . . 0.0 108.754 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.5 m -135.78 0.76 2.72 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 62.6 151.22 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.641 2.376 . . . . 0.0 112.205 -166.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.99 6.52 25.5 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.683 -1.065 . . . . 0.0 113.73 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.38 128.88 38.12 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.429 1.492 . . . . 0.0 107.817 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -81.28 109.96 16.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.843 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.99 124.66 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.94 -57.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.128 1.371 . . . . 0.0 108.893 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -128.56 150.47 50.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.284 1.034 . . . . 0.0 109.229 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.2 mt -127.86 126.65 67.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 164.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 43.64 52.84 6.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 111.046 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 59.94 -7.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.973 2.509 . . . . 0.0 116.371 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -69.63 117.08 10.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -58.11 115.9 3.2 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 163.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 0.8 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 O-C-N 124.057 0.848 . . . . 0.0 112.397 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -54.49 -21.9 11.34 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -170.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -112.03 -2.86 14.93 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 121.319 1.872 . . . . 0.0 112.663 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.55 160.25 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.321 -0.862 . . . . 0.0 109.198 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -89.53 157.11 18.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.209 1.004 . . . . 0.0 109.793 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -40.83 -56.8 2.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.984 1.714 . . . . 0.0 112.132 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.7 m -67.0 -26.26 66.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.896 0.878 . . . . 0.0 111.038 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.29 -44.96 67.3 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.243 0.928 . . . . 0.0 109.364 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.6 -40.57 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.384 1.073 . . . . 0.0 109.646 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.68 -53.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 123.715 0.806 . . . . 0.0 109.029 169.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.559 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 12.9 t70 -57.22 -46.39 82.98 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.352 0.661 . . . . 0.0 111.722 -172.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.4 mt -55.27 -45.52 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.649 1.18 . . . . 0.0 109.494 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -67.74 -35.72 79.24 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.716 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' A' ' 72' ' ' ASP . 9.0 mtmp? -55.01 -47.9 74.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.266 1.848 . . . . 0.0 109.589 167.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -34.73 75.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.218 1.007 . . . . 0.0 112.478 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 84.8 m -52.76 138.04 43.4 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.157 0.983 . . . . 0.0 109.689 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 77' ' ' CYS . 33.8 Cg_exo -54.29 144.27 61.04 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.347 2.698 . . . . 0.0 110.119 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.5 mt -80.43 131.43 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 161.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.91 35.79 72.86 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.268 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.7 m -146.43 131.79 18.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.746 1.273 . . . . 0.0 108.831 161.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -61.45 152.7 29.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.616 1.198 . . . . 0.0 111.094 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -137.55 135.57 36.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.966 2.906 . . . . 0.0 105.116 -168.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -112.49 110.85 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.822 1.249 . . . . 0.0 108.29 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.96 112.63 18.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.514 0.597 . . . . 0.0 110.84 -169.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -89.17 141.72 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.37 146.58 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.851 0.834 . . . . 0.0 111.819 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.0 96.61 5.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.205 1.002 . . . . 0.0 109.327 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -150.49 124.25 9.18 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -176.75 95.28 0.1 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -169.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -145.02 -105.88 0.11 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 169.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.29 179.83 31.86 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 156.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -80.08 102.17 1.42 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.419 2.746 . . . . 0.0 108.715 171.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.9 p -138.21 142.84 39.96 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.912 0.885 . . . . 0.0 109.606 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 m -111.57 103.56 11.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 169.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.821 0 CA-C-O 115.272 -2.96 . . . . 0.0 111.246 -177.79 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.941 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -168.9 162.72 11.41 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -172.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -125.2 166.25 16.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.549 0.74 . . . . 0.0 109.877 -175.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.52 166.95 33.8 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 155.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.82 148.52 27.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.049 0.939 . . . . 0.0 108.498 176.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -111.77 12.1 20.97 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.344 1.858 . . . . 0.0 110.7 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.97 -111.45 4.11 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -162.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 tm0? 64.09 136.62 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.802 2.041 . . . . 0.0 111.201 -170.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.04 -178.3 5.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.093 1.757 . . . . 0.0 108.332 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.47 104.65 11.65 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.01 155.72 32.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -87.35 145.8 26.17 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.2 m -123.45 139.17 54.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.3 mt -142.81 167.88 21.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.444 2.297 . . . . 0.0 106.837 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.8 m -128.95 154.61 46.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.3 -0.875 . . . . 0.0 108.694 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.693 HG22 ' HA ' ' A' ' 45' ' ' CYS . 11.1 pt -145.66 166.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 126.054 1.741 . . . . 0.0 109.907 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.82 143.37 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.636 1.575 . . . . 0.0 107.582 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -88.62 145.68 25.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.26 1.024 . . . . 0.0 111.232 -175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.32 82.8 0.35 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.264 1.411 . . . . 0.0 113.899 -168.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.97 -84.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.035 2.134 . . . . 0.0 115.697 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.25 -15.4 46.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.934 1.243 . . . . 0.0 112.862 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.39 28.73 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.448 ' CE1' HD22 ' A' ' 74' ' ' LEU . 71.3 m-85 -66.36 146.0 55.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 118.869 1.334 . . . . 0.0 108.173 170.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.24 -51.84 53.79 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -61.82 164.02 6.81 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.368 1.08 . . . . 0.0 110.198 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.0 p -117.37 156.78 27.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.973 0.909 . . . . 0.0 109.25 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.02 158.32 18.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 167.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.12 163.1 25.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 165.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.83 147.13 47.48 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 159.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.3 p -139.7 161.9 53.92 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 163.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.32 -42.66 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.016 2.477 . . . . 0.0 113.256 -174.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -73.29 -23.84 60.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 111.159 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.75 178.86 26.9 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -172.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.421 ' CD ' HG21 ' A' ' 70' ' ' VAL . 24.0 mp0 -62.42 145.74 53.26 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -134.17 161.11 35.8 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 123.134 0.574 . . . . 0.0 111.134 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.86 107.27 7.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 -58.2 9.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.112 0.965 . . . . 0.0 109.553 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -151.69 148.14 27.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.788 1.635 . . . . 0.0 106.778 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.482 HG23 ' SG ' ' A' ' 45' ' ' CYS . 57.6 mt -91.2 97.14 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 166.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.7 -26.15 61.49 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.219 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -142.71 95.57 2.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.446 1.898 . . . . 0.0 108.998 -158.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.4 -57.06 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.76 1.224 . . . . 0.0 109.105 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.15 -25.32 66.92 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.802 0.728 . . . . 0.0 111.608 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 -32.35 66.77 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.213 170.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.693 ' HA ' HG22 ' A' ' 16' ' ' ILE . 29.3 p -130.08 70.36 82.13 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 120.058 1.929 . . . . 0.0 112.774 -171.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.39 111.59 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.748 2.299 . . . . 0.0 111.636 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.04 85.34 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.407 1.479 . . . . 0.0 114.844 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 152.97 43.15 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.03 1.415 . . . . 0.0 108.089 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.7 m -129.12 156.0 44.58 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.303 1.041 . . . . 0.0 110.023 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.24 137.48 53.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.14 12.41 79.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.494 -1.725 . . . . 0.0 114.182 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -58.43 129.53 42.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.093 1.946 . . . . 0.0 110.117 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 tp -78.5 144.42 35.71 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.2 mt -108.0 135.9 45.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 125.359 1.464 . . . . 0.0 108.206 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -122.45 -57.04 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.274 1.03 . . . . 0.0 110.085 -170.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 64.0 mt-10 -129.89 149.7 51.5 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.3 mt -135.93 129.39 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 168.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 41.13 45.33 2.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.392 2.277 . . . . 0.0 111.573 -173.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 57.51 4.54 0.24 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.391 2.276 . . . . 0.0 115.795 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.1 126.04 29.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 160.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.532 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 21.8 t-20 -73.02 132.22 43.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 168.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.84 -2.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.516 1.126 . . . . 0.0 110.844 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -6.69 1.27 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -121.03 -2.28 9.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.022 1.329 . . . . 0.0 111.659 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.5 mt -77.42 167.97 20.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.581 1.082 . . . . 0.0 110.517 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.5 m -88.66 155.53 19.55 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -47.76 -50.65 24.9 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.839 1.256 . . . . 0.0 112.341 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 m -65.73 -29.43 69.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.251 1.02 . . . . 0.0 111.266 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.37 -44.46 83.09 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 34' ' ' GLN . 21.6 t -67.44 -39.95 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 121.172 -0.955 . . . . 0.0 110.564 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.53 -50.68 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 124.493 1.117 . . . . 0.0 108.893 171.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -66.25 -37.38 85.34 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.23 0.956 . . . . 0.0 112.011 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.88 -44.23 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.469 -0.769 . . . . 0.0 109.308 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.448 HD22 ' CE1' ' A' ' 23' ' ' PHE . 85.8 mt -65.06 -17.59 64.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.946 -1.096 . . . . 0.0 112.29 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.03 -46.58 42.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.776 1.625 . . . . 0.0 108.993 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.07 -27.22 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.039 0.836 . . . . 0.0 112.85 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.95 123.82 61.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 118.849 0.75 . . . . 0.0 109.432 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -68.69 157.71 60.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.921 3.08 . . . . 0.0 113.276 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mm -90.08 124.56 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.575 1.55 . . . . 0.0 106.953 -170.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.41 73.77 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.571 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 m -110.64 157.75 19.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 162.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 153.83 41.07 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.797 1.284 . . . . 0.0 109.756 166.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -140.78 131.37 25.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.512 1.925 . . . . 0.0 105.961 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -97.17 121.12 38.71 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.923 1.689 . . . . 0.0 106.537 -171.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.68 149.87 42.6 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.815 1.189 . . . . 0.0 110.017 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.03 125.24 66.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.72 177.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.966 1.306 . . . . 0.0 109.549 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -107.21 124.32 49.57 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.077 0.853 . . . . 0.0 111.683 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 90' ' ' GLY . 4.0 tpm_? -159.63 -145.67 0.13 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 130.539 3.536 . . . . 0.0 106.344 -170.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 89' ' ' ARG . . . 131.38 161.15 10.1 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 128.57 2.986 . . . . 0.0 110.455 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 72.2 m -138.4 172.59 12.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.088 1.355 . . . . 0.0 109.971 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.96 162.42 9.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.011 1.767 . . . . 0.0 110.466 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.16 160.41 42.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 N-CA-C 108.203 -1.499 . . . . 0.0 108.203 156.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 t -65.74 -29.39 69.9 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.114 -0.991 . . . . 0.0 109.98 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.8 m -161.37 152.04 17.98 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 128.13 2.572 . . . . 0.0 105.872 157.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.218 0 N-CA-C 105.124 -3.19 . . . . 0.0 105.124 173.586 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.873 0 N-CA-C 107.438 -2.265 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -66.77 141.39 57.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.818 1.309 . . . . 0.0 108.166 166.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.18 170.44 21.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.045 1.338 . . . . 0.0 108.503 166.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.58 120.78 0.77 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 t -155.69 162.66 40.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 m 59.76 174.73 0.08 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.147 1.379 . . . . 0.0 111.231 -165.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.97 -37.2 4.48 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.659 -1.079 . . . . 0.0 111.472 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.37 164.67 18.38 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.579 1.19 . . . . 0.0 110.101 163.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.57 -174.75 4.69 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.73 2.012 . . . . 0.0 108.381 168.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 65.41 97.78 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.234 1.813 . . . . 0.0 110.424 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.7 mt -102.27 172.94 6.6 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.337 2.255 . . . . 0.0 108.594 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.57 129.87 50.55 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.467 1.107 . . . . 0.0 108.413 171.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 m -95.33 136.2 35.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.57 168.45 20.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.369 1.867 . . . . 0.0 108.509 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 m -135.64 131.17 35.43 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.322 -0.861 . . . . 0.0 108.909 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.5 pt -120.67 166.39 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.262 1.025 . . . . 0.0 110.11 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.72 132.9 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.12 106.51 17.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.632 -0.668 . . . . 0.0 109.735 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.31 171.73 6.36 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 121.876 0.709 . . . . 0.0 112.408 171.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.78 64.13 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.581 1.152 . . . . 0.0 111.009 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -80.3 29.52 0.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.511 1.124 . . . . 0.0 110.31 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.58 -171.43 54.27 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 125.439 1.495 . . . . 0.0 109.512 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' CD2' HD12 ' A' ' 16' ' ' ILE . 94.3 m-85 -67.15 -0.79 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.423 1.889 . . . . 0.0 114.715 -172.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.54 -61.03 3.24 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 119.819 -1.801 . . . . 0.0 111.198 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -54.09 152.35 6.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 118.659 1.229 . . . . 0.0 111.232 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.4 p -118.84 159.17 24.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.199 1.4 . . . . 0.0 108.151 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 71' ' ' VAL . 35.9 pt -123.56 166.72 18.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.639 0.733 . . . . 0.0 109.996 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.09 170.04 16.77 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.547 2.739 . . . . 0.0 108.168 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.25 115.93 31.27 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.37 2.268 . . . . 0.0 106.834 169.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 52.4 p -111.27 169.28 6.47 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.064 1.346 . . . . 0.0 108.251 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 23.4 Cg_endo -64.09 10.52 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 125.14 3.893 . . . . 0.0 115.065 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.3 p -131.33 -11.76 3.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 111.632 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.61 -165.09 24.27 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -169.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.508 ' CG ' HG21 ' A' ' 70' ' ' VAL . 12.8 mp0 -66.48 141.36 57.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -130.57 162.82 28.47 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.544 0.688 . . . . 0.0 109.643 166.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 48' ' ' LEU . 86.6 t -71.11 138.3 22.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 168.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -93.19 -48.42 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.434 1.094 . . . . 0.0 109.418 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -161.81 159.13 26.61 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.091 1.756 . . . . 0.0 106.88 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.2 139.99 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 46.3 mt -123.13 -54.52 1.8 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -87.57 77.7 8.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.9 mt -61.82 -51.37 73.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 125.472 1.509 . . . . 0.0 108.666 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -57.5 -35.29 70.04 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.047 0.939 . . . . 0.0 112.41 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.34 -23.48 70.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.172 0.897 . . . . 0.0 112.115 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.497 ' HA ' HG22 ' A' ' 16' ' ' ILE . 75.5 m -118.84 60.5 4.64 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 119.007 1.404 . . . . 0.0 110.824 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.4 138.58 51.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.678 2.252 . . . . 0.0 110.722 -167.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 -9.16 27.88 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.893 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 36' ' ' VAL . 2.4 tt -73.54 146.19 44.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.152 1.476 . . . . 0.0 108.728 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.73 162.12 27.34 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.734 1.214 . . . . 0.0 112.155 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.69 149.58 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.476 -0.765 . . . . 0.0 109.845 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 14.13 58.06 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.363 -0.836 . . . . 0.0 113.916 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.3 129.68 36.18 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.169 1.484 . . . . 0.0 108.37 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tp -76.64 133.4 39.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 mt -95.18 125.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.529 1.132 . . . . 0.0 109.293 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -112.71 -51.94 5.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.845 1.258 . . . . 0.0 110.713 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.3 mt-10 -123.28 153.32 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.416 0.686 . . . . 0.0 109.558 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.68 134.85 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 161.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 35.89 57.11 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.702 2.001 . . . . 0.0 113.774 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 59.0 24.47 12.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.483 1.113 . . . . 0.0 112.856 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -117.39 120.59 38.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.904 2.482 . . . . 0.0 106.323 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 126.31 28.17 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG12 HD12 ' A' ' 65' ' ' LEU . 34.2 m -126.22 -3.42 5.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -9.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 169.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.79 -8.27 14.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.303 1.41 . . . . 0.0 112.222 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 62' ' ' VAL . 15.7 mt -77.57 158.6 29.76 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.534 0.734 . . . . 0.0 111.856 -172.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.669 ' O ' HG22 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -71.75 148.69 46.09 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.581 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.656 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 1.7 t-80 -54.86 -22.86 16.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.333 1.453 . . . . 0.0 112.241 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -79.45 -17.24 54.66 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.912 -1.743 . . . . 0.0 112.805 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -87.66 -51.4 5.91 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.325 -1.484 . . . . 0.0 108.105 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 66' ' ' SER . 2.5 m -49.24 -38.19 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 131.558 3.943 . . . . 0.0 112.776 166.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 27' ' ' ILE . 10.9 t -63.56 -54.5 31.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.775 0.83 . . . . 0.0 109.53 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.84 -40.79 89.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.746 0.654 . . . . 0.0 111.095 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.15 -45.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 125.837 1.655 . . . . 0.0 110.996 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.75 -33.86 76.59 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.933 -0.479 . . . . 0.0 110.949 174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -68.24 -34.85 76.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.287 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -74.14 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 173.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.6 m -59.47 141.71 87.72 Favored Pre-proline 0 CA--C 1.536 0.438 0 O-C-N 120.444 -1.41 . . . . 0.0 109.342 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.19 125.79 14.64 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 123.536 2.824 . . . . 0.0 110.594 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.9 mt -58.98 135.59 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.91 85.25 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.823 1.202 . . . . 0.0 113.268 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 t -103.64 147.76 26.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -66.98 142.33 57.29 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 165.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.9 m -127.49 132.55 49.97 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.772 2.829 . . . . 0.0 105.591 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -88.04 130.26 35.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mp -130.6 149.53 52.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 56' ' ' GLU . 6.1 mt -128.82 123.5 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 172.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -111.49 152.71 13.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.037 1.335 . . . . 0.0 107.552 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -88.07 106.17 17.97 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.94 123.59 9.81 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.82 115.69 0.54 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.0 m 50.93 51.71 16.49 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.685 1.594 . . . . 0.0 112.542 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.1 169.19 28.01 Favored Glycine 0 CA--C 1.54 1.65 0 C-N-CA 123.933 0.778 . . . . 0.0 114.543 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -78.32 -164.17 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.017 1 C-N-CA 126.158 4.572 . . . . 0.0 113.05 -175.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 m -107.02 177.56 4.82 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.765 1.626 . . . . 0.0 111.452 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.8 m -67.34 -175.69 0.5 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.551 1.54 . . . . 0.0 110.019 167.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 CA-C-O 116.736 -2.147 . . . . 0.0 108.073 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.219 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 m -145.02 162.8 36.04 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 p -134.44 165.0 26.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.559 1.143 . . . . 0.0 108.62 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.41 -174.8 41.47 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t 109.83 159.93 0.0 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 130.617 3.567 . . . . 0.0 106.471 -172.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.56 -23.79 63.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.079 0.952 . . . . 0.0 112.856 -170.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.34 -136.98 39.89 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -142.06 163.04 33.95 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.499 1.519 . . . . 0.0 107.855 173.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.05 83.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -160.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.83 98.34 7.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.208 1.403 . . . . 0.0 108.078 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 88' ' ' HIS . 2.4 mm? -53.86 133.31 42.73 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.654 1.581 . . . . 0.0 108.611 169.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.5 mtm -88.98 155.91 19.2 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.42 HG23 HG12 ' A' ' 86' ' ' ILE . 35.8 m -134.78 108.91 8.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.0 mt -98.77 169.23 9.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.547 2.339 . . . . 0.0 107.532 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -135.25 151.38 50.54 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.315 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.577 HG22 ' HA ' ' A' ' 45' ' ' CYS . 28.9 pt -144.35 128.28 12.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.17 1.388 . . . . 0.0 110.249 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 120.92 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 123.523 1.63 . . . . 0.0 109.291 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 7.1 mttt -57.66 118.23 5.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.034 174.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.36 -75.49 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.29 165.87 30.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.599 0.699 . . . . 0.0 109.47 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 60.87 -16.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 129.191 2.996 . . . . 0.0 116.809 172.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 123.61 138.03 5.1 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -167.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -52.08 131.49 31.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.64 84.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.09 145.04 21.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.26 1.03 . . . . 0.0 110.995 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 p -107.27 156.43 18.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.13 149.16 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.446 0.641 . . . . 0.0 110.535 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -124.95 143.28 50.96 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.076 2.15 . . . . 0.0 108.087 -177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -89.12 87.12 7.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -171.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -70.39 167.29 27.44 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 124.64 1.176 . . . . 0.0 109.09 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.03 9.36 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.387 2.724 . . . . 0.0 112.968 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.63 -2.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -152.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.64 -169.1 22.52 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -166.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.637 ' HG2' HG21 ' A' ' 70' ' ' VAL . 2.5 mm100 -87.52 142.08 28.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.012 -1.287 . . . . 0.0 109.188 174.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -124.19 162.81 22.86 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 123.49 0.716 . . . . 0.0 110.995 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 48' ' ' LEU . 54.9 t -88.28 116.57 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -69.51 -68.71 0.39 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.995 1.318 . . . . 0.0 108.519 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -148.41 154.87 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.441 1.496 . . . . 0.0 107.26 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.402 ' CD1' HD13 ' A' ' 48' ' ' LEU . 65.0 mt -120.53 107.84 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.005 1.322 . . . . 0.0 108.222 -173.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.2 -53.49 3.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.918 0.866 . . . . 0.0 109.971 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.18 74.45 7.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.0 mt -50.36 -48.81 24.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.748 1.219 . . . . 0.0 109.516 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -63.62 -37.88 88.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.588 -172.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.85 -5.15 60.57 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.694 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HA ' HG22 ' A' ' 16' ' ' ILE . 40.9 m -131.08 71.9 81.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 120.191 1.996 . . . . 0.0 109.528 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.2 129.13 23.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.009 2.473 . . . . 0.0 111.136 -174.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.59 -7.77 52.15 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.04 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.566 HD12 ' CB ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -61.69 147.07 47.17 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.988 1.394 . . . . 0.0 109.26 -176.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.4 m -138.14 141.5 40.13 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.312 1.445 . . . . 0.0 107.297 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.58 158.39 27.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.47 47.53 56.75 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.815 -0.553 . . . . 0.0 111.729 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.44 -159.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.225 2.21 . . . . 0.0 109.595 152.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -154.95 110.18 3.07 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 160.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.18 134.8 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 120.785 1.63 . . . . 0.0 109.106 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.55 -50.29 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.806 1.243 . . . . 0.0 110.347 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 40.4 mt-10 -133.85 151.04 51.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.393 0.677 . . . . 0.0 109.427 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.4 mt -124.45 127.34 72.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 65.68 -36.96 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 131.027 3.731 . . . . 0.0 115.741 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.26 19.7 pt20 162.31 -7.54 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.796 3.638 . . . . 0.0 112.592 -171.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -99.84 142.25 31.57 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.79 -1.194 . . . . 0.0 109.502 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 19.4 t-20 -72.73 137.74 46.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.808 1.243 . . . . 0.0 110.381 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.587 HG12 HD22 ' A' ' 65' ' ' LEU . 6.3 m -139.73 19.63 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 126.966 2.107 . . . . 0.0 108.394 -175.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.99 -58.47 4.07 Favored 'General case' 0 C--N 1.343 0.316 0 O-C-N 120.382 -1.449 . . . . 0.0 109.994 171.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -67.7 -19.96 65.22 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.341 0.657 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.587 HD22 HG12 ' A' ' 62' ' ' VAL . 6.7 mp -56.09 137.44 51.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.216 2.206 . . . . 0.0 111.744 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -60.61 156.4 16.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.198 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -46.98 -51.14 17.82 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.0 0.92 . . . . 0.0 110.192 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -55.82 -35.59 66.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.198 2.599 . . . . 0.0 111.669 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.38 -50.06 49.58 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.848 1.259 . . . . 0.0 107.613 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.637 HG21 ' HG2' ' A' ' 34' ' ' GLN . 97.3 t -63.55 -39.31 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.593 0.757 . . . . 0.0 109.348 -176.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.78 -51.96 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -66.86 -33.49 75.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.433 0.56 . . . . 0.0 112.1 -170.469 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.94 -52.28 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 124.043 0.937 . . . . 0.0 109.584 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.07 -35.75 81.29 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.008 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 43.9 mtmt -59.38 -48.56 81.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 121.189 1.813 . . . . 0.0 111.38 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.5 -33.28 74.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.618 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 97.0 m -46.7 125.29 8.01 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.06 0.944 . . . . 0.0 110.087 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' CYS . 7.1 Cg_exo -58.17 145.31 93.14 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.685 2.924 . . . . 0.0 109.991 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 17.7 mm -72.63 139.66 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.856 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.84 75.59 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.05 1.31 . . . . 0.0 113.352 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -99.27 128.19 45.37 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.784 1.292 . . . . 0.0 108.152 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.19 139.63 58.47 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.9 m -124.17 125.93 45.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 m -88.68 122.47 32.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.79 112.67 19.12 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 13' ' ' THR . 6.5 mt -80.13 131.51 33.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 169.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.36 150.75 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 109.815 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.466 ' HA ' HD13 ' A' ' 11' ' ' LEU . 1.6 t-160 -81.26 113.88 19.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.829 0.852 . . . . 0.0 109.685 -176.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -144.81 179.3 7.41 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.106 1.363 . . . . 0.0 107.709 171.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.13 64.54 0.53 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 123.557 0.598 . . . . 0.0 111.61 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.2 t -153.27 158.46 41.67 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.47 164.01 30.76 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -92.57 -26.3 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.704 2.936 . . . . 0.0 114.295 -170.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 m -178.3 149.34 0.52 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.99 2.916 . . . . 0.0 107.625 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.42 177.99 0.16 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.954 1.702 . . . . 0.0 113.585 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.753 0 N-CA-C 106.368 -2.693 . . . . 0.0 106.368 177.732 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -148.78 127.24 12.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.024 2.13 . . . . 0.0 106.448 163.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.9 p 55.01 173.63 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.802 2.441 . . . . 0.0 113.314 -162.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.97 -175.24 50.77 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.202 0.906 . . . . 0.0 112.231 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m -81.95 -51.0 8.5 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.801 -0.823 . . . . 0.0 111.914 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 t 57.16 85.66 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.265 1.426 . . . . 0.0 111.101 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.66 117.06 4.51 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.774 0.702 . . . . 0.0 112.145 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -144.58 174.66 10.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.094 1.358 . . . . 0.0 109.542 162.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.62 135.51 36.6 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.343 0.657 . . . . 0.0 110.853 -174.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -140.42 147.25 39.43 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 166.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 49.5 -160.75 0.05 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.049 2.139 . . . . 0.0 111.943 173.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.9 mtm -142.18 148.17 37.78 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.484 1.514 . . . . 0.0 107.914 153.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -99.7 142.47 31.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 165.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -138.1 160.79 38.47 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.717 1.607 . . . . 0.0 106.791 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -130.8 144.8 51.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 16' ' ' ILE . 11.5 pt -138.69 152.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 125.351 1.46 . . . . 0.0 110.442 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.91 98.34 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.236 1.014 . . . . 0.0 109.641 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 52.1 tttt -43.58 112.41 0.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.574 2.35 . . . . 0.0 111.1 177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -67.52 1.88 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.72 150.77 3.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.458 1.503 . . . . 0.0 108.557 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 40.9 57.49 2.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.105 1.362 . . . . 0.0 110.813 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 76.99 -144.16 29.57 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -112.46 160.17 18.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.516 1.526 . . . . 0.0 108.084 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.04 7.73 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 124.4 1.0 . . . . 0.0 110.615 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -58.56 170.25 0.79 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.346 1.069 . . . . 0.0 111.093 172.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -132.73 159.08 40.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.529 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 pt -118.78 141.83 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.268 1.032 . . . . 0.0 109.031 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.04 133.56 43.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 127.232 2.213 . . . . 0.0 105.77 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 141.85 50.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 163.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -128.9 169.84 12.09 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.47 1.508 . . . . 0.0 108.216 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.63 4.14 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.127 3.218 . . . . 0.0 113.452 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.1 p -131.55 -27.49 1.94 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.543 1.065 . . . . 0.0 112.115 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.26 -166.1 37.44 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -83.65 137.96 33.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -128.34 162.78 26.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 126.888 2.075 . . . . 0.0 107.466 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -77.91 123.38 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -75.36 -70.57 0.41 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -149.13 158.45 44.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.37 0.986 . . . . 0.0 109.049 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.432 HG23 ' SG ' ' A' ' 45' ' ' CYS . 69.0 mt -117.46 120.65 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.2 mt -105.21 -17.67 14.39 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.265 1.426 . . . . 0.0 111.008 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -142.22 82.78 1.8 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.702 2.001 . . . . 0.0 106.548 -162.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.59 -36.56 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.931 1.292 . . . . 0.0 110.682 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.43 -26.11 65.36 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.034 -1.041 . . . . 0.0 113.11 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.2 -11.74 71.33 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.708 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.432 ' SG ' HG23 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -153.03 67.15 6.31 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.588 1.694 . . . . 0.0 110.678 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.7 130.15 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.838 2.359 . . . . 0.0 109.849 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.68 -5.96 72.01 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.202 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 tp -77.79 142.73 38.45 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.493 1.146 . . . . 0.0 109.091 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.4 m -132.21 159.36 39.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.811 1.245 . . . . 0.0 109.554 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.51 144.29 57.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 -1.0 84.22 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.585 -1.675 . . . . 0.0 114.446 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -63.62 106.33 0.94 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.44 1.62 . . . . 0.0 110.005 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.86 126.04 28.48 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.695 1.598 . . . . 0.0 109.571 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.57 144.58 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 109.208 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.42 -43.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 126.293 1.837 . . . . 0.0 108.847 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -136.12 153.59 51.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.579 0.752 . . . . 0.0 110.161 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 58' ' ' ASN . 6.8 mt -111.41 -157.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 167.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.676 ' H ' HG22 ' A' ' 57' ' ' ILE . 85.7 m-20 -53.25 76.56 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.268 2.227 . . . . 0.0 110.92 168.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 55.76 38.97 30.74 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.182 1.393 . . . . 0.0 111.989 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.75 125.82 38.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.834 1.654 . . . . 0.0 107.212 162.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.35 114.77 22.67 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.417 1.487 . . . . 0.0 108.141 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.582 HG12 HD12 ' A' ' 65' ' ' LEU . 28.2 m -117.47 6.61 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -163.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -53.48 -19.88 4.16 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -114.96 -10.09 12.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.064 1.346 . . . . 0.0 112.116 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.582 HD12 HG12 ' A' ' 62' ' ' VAL . 15.2 mt -68.11 147.15 52.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.977 0.894 . . . . 0.0 108.635 175.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.4 m -74.76 164.68 26.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.419 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -48.08 -56.3 8.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.644 0.777 . . . . 0.0 109.535 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.9 m -60.85 -28.76 69.08 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.958 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.68 -45.97 27.54 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.13 1.372 . . . . 0.0 110.73 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.25 -41.51 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.11 -43.0 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.137 0.975 . . . . 0.0 109.225 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.75 89.76 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.853 1.261 . . . . 0.0 110.722 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.81 -51.33 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.035 0.934 . . . . 0.0 108.76 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.404 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 29.9 mt -62.9 -26.4 68.77 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.757 -0.589 . . . . 0.0 111.729 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -68.92 -40.31 79.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.305 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.58 -33.88 75.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.527 1.058 . . . . 0.0 113.193 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.8 m -49.62 134.25 19.3 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.778 1.231 . . . . 0.0 111.563 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.13 121.47 8.63 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.234 3.289 . . . . 0.0 111.777 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.16 124.13 11.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.206 1.402 . . . . 0.0 107.742 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.19 14.92 70.59 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.24 -0.756 . . . . 0.0 113.208 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.4 m -115.62 147.94 40.22 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 118.655 1.227 . . . . 0.0 108.165 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.98 141.18 58.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.885 1.274 . . . . 0.0 108.487 171.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -128.89 124.9 36.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.081 1.753 . . . . 0.0 106.419 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -89.46 128.74 36.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 mp -133.46 158.28 43.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.1 130.83 73.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.0 148.25 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.715 1.206 . . . . 0.0 110.18 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -82.99 84.71 7.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.716 0.807 . . . . 0.0 109.502 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -85.93 158.99 19.77 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.63 -59.87 0.08 OUTLIER Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.5 m -150.2 -172.93 4.3 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 162.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -141.96 153.33 24.2 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 164.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.94 -42.91 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.482 2.122 . . . . 0.0 110.968 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 p -71.23 128.89 37.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.3 1.44 . . . . 0.0 109.591 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.0 m -57.45 -39.15 75.67 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.824 0.449 . . . . 0.0 111.414 169.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -153.259 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.823 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -130.16 118.94 22.21 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.354 1.461 . . . . 0.0 107.709 -173.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -171.47 100.61 0.19 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.39 -150.14 14.68 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.171 1.367 . . . . 0.0 110.795 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.61 115.06 2.12 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.057 1.343 . . . . 0.0 109.895 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -73.1 167.94 20.11 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 168.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.75 136.47 4.03 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 169.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.83 77.8 6.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.726 0.763 . . . . 0.0 109.536 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.91 165.84 12.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.77 0.828 . . . . 0.0 109.948 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -103.77 111.12 23.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 155.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.79 155.43 37.61 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 166.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.572 ' HE2' HD11 ' A' ' 87' ' ' ILE . 31.6 mtm -92.53 113.84 26.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.742 0.701 . . . . 0.0 109.292 174.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -82.95 129.07 34.98 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -145.7 142.56 29.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.685 1.594 . . . . 0.0 107.641 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -125.08 140.18 53.13 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.965 . . . . 0.0 110.665 -166.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.563 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.0 pt -129.51 158.29 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.174 1.389 . . . . 0.0 111.03 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -128.14 116.79 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.858 1.263 . . . . 0.0 108.516 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HG2' HD13 ' A' ' 79' ' ' ILE . 55.6 tttt -75.26 104.81 5.98 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.571 1.148 . . . . 0.0 109.915 -174.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.76 -67.63 1.87 Allowed Glycine 0 CA--C 1.523 0.564 0 CA-C-O 119.703 -0.498 . . . . 0.0 112.599 -169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 -70.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.514 0.657 . . . . 0.0 111.243 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -78.11 72.0 4.62 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.023 1.329 . . . . 0.0 107.922 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 61.6 -149.75 45.84 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD12 ' A' ' 16' ' ' ILE . 97.5 m-85 -83.51 1.41 42.03 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.53 -63.14 1.48 Allowed Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.761 -1.212 . . . . 0.0 111.623 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -52.58 155.14 2.3 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.028 1.414 . . . . 0.0 111.765 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -122.17 157.38 31.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.0 107.915 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.38 174.68 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 109.232 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.13 165.18 14.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.496 1.918 . . . . 0.0 107.513 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 141.01 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 151.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.64 154.92 60.16 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.58 16.06 1.5 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.292 2.661 . . . . 0.0 113.983 -160.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -144.63 4.04 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.768 1.627 . . . . 0.0 112.092 -160.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.76 169.48 21.72 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -156.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.7 mm-40 -77.08 160.77 28.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.995 0.897 . . . . 0.0 111.856 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -131.48 146.46 52.25 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.64 127.07 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -100.73 -52.54 3.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.376 1.07 . . . . 0.0 109.862 -173.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -150.39 133.9 16.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.05 128.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -118.43 9.29 12.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.409 1.083 . . . . 0.0 110.509 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.55 81.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.678 HD12 ' H ' ' A' ' 42' ' ' ILE . 3.5 mp -59.2 -60.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 124.834 1.253 . . . . 0.0 109.073 -166.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.81 -9.99 59.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.14 -38.15 94.94 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 164.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.563 ' HA ' HG22 ' A' ' 16' ' ' ILE . 80.4 m -123.31 67.07 34.87 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.47 0.708 . . . . 0.0 111.96 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.88 142.56 93.71 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.216 1.944 . . . . 0.0 109.641 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.22 -31.66 3.72 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 117.984 -1.453 . . . . 0.0 113.065 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -63.9 147.34 52.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.204 1.502 . . . . 0.0 110.387 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.6 m -137.08 168.95 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.342 1.857 . . . . 0.0 109.421 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.53 146.23 31.41 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.218 -0.926 . . . . 0.0 110.598 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.63 -3.16 80.17 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.132 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -55.59 115.83 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.403 1.481 . . . . 0.0 108.211 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.26 98.13 3.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.56 119.73 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.525 1.53 . . . . 0.0 108.229 177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.18 -52.15 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.038 1.735 . . . . 0.0 109.123 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -136.03 143.65 44.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.879 1.272 . . . . 0.0 108.543 -169.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 74' ' ' LEU . 97.7 mt -131.21 134.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.961 1.304 . . . . 0.0 107.574 170.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 39.95 47.99 2.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.787 2.035 . . . . 0.0 110.402 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 66.41 13.19 9.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.261 1.425 . . . . 0.0 112.79 171.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.01 130.18 46.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.884 1.673 . . . . 0.0 107.828 167.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -58.21 123.87 17.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.994 0.918 . . . . 0.0 110.476 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.29 -3.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 118.176 -0.916 . . . . 0.0 113.251 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -54.21 -37.03 64.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.48 1.491 . . . . 0.0 112.502 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -97.51 2.28 49.97 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.327 1.051 . . . . 0.0 111.649 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.7 mt -87.5 160.77 18.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.155 0.982 . . . . 0.0 108.894 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 152.26 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -41.14 -52.51 3.27 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.675 1.59 . . . . 0.0 111.715 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.5 m -56.97 -42.28 79.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.149 1.379 . . . . 0.0 112.224 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -64.19 -38.22 90.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.704 ' O ' HD22 ' A' ' 74' ' ' LEU . 19.4 t -69.8 -51.47 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.567 0.747 . . . . 0.0 109.473 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.86 -38.03 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.172 1.389 . . . . 0.0 110.268 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.41 -34.47 70.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.048 0.842 . . . . 0.0 111.97 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -54.31 -60.3 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -56.5 -31.61 64.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 174.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.07 -50.94 68.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 121.109 1.777 . . . . 0.0 108.736 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.68 -35.28 75.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.14 0.976 . . . . 0.0 111.455 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 50.6 m -56.64 144.28 65.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.574 0.749 . . . . 0.0 112.704 -169.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.36 123.44 10.24 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.454 3.436 . . . . 0.0 112.311 -172.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.463 HD13 ' HG2' ' A' ' 18' ' ' LYS . 5.5 mm -59.29 131.58 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.5 26.57 72.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.462 1.029 . . . . 0.0 112.988 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -103.84 157.44 17.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 154.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.83 152.69 30.92 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.196 152.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.2 m -139.97 125.68 19.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -89.36 119.44 29.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -166.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.27 154.94 35.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 56' ' ' GLU . 5.7 mt -134.04 129.81 54.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.572 HD11 ' HE2' ' A' ' 12' ' ' MET . 1.2 pp -119.69 167.39 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 108.122 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.29 -120.32 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 110.93 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 59.28 -107.22 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.508 1.923 . . . . 0.0 110.791 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.89 60.71 8.39 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.832 1.206 . . . . 0.0 112.024 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m -137.36 -25.94 1.02 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.16 174.24 0.27 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.159 1.361 . . . . 0.0 113.593 -167.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -84.53 -179.29 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.644 2.896 . . . . 0.0 109.597 166.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m 51.19 67.03 1.01 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.387 1.475 . . . . 0.0 111.308 -174.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.3 t -77.8 177.87 7.84 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 151.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.785 0 C-N-CA 126.204 1.859 . . . . 0.0 108.774 -174.902 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m 67.72 173.12 0.27 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.58 1.952 . . . . 0.0 111.398 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.0 p -150.3 159.17 44.64 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.828 -0.545 . . . . 0.0 111.569 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.31 128.87 1.42 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.237 1.398 . . . . 0.0 112.435 173.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 m 45.08 -81.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 128.274 2.63 . . . . 0.0 114.484 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -56.45 144.58 30.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.229 1.377 . . . . 0.0 108.263 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.66 -178.71 48.58 Favored Glycine 0 N--CA 1.449 -0.453 0 O-C-N 120.573 -1.329 . . . . 0.0 110.094 -168.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -156.16 147.93 22.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -168.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.06 161.66 0.13 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.478 2.711 . . . . 0.0 111.731 -164.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.55 100.83 2.89 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -170.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -132.29 178.0 7.15 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.737 1.615 . . . . 0.0 109.175 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mtm -113.92 154.73 27.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.004 0.922 . . . . 0.0 109.309 168.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.9 m -131.06 134.58 46.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.31 167.73 22.15 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.035 1.734 . . . . 0.0 108.62 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -122.97 153.06 40.26 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 45' ' ' CYS . 23.1 pt -139.9 155.39 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.203 1.801 . . . . 0.0 110.013 174.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.26 99.31 4.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.011 1.725 . . . . 0.0 107.968 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 53.2 tttt -53.64 109.17 0.42 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.268 2.227 . . . . 0.0 111.617 -174.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.35 33.44 4.32 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.15 1.357 . . . . 0.0 115.862 -163.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . 59.56 162.41 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.387 2.275 . . . . 0.0 113.69 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 52.32 -10.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.249 1.82 . . . . 0.0 114.854 -153.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 147.39 -155.58 26.57 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' CD2' HD12 ' A' ' 16' ' ' ILE . 54.5 m-85 -83.96 152.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 153.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.57 -56.0 26.83 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -54.75 159.94 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.488 1.137 . . . . 0.0 111.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.5 p -128.65 161.44 29.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.882 1.673 . . . . 0.0 108.368 -172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.2 162.97 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 122.066 0.936 . . . . 0.0 109.758 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.98 146.97 39.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.017 1.327 . . . . 0.0 107.864 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.57 136.01 47.26 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.253 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 p -133.74 165.72 34.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.61 -12.74 35.54 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.085 1.857 . . . . 0.0 112.574 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -109.36 5.63 23.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.44 1.496 . . . . 0.0 111.817 -168.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.0 -159.47 15.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -165.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.537 ' CG ' HG21 ' A' ' 70' ' ' VAL . 93.6 mm-40 -87.44 152.58 22.12 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.274 -1.133 . . . . 0.0 110.274 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -120.51 158.93 26.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 109.552 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.33 119.09 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -69.06 -68.89 0.37 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 171.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -151.98 151.89 31.78 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -174.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.26 92.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.4 mt -82.78 -18.44 40.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.117 1.367 . . . . 0.0 112.162 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -124.06 91.58 3.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.04 -29.21 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.499 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -73.65 -60.25 2.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.631 0.772 . . . . 0.0 110.003 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -5.01 87.68 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 123.694 0.664 . . . . 0.0 112.663 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' HG22 ' A' ' 16' ' ' ILE . 12.0 m -120.02 66.18 10.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.976 1.388 . . . . 0.0 107.759 165.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.38 146.58 56.78 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.624 2.216 . . . . 0.0 110.404 -170.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.14 -7.89 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.941 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.433 HD12 ' CG2' ' A' ' 16' ' ' ILE . 2.8 tt -73.86 132.81 42.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.7 m -110.98 155.02 23.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 123.416 1.579 . . . . 0.0 110.415 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.35 148.38 51.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.579 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.18 8.83 12.77 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 117.841 -1.533 . . . . 0.0 116.098 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -59.98 139.45 57.42 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.8 1.8 . . . . 0.0 109.219 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.75 129.39 37.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.862 1.665 . . . . 0.0 110.34 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mt -81.66 130.1 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.844 0.858 . . . . 0.0 110.598 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -116.25 -55.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.265 1.826 . . . . 0.0 109.205 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -125.29 152.92 44.03 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.55 135.08 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 157.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 33.57 56.66 0.54 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.411 2.685 . . . . 0.0 113.351 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 61.29 25.92 15.83 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -121.51 129.49 52.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 170.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -72.46 126.62 30.3 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.277 0.631 . . . . 0.0 111.018 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.503 HG12 HD12 ' A' ' 65' ' ' LEU . 21.2 m -128.76 17.47 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.98 0.912 . . . . 0.0 112.272 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.8 -15.98 62.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.931 -1.106 . . . . 0.0 112.196 173.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.33 17.32 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.429 1.892 . . . . 0.0 110.664 -169.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 62' ' ' VAL . 17.7 mt -110.66 147.19 34.83 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.095 -1.003 . . . . 0.0 111.173 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.557 ' O ' HG22 ' A' ' 70' ' ' VAL . 14.1 m -75.12 147.5 40.47 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 117.173 -1.394 . . . . 0.0 108.115 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.596 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 70.1 t60 -42.99 -34.21 0.95 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.774 2.029 . . . . 0.0 113.943 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.69 -34.01 76.91 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 120.969 -1.082 . . . . 0.0 112.208 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.02 -49.09 16.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.248 2.219 . . . . 0.0 110.748 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.596 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -59.4 -42.62 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 1 C-N-CA 132.589 4.355 . . . . 0.0 111.896 172.518 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.6 -50.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 167.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.51 -40.97 93.34 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.603 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mt -59.34 -50.68 78.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.949 1.3 . . . . 0.0 109.918 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -60.94 -28.87 69.28 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.876 -0.515 . . . . 0.0 110.144 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -72.77 -42.19 64.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.672 -1.268 . . . . 0.0 109.632 174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -68.32 -16.49 63.97 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.39 1.45 . . . . 0.0 112.852 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -60.61 140.49 92.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 O-C-N 121.17 -0.956 . . . . 0.0 110.004 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -58.62 142.92 98.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.609 3.54 . . . . 0.0 111.501 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.07 136.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 159.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.22 51.47 54.71 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 123.293 0.37 . . . . 0.0 112.358 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.2 m -150.03 151.49 33.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -61.89 102.31 0.26 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.862 1.265 . . . . 0.0 109.461 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.6 m -83.04 146.11 28.91 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 160.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.6 m -120.56 131.2 54.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mp -127.04 149.93 49.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.87 126.11 73.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.58 154.48 27.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.004 0.907 . . . . 0.0 110.814 -175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -91.25 80.24 5.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.514 -170.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.88 -155.67 0.19 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.941 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.75 -6.11 4.46 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 119.678 1.126 . . . . 0.0 114.774 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -115.96 -65.18 1.22 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.109 1.454 . . . . 0.0 110.773 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.11 -160.02 26.21 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 118.863 0.756 . . . . 0.0 111.634 -174.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.7 166.92 25.91 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.677 1.585 . . . . 0.0 111.416 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 46.99 59.57 3.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.421 1.888 . . . . 0.0 112.81 165.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 m -89.17 -30.96 18.19 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.586 0.755 . . . . 0.0 112.335 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.463 0 C-N-CA 126.058 1.789 . . . . 0.0 110.054 178.13 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.235 0.316 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtm -89.07 113.88 25.06 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.734 -169.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.5 m -78.1 137.31 38.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 159.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -131.42 161.77 31.71 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -119.81 144.89 47.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.819 HG22 ' HA ' ' A' ' 45' ' ' CYS . 21.7 pt -138.89 162.81 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.368 1.467 . . . . 0.0 109.333 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.4 t -132.14 137.28 55.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.894 0.854 . . . . 0.0 108.713 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -97.62 85.56 3.62 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 121.883 -0.511 . . . . 0.0 111.569 -166.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.32 -69.25 1.23 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.579 0.609 . . . . 0.0 114.445 -166.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.64 -62.41 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.247 1.419 . . . . 0.0 109.183 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -65.1 6.4 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.997 2.519 . . . . 0.0 114.653 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.63 71.6 1.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 63.54 173.06 0.17 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.499 1.919 . . . . 0.0 111.188 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.54 49.1 0.87 Allowed Glycine 0 C--O 1.222 -0.605 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -157.97 163.55 37.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.7 p -121.17 161.75 21.32 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.381 1.072 . . . . 0.0 108.805 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 pt -123.34 162.94 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.061 0.934 . . . . 0.0 110.132 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.77 140.31 40.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 107.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.75 121.04 18.22 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 p -110.2 168.47 7.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -64.97 -10.52 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.507 1.471 . . . . 0.0 112.224 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 p -114.58 7.2 16.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 112.758 -170.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.52 -172.5 15.76 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -171.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.437 ' HG2' HG21 ' A' ' 70' ' ' VAL . 43.3 mm-40 -77.07 149.98 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.666 -0.902 . . . . 0.0 108.751 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -130.17 164.02 25.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.588 1.155 . . . . 0.0 108.498 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.52 122.39 22.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -73.99 -62.33 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -154.66 145.58 22.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.19 136.64 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.7 mt -119.63 -8.94 9.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 111.313 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -155.81 108.51 2.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.362 2.265 . . . . 0.0 106.842 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.97 -53.7 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.16 0.984 . . . . 0.0 110.07 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -72.86 -4.19 30.31 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.065 -1.022 . . . . 0.0 112.521 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.77 -16.17 79.31 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.15 -0.969 . . . . 0.0 111.797 163.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.819 ' HA ' HG22 ' A' ' 16' ' ' ILE . 25.7 p -150.23 57.99 2.9 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 118.956 1.378 . . . . 0.0 113.541 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.27 112.32 1.53 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.342 2.028 . . . . 0.0 111.534 -170.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.75 -5.96 37.57 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.514 1.53 . . . . 0.0 113.62 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.81 139.37 41.72 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.377 1.589 . . . . 0.0 109.795 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.8 m -123.82 9.84 8.88 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 66.2 152.3 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.056 2.142 . . . . 0.0 112.784 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.88 -3.0 0.17 Allowed Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.896 1.236 . . . . 0.0 115.31 -170.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.98 158.43 19.34 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.286 2.043 . . . . 0.0 109.718 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.86 114.11 26.85 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.626 1.57 . . . . 0.0 109.978 -161.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 62' ' ' VAL . 53.1 mt -65.26 129.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.812 1.245 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 62' ' ' VAL . 59.8 t -124.78 -51.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.429 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.5 145.54 51.87 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.834 1.652 . . . . 0.0 109.873 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.6 mt -125.06 122.26 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 45.05 42.26 6.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.264 1.426 . . . . 0.0 111.656 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 65.76 8.39 5.22 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.177 1.391 . . . . 0.0 113.609 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -77.68 138.6 39.16 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.641 -1.287 . . . . 0.0 108.031 163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.67 116.86 22.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.672 2.389 . . . . 0.0 108.33 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG12 HD22 ' A' ' 65' ' ' LEU . 7.2 m -135.53 13.61 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 125.449 1.5 . . . . 0.0 112.016 -169.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.44 -55.41 35.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 118.319 -2.738 . . . . 0.0 112.562 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -81.45 -6.77 59.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.596 0.758 . . . . 0.0 111.095 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.679 HD22 HG12 ' A' ' 62' ' ' VAL . 6.4 mp -64.46 135.17 55.81 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.28 1.832 . . . . 0.0 111.203 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -63.41 160.81 15.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.037 171.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -48.77 -49.57 38.01 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.25 0.62 . . . . 0.0 111.012 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -42.92 73.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.043 1.737 . . . . 0.0 112.227 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.442 1.497 . . . . 0.0 108.069 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 34' ' ' GLN . 62.6 t -68.22 -43.76 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 110.617 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.33 -42.58 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 124.26 1.024 . . . . 0.0 109.926 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -44.47 91.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.183 0.993 . . . . 0.0 110.156 -176.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.04 -44.48 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.519 -0.738 . . . . 0.0 109.146 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.5 -23.73 66.96 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.57 -0.706 . . . . 0.0 111.571 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -72.95 -42.92 62.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.943 1.247 . . . . 0.0 109.977 171.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -55.55 -35.45 65.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.109 0.868 . . . . 0.0 110.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 81.9 m -54.67 138.8 61.38 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.3 141.14 55.52 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.827 3.685 . . . . 0.0 110.814 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mm -70.86 142.28 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.97 -2.08 28.16 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.446 1.974 . . . . 0.0 113.385 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.4 m -103.01 165.02 11.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.076 1.35 . . . . 0.0 107.862 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -69.21 153.35 43.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 123.128 1.442 . . . . 0.0 111.216 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -140.6 141.46 35.16 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.061 2.144 . . . . 0.0 105.653 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 m -112.62 115.9 29.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.406 HD13 HD11 ' A' ' 16' ' ' ILE . 6.1 mp -113.04 153.01 28.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mt -126.55 122.41 60.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.72 164.14 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.708 0.803 . . . . 0.0 110.764 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -84.13 124.02 30.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.383 0.673 . . . . 0.0 111.13 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 . . . . . 0 CA--C 1.539 0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 108.471 176.29 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.404 HD23 ' CD2' ' A' ' 88' ' ' HIS . 18.4 mt . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 mtm -88.78 150.06 23.12 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.9 m -116.04 148.29 40.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -145.46 168.3 20.88 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 128.62 2.768 . . . . 0.0 107.457 -172.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.12 153.97 51.03 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.247 -0.908 . . . . 0.0 108.591 170.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.0 pt -134.07 167.38 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 126.461 1.905 . . . . 0.0 109.227 173.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.7 139.67 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HG2' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.24 152.56 40.98 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 176.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.09 74.72 0.28 Allowed Glycine 0 C--O 1.238 0.377 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.27 -166.92 0.08 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.051 1.34 . . . . 0.0 111.157 -167.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 40.47 9.7 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 131.579 3.952 . . . . 0.0 118.643 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.16 67.93 1.86 Allowed Glycine 0 N--CA 1.445 -0.736 0 O-C-N 120.65 -1.281 . . . . 0.0 110.553 -165.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CE1' HD22 ' A' ' 74' ' ' LEU . 23.1 m-85 63.75 174.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.227 2.211 . . . . 0.0 111.544 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.81 34.96 4.95 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.545 1.545 . . . . 0.0 110.233 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -140.89 167.03 23.17 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 p -129.96 151.38 50.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.6 pt -114.22 144.96 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.77 131.36 46.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.09 144.41 50.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.6 p -138.57 167.0 21.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 127.676 2.391 . . . . 0.0 105.567 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.71 -36.45 97.13 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 p -79.0 -28.39 43.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.576 1.95 . . . . 0.0 111.684 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.99 -134.34 4.79 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -162.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -106.63 147.2 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.952 . . . . 0.0 110.094 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -146.78 161.13 41.28 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.234 1.014 . . . . 0.0 108.342 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -77.26 114.49 17.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -63.37 -61.36 2.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.105 1.362 . . . . 0.0 108.759 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -157.08 154.23 29.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.86 114.25 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.9 mt -87.63 -25.11 23.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.798 0.839 . . . . 0.0 110.106 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -150.1 96.15 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.011 1.724 . . . . 0.0 107.598 -169.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 mt -60.47 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 109.949 -166.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -64.12 -12.39 39.0 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.48 -34.96 63.22 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 119.232 0.924 . . . . 0.0 111.426 170.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.493 ' HA ' HG22 ' A' ' 16' ' ' ILE . 79.3 m -126.87 67.64 69.19 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.467 1.107 . . . . 0.0 108.703 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.55 132.92 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.38 2.053 . . . . 0.0 109.124 -172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.05 -3.4 71.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.259 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.94 135.08 49.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.22 1.51 . . . . 0.0 107.003 166.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.7 m -137.17 131.69 32.88 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.85 153.47 41.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.245 0.618 . . . . 0.0 111.89 -163.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.94 37.14 93.92 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -166.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.48 -173.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.081 1.352 . . . . 0.0 110.389 160.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.38 122.45 20.25 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 154.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.7 mt -69.52 129.51 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.28 -58.08 2.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.521 1.128 . . . . 0.0 111.425 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 22.1 mt-10 -136.61 131.67 34.05 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.19 127.24 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 45.55 38.56 4.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.105 1.762 . . . . 0.0 111.575 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 61.1 18.47 9.04 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.14 1.776 . . . . 0.0 114.056 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -92.49 135.52 33.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 156.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 23.1 t-20 -80.83 138.62 36.22 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.227 0.536 . . . . 0.0 110.067 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.798 HG12 HD22 ' A' ' 65' ' ' LEU . 16.6 m -137.89 10.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 126.35 1.86 . . . . 0.0 108.347 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -24.51 66.99 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 119.265 -2.147 . . . . 0.0 112.477 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.55 -13.01 16.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.137 0.88 . . . . 0.0 110.598 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.798 HD22 HG12 ' A' ' 62' ' ' VAL . 5.6 mp -59.38 127.73 33.57 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 126.366 1.866 . . . . 0.0 111.67 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.09 162.11 3.65 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.362 1.039 . . . . 0.0 110.316 176.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -49.85 -48.33 51.18 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.169 0.588 . . . . 0.0 109.989 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -58.38 -36.13 73.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.724 1.21 . . . . 0.0 111.848 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.45 -47.71 54.08 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.198 1.399 . . . . 0.0 107.818 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.03 -46.48 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.937 0.895 . . . . 0.0 109.462 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.07 -42.83 91.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.886 0.874 . . . . 0.0 110.851 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -67.59 -30.73 70.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.42 0.688 . . . . 0.0 111.914 -177.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.25 -40.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 23' ' ' PHE . 35.6 mt -62.03 -27.59 68.99 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.001 -1.062 . . . . 0.0 110.773 172.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 8.6 mtpm? -69.6 -29.91 67.54 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.653 -1.279 . . . . 0.0 111.863 172.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.72 -22.45 53.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.213 0.915 . . . . 0.0 111.24 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.57 132.88 91.24 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 118.974 0.806 . . . . 0.0 110.476 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.19 132.45 46.95 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.526 2.818 . . . . 0.0 109.595 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.43 HD13 ' HG2' ' A' ' 18' ' ' LYS . 3.2 mm -72.13 106.84 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.85 6.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.059 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -136.09 163.34 30.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 118.839 1.32 . . . . 0.0 109.736 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.31 143.65 57.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.28 1.038 . . . . 0.0 111.025 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -131.03 135.17 47.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.478 1.911 . . . . 0.0 105.929 171.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 m -111.5 128.38 55.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -164.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -129.23 137.09 50.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -112.15 129.94 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.81 145.61 35.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 109.711 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.404 ' CD2' HD23 ' A' ' 11' ' ' LEU . 6.2 t-160 -76.04 99.84 4.73 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 109.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 . . . . . 0 C--O 1.232 0.161 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 172.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 mtm -106.7 118.03 35.61 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.771 0.796 . . . . 0.0 109.682 174.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.3 m -84.33 143.69 29.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.6 mt -143.87 168.08 20.8 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.089 2.156 . . . . 0.0 106.351 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.6 m -127.47 148.5 50.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.167 0.987 . . . . 0.0 109.169 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 45' ' ' CYS . 15.7 pt -139.68 160.03 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.846 1.258 . . . . 0.0 111.126 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.1 t -129.06 113.69 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 123.011 1.386 . . . . 0.0 108.615 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.65 102.82 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.08 2.152 . . . . 0.0 108.643 168.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.83 -62.31 3.88 Favored Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.32 -62.44 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 109.225 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.0 51.35 0.5 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.42 2.288 . . . . 0.0 111.913 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.66 47.47 12.98 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.113 1.816 . . . . 0.0 113.597 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 84.9 -11.46 0.78 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 130.54 3.536 . . . . 0.0 113.72 174.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -60.6 1.95 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.86 1.209 . . . . 0.0 111.552 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -49.4 151.05 1.63 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.051 1.426 . . . . 0.0 110.38 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -125.18 159.48 31.43 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -171.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 pt -126.87 152.44 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.526 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.93 137.24 49.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.745 1.218 . . . . 0.0 109.453 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -71.65 124.46 24.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 126.064 1.745 . . . . 0.0 109.389 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 p -120.69 159.75 47.22 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -58.91 -28.87 88.74 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.388 2.725 . . . . 0.0 111.878 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 p -98.23 -5.63 32.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.238 2.615 . . . . 0.0 113.61 -168.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.59 173.72 17.11 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -76.72 145.52 38.62 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.411 -1.052 . . . . 0.0 109.461 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -129.15 151.07 50.23 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.25 108.44 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -66.72 -62.25 1.55 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -155.06 143.19 20.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -90.98 126.61 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 127.044 2.138 . . . . 0.0 106.211 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.7 mt -110.78 -17.95 13.24 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.319 0.648 . . . . 0.0 111.029 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -133.96 77.21 1.7 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.315 1.446 . . . . 0.0 108.165 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.53 -39.61 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.658 1.183 . . . . 0.0 111.222 -169.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -10.4 59.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.87 -15.9 66.61 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 119.27 0.941 . . . . 0.0 111.798 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.631 ' HA ' HG22 ' A' ' 16' ' ' ILE . 48.0 m -130.77 70.73 82.55 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 118.56 1.18 . . . . 0.0 109.91 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -60.42 121.56 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.758 2.972 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.85 71.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.687 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.58 144.81 56.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.325 1.562 . . . . 0.0 109.822 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.0 m -129.53 161.78 29.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.89 1.328 . . . . 0.0 110.444 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.56 136.17 57.76 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.449 1.5 . . . . 0.0 108.261 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.22 17.77 70.5 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.565 1.555 . . . . 0.0 115.044 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.76 101.42 0.64 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.16 1.98 . . . . 0.0 111.405 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.69 114.26 6.89 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.531 1.932 . . . . 0.0 111.09 -167.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.55 134.38 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.607 1.094 . . . . 0.0 110.545 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HG2' ' A' ' 63' ' ' GLN . 73.9 t -119.55 -49.51 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.232 1.413 . . . . 0.0 110.062 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.89 146.11 49.97 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.545 0.688 . . . . 0.0 109.549 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -121.29 135.58 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 153.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 32.28 54.42 0.33 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.638 2.375 . . . . 0.0 113.306 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 47.78 4.49 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 130.421 3.488 . . . . 0.0 118.813 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -26.16 67.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.059 1.754 . . . . 0.0 113.055 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 65.88 126.42 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 130.299 3.44 . . . . 0.0 111.336 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.607 HG12 HD22 ' A' ' 65' ' ' LEU . 12.5 m -134.87 20.78 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.644 1.978 . . . . 0.0 108.49 -163.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -62.99 -59.94 4.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 119.5 -2.0 . . . . 0.0 112.343 173.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -76.89 -12.17 59.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.159 0.583 . . . . 0.0 111.794 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.607 HD22 HG12 ' A' ' 62' ' ' VAL . 6.0 mp -56.93 131.6 50.16 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 126.119 1.768 . . . . 0.0 110.396 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 160.14 15.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.474 174.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -43.24 -50.85 6.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.834 0.854 . . . . 0.0 110.53 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.1 m -60.39 -32.72 71.58 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.814 0.846 . . . . 0.0 112.016 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.39 -45.25 60.56 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.23 -38.22 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.402 0.681 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.9 -52.07 65.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.049 1.34 . . . . 0.0 109.743 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.23 -39.6 93.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.618 1.167 . . . . 0.0 109.942 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.2 mt -56.92 -55.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.65 1.18 . . . . 0.0 110.14 169.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.8 -21.98 66.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.411 0.551 . . . . 0.0 111.604 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -70.66 -40.82 72.79 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.543 -1.348 . . . . 0.0 110.226 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -74.31 -21.7 59.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.921 0.889 . . . . 0.0 113.272 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.8 m -55.09 128.79 66.34 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 168.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -61.89 140.07 83.18 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.761 2.974 . . . . 0.0 111.689 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.01 117.28 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.68 49.65 5.32 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -145.63 155.49 43.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.939 -1.33 . . . . 0.0 108.681 160.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -70.17 129.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 168.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -101.89 142.75 32.7 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.524 1.529 . . . . 0.0 107.414 165.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -104.89 126.8 52.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.15 156.99 47.33 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.83 135.11 63.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.42 159.34 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 110.17 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -81.84 122.59 27.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.162 0.585 . . . . 0.0 110.826 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 N--CA 1.461 0.115 0 C-N-CA 123.876 0.87 . . . . 0.0 111.738 173.72 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.238 0.469 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.8 mtm -111.11 114.82 28.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.201 1.0 . . . . 0.0 109.07 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.1 m -83.72 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 168.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.5 mt -138.99 168.67 19.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.136 2.174 . . . . 0.0 107.258 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 82' ' ' GLU . 11.7 m -123.09 149.85 43.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 45' ' ' CYS . 24.9 pt -130.82 154.37 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.898 1.679 . . . . 0.0 108.637 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 104.6 3.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -68.85 118.09 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.998 1.719 . . . . 0.0 109.629 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.84 -63.29 2.22 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.176 0.893 . . . . 0.0 111.007 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.34 -58.11 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.396 1.078 . . . . 0.0 110.87 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -76.69 56.54 1.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.879 2.072 . . . . 0.0 110.138 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.76 61.59 2.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.178 1.371 . . . . 0.0 111.796 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 69.69 -71.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 126.988 2.115 . . . . 0.0 109.418 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.21 -52.4 0.66 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.09 158.68 1.05 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.647 1.213 . . . . 0.0 111.76 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.3 p -115.51 151.92 33.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.252 -173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.1 159.92 16.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.96 129.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.146 2.578 . . . . 0.0 106.603 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.77 128.35 35.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 p -122.99 168.4 12.17 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.509 1.124 . . . . 0.0 108.081 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.01 -35.56 92.66 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.238 2.625 . . . . 0.0 110.595 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -82.37 6.81 15.88 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.221 2.209 . . . . 0.0 113.367 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.47 -157.02 18.35 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -84.76 141.45 30.52 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.788 -0.83 . . . . 0.0 110.176 -169.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -132.02 165.56 23.69 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.639 1.176 . . . . 0.0 108.74 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -89.38 124.44 42.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -73.71 -68.4 0.51 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.114 1.366 . . . . 0.0 108.663 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -155.06 137.93 15.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.1 mt -85.09 129.21 38.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 mt -108.57 -8.11 15.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.576 0.75 . . . . 0.0 111.225 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -149.64 114.17 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.44 -55.93 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.571 1.148 . . . . 0.0 110.055 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -57.16 -32.73 66.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.931 0.787 . . . . 0.0 110.889 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.04 75.03 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 123.413 0.53 . . . . 0.0 113.287 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.567 ' HA ' HG22 ' A' ' 16' ' ' ILE . 59.7 m -132.94 73.34 75.74 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 119.132 1.466 . . . . 0.0 111.159 -175.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.95 110.55 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.718 1 C-N-CA 125.971 4.447 . . . . 0.0 115.671 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.82 55.25 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.061 -1.025 . . . . 0.0 113.446 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 49' ' ' CYS . 1.7 tm? -55.73 152.92 8.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.769 2.027 . . . . 0.0 109.768 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.552 ' N ' HD13 ' A' ' 48' ' ' LEU . 57.2 m -144.69 151.12 38.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.108 1.363 . . . . 0.0 111.515 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -60.39 142.65 54.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.693 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.52 10.3 48.31 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.886 -2.063 . . . . 0.0 114.712 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -53.86 115.96 2.28 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.614 1.707 . . . . 0.0 106.405 166.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.54 103.62 8.6 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.85 143.59 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.514 1.052 . . . . 0.0 109.043 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 63' ' ' GLN . 57.8 t -130.46 -52.24 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.294 1.038 . . . . 0.0 110.021 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -130.05 145.72 51.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -126.49 125.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.45 38.99 11.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.153 2.181 . . . . 0.0 110.551 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 72.77 -1.42 3.01 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.956 2.102 . . . . 0.0 113.263 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -78.85 135.47 37.04 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.744 -1.222 . . . . 0.0 108.066 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -71.8 121.53 19.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.977 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.411 ' HB ' HG22 ' A' ' 70' ' ' VAL . 32.6 m -121.88 6.37 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 111.913 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.429 ' HG3' HG13 ' A' ' 55' ' ' VAL . 19.1 mt-30 -59.97 -45.12 93.73 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.289 1.404 . . . . 0.0 110.097 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -88.27 24.86 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.574 1.549 . . . . 0.0 111.384 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.83 140.62 52.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.483 1.513 . . . . 0.0 110.133 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.8 m -67.93 158.23 33.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.596 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -47.57 -51.55 20.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.057 0.943 . . . . 0.0 110.996 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.6 m -67.1 -27.03 67.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.828 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.8 -43.53 71.93 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.471 1.032 . . . . 0.0 108.965 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -66.1 -36.97 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.154 -0.966 . . . . 0.0 110.325 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.8 t -57.74 -47.72 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.58 0.752 . . . . 0.0 109.411 169.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.9 -30.61 69.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.022 0.915 . . . . 0.0 112.575 -172.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.4 mt -67.88 -48.15 76.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.21 -25.26 67.7 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.959 -1.088 . . . . 0.0 111.893 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -74.39 -35.33 63.48 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.345 -1.472 . . . . 0.0 110.808 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.68 -49.72 56.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.974 0.806 . . . . 0.0 108.944 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.7 m -42.03 115.33 1.5 Allowed Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.696 1.599 . . . . 0.0 112.376 -170.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.88 127.61 25.79 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.913 3.075 . . . . 0.0 107.391 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.73 141.09 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.43 16.19 48.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.805 1.669 . . . . 0.0 114.019 -171.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.8 t -87.28 160.68 18.33 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.691 1.745 . . . . 0.0 106.975 164.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 15' ' ' THR . 0.0 OUTLIER -80.29 135.45 36.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.9 m -120.52 109.8 15.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -87.05 104.28 16.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.904 2.482 . . . . 0.0 108.474 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.29 160.27 14.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.394 0.543 . . . . 0.0 109.565 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.74 130.76 68.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.32 150.56 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.5 1.12 . . . . 0.0 108.853 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 116.98 22.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.041 1.736 . . . . 0.0 108.55 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.41 ' CE ' HD11 ' A' ' 87' ' ' ILE . 3.9 mtp -131.48 114.71 15.25 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.739 1.216 . . . . 0.0 108.383 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 m -78.27 142.77 37.58 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 164.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.2 mt -142.84 168.48 19.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.78 2.432 . . . . 0.0 107.006 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.86 155.6 37.75 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.14 -0.975 . . . . 0.0 108.731 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 45' ' ' CYS . 15.3 pt -132.83 169.85 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 t -115.65 151.14 17.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 162.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 56.9 tttt -70.02 165.4 21.91 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.809 -1.182 . . . . 0.0 110.091 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -136.62 165.61 24.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.07 -24.25 60.65 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -165.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -75.89 12.86 0.97 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.222 1.374 . . . . 0.0 111.004 165.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 72.71 69.71 1.35 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.729 1.633 . . . . 0.0 109.817 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 77.0 168.08 0.24 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.69 2.796 . . . . 0.0 111.236 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.86 28.16 9.11 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.152 1.834 . . . . 0.0 111.71 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -138.45 172.92 12.18 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.2 p -131.01 146.8 52.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.134 1.374 . . . . 0.0 108.039 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.48 152.17 19.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -126.48 154.16 44.11 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.53 1.932 . . . . 0.0 108.032 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.06 128.62 36.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.538 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 p -121.79 159.01 52.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 11.33 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.037 3.158 . . . . 0.0 114.332 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.4 p -127.18 -6.1 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.38 0.991 . . . . 0.0 112.863 -168.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.56 170.0 12.6 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -160.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -72.95 151.44 41.85 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.497 -1.002 . . . . 0.0 110.0 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -139.63 161.04 38.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.835 0.826 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 48' ' ' LEU . 51.0 t -78.39 122.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 125.547 1.539 . . . . 0.0 107.88 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -71.59 -55.93 6.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.608 162.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -162.24 146.13 12.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.244 0.474 . . . . 0.0 110.476 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.85 93.72 2.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.3 mt -70.57 -28.08 64.62 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.286 1.034 . . . . 0.0 109.945 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -136.78 91.09 2.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.214 1.406 . . . . 0.0 109.674 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.62 -41.57 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 123.67 0.788 . . . . 0.0 110.322 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -71.46 -5.16 30.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.128 -0.983 . . . . 0.0 113.13 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -23.47 28.04 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.636 1.107 . . . . 0.0 111.471 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.442 ' HA ' HG22 ' A' ' 16' ' ' ILE . 84.2 m -136.14 67.47 62.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 109.857 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 136.38 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.326 2.017 . . . . 0.0 111.75 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.82 -9.25 3.82 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.266 -1.296 . . . . 0.0 115.295 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' CD2' HG21 ' A' ' 36' ' ' VAL . 5.6 tt -61.56 145.49 51.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.216 1.508 . . . . 0.0 108.956 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.9 m -110.94 147.24 35.07 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.93 0.892 . . . . 0.0 111.527 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.76 151.0 42.33 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.92 44.84 7.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.388 0.994 . . . . 0.0 111.805 -170.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.15 -174.99 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.65 1.98 . . . . 0.0 109.615 159.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.45 104.03 4.34 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 119.801 -1.812 . . . . 0.0 106.665 163.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.13 131.47 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.24 -50.37 4.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.129 1.372 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -136.53 143.79 43.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.86 125.28 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.509 -2.775 . . . . 0.0 103.509 168.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 44.8 51.91 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.21 1.404 . . . . 0.0 111.258 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 65.64 -24.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.978 2.511 . . . . 0.0 115.094 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -69.31 135.79 50.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.55 118.65 36.8 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.429 -157.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.484 HG12 HD12 ' A' ' 65' ' ' LEU . 34.6 m -125.05 2.14 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.516 -156.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -14.98 0.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.543 1.137 . . . . 0.0 113.156 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.96 6.81 6.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.061 2.544 . . . . 0.0 112.828 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.484 HD12 HG12 ' A' ' 62' ' ' VAL . 23.8 mt -90.28 160.57 16.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.174 1.352 . . . . 0.0 110.101 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -83.87 162.77 20.42 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.95 0.5 . . . . 0.0 110.831 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -49.21 -51.43 33.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -59.05 -35.63 73.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.381 0.673 . . . . 0.0 111.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -74.49 -39.99 62.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.85 -41.85 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.41 -46.4 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.79 1.236 . . . . 0.0 110.37 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -38.78 70.37 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.595 0.56 . . . . 0.0 111.732 -171.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.26 -44.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.226 1.01 . . . . 0.0 109.315 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.59 -32.75 74.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.757 -0.59 . . . . 0.0 110.761 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -64.2 -42.11 96.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.049 1.295 . . . . 0.0 109.847 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.63 -20.25 65.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.526 1.53 . . . . 0.0 112.678 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.55 143.31 93.62 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 124.797 1.239 . . . . 0.0 110.578 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 142.45 49.05 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 124.447 3.431 . . . . 0.0 111.049 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.37 144.69 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.9 -1.08 64.0 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.892 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.45 158.09 16.71 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 119.703 1.751 . . . . 0.0 107.474 173.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.21 153.73 37.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.978 0.911 . . . . 0.0 111.034 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 m -126.21 128.26 46.95 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.737 1.615 . . . . 0.0 106.795 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -80.06 126.32 30.91 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.25 152.19 40.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.04 128.6 59.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 ' CE ' ' A' ' 12' ' ' MET . 1.3 pp -125.83 164.56 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.33 1.052 . . . . 0.0 110.546 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 118.7 36.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.651 0.78 . . . . 0.0 110.887 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 0.0 109.399 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.232 0.174 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtm -128.16 146.07 50.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.074 0.95 . . . . 0.0 108.954 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -122.56 112.21 17.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -117.69 168.3 10.57 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.215 2.206 . . . . 0.0 108.464 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.8 m -133.66 150.03 51.56 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.837 -0.539 . . . . 0.0 109.601 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.657 HG22 ' HA ' ' A' ' 45' ' ' CYS . 5.4 pt -140.13 145.7 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.651 1.18 . . . . 0.0 110.258 173.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.91 118.5 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 9.6 tttt -56.08 129.92 41.95 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.166 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.05 -81.99 0.63 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.91 143.69 20.75 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.659 1.184 . . . . 0.0 108.522 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 55.71 -3.31 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.294 3.038 . . . . 0.0 115.557 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 163.26 -177.3 39.29 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -92.66 3.81 54.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.236 1.014 . . . . 0.0 111.088 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.11 -52.85 3.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.751 -1.218 . . . . 0.0 112.066 -172.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -61.67 166.75 4.01 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 123.165 1.459 . . . . 0.0 111.886 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 p -126.9 151.33 48.58 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.235 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.9 171.45 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.65 161.52 36.27 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.181 1.393 . . . . 0.0 109.207 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 143.49 45.64 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 p -130.17 176.68 2.66 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.28 -19.1 62.1 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.319 2.013 . . . . 0.0 112.166 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p -109.47 3.27 21.16 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.529 1.132 . . . . 0.0 112.496 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.11 -163.17 12.4 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.722 ' HG3' HG21 ' A' ' 70' ' ' VAL . 4.1 mm100 -82.3 145.57 29.9 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.835 0.817 . . . . 0.0 109.986 -167.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -131.69 156.65 45.52 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.265 0.626 . . . . 0.0 109.369 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.17 140.67 17.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 171.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -106.09 -64.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.036 1.335 . . . . 0.0 108.581 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -142.84 134.45 26.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.74 136.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.742 1.617 . . . . 0.0 107.298 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -122.26 -50.57 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.955 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -93.23 95.26 9.26 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.9 mt -65.53 -54.28 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.256 1.822 . . . . 0.0 109.975 -171.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -60.0 -28.32 67.62 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.702 0.683 . . . . 0.0 111.067 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.15 -25.62 72.28 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 118.024 -1.431 . . . . 0.0 112.277 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.657 ' HA ' HG22 ' A' ' 16' ' ' ILE . 4.7 m -140.31 75.9 27.07 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 119.686 1.743 . . . . 0.0 112.42 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.77 154.8 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.135 2.557 . . . . 0.0 110.218 170.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.82 -45.1 2.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.753 1.168 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.57 132.05 30.01 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.093 2.157 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.44 -173.3 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.076 1.351 . . . . 0.0 109.038 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.17 104.72 14.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.49 -15.67 3.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.946 1.736 . . . . 0.0 111.653 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.51 105.53 0.11 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 128.416 2.686 . . . . 0.0 110.659 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.2 101.34 4.59 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.084 1.354 . . . . 0.0 109.102 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.65 129.95 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.438 1.895 . . . . 0.0 109.944 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.79 -43.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.57 1.548 . . . . 0.0 110.435 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.44 149.42 51.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.937 0.895 . . . . 0.0 109.53 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.1 mt -130.67 127.2 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 163.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 42.45 58.33 3.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 112.223 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 67.06 -18.78 0.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.598 2.359 . . . . 0.0 114.886 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -76.89 132.42 39.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.05 126.84 32.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 65' ' ' LEU . 27.8 m -124.31 8.29 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -59.56 -13.61 9.94 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -129.63 38.62 3.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.055 1.342 . . . . 0.0 109.107 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.434 HD12 HG12 ' A' ' 62' ' ' VAL . 17.5 mt -121.5 146.04 47.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 126.5 1.92 . . . . 0.0 108.662 171.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -76.53 155.98 33.27 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 116.993 -1.479 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.609 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 7.6 t60 -49.21 -28.72 4.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.739 175.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.5 m -74.32 -31.2 62.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.117 1.326 . . . . 0.0 111.945 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.82 -47.87 15.83 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 125.004 1.322 . . . . 0.0 110.554 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.722 HG21 ' HG3' ' A' ' 34' ' ' GLN . 2.7 m -54.56 -37.84 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 130.591 3.556 . . . . 0.0 111.726 168.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.98 -47.18 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.279 0.632 . . . . 0.0 109.843 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.59 -42.55 99.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.433 1.093 . . . . 0.0 111.759 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.86 -58.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 126.288 1.835 . . . . 0.0 108.879 169.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.45 -33.44 71.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.118 0.417 . . . . 0.0 111.406 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -64.66 -46.78 80.98 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.434 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.07 -28.89 69.18 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.174 0.99 . . . . 0.0 112.493 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.1 m -50.81 135.98 26.82 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 112.39 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.84 150.31 83.85 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.254 3.303 . . . . 0.0 110.615 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 75.7 mt -91.89 148.78 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.29 13.78 55.04 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.47 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -109.23 136.02 49.37 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.78 140.5 58.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.6 m -134.53 124.18 25.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.183 1.793 . . . . 0.0 106.997 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.0 m -91.45 127.94 37.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mp -124.89 125.04 43.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.38 129.23 58.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.44 150.37 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.37 1.068 . . . . 0.0 108.833 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -84.74 107.8 17.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 119.468 1.031 . . . . 0.0 110.299 179.083 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.54 0.559 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.5 mtm -128.02 136.34 51.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.424 HG23 HG12 ' A' ' 86' ' ' ILE . 76.6 m -134.82 104.97 6.22 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 -168.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.37 168.43 9.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.116 1.767 . . . . 0.0 108.53 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.26 144.88 50.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.7 pt -137.94 131.94 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.111 0.965 . . . . 0.0 111.148 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.1 t -90.4 114.59 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 122.292 1.044 . . . . 0.0 109.063 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 34.7 tttm -65.11 126.43 28.07 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 170.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.04 -71.85 1.3 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 119.43 1.013 . . . . 0.0 111.719 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.55 -52.87 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.866 1.266 . . . . 0.0 109.893 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . 0.256 5.8 pt20 -74.28 58.22 0.72 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.966 1.365 . . . . 0.0 110.555 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 56.72 -150.59 26.85 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.739 -161.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -81.95 157.89 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 160.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.36 -45.36 30.54 Favored Glycine 0 C--O 1.223 -0.586 0 C-N-CA 119.403 -1.38 . . . . 0.0 112.05 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -52.07 155.94 1.73 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.667 1.233 . . . . 0.0 111.225 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.2 p -120.39 161.15 21.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.193 1.397 . . . . 0.0 108.04 -172.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.31 159.41 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.525 -0.735 . . . . 0.0 110.079 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 149.0 52.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.091 1.756 . . . . 0.0 107.527 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -76.5 141.08 41.38 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.277 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.08 165.36 29.77 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.646 1.179 . . . . 0.0 108.578 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.04 -2.86 8.67 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.791 2.994 . . . . 0.0 116.084 -164.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -136.81 2.53 2.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.468 1.031 . . . . 0.0 112.723 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.32 -176.63 28.85 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -77.93 148.62 34.43 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.15 -0.618 . . . . 0.0 110.332 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -131.63 162.64 29.9 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.814 0.845 . . . . 0.0 109.633 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.16 127.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -76.57 -69.05 0.54 Allowed 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.097 1.359 . . . . 0.0 107.625 172.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -152.33 141.1 20.98 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.5 0.591 . . . . 0.0 109.915 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -85.57 114.76 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -104.35 -9.8 18.24 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.968 0.907 . . . . 0.0 110.888 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -140.23 81.28 1.8 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.561 1.944 . . . . 0.0 105.952 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.51 -45.2 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.169 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.22 -34.44 59.25 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.514 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.94 87.03 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.783 0.719 . . . . 0.0 111.889 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.705 ' HA ' HG22 ' A' ' 16' ' ' ILE . 12.4 m -126.21 67.44 63.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 118.755 1.278 . . . . 0.0 110.748 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -58.53 158.69 22.47 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.656 2.237 . . . . 0.0 112.393 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.18 -20.72 0.41 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.598 1.57 . . . . 0.0 114.314 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 tp -63.52 133.61 54.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.258 1.823 . . . . 0.0 107.902 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.2 t -125.37 10.9 8.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.904 0.881 . . . . 0.0 112.438 -167.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.29 150.96 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 130.502 3.521 . . . . 0.0 114.849 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 8.06 32.8 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 113.542 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.46 113.07 2.46 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.603 1.561 . . . . 0.0 109.623 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.43 106.32 4.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.703 1.201 . . . . 0.0 109.79 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.49 142.29 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.336 1.054 . . . . 0.0 110.229 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.49 -55.74 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.338 1.455 . . . . 0.0 110.504 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.27 155.22 46.67 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.892 0.877 . . . . 0.0 109.463 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.2 mt -133.59 132.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 163.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 42.04 44.22 2.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.581 1.952 . . . . 0.0 113.654 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 59.06 42.52 18.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.636 1.175 . . . . 0.0 112.815 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -128.55 136.48 50.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.421 1.888 . . . . 0.0 107.12 160.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.16 120.59 23.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.411 1.084 . . . . 0.0 109.67 175.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.694 HG12 HD22 ' A' ' 65' ' ' LEU . 10.4 m -115.89 16.94 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 128.046 2.538 . . . . 0.0 107.86 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -42.45 97.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 119.714 -1.866 . . . . 0.0 111.223 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.9 -25.53 58.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.347 0.976 . . . . 0.0 111.285 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 HG12 ' A' ' 62' ' ' VAL . 5.6 mp -60.11 138.69 57.84 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.966 1.706 . . . . 0.0 112.887 -163.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 m -63.58 165.33 8.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.43 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.47 -53.61 35.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.199 0.599 . . . . 0.0 110.624 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.4 m -62.52 -34.36 76.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.803 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -62.94 -47.04 84.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.24 0.927 . . . . 0.0 108.814 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.7 -44.5 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.704 1.202 . . . . 0.0 110.275 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.28 -43.11 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 O-C-N 121.64 -0.662 . . . . 0.0 109.987 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -44.6 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.96 0.904 . . . . 0.0 110.5 -172.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.49 -51.47 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.474 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 50.7 mt -68.24 -13.58 62.35 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.537 -0.727 . . . . 0.0 112.646 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -83.44 -33.64 25.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.397 1.453 . . . . 0.0 110.657 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -72.3 -36.01 68.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.912 0.778 . . . . 0.0 109.409 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -47.84 137.65 10.13 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.875 1.27 . . . . 0.0 112.208 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.63 127.33 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.503 3.469 . . . . 0.0 111.873 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 53.4 mt -66.88 134.7 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 10.94 85.93 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.236 0.922 . . . . 0.0 112.391 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -113.89 158.96 20.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.307 1.443 . . . . 0.0 108.54 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.19 150.32 43.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 162.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.6 m -131.46 146.25 52.16 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 127.803 2.441 . . . . 0.0 106.36 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.87 122.7 45.71 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -168.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -123.65 157.3 34.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.563 1.074 . . . . 0.0 109.308 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 13' ' ' THR . 4.1 mt -129.62 140.54 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 167.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.52 156.06 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.543 1.137 . . . . 0.0 109.939 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.96 84.96 5.41 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.178 -0.951 . . . . 0.0 110.824 -168.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 162.898 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.3 mtp -89.69 135.77 33.42 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 162.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.8 m -112.92 142.72 45.28 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -133.54 167.83 19.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.159 1.784 . . . . 0.0 109.24 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -135.5 153.08 51.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 108.687 168.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 45' ' ' CYS . 13.6 pt -144.18 161.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.252 1.421 . . . . 0.0 110.071 174.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.52 115.15 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 122.363 1.077 . . . . 0.0 108.418 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -67.77 115.17 7.02 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.425 1.49 . . . . 0.0 109.824 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.86 -81.98 0.4 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.174 -171.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.35 139.77 18.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.512 1.656 . . . . 0.0 111.071 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 61.64 -35.68 0.11 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.014 2.126 . . . . 0.0 112.45 -166.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.52 -141.48 3.37 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.634 1.588 . . . . 0.0 109.472 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -94.04 153.48 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.12 -42.33 58.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.194 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.479 ' HD1' ' HG ' ' A' ' 45' ' ' CYS . 12.8 p90 -62.96 166.96 5.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.419 1.104 . . . . 0.0 111.786 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.0 p -125.79 153.34 44.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.593 1.157 . . . . 0.0 109.514 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.22 170.58 11.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.079 0.952 . . . . 0.0 109.823 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.1 149.71 41.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.95 2.1 . . . . 0.0 108.674 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.95 148.47 47.66 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -147.29 163.05 30.12 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.575 1.95 . . . . 0.0 106.726 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.96 12.73 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.961 1 C-N-CA 125.521 4.148 . . . . 0.0 113.884 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -144.17 -3.72 0.84 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.887 2.075 . . . . 0.0 111.134 -162.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.86 -164.4 17.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -82.91 146.98 28.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.094 1.447 . . . . 0.0 110.369 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -127.57 163.66 23.69 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 126.018 1.727 . . . . 0.0 109.298 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.52 117.43 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -70.16 -61.63 1.7 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.052 1.341 . . . . 0.0 108.502 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -151.13 154.29 36.65 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.097 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.8 mt -106.18 110.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.795 2.438 . . . . 0.0 106.811 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.52 -5.58 22.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.918 1.287 . . . . 0.0 111.723 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.68 69.58 0.75 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.765 1.626 . . . . 0.0 109.192 -161.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.45 -62.56 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 125.186 1.395 . . . . 0.0 110.579 -159.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.92 -12.38 60.58 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.703 0.683 . . . . 0.0 112.658 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.02 -25.09 62.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.87 0.748 . . . . 0.0 111.856 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.581 ' HA ' HG22 ' A' ' 16' ' ' ILE . 34.9 m -128.35 76.88 77.79 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.199 1.0 . . . . 0.0 109.095 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -62.82 159.54 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.413 2.075 . . . . 0.0 110.833 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.27 -48.46 0.71 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.179 1.847 . . . . 0.0 114.238 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.9 tp -44.9 140.21 2.72 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 129.176 2.99 . . . . 0.0 112.357 -170.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.8 m -132.37 159.63 38.66 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.346 1.459 . . . . 0.0 110.255 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -60.09 146.46 42.92 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 165.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 2.44 59.75 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.444 -0.642 . . . . 0.0 113.673 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -62.8 112.6 2.61 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 163.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tp -80.52 129.52 34.56 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 mt -95.04 130.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -167.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.99 -51.02 6.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.633 1.573 . . . . 0.0 109.8 -170.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -138.6 150.43 46.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.935 0.894 . . . . 0.0 108.764 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -131.72 124.96 54.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 38.92 54.92 2.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.801 1.641 . . . . 0.0 111.244 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 61.66 -6.89 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.769 2.828 . . . . 0.0 116.437 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.14 125.06 26.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.378 1.444 . . . . 0.0 108.052 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.1 129.68 41.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.648 HG12 HD12 ' A' ' 65' ' ' LEU . 22.5 m -127.75 4.03 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.647 0.779 . . . . 0.0 111.833 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -50.67 -38.9 49.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.627 1.171 . . . . 0.0 110.861 165.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -105.36 21.31 17.38 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.648 HD12 HG12 ' A' ' 62' ' ' VAL . 17.3 mt -117.67 150.33 39.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.913 1.233 . . . . 0.0 113.821 -171.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.92 154.16 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.507 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.18 -52.07 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.145 0.578 . . . . 0.0 111.951 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 m -63.93 -24.71 67.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.711 -0.662 . . . . 0.0 111.898 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.54 -42.12 62.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.628 1.104 . . . . 0.0 109.546 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 62' ' ' VAL . 57.8 t -64.84 -40.66 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.548 0.739 . . . . 0.0 109.48 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -46.25 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.497 0.719 . . . . 0.0 109.492 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.42 -41.91 99.05 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.621 1.169 . . . . 0.0 110.909 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -66.62 -44.54 89.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.31 -31.91 72.58 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.902 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 121.651 2.023 . . . . 0.0 110.82 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.85 -36.87 77.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.359 1.063 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.3 m -55.67 136.86 71.21 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.37 144.16 90.4 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.146 3.231 . . . . 0.0 111.575 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -76.89 134.07 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 168.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.05 28.43 68.5 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.63 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -129.83 159.89 35.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.13 134.96 41.16 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -105.36 129.8 53.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 m -87.59 135.58 33.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.57 167.65 20.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.692 0.678 . . . . 0.0 109.303 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -132.7 141.55 44.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.35 150.89 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.405 1.082 . . . . 0.0 110.404 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.7 97.14 8.95 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 107.911 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 . . . . . 0 CA--C 1.52 -0.189 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.25 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 88' ' ' HIS . 2.8 mm? . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtp -88.57 135.81 33.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.406 HG23 HG12 ' A' ' 86' ' ' ILE . 85.3 m -134.45 103.82 5.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -172.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 168.36 9.45 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 126.085 1.754 . . . . 0.0 108.748 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.3 m -126.94 142.91 51.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' A' ' 45' ' ' CYS . 26.9 pt -127.62 167.85 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.764 1.626 . . . . 0.0 108.943 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.0 t -129.22 149.7 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.253 1.821 . . . . 0.0 106.963 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -113.24 99.82 8.1 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.822 1.249 . . . . 0.0 111.359 -164.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 54.23 4.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.744 1.64 . . . . 0.0 114.183 -172.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.07 -42.43 0.53 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.583 . . . . 0.0 116.53 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -80.21 -11.52 59.73 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.001 1.728 . . . . 0.0 113.106 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 16' ' ' ILE . 19.1 m-85 65.91 149.92 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.015 2.526 . . . . 0.0 110.32 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.62 -53.77 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.23 153.24 2.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.044 1.337 . . . . 0.0 111.831 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.3 p -116.96 148.47 41.38 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.465 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 pt -110.34 153.78 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.88 156.67 45.68 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.128 1.371 . . . . 0.0 108.757 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.79 139.52 39.35 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.16 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.02 175.91 2.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.847 1.659 . . . . 0.0 108.831 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.39 -21.42 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.963 3.109 . . . . 0.0 113.373 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -104.27 -4.31 23.15 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -162.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.1 177.26 14.81 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -162.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -71.35 148.43 47.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.351 1.075 . . . . 0.0 108.855 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -133.63 154.74 50.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG21 HD21 ' A' ' 48' ' ' LEU . 53.4 t -82.57 116.92 27.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -64.32 -58.96 5.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.603 169.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -153.74 144.34 22.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.0 mt -91.39 124.57 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -119.06 -3.24 10.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.512 1.125 . . . . 0.0 112.336 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -136.0 91.54 2.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.58 -55.38 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -63.58 -29.83 71.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.692 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.67 -16.98 61.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.642 1.11 . . . . 0.0 112.869 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.634 ' HA ' HG22 ' A' ' 16' ' ' ILE . 98.3 m -136.7 66.92 57.67 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 120.0 1.9 . . . . 0.0 111.124 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.68 117.8 4.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.684 2.923 . . . . 0.0 112.581 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -7.49 81.85 Favored Glycine 0 C--N 1.335 0.493 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.213 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.556 HD21 HG21 ' A' ' 36' ' ' VAL . 2.1 tt -66.07 153.27 42.73 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 82.6 m -124.46 159.8 29.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.517 1.127 . . . . 0.0 111.036 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.64 145.95 24.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.84 43.69 23.53 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -167.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.9 -170.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.494 1.117 . . . . 0.0 108.766 161.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.96 119.0 9.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.2 mt -89.63 127.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -171.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.05 -48.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.861 -163.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -134.74 132.6 38.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -115.62 129.41 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 167.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.86 16.77 7.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.48 1.912 . . . . 0.0 114.809 164.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 58.87 50.3 8.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.19 1.359 . . . . 0.0 112.019 -165.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.56 -15.38 10.85 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.95 133.19 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 130.712 3.605 . . . . 0.0 113.53 -165.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.29 7.34 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.001 0.921 . . . . 0.0 112.882 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.46 -18.22 64.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 113.597 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -110.37 -21.85 11.99 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.891 0.877 . . . . 0.0 110.047 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.23 139.47 58.49 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.916 0.865 . . . . 0.0 111.735 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.8 m -65.54 158.18 27.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.238 1.415 . . . . 0.0 110.553 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -50.61 -54.07 25.73 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 124.353 1.061 . . . . 0.0 110.154 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.04 -17.78 63.69 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.819 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.44 -36.81 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.433 1.093 . . . . 0.0 108.996 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -74.21 -43.45 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.662 1.185 . . . . 0.0 109.286 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.9 t -51.54 -43.73 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.039 0 C-N-CA 123.875 0.87 . . . . 0.0 108.894 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.506 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -65.02 -42.97 93.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.2 mt -60.44 -44.36 96.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -65.35 -31.28 72.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.465 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.506 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 47.8 mtmt -62.37 -43.4 98.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.219 1.827 . . . . 0.0 111.298 165.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.66 -32.78 71.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.984 1.314 . . . . 0.0 112.547 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -53.67 139.33 50.57 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.053 1.341 . . . . 0.0 111.811 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.19 122.33 9.38 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.727 2.951 . . . . 0.0 110.048 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 mt -61.1 147.66 10.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.27 9.8 13.25 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.36 -1.244 . . . . 0.0 114.144 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 m -121.29 173.59 7.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.667 1.587 . . . . 0.0 108.192 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.3 153.19 25.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.687 0.756 . . . . 0.0 111.425 -175.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.2 m -142.22 144.34 33.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.415 1.486 . . . . 0.0 108.834 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -110.93 107.62 17.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.049 2.14 . . . . 0.0 109.144 -157.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.3 112.53 16.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.159 1.8 . . . . 0.0 111.615 -170.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 13' ' ' THR . 3.4 mt -87.23 130.12 37.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.595 1.558 . . . . 0.0 108.608 171.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.25 150.21 30.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.011 1.324 . . . . 0.0 111.187 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.76 ' HA ' HD12 ' A' ' 11' ' ' LEU . 6.1 t-160 -78.11 77.34 4.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 0.0 111.329 -168.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 . . . . . 0 CA--C 1.54 0.562 0 C-N-CA 126.487 1.915 . . . . 0.0 108.216 174.266 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.7 mt . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.78 137.09 41.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.825 1.25 . . . . 0.0 107.913 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.8 m -125.45 120.03 29.87 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -168.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 mt -137.19 167.07 22.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.804 1.242 . . . . 0.0 107.943 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.58 143.83 51.09 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.545 HG21 HD12 ' A' ' 48' ' ' LEU . 20.9 pt -137.91 161.85 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.779 1.232 . . . . 0.0 109.733 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.1 t -117.46 147.5 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HG2' HD13 ' A' ' 79' ' ' ILE . 75.3 tttt -97.12 86.7 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -171.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 71.87 0.68 Allowed Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.614 -160.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.52 154.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.823 2.849 . . . . 0.0 115.043 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 47.78 -0.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.211 2.204 . . . . 0.0 115.58 -158.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.98 -129.97 5.46 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 104.453 -3.459 . . . . 0.0 104.453 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE2' HD12 ' A' ' 16' ' ' ILE . 48.7 m-85 -97.79 168.06 10.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 166.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.17 -45.12 57.52 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 121.706 -0.621 . . . . 0.0 111.895 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -64.47 -179.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.052 2.141 . . . . 0.0 113.388 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 p -132.81 147.04 52.31 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.834 1.254 . . . . 0.0 109.76 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 pt -110.7 167.68 4.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.286 1.035 . . . . 0.0 109.28 166.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.35 161.96 35.61 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.433 1.893 . . . . 0.0 107.217 168.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.33 148.73 41.07 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.687 1.195 . . . . 0.0 108.11 163.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.07 163.6 23.04 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.163 0.985 . . . . 0.0 108.41 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.16 -1.34 2.85 Favored 'Trans proline' 0 C--N 1.345 0.371 1 C-N-CA 126.166 4.577 . . . . 0.0 116.993 -170.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -132.62 -13.34 2.95 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.337 1.055 . . . . 0.0 111.848 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.08 172.32 17.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -164.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -68.03 124.87 24.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.856 1.262 . . . . 0.0 109.15 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -102.71 163.48 12.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 122.188 0.994 . . . . 0.0 109.625 171.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.48 HG21 HD21 ' A' ' 48' ' ' LEU . 92.8 t -72.03 128.03 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 163.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -71.62 -69.26 0.39 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -154.22 141.33 19.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.987 0.915 . . . . 0.0 108.592 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.487 HD11 HD23 ' A' ' 48' ' ' LEU . 30.8 mt -89.72 135.35 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.15 -31.0 4.22 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.445 0.698 . . . . 0.0 110.778 -171.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -130.65 95.92 3.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.57 -40.71 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.548 0.739 . . . . 0.0 110.513 -171.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.06 -19.21 61.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.915 -1.116 . . . . 0.0 111.656 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.38 -23.16 75.05 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.135 -0.978 . . . . 0.0 111.562 166.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 16' ' ' ILE . 90.2 m -147.51 74.48 11.51 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 119.559 1.68 . . . . 0.0 110.067 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.29 158.94 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.54 1.493 . . . . 0.0 112.531 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.46 -46.51 1.64 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.824 -0.987 . . . . 0.0 113.251 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 16' ' ' ILE . 3.0 tt -52.74 146.12 10.99 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.253 2.221 . . . . 0.0 109.993 -166.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.54 162.02 31.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.045 0.926 . . . . 0.0 111.71 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -69.32 148.39 49.78 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.453 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.56 7.13 25.85 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.007 -1.441 . . . . 0.0 114.176 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -51.53 126.53 17.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.576 1.688 . . . . 0.0 106.542 166.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -96.11 110.94 23.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.6 mt -70.91 141.58 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.321 1.419 . . . . 0.0 109.254 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.81 -43.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.061 1.344 . . . . 0.0 110.261 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -135.87 156.74 48.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.272 0.558 . . . . 0.0 109.53 171.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.34 125.67 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 164.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 45.87 37.83 3.91 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.237 1.415 . . . . 0.0 114.819 169.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 54.59 60.55 3.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.187 1.795 . . . . 0.0 112.629 -169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -134.79 133.93 40.36 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 151.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.24 122.51 34.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.293 1.037 . . . . 0.0 108.595 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.45 -1.35 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -162.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -24.29 40.11 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.869 1.668 . . . . 0.0 113.447 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -91.25 1.13 57.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.723 1.609 . . . . 0.0 112.126 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.54 173.48 6.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.287 1.435 . . . . 0.0 111.255 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.2 m -109.27 159.98 16.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.208 1.803 . . . . 0.0 108.814 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -50.21 -50.73 48.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.367 0.667 . . . . 0.0 111.922 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.5 m -64.57 -31.33 72.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.562 0.745 . . . . 0.0 111.068 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.24 -45.49 84.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.725 0.693 . . . . 0.0 109.273 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.87 -37.35 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.566 1.147 . . . . 0.0 108.942 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.2 -45.62 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.057 0.943 . . . . 0.0 109.152 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -34.25 71.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.329 0.585 . . . . 0.0 112.345 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.24 -56.08 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.775 1.63 . . . . 0.0 107.654 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.6 mt -61.53 -27.39 68.57 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.603 -0.686 . . . . 0.0 111.933 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -66.25 -41.07 90.47 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 109.889 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.66 -40.77 88.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.582 1.153 . . . . 0.0 110.736 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.9 m -49.41 139.65 14.23 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.747 1.219 . . . . 0.0 112.173 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -67.15 118.74 5.8 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.299 3.333 . . . . 0.0 110.995 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.437 HD13 ' HG2' ' A' ' 18' ' ' LYS . 4.4 mm -56.36 137.25 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.09 18.86 71.42 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.223 1.392 . . . . 0.0 113.372 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 t -113.72 163.87 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.391 1.477 . . . . 0.0 107.403 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -62.99 153.92 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.43 1.109 . . . . 0.0 110.309 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -133.15 140.94 47.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.167 2.587 . . . . 0.0 105.166 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.3 m -89.32 135.77 33.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.237 1.815 . . . . 0.0 106.259 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 16' ' ' ILE . 3.9 mp -117.28 164.31 15.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 162.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.9 mt -132.26 137.49 54.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 164.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -134.47 157.25 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.932 1.693 . . . . 0.0 109.112 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.92 98.62 11.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.311 1.044 . . . . 0.0 109.144 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 . . . . . 0 N--CA 1.466 0.354 0 O-C-N 121.56 -0.713 . . . . 0.0 110.01 168.127 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--O 1.234 0.255 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.2 mtm -105.32 114.97 29.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 m -76.74 140.9 40.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 157.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -140.57 168.51 19.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.01 2.124 . . . . 0.0 106.955 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.8 m -125.07 147.7 48.86 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.142 -0.974 . . . . 0.0 108.487 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 45' ' ' CYS . 30.0 pt -131.97 163.47 37.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.524 1.129 . . . . 0.0 109.216 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 t -136.04 137.68 48.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 72.7 tttt -108.38 81.9 1.54 Allowed 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.177 -0.952 . . . . 0.0 113.452 -153.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.69 -78.7 0.08 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.514 1.054 . . . . 0.0 115.236 -165.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.82 -60.34 0.26 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.362 1.581 . . . . 0.0 112.392 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -82.74 44.73 0.93 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.892 0.853 . . . . 0.0 111.046 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 64.48 74.94 0.41 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.64 1.114 . . . . 0.0 111.896 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.09 -86.85 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 125.774 1.63 . . . . 0.0 108.737 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.48 -31.61 0.58 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.643 1.592 . . . . 0.0 111.159 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 34.0 p90 -61.44 165.72 4.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.046 1.339 . . . . 0.0 110.353 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.412 HG23 HD23 ' A' ' 40' ' ' LEU . 17.3 p -119.8 147.46 44.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.771 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 pt -113.32 162.66 11.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.353 0.661 . . . . 0.0 109.332 167.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.51 157.8 41.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.521 2.329 . . . . 0.0 106.713 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -74.53 148.07 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.6 p -137.52 162.73 53.23 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.17 1.45 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.319 3.346 . . . . 0.0 114.567 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -131.73 -0.87 3.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.014 1.326 . . . . 0.0 112.453 -166.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.63 179.26 15.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -168.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -77.06 154.84 32.96 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 118.541 1.171 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -148.37 159.83 43.62 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 112.579 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.41 115.4 22.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 125.554 1.541 . . . . 0.0 107.56 -173.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -72.93 -44.2 61.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.598 171.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HB3' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -163.25 160.4 23.88 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -171.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 38' ' ' GLN . 1.4 mm? -105.2 -4.25 21.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.061 1.745 . . . . 0.0 112.466 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -143.42 96.38 2.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 157.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.23 -42.49 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 109.403 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.93 -33.53 75.8 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.368 -0.833 . . . . 0.0 111.144 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.19 -21.41 79.26 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.109 -0.828 . . . . 0.0 112.371 171.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.675 ' HA ' HG22 ' A' ' 16' ' ' ILE . 4.4 m -129.47 68.62 80.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 118.891 1.345 . . . . 0.0 110.123 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.03 149.77 88.89 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.143 1.895 . . . . 0.0 110.246 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.02 -21.44 0.37 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.077 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.29 136.15 57.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.357 1.578 . . . . 0.0 110.004 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -127.72 160.62 31.13 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.969 1.308 . . . . 0.0 109.633 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -71.97 139.85 48.85 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.193 0.997 . . . . 0.0 109.418 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.02 66.32 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.57 -167.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.575 1.95 . . . . 0.0 110.105 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.73 115.86 6.96 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.411 HG22 HG23 ' A' ' 62' ' ' VAL . 2.7 mm -70.74 125.58 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.353 1.461 . . . . 0.0 110.546 -171.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.68 -56.9 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.67 1.188 . . . . 0.0 111.381 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -133.96 145.84 49.91 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.5 mt -134.36 123.81 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 50.85 33.62 8.95 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.871 1.268 . . . . 0.0 112.543 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.7 11.48 8.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.635 2.774 . . . . 0.0 115.162 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.24 132.26 34.96 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.187 1.395 . . . . 0.0 107.451 163.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -80.13 138.81 36.99 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 54' ' ' ILE . 35.3 m -135.99 13.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.403 1.481 . . . . 0.0 111.659 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.852 -1.155 . . . . 0.0 113.383 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -120.37 30.09 7.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.978 0.808 . . . . 0.0 109.698 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -98.04 164.88 12.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.194 0.998 . . . . 0.0 110.606 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -84.91 162.5 19.43 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.076 1.35 . . . . 0.0 109.984 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -45.69 -58.46 3.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 126.608 1.963 . . . . 0.0 110.551 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.4 m -58.53 -40.36 82.74 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.284 1.033 . . . . 0.0 110.694 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -65.68 -44.48 86.09 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.851 1.26 . . . . 0.0 109.962 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.63 -39.75 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.957 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.15 -40.48 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 O-C-N 121.617 -0.677 . . . . 0.0 109.579 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -48.63 78.87 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.551 1.54 . . . . 0.0 110.199 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.4 mt -60.09 -43.75 93.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.979 1.312 . . . . 0.0 109.24 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -69.05 -27.11 65.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.783 175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -65.57 -44.39 86.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 121.15 1.795 . . . . 0.0 108.268 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.47 -26.14 68.31 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.711 0.632 . . . . 0.0 112.374 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.6 m -53.51 134.13 53.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.045 0.538 . . . . 0.0 110.67 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -68.0 135.13 34.01 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.217 3.278 . . . . 0.0 110.698 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -71.27 127.69 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.534 1.534 . . . . 0.0 107.983 -175.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.96 11.87 59.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.935 2.207 . . . . 0.0 113.134 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -92.2 167.36 12.09 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 149.17 34.45 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -131.44 126.35 34.84 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.3 m -101.23 113.63 26.86 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -167.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.55 153.84 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.198 0.908 . . . . 0.0 109.733 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -129.55 136.36 59.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.06 153.27 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.845 1.258 . . . . 0.0 110.869 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 105.95 17.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.641 1.977 . . . . 0.0 107.316 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 126.221 1.809 . . . . 0.0 109.872 170.22 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.2 mtm -113.38 146.47 39.43 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.459 HG23 HG12 ' A' ' 86' ' ' ILE . 44.8 m -135.22 98.8 4.07 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.028 1.331 . . . . 0.0 107.996 -173.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.86 167.6 9.61 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.352 1.461 . . . . 0.0 109.82 -172.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -122.27 145.81 47.87 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.906 0.883 . . . . 0.0 110.537 -177.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 45' ' ' CYS . 13.4 pt -139.65 134.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 125.562 1.545 . . . . 0.0 108.832 173.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.45 121.76 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 73.6 tttt -69.93 116.85 10.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.282 1.033 . . . . 0.0 109.58 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.73 -68.86 1.43 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.861 -169.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.21 -73.5 0.13 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.809 1.304 . . . . 0.0 112.01 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -76.41 36.22 0.15 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.112 0.965 . . . . 0.0 111.164 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 87.85 -126.68 8.16 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 -158.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CD2' HD12 ' A' ' 16' ' ' ILE . 97.9 m-85 -113.71 166.8 11.18 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.72 25.62 3.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.087 1.803 . . . . 0.0 113.611 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -151.07 167.64 27.09 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.892 1.346 . . . . 0.0 108.472 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 p -129.37 159.84 34.95 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.241 0.617 . . . . 0.0 109.797 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 pt -125.21 152.4 31.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.09 0.556 . . . . 0.0 110.502 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.22 145.42 30.41 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.446 1.099 . . . . 0.0 108.202 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.48 148.45 48.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.057 0.932 . . . . 0.0 110.809 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p -137.44 166.57 25.72 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.389 1.875 . . . . 0.0 105.985 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -70.75 -5.33 16.57 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.406 2.737 . . . . 0.0 112.871 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -129.33 -6.91 4.77 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.074 0.852 . . . . 0.0 112.804 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.89 -177.7 35.37 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.848 1.213 . . . . 0.0 110.587 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -94.12 92.62 7.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.57 -0.959 . . . . 0.0 110.601 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -86.88 161.56 18.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 119.629 1.104 . . . . 0.0 111.791 -162.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.54 115.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -71.63 -61.63 1.71 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 170.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -150.29 143.57 25.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.4 mt -96.11 110.51 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.2 mt -78.27 -36.28 47.01 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.798 0.839 . . . . 0.0 109.022 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -132.02 93.36 3.27 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.153 1.781 . . . . 0.0 109.083 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.8 mt -56.81 -44.06 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 110.154 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -68.07 -12.28 60.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.1 -14.01 52.87 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 119.509 1.05 . . . . 0.0 111.349 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.668 ' HA ' HG22 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -132.52 54.96 15.22 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.709 1.204 . . . . 0.0 109.67 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.07 124.3 10.83 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.922 1.748 . . . . 0.0 111.233 -164.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -16.24 61.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.971 1.272 . . . . 0.0 113.411 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.94 152.69 39.26 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.8 p -124.84 151.79 44.81 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.724 0.81 . . . . 0.0 108.901 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -76.4 138.57 40.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.06 96.32 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -168.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.63 -177.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.852 0.826 . . . . 0.0 111.554 163.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -140.59 91.19 2.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 62' ' ' VAL . 37.2 mt -55.84 135.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.559 1.544 . . . . 0.0 109.196 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.17 -45.98 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.166 1.387 . . . . 0.0 110.367 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -128.79 148.84 50.9 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.75 138.75 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 152.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 67.82 -54.42 0.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 128.979 2.911 . . . . 0.0 116.203 167.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 165.27 13.85 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 130.793 3.637 . . . . 0.0 113.584 -156.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -131.76 141.9 49.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.909 1.686 . . . . 0.0 109.194 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -69.55 128.83 37.87 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.592 HG12 HD22 ' A' ' 65' ' ' LEU . 10.8 m -133.75 22.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 125.402 1.481 . . . . 0.0 107.563 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -60.43 3.69 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 119.977 -1.702 . . . . 0.0 110.719 176.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.22 -21.15 62.17 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.456 0.169 . . . . 0.0 111.193 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.592 HD22 HG12 ' A' ' 62' ' ' VAL . 6.8 mp -52.89 134.58 37.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.867 1.667 . . . . 0.0 111.61 -167.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -56.63 162.33 2.31 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.674 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -49.28 -51.38 34.07 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.69 0.796 . . . . 0.0 109.311 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -52.07 17.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.036 2.534 . . . . 0.0 111.495 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.31 -46.71 82.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.516 1.126 . . . . 0.0 108.531 -170.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.37 -46.46 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.471 1.509 . . . . 0.0 110.443 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.413 HG12 ' HD3' ' A' ' 75' ' ' LYS . 54.2 t -55.57 -45.17 78.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -40.55 77.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.126 0.97 . . . . 0.0 111.473 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.59 -48.95 85.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 123.996 0.919 . . . . 0.0 109.109 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.12 -26.96 68.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.737 0.415 . . . . 0.0 111.58 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HD3' HG12 ' A' ' 71' ' ' VAL . 39.1 mtpt -71.51 -41.47 69.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.808 1.186 . . . . 0.0 110.382 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.51 -27.65 67.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.447 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.9 m -49.72 127.17 19.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 123.275 0.63 . . . . 0.0 110.739 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.04 132.84 46.73 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.937 3.092 . . . . 0.0 110.773 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 mm -64.01 127.75 25.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 166.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.44 17.71 75.36 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.323 0.963 . . . . 0.0 112.294 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -115.24 159.45 20.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 123.313 1.53 . . . . 0.0 108.823 159.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HG2' HG22 ' A' ' 15' ' ' THR . 3.8 tm-20 -65.05 153.58 40.32 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.876 168.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.6 m -137.77 149.11 46.14 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 126.936 2.094 . . . . 0.0 107.869 165.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 126.1 54.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.627 2.371 . . . . 0.0 105.941 -168.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.405 HD13 HD11 ' A' ' 16' ' ' ILE . 4.9 mp -128.46 115.69 18.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.996 1.271 . . . . 0.0 109.171 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.459 HG12 HG23 ' A' ' 13' ' ' THR . 3.6 mt -97.62 125.59 50.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.06 155.11 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.607 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -108.81 74.86 0.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.041 2.136 . . . . 0.0 109.693 -170.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 . . . . . 0 C--N 1.327 -0.378 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 171.29 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.471 ' HE2' HD11 ' A' ' 87' ' ' ILE . 23.1 mtm -89.72 125.1 35.15 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 175.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -96.66 142.94 28.1 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.16 145.4 51.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.789 1.636 . . . . 0.0 108.06 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 m -103.06 135.15 45.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.179 0.592 . . . . 0.0 109.882 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.9 pt -143.98 137.59 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.285 1.034 . . . . 0.0 111.595 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 82' ' ' GLU 0.254 0.2 OUTLIER -110.35 136.03 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.598 1.189 . . . . 0.0 112.338 178.654 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 66.3 tttt -79.06 117.6 20.26 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.813 1.645 . . . . 0.0 111.924 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 23' ' ' PHE . . . -81.73 171.98 52.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 166.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.55 -59.64 3.59 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.686 1.994 . . . . 0.0 113.882 -168.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -82.16 10.83 6.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.695 -0.628 . . . . 0.0 111.096 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 82.23 1.64 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 126.298 1.904 . . . . 0.0 108.364 169.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HA ' ' H ' ' A' ' 19' ' ' GLY . 43.9 m-85 61.13 -175.97 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.995 1.318 . . . . 0.0 111.049 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.2 -63.61 1.5 Allowed Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -60.17 170.92 1.12 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.536 1.135 . . . . 0.0 113.775 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -131.43 158.38 40.98 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.026 1.33 . . . . 0.0 109.541 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.3 pt -123.68 162.01 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 124.732 1.213 . . . . 0.0 108.717 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.21 158.17 43.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.89 114.82 9.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.849 1.259 . . . . 0.0 107.962 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -99.31 168.36 9.75 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -66.35 -8.83 21.76 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.308 2.005 . . . . 0.0 114.568 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -129.12 -4.43 5.0 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 120.104 1.32 . . . . 0.0 114.022 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.59 -172.94 33.73 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -162.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -84.82 143.32 29.16 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 121.526 -0.985 . . . . 0.0 108.655 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -134.48 154.24 51.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.588 171.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.09 126.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.597 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -81.07 -57.05 3.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.739 1.216 . . . . 0.0 108.526 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -157.32 149.53 22.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 48' ' ' LEU . 22.1 mt -122.54 132.77 70.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.67 -58.2 1.6 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.204 1.002 . . . . 0.0 109.45 -164.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -88.04 87.98 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.8 1.24 . . . . 0.0 110.107 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.02 -38.55 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.062 0.945 . . . . 0.0 112.116 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.85 -36.17 67.38 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.772 -0.58 . . . . 0.0 111.123 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.19 -9.74 81.59 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.183 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.801 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.27 64.59 73.97 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 119.454 1.627 . . . . 0.0 108.614 172.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.41 125.41 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.201 1.934 . . . . 0.0 112.057 -165.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.62 0.38 84.09 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.125 -0.819 . . . . 0.0 112.696 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -67.99 140.95 56.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.781 1.291 . . . . 0.0 108.387 178.016 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 151.29 43.12 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 122.177 0.989 . . . . 0.0 110.464 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -77.78 148.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.14 56.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 117.4 -1.778 . . . . 0.0 114.383 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -63.63 126.75 28.57 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.926 1.863 . . . . 0.0 109.424 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 123.05 25.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.784 1.633 . . . . 0.0 108.363 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.83 146.23 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.2 -53.62 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.708 0.803 . . . . 0.0 110.916 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.5 131.61 24.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG13 HG21 ' A' ' 62' ' ' VAL . 3.2 mt -116.95 124.3 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 170.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.591 HD21 HG23 ' A' ' 83' ' ' THR . 77.5 m-20 46.1 46.35 12.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.791 1.636 . . . . 0.0 113.002 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.266 0.2 OUTLIER 61.15 31.7 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.271 1.829 . . . . 0.0 115.22 -177.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.15 132.11 55.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.121 1.768 . . . . 0.0 106.752 165.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -83.4 120.76 26.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.33 1.452 . . . . 0.0 110.85 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.45 HG21 HG13 ' A' ' 57' ' ' ILE . 21.3 m -121.98 7.01 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.679 1.992 . . . . 0.0 109.412 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -37.97 39.82 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.029 1.286 . . . . 0.0 112.085 -173.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -115.71 7.75 14.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD22 HG12 ' A' ' 62' ' ' VAL . 3.4 mp -62.06 143.37 56.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.382 1.873 . . . . 0.0 109.991 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -54.77 159.16 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.939 0.774 . . . . 0.0 110.069 165.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -50.38 -49.65 53.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 168.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -55.57 -44.73 77.13 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.873 1.269 . . . . 0.0 112.725 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.77 -39.89 95.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.398 1.079 . . . . 0.0 109.715 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.2 -49.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.497 0.719 . . . . 0.0 109.814 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.5 -38.12 54.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.472 1.509 . . . . 0.0 109.888 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.68 -46.11 80.3 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.771 0.828 . . . . 0.0 111.024 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mt -59.16 -46.14 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.604 1.161 . . . . 0.0 109.52 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 98.0 mt -61.09 -17.41 52.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.222 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -86.19 -33.64 20.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.379 1.445 . . . . 0.0 111.523 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -42.57 69.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.473 1.109 . . . . 0.0 109.406 165.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 91.9 m -51.35 135.55 31.9 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 111.776 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -67.56 112.67 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 1 C-N-CA 125.636 4.224 . . . . 0.0 112.098 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -51.32 117.76 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.382 1.473 . . . . 0.0 107.548 170.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.49 8.75 57.21 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.862 1.22 . . . . 0.0 113.249 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.85 151.74 51.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.972 1.386 . . . . 0.0 110.339 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' HG3' HG12 ' A' ' 17' ' ' VAL . 50.4 mp0 -72.38 153.37 41.49 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.329 1.452 . . . . 0.0 112.123 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.591 HG23 HD21 ' A' ' 58' ' ' ASN . 1.4 m -131.23 143.82 50.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 130.083 3.353 . . . . 0.0 105.905 -176.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.4 m -109.02 116.62 32.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -116.56 115.62 26.09 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.572 1.149 . . . . 0.0 108.549 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.37 134.47 28.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' A' ' 12' ' ' MET . 1.8 pp -129.43 152.61 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 110.723 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.539 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.2 t-160 -88.01 67.69 9.01 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.185 -0.947 . . . . 0.0 110.768 -170.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.239 0.538 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.7 mtm -111.09 153.69 25.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.601 0.637 . . . . 0.0 109.543 165.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.9 m -132.17 120.25 22.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.4 mt -126.85 168.41 14.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.532 1.533 . . . . 0.0 107.936 -175.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 m -134.67 141.97 46.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 45' ' ' CYS . 44.6 pt -138.46 151.31 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 110.981 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.5 153.19 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.625 1.97 . . . . 0.0 108.942 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -113.23 105.69 13.73 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.341 1.456 . . . . 0.0 109.022 -145.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.69 61.39 3.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.662 1.601 . . . . 0.0 112.577 -165.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.23 152.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.975 2.51 . . . . 0.0 112.459 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 65.42 -25.42 0.09 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.336 2.255 . . . . 0.0 115.56 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -164.16 31.13 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.681 -2.568 . . . . 0.0 106.681 -159.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -102.29 12.89 35.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -174.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.34 -66.15 1.28 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.609 1.1 . . . . 0.0 110.879 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -54.05 158.04 2.31 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 122.143 0.973 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -114.56 159.88 19.9 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.586 1.154 . . . . 0.0 109.418 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.7 pt -118.31 154.33 20.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.548 0.69 . . . . 0.0 110.432 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.91 170.26 9.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.263 2.225 . . . . 0.0 108.286 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.08 122.04 46.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 107.512 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.4 p -126.03 171.51 7.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.959 1.303 . . . . 0.0 109.734 -167.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.15 -14.69 45.17 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.164 1.909 . . . . 0.0 112.64 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -104.67 -11.83 16.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.019 1.328 . . . . 0.0 111.72 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.28 -162.25 23.63 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -73.34 147.58 44.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -139.73 165.09 28.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.306 0.574 . . . . 0.0 109.465 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.19 117.1 16.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.6 -74.18 0.15 Allowed 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -140.12 153.61 46.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -99.54 106.86 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.095 1.758 . . . . 0.0 108.168 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -101.82 -0.0 34.94 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.267 1.427 . . . . 0.0 110.957 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -149.83 114.06 5.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.037 1.735 . . . . 0.0 108.596 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.09 -58.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.484 1.513 . . . . 0.0 109.216 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.69 -37.1 75.34 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.037 1.335 . . . . 0.0 111.636 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.25 -25.75 72.3 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.68 ' HA ' HG22 ' A' ' 16' ' ' ILE . 46.3 m -126.94 67.61 69.72 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 118.947 1.373 . . . . 0.0 111.198 -172.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.8 128.16 20.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.718 2.279 . . . . 0.0 111.224 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.12 76.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 124.401 1.001 . . . . 0.0 114.297 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 48' ' ' LEU . 11.1 tp -66.84 153.12 44.23 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.444 1.122 . . . . 0.0 108.754 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.5 m -135.78 0.76 2.72 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 62.6 151.22 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.641 2.376 . . . . 0.0 112.205 -166.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.99 6.52 25.5 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.683 -1.065 . . . . 0.0 113.73 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.38 128.88 38.12 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.429 1.492 . . . . 0.0 107.817 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -81.28 109.96 16.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.843 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.99 124.66 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.94 -57.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.128 1.371 . . . . 0.0 108.893 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -128.56 150.47 50.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.284 1.034 . . . . 0.0 109.229 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.2 mt -127.86 126.65 67.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 164.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 43.64 52.84 6.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 111.046 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 59.94 -7.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.973 2.509 . . . . 0.0 116.371 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -69.63 117.08 10.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 63' ' ' GLN . 19.0 t-20 -58.11 115.9 3.2 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 163.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 0.8 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 O-C-N 124.057 0.848 . . . . 0.0 112.397 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.532 ' HB2' HD21 ' A' ' 61' ' ' ASN . 15.8 mt-30 -54.49 -21.9 11.34 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -170.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -112.03 -2.86 14.93 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 121.319 1.872 . . . . 0.0 112.663 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.55 160.25 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.321 -0.862 . . . . 0.0 109.198 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -89.53 157.11 18.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.209 1.004 . . . . 0.0 109.793 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -40.83 -56.8 2.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.984 1.714 . . . . 0.0 112.132 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.7 m -67.0 -26.26 66.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.896 0.878 . . . . 0.0 111.038 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.29 -44.96 67.3 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.243 0.928 . . . . 0.0 109.364 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.6 -40.57 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.384 1.073 . . . . 0.0 109.646 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.68 -53.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 123.715 0.806 . . . . 0.0 109.029 169.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.559 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 12.9 t70 -57.22 -46.39 82.98 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.352 0.661 . . . . 0.0 111.722 -172.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.4 mt -55.27 -45.52 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.649 1.18 . . . . 0.0 109.494 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -67.74 -35.72 79.24 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.716 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' A' ' 72' ' ' ASP . 9.0 mtmp? -55.01 -47.9 74.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.266 1.848 . . . . 0.0 109.589 167.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -34.73 75.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.218 1.007 . . . . 0.0 112.478 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 84.8 m -52.76 138.04 43.4 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.157 0.983 . . . . 0.0 109.689 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 77' ' ' CYS . 33.8 Cg_exo -54.29 144.27 61.04 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.347 2.698 . . . . 0.0 110.119 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.5 mt -80.43 131.43 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 161.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.91 35.79 72.86 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.268 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.7 m -146.43 131.79 18.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.746 1.273 . . . . 0.0 108.831 161.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -61.45 152.7 29.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.616 1.198 . . . . 0.0 111.094 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -137.55 135.57 36.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.966 2.906 . . . . 0.0 105.116 -168.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -112.49 110.85 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.822 1.249 . . . . 0.0 108.29 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.96 112.63 18.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.514 0.597 . . . . 0.0 110.84 -169.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -89.17 141.72 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.37 146.58 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.851 0.834 . . . . 0.0 111.819 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.0 96.61 5.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.205 1.002 . . . . 0.0 109.327 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 . . . . . 0 CA--C 1.519 -0.215 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.398 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -87.35 145.8 26.17 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.2 m -123.45 139.17 54.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.3 mt -142.81 167.88 21.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.444 2.297 . . . . 0.0 106.837 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.8 m -128.95 154.61 46.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.3 -0.875 . . . . 0.0 108.694 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.693 HG22 ' HA ' ' A' ' 45' ' ' CYS . 11.1 pt -145.66 166.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 126.054 1.741 . . . . 0.0 109.907 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.82 143.37 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.636 1.575 . . . . 0.0 107.582 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -88.62 145.68 25.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.26 1.024 . . . . 0.0 111.232 -175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.32 82.8 0.35 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.264 1.411 . . . . 0.0 113.899 -168.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.97 -84.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.035 2.134 . . . . 0.0 115.697 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.25 -15.4 46.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.934 1.243 . . . . 0.0 112.862 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.39 28.73 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.448 ' CE1' HD22 ' A' ' 74' ' ' LEU . 71.3 m-85 -66.36 146.0 55.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 118.869 1.334 . . . . 0.0 108.173 170.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.24 -51.84 53.79 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -61.82 164.02 6.81 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.368 1.08 . . . . 0.0 110.198 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.0 p -117.37 156.78 27.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.973 0.909 . . . . 0.0 109.25 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.02 158.32 18.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 167.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.12 163.1 25.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 165.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.83 147.13 47.48 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 159.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.3 p -139.7 161.9 53.92 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 163.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.32 -42.66 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.016 2.477 . . . . 0.0 113.256 -174.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -73.29 -23.84 60.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 111.159 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.75 178.86 26.9 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -172.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.421 ' CD ' HG21 ' A' ' 70' ' ' VAL . 24.0 mp0 -62.42 145.74 53.26 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -134.17 161.11 35.8 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 123.134 0.574 . . . . 0.0 111.134 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.86 107.27 7.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 -58.2 9.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.112 0.965 . . . . 0.0 109.553 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -151.69 148.14 27.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.788 1.635 . . . . 0.0 106.778 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.482 HG23 ' SG ' ' A' ' 45' ' ' CYS . 57.6 mt -91.2 97.14 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 166.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.7 -26.15 61.49 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.219 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -142.71 95.57 2.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.446 1.898 . . . . 0.0 108.998 -158.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.4 -57.06 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.76 1.224 . . . . 0.0 109.105 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.15 -25.32 66.92 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.802 0.728 . . . . 0.0 111.608 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 -32.35 66.77 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.213 170.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.693 ' HA ' HG22 ' A' ' 16' ' ' ILE . 29.3 p -130.08 70.36 82.13 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 120.058 1.929 . . . . 0.0 112.774 -171.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.39 111.59 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.748 2.299 . . . . 0.0 111.636 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.04 85.34 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.407 1.479 . . . . 0.0 114.844 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 152.97 43.15 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.03 1.415 . . . . 0.0 108.089 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.7 m -129.12 156.0 44.58 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.303 1.041 . . . . 0.0 110.023 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.24 137.48 53.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.14 12.41 79.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.494 -1.725 . . . . 0.0 114.182 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -58.43 129.53 42.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.093 1.946 . . . . 0.0 110.117 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 tp -78.5 144.42 35.71 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.2 mt -108.0 135.9 45.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 125.359 1.464 . . . . 0.0 108.206 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -122.45 -57.04 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.274 1.03 . . . . 0.0 110.085 -170.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 64.0 mt-10 -129.89 149.7 51.5 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.3 mt -135.93 129.39 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 168.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 41.13 45.33 2.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.392 2.277 . . . . 0.0 111.573 -173.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 57.51 4.54 0.24 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.391 2.276 . . . . 0.0 115.795 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.1 126.04 29.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 160.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.532 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 21.8 t-20 -73.02 132.22 43.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 168.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.84 -2.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.516 1.126 . . . . 0.0 110.844 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -6.69 1.27 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -121.03 -2.28 9.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.022 1.329 . . . . 0.0 111.659 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.5 mt -77.42 167.97 20.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.581 1.082 . . . . 0.0 110.517 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.5 m -88.66 155.53 19.55 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -47.76 -50.65 24.9 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.839 1.256 . . . . 0.0 112.341 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 m -65.73 -29.43 69.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.251 1.02 . . . . 0.0 111.266 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.37 -44.46 83.09 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 34' ' ' GLN . 21.6 t -67.44 -39.95 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 121.172 -0.955 . . . . 0.0 110.564 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.53 -50.68 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 124.493 1.117 . . . . 0.0 108.893 171.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -66.25 -37.38 85.34 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.23 0.956 . . . . 0.0 112.011 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.88 -44.23 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.469 -0.769 . . . . 0.0 109.308 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.448 HD22 ' CE1' ' A' ' 23' ' ' PHE . 85.8 mt -65.06 -17.59 64.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.946 -1.096 . . . . 0.0 112.29 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.03 -46.58 42.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.776 1.625 . . . . 0.0 108.993 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.07 -27.22 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.039 0.836 . . . . 0.0 112.85 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.95 123.82 61.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 118.849 0.75 . . . . 0.0 109.432 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -68.69 157.71 60.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.921 3.08 . . . . 0.0 113.276 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mm -90.08 124.56 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.575 1.55 . . . . 0.0 106.953 -170.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.41 73.77 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.571 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 m -110.64 157.75 19.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 162.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 153.83 41.07 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.797 1.284 . . . . 0.0 109.756 166.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -140.78 131.37 25.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.512 1.925 . . . . 0.0 105.961 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -97.17 121.12 38.71 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.923 1.689 . . . . 0.0 106.537 -171.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.68 149.87 42.6 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.815 1.189 . . . . 0.0 110.017 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.03 125.24 66.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.72 177.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.966 1.306 . . . . 0.0 109.549 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -107.21 124.32 49.57 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.077 0.853 . . . . 0.0 111.683 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 130.539 3.536 . . . . 0.0 106.344 -170.401 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.7 mt . . . . . 0 C--O 1.236 0.389 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.57 129.87 50.55 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.467 1.107 . . . . 0.0 108.413 171.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 m -95.33 136.2 35.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.57 168.45 20.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.369 1.867 . . . . 0.0 108.509 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 m -135.64 131.17 35.43 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.322 -0.861 . . . . 0.0 108.909 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.5 pt -120.67 166.39 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.262 1.025 . . . . 0.0 110.11 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.72 132.9 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.12 106.51 17.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.632 -0.668 . . . . 0.0 109.735 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.31 171.73 6.36 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 121.876 0.709 . . . . 0.0 112.408 171.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.78 64.13 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.581 1.152 . . . . 0.0 111.009 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -80.3 29.52 0.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.511 1.124 . . . . 0.0 110.31 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.58 -171.43 54.27 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 125.439 1.495 . . . . 0.0 109.512 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.444 ' CD2' HD12 ' A' ' 16' ' ' ILE . 94.3 m-85 -67.15 -0.79 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.423 1.889 . . . . 0.0 114.715 -172.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.54 -61.03 3.24 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 119.819 -1.801 . . . . 0.0 111.198 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -54.09 152.35 6.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 118.659 1.229 . . . . 0.0 111.232 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.4 p -118.84 159.17 24.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.199 1.4 . . . . 0.0 108.151 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 71' ' ' VAL . 35.9 pt -123.56 166.72 18.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.639 0.733 . . . . 0.0 109.996 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.09 170.04 16.77 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.547 2.739 . . . . 0.0 108.168 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.25 115.93 31.27 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.37 2.268 . . . . 0.0 106.834 169.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 52.4 p -111.27 169.28 6.47 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.064 1.346 . . . . 0.0 108.251 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 23.4 Cg_endo -64.09 10.52 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 125.14 3.893 . . . . 0.0 115.065 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.3 p -131.33 -11.76 3.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 111.632 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.61 -165.09 24.27 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -169.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.508 ' CG ' HG21 ' A' ' 70' ' ' VAL . 12.8 mp0 -66.48 141.36 57.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -130.57 162.82 28.47 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.544 0.688 . . . . 0.0 109.643 166.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 48' ' ' LEU . 86.6 t -71.11 138.3 22.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 168.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -93.19 -48.42 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.434 1.094 . . . . 0.0 109.418 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -161.81 159.13 26.61 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.091 1.756 . . . . 0.0 106.88 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.2 139.99 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 46.3 mt -123.13 -54.52 1.8 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -87.57 77.7 8.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.9 mt -61.82 -51.37 73.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 125.472 1.509 . . . . 0.0 108.666 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -57.5 -35.29 70.04 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.047 0.939 . . . . 0.0 112.41 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.34 -23.48 70.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.172 0.897 . . . . 0.0 112.115 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.497 ' HA ' HG22 ' A' ' 16' ' ' ILE . 75.5 m -118.84 60.5 4.64 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 119.007 1.404 . . . . 0.0 110.824 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.4 138.58 51.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.678 2.252 . . . . 0.0 110.722 -167.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 -9.16 27.88 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.893 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 36' ' ' VAL . 2.4 tt -73.54 146.19 44.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.152 1.476 . . . . 0.0 108.728 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.73 162.12 27.34 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.734 1.214 . . . . 0.0 112.155 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.69 149.58 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.476 -0.765 . . . . 0.0 109.845 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 14.13 58.06 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.363 -0.836 . . . . 0.0 113.916 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.3 129.68 36.18 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.169 1.484 . . . . 0.0 108.37 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tp -76.64 133.4 39.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 mt -95.18 125.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.529 1.132 . . . . 0.0 109.293 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -112.71 -51.94 5.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.845 1.258 . . . . 0.0 110.713 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.3 mt-10 -123.28 153.32 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.416 0.686 . . . . 0.0 109.558 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.68 134.85 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 161.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 35.89 57.11 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.702 2.001 . . . . 0.0 113.774 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 59.0 24.47 12.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.483 1.113 . . . . 0.0 112.856 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -117.39 120.59 38.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.904 2.482 . . . . 0.0 106.323 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 126.31 28.17 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG12 HD12 ' A' ' 65' ' ' LEU . 34.2 m -126.22 -3.42 5.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -9.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 169.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.79 -8.27 14.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.303 1.41 . . . . 0.0 112.222 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 62' ' ' VAL . 15.7 mt -77.57 158.6 29.76 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.534 0.734 . . . . 0.0 111.856 -172.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.669 ' O ' HG22 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -71.75 148.69 46.09 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.656 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 3.1 t60 -54.86 -22.86 16.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.333 1.453 . . . . 0.0 112.241 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -79.45 -17.24 54.66 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.912 -1.743 . . . . 0.0 112.805 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -87.66 -51.4 5.91 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.325 -1.484 . . . . 0.0 108.105 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 66' ' ' SER . 2.5 m -49.24 -38.19 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 131.558 3.943 . . . . 0.0 112.776 166.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 27' ' ' ILE . 10.9 t -63.56 -54.5 31.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.775 0.83 . . . . 0.0 109.53 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.84 -40.79 89.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.746 0.654 . . . . 0.0 111.095 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.15 -45.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 125.837 1.655 . . . . 0.0 110.996 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.75 -33.86 76.59 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.933 -0.479 . . . . 0.0 110.949 174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -68.24 -34.85 76.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.287 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -74.14 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 173.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.6 m -59.47 141.71 87.72 Favored Pre-proline 0 CA--C 1.536 0.438 0 O-C-N 120.444 -1.41 . . . . 0.0 109.342 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.19 125.79 14.64 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 123.536 2.824 . . . . 0.0 110.594 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.9 mt -58.98 135.59 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.91 85.25 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.823 1.202 . . . . 0.0 113.268 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 t -103.64 147.76 26.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -66.98 142.33 57.29 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 165.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.9 m -127.49 132.55 49.97 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.772 2.829 . . . . 0.0 105.591 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -88.04 130.26 35.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mp -130.6 149.53 52.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 56' ' ' GLU . 6.1 mt -128.82 123.5 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 172.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -111.49 152.71 13.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.037 1.335 . . . . 0.0 107.552 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -88.07 106.17 17.97 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 88' ' ' HIS . 2.4 mm? . . . . . 0 C--O 1.234 0.251 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.5 mtm -88.98 155.91 19.2 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.42 HG23 HG12 ' A' ' 86' ' ' ILE . 35.8 m -134.78 108.91 8.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.0 mt -98.77 169.23 9.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.547 2.339 . . . . 0.0 107.532 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -135.25 151.38 50.54 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.315 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.577 HG22 ' HA ' ' A' ' 45' ' ' CYS . 28.9 pt -144.35 128.28 12.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.17 1.388 . . . . 0.0 110.249 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 120.92 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 123.523 1.63 . . . . 0.0 109.291 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 7.1 mttt -57.66 118.23 5.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.034 174.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.36 -75.49 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.29 165.87 30.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.599 0.699 . . . . 0.0 109.47 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 60.87 -16.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 129.191 2.996 . . . . 0.0 116.809 172.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 123.61 138.03 5.1 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -167.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -52.08 131.49 31.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.64 84.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.09 145.04 21.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.26 1.03 . . . . 0.0 110.995 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 p -107.27 156.43 18.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.13 149.16 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.446 0.641 . . . . 0.0 110.535 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -124.95 143.28 50.96 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.076 2.15 . . . . 0.0 108.087 -177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -89.12 87.12 7.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -171.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -70.39 167.29 27.44 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 124.64 1.176 . . . . 0.0 109.09 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.03 9.36 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.387 2.724 . . . . 0.0 112.968 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.63 -2.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -152.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.64 -169.1 22.52 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -166.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.637 ' HG2' HG21 ' A' ' 70' ' ' VAL . 2.5 mm100 -87.52 142.08 28.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.012 -1.287 . . . . 0.0 109.188 174.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -124.19 162.81 22.86 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 123.49 0.716 . . . . 0.0 110.995 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 48' ' ' LEU . 54.9 t -88.28 116.57 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -69.51 -68.71 0.39 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.995 1.318 . . . . 0.0 108.519 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -148.41 154.87 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.441 1.496 . . . . 0.0 107.26 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.402 ' CD1' HD13 ' A' ' 48' ' ' LEU . 65.0 mt -120.53 107.84 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.005 1.322 . . . . 0.0 108.222 -173.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.2 -53.49 3.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.918 0.866 . . . . 0.0 109.971 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.18 74.45 7.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.0 mt -50.36 -48.81 24.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.748 1.219 . . . . 0.0 109.516 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -63.62 -37.88 88.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.588 -172.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.85 -5.15 60.57 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.694 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HA ' HG22 ' A' ' 16' ' ' ILE . 40.9 m -131.08 71.9 81.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 120.191 1.996 . . . . 0.0 109.528 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.2 129.13 23.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.009 2.473 . . . . 0.0 111.136 -174.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.59 -7.77 52.15 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.04 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.566 HD12 ' CB ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -61.69 147.07 47.17 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.988 1.394 . . . . 0.0 109.26 -176.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.4 m -138.14 141.5 40.13 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.312 1.445 . . . . 0.0 107.297 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.58 158.39 27.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.47 47.53 56.75 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.815 -0.553 . . . . 0.0 111.729 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.44 -159.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.225 2.21 . . . . 0.0 109.595 152.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -154.95 110.18 3.07 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 160.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.18 134.8 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 120.785 1.63 . . . . 0.0 109.106 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.55 -50.29 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.806 1.243 . . . . 0.0 110.347 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 40.4 mt-10 -133.85 151.04 51.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.393 0.677 . . . . 0.0 109.427 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.4 mt -124.45 127.34 72.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 65.68 -36.96 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 131.027 3.731 . . . . 0.0 115.741 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.26 19.7 pt20 162.31 -7.54 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.796 3.638 . . . . 0.0 112.592 -171.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -99.84 142.25 31.57 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.79 -1.194 . . . . 0.0 109.502 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 19.4 t-20 -72.73 137.74 46.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.808 1.243 . . . . 0.0 110.381 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.587 HG12 HD22 ' A' ' 65' ' ' LEU . 6.3 m -139.73 19.63 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 126.966 2.107 . . . . 0.0 108.394 -175.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.99 -58.47 4.07 Favored 'General case' 0 C--N 1.343 0.316 0 O-C-N 120.382 -1.449 . . . . 0.0 109.994 171.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -67.7 -19.96 65.22 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.341 0.657 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.587 HD22 HG12 ' A' ' 62' ' ' VAL . 6.7 mp -56.09 137.44 51.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.216 2.206 . . . . 0.0 111.744 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -60.61 156.4 16.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.198 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -46.98 -51.14 17.82 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.0 0.92 . . . . 0.0 110.192 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -55.82 -35.59 66.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.198 2.599 . . . . 0.0 111.669 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.38 -50.06 49.58 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.848 1.259 . . . . 0.0 107.613 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.637 HG21 ' HG2' ' A' ' 34' ' ' GLN . 97.3 t -63.55 -39.31 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.593 0.757 . . . . 0.0 109.348 -176.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.78 -51.96 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -66.86 -33.49 75.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.433 0.56 . . . . 0.0 112.1 -170.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.94 -52.28 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 124.043 0.937 . . . . 0.0 109.584 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.07 -35.75 81.29 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.008 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 43.9 mtmt -59.38 -48.56 81.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 121.189 1.813 . . . . 0.0 111.38 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.5 -33.28 74.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.618 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 97.0 m -46.7 125.29 8.01 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.06 0.944 . . . . 0.0 110.087 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' CYS . 7.1 Cg_exo -58.17 145.31 93.14 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.685 2.924 . . . . 0.0 109.991 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 17.7 mm -72.63 139.66 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.856 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.84 75.59 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.05 1.31 . . . . 0.0 113.352 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -99.27 128.19 45.37 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.784 1.292 . . . . 0.0 108.152 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.19 139.63 58.47 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.9 m -124.17 125.93 45.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 m -88.68 122.47 32.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.79 112.67 19.12 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 13' ' ' THR . 6.5 mt -80.13 131.51 33.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 169.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.36 150.75 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 109.815 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.466 ' HA ' HD13 ' A' ' 11' ' ' LEU . 1.6 t-160 -81.26 113.88 19.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.829 0.852 . . . . 0.0 109.685 -176.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 . . . . . 0 C--O 1.235 0.317 0 C-N-CA 125.106 1.363 . . . . 0.0 107.709 171.991 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.9 mtm -142.18 148.17 37.78 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.484 1.514 . . . . 0.0 107.914 153.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -99.7 142.47 31.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 165.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -138.1 160.79 38.47 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.717 1.607 . . . . 0.0 106.791 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -130.8 144.8 51.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 16' ' ' ILE . 11.5 pt -138.69 152.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 125.351 1.46 . . . . 0.0 110.442 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.91 98.34 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.236 1.014 . . . . 0.0 109.641 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 52.1 tttt -43.58 112.41 0.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.574 2.35 . . . . 0.0 111.1 177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -67.52 1.88 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.72 150.77 3.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.458 1.503 . . . . 0.0 108.557 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 40.9 57.49 2.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.105 1.362 . . . . 0.0 110.813 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 76.99 -144.16 29.57 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -112.46 160.17 18.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.516 1.526 . . . . 0.0 108.084 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.04 7.73 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 124.4 1.0 . . . . 0.0 110.615 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -58.56 170.25 0.79 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.346 1.069 . . . . 0.0 111.093 172.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -132.73 159.08 40.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.529 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 pt -118.78 141.83 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.268 1.032 . . . . 0.0 109.031 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.04 133.56 43.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 127.232 2.213 . . . . 0.0 105.77 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 141.85 50.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 163.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -128.9 169.84 12.09 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.47 1.508 . . . . 0.0 108.216 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.63 4.14 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.127 3.218 . . . . 0.0 113.452 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.1 p -131.55 -27.49 1.94 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.543 1.065 . . . . 0.0 112.115 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.26 -166.1 37.44 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -83.65 137.96 33.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -128.34 162.78 26.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 126.888 2.075 . . . . 0.0 107.466 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -77.91 123.38 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -75.36 -70.57 0.41 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -149.13 158.45 44.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.37 0.986 . . . . 0.0 109.049 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.432 HG23 ' SG ' ' A' ' 45' ' ' CYS . 69.0 mt -117.46 120.65 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.2 mt -105.21 -17.67 14.39 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.265 1.426 . . . . 0.0 111.008 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -142.22 82.78 1.8 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.702 2.001 . . . . 0.0 106.548 -162.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.59 -36.56 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.931 1.292 . . . . 0.0 110.682 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.43 -26.11 65.36 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.034 -1.041 . . . . 0.0 113.11 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.2 -11.74 71.33 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.708 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.432 ' SG ' HG23 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -153.03 67.15 6.31 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.588 1.694 . . . . 0.0 110.678 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.7 130.15 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.838 2.359 . . . . 0.0 109.849 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.68 -5.96 72.01 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.202 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 tp -77.79 142.73 38.45 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.493 1.146 . . . . 0.0 109.091 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.4 m -132.21 159.36 39.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.811 1.245 . . . . 0.0 109.554 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.51 144.29 57.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 -1.0 84.22 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.585 -1.675 . . . . 0.0 114.446 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -63.62 106.33 0.94 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.44 1.62 . . . . 0.0 110.005 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.86 126.04 28.48 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.695 1.598 . . . . 0.0 109.571 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.57 144.58 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 109.208 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.42 -43.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 126.293 1.837 . . . . 0.0 108.847 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -136.12 153.59 51.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.579 0.752 . . . . 0.0 110.161 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 58' ' ' ASN . 6.8 mt -111.41 -157.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 167.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.676 ' H ' HG22 ' A' ' 57' ' ' ILE . 85.7 m-20 -53.25 76.56 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.268 2.227 . . . . 0.0 110.92 168.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 55.76 38.97 30.74 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.182 1.393 . . . . 0.0 111.989 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.75 125.82 38.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.834 1.654 . . . . 0.0 107.212 162.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.35 114.77 22.67 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.417 1.487 . . . . 0.0 108.141 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.582 HG12 HD12 ' A' ' 65' ' ' LEU . 28.2 m -117.47 6.61 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -163.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -53.48 -19.88 4.16 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -114.96 -10.09 12.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.064 1.346 . . . . 0.0 112.116 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.582 HD12 HG12 ' A' ' 62' ' ' VAL . 15.2 mt -68.11 147.15 52.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.977 0.894 . . . . 0.0 108.635 175.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.4 m -74.76 164.68 26.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.419 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -48.08 -56.3 8.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.644 0.777 . . . . 0.0 109.535 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.9 m -60.85 -28.76 69.08 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.958 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.68 -45.97 27.54 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.13 1.372 . . . . 0.0 110.73 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.25 -41.51 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.11 -43.0 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.137 0.975 . . . . 0.0 109.225 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.75 89.76 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.853 1.261 . . . . 0.0 110.722 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.81 -51.33 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.035 0.934 . . . . 0.0 108.76 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.404 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 29.9 mt -62.9 -26.4 68.77 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.757 -0.589 . . . . 0.0 111.729 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -68.92 -40.31 79.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.305 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.58 -33.88 75.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.527 1.058 . . . . 0.0 113.193 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.8 m -49.62 134.25 19.3 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.778 1.231 . . . . 0.0 111.563 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.13 121.47 8.63 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.234 3.289 . . . . 0.0 111.777 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.16 124.13 11.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.206 1.402 . . . . 0.0 107.742 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.19 14.92 70.59 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.24 -0.756 . . . . 0.0 113.208 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.4 m -115.62 147.94 40.22 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 118.655 1.227 . . . . 0.0 108.165 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.98 141.18 58.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.885 1.274 . . . . 0.0 108.487 171.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -128.89 124.9 36.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.081 1.753 . . . . 0.0 106.419 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -89.46 128.74 36.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 mp -133.46 158.28 43.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.1 130.83 73.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.0 148.25 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.715 1.206 . . . . 0.0 110.18 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -82.99 84.71 7.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.716 0.807 . . . . 0.0 109.502 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? . . . . . 0 CA--C 1.536 0.441 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.518 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 C--O 1.239 0.501 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.572 ' HE2' HD11 ' A' ' 87' ' ' ILE . 31.6 mtm -92.53 113.84 26.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.742 0.701 . . . . 0.0 109.292 174.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -82.95 129.07 34.98 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -145.7 142.56 29.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.685 1.594 . . . . 0.0 107.641 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -125.08 140.18 53.13 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.965 . . . . 0.0 110.665 -166.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.563 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.0 pt -129.51 158.29 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.174 1.389 . . . . 0.0 111.03 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -128.14 116.79 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.858 1.263 . . . . 0.0 108.516 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HG2' HD13 ' A' ' 79' ' ' ILE . 55.6 tttt -75.26 104.81 5.98 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.571 1.148 . . . . 0.0 109.915 -174.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.76 -67.63 1.87 Allowed Glycine 0 CA--C 1.523 0.564 0 CA-C-O 119.703 -0.498 . . . . 0.0 112.599 -169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 -70.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.514 0.657 . . . . 0.0 111.243 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -78.11 72.0 4.62 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.023 1.329 . . . . 0.0 107.922 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 61.6 -149.75 45.84 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD12 ' A' ' 16' ' ' ILE . 97.5 m-85 -83.51 1.41 42.03 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.53 -63.14 1.48 Allowed Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.761 -1.212 . . . . 0.0 111.623 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -52.58 155.14 2.3 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.028 1.414 . . . . 0.0 111.765 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -122.17 157.38 31.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.0 107.915 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.38 174.68 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 109.232 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.13 165.18 14.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.496 1.918 . . . . 0.0 107.513 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 141.01 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 151.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.64 154.92 60.16 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.58 16.06 1.5 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.292 2.661 . . . . 0.0 113.983 -160.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -144.63 4.04 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.768 1.627 . . . . 0.0 112.092 -160.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.76 169.48 21.72 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -156.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -77.08 160.77 28.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.995 0.897 . . . . 0.0 111.856 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -131.48 146.46 52.25 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.64 127.07 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -100.73 -52.54 3.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.376 1.07 . . . . 0.0 109.862 -173.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -150.39 133.9 16.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.05 128.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -118.43 9.29 12.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.409 1.083 . . . . 0.0 110.509 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.55 81.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.678 HD12 ' H ' ' A' ' 42' ' ' ILE . 3.5 mp -59.2 -60.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 124.834 1.253 . . . . 0.0 109.073 -166.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.81 -9.99 59.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.14 -38.15 94.94 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 164.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.563 ' HA ' HG22 ' A' ' 16' ' ' ILE . 80.4 m -123.31 67.07 34.87 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.47 0.708 . . . . 0.0 111.96 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.88 142.56 93.71 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.216 1.944 . . . . 0.0 109.641 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.22 -31.66 3.72 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 117.984 -1.453 . . . . 0.0 113.065 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -63.9 147.34 52.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.204 1.502 . . . . 0.0 110.387 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.6 m -137.08 168.95 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.342 1.857 . . . . 0.0 109.421 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.53 146.23 31.41 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.218 -0.926 . . . . 0.0 110.598 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.63 -3.16 80.17 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.132 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -55.59 115.83 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.403 1.481 . . . . 0.0 108.211 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.26 98.13 3.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.56 119.73 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.525 1.53 . . . . 0.0 108.229 177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.18 -52.15 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.038 1.735 . . . . 0.0 109.123 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -136.03 143.65 44.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.879 1.272 . . . . 0.0 108.543 -169.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 74' ' ' LEU . 97.7 mt -131.21 134.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.961 1.304 . . . . 0.0 107.574 170.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 39.95 47.99 2.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.787 2.035 . . . . 0.0 110.402 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 66.41 13.19 9.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.261 1.425 . . . . 0.0 112.79 171.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.01 130.18 46.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.884 1.673 . . . . 0.0 107.828 167.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -58.21 123.87 17.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.994 0.918 . . . . 0.0 110.476 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.29 -3.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 118.176 -0.916 . . . . 0.0 113.251 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -54.21 -37.03 64.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.48 1.491 . . . . 0.0 112.502 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -97.51 2.28 49.97 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.327 1.051 . . . . 0.0 111.649 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.7 mt -87.5 160.77 18.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.155 0.982 . . . . 0.0 108.894 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 152.26 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -41.14 -52.51 3.27 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.675 1.59 . . . . 0.0 111.715 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.5 m -56.97 -42.28 79.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.149 1.379 . . . . 0.0 112.224 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -64.19 -38.22 90.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.704 ' O ' HD22 ' A' ' 74' ' ' LEU . 19.4 t -69.8 -51.47 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.567 0.747 . . . . 0.0 109.473 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.86 -38.03 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.172 1.389 . . . . 0.0 110.268 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.41 -34.47 70.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.048 0.842 . . . . 0.0 111.97 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -54.31 -60.3 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -56.5 -31.61 64.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 174.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.07 -50.94 68.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 121.109 1.777 . . . . 0.0 108.736 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.68 -35.28 75.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.14 0.976 . . . . 0.0 111.455 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 50.6 m -56.64 144.28 65.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.574 0.749 . . . . 0.0 112.704 -169.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.36 123.44 10.24 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.454 3.436 . . . . 0.0 112.311 -172.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.463 HD13 ' HG2' ' A' ' 18' ' ' LYS . 5.5 mm -59.29 131.58 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.5 26.57 72.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.462 1.029 . . . . 0.0 112.988 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -103.84 157.44 17.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 154.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.83 152.69 30.92 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.196 152.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.2 m -139.97 125.68 19.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -89.36 119.44 29.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -166.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.27 154.94 35.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 56' ' ' GLU . 5.7 mt -134.04 129.81 54.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.572 HD11 ' HE2' ' A' ' 12' ' ' MET . 1.2 pp -119.69 167.39 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 108.122 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.29 -120.32 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 110.93 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 126.508 1.923 . . . . 0.0 110.791 175.659 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mtm -113.92 154.73 27.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.004 0.922 . . . . 0.0 109.309 168.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.9 m -131.06 134.58 46.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.31 167.73 22.15 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.035 1.734 . . . . 0.0 108.62 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -122.97 153.06 40.26 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 45' ' ' CYS . 23.1 pt -139.9 155.39 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.203 1.801 . . . . 0.0 110.013 174.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.26 99.31 4.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.011 1.725 . . . . 0.0 107.968 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 53.2 tttt -53.64 109.17 0.42 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.268 2.227 . . . . 0.0 111.617 -174.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.35 33.44 4.32 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.15 1.357 . . . . 0.0 115.862 -163.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . 59.56 162.41 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.387 2.275 . . . . 0.0 113.69 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 52.32 -10.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.249 1.82 . . . . 0.0 114.854 -153.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 147.39 -155.58 26.57 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' CD2' HD12 ' A' ' 16' ' ' ILE . 54.5 m-85 -83.96 152.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 153.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.57 -56.0 26.83 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -54.75 159.94 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.488 1.137 . . . . 0.0 111.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.5 p -128.65 161.44 29.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.882 1.673 . . . . 0.0 108.368 -172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.2 162.97 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 122.066 0.936 . . . . 0.0 109.758 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.98 146.97 39.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.017 1.327 . . . . 0.0 107.864 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.57 136.01 47.26 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.253 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 p -133.74 165.72 34.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.61 -12.74 35.54 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.085 1.857 . . . . 0.0 112.574 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -109.36 5.63 23.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.44 1.496 . . . . 0.0 111.817 -168.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.0 -159.47 15.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -165.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.537 ' CG ' HG21 ' A' ' 70' ' ' VAL . 93.6 mm-40 -87.44 152.58 22.12 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.274 -1.133 . . . . 0.0 110.274 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -120.51 158.93 26.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 109.552 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.33 119.09 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -69.06 -68.89 0.37 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 171.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -151.98 151.89 31.78 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -174.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.26 92.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.4 mt -82.78 -18.44 40.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.117 1.367 . . . . 0.0 112.162 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -124.06 91.58 3.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.04 -29.21 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.499 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -73.65 -60.25 2.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.631 0.772 . . . . 0.0 110.003 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -5.01 87.68 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 123.694 0.664 . . . . 0.0 112.663 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' HG22 ' A' ' 16' ' ' ILE . 12.0 m -120.02 66.18 10.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.976 1.388 . . . . 0.0 107.759 165.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.38 146.58 56.78 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.624 2.216 . . . . 0.0 110.404 -170.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.14 -7.89 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.941 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.433 HD12 ' CG2' ' A' ' 16' ' ' ILE . 2.8 tt -73.86 132.81 42.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.7 m -110.98 155.02 23.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 123.416 1.579 . . . . 0.0 110.415 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.35 148.38 51.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.579 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.18 8.83 12.77 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 117.841 -1.533 . . . . 0.0 116.098 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -59.98 139.45 57.42 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.8 1.8 . . . . 0.0 109.219 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.75 129.39 37.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.862 1.665 . . . . 0.0 110.34 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mt -81.66 130.1 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.844 0.858 . . . . 0.0 110.598 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -116.25 -55.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.265 1.826 . . . . 0.0 109.205 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -125.29 152.92 44.03 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.55 135.08 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 157.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 33.57 56.66 0.54 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.411 2.685 . . . . 0.0 113.351 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 61.29 25.92 15.83 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -121.51 129.49 52.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 170.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -72.46 126.62 30.3 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.277 0.631 . . . . 0.0 111.018 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.503 HG12 HD12 ' A' ' 65' ' ' LEU . 21.2 m -128.76 17.47 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.98 0.912 . . . . 0.0 112.272 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.8 -15.98 62.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.931 -1.106 . . . . 0.0 112.196 173.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.33 17.32 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.429 1.892 . . . . 0.0 110.664 -169.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 62' ' ' VAL . 17.7 mt -110.66 147.19 34.83 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.095 -1.003 . . . . 0.0 111.173 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.557 ' O ' HG22 ' A' ' 70' ' ' VAL . 14.1 m -75.12 147.5 40.47 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 117.173 -1.394 . . . . 0.0 108.115 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.596 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 70.1 t60 -42.99 -34.21 0.95 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.774 2.029 . . . . 0.0 113.943 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.69 -34.01 76.91 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 120.969 -1.082 . . . . 0.0 112.208 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.02 -49.09 16.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.248 2.219 . . . . 0.0 110.748 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.596 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -59.4 -42.62 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 1 C-N-CA 132.589 4.355 . . . . 0.0 111.896 172.518 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.6 -50.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 167.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.51 -40.97 93.34 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.603 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mt -59.34 -50.68 78.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.949 1.3 . . . . 0.0 109.918 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -60.94 -28.87 69.28 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.876 -0.515 . . . . 0.0 110.144 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -72.77 -42.19 64.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.672 -1.268 . . . . 0.0 109.632 174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -68.32 -16.49 63.97 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.39 1.45 . . . . 0.0 112.852 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -60.61 140.49 92.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 O-C-N 121.17 -0.956 . . . . 0.0 110.004 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -58.62 142.92 98.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.609 3.54 . . . . 0.0 111.501 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.07 136.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 159.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.22 51.47 54.71 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 123.293 0.37 . . . . 0.0 112.358 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.2 m -150.03 151.49 33.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -61.89 102.31 0.26 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.862 1.265 . . . . 0.0 109.461 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.6 m -83.04 146.11 28.91 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 160.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.6 m -120.56 131.2 54.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mp -127.04 149.93 49.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.87 126.11 73.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.58 154.48 27.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.004 0.907 . . . . 0.0 110.814 -175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -91.25 80.24 5.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.514 -170.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.941 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.102 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t -123.19 -56.49 1.73 Allowed 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 118.914 1.357 . . . . 0.0 108.319 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m 44.3 -141.79 0.22 Allowed 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.779 0.831 . . . . 0.0 111.287 -167.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.84 51.96 0.4 Allowed Glycine 0 C--N 1.332 0.336 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -158.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 p -140.83 169.68 17.18 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 158.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -130.7 165.09 23.62 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.29 126.22 0.94 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 104.656 -3.378 . . . . 0.0 104.656 -170.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.93 157.13 42.51 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 117.379 0.59 . . . . 0.0 110.096 -167.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.55 -176.21 5.31 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.846 1.658 . . . . 0.0 108.701 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -139.36 105.72 5.28 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -101.18 153.49 19.56 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.319 0.647 . . . . 0.0 109.568 -160.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.5 mtm -89.07 113.88 25.06 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.734 -169.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.5 m -78.1 137.31 38.15 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 159.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.3 mt -131.42 161.77 31.71 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 104.781 -2.303 . . . . 0.0 104.781 171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.0 m -119.81 144.89 47.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.819 HG22 ' HA ' ' A' ' 45' ' ' CYS . 21.7 pt -138.89 162.81 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 125.368 1.467 . . . . 0.0 109.333 -175.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.4 t -132.14 137.28 55.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.894 0.854 . . . . 0.0 108.713 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -97.62 85.56 3.62 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 121.883 -0.511 . . . . 0.0 111.569 -166.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -52.32 -69.25 1.23 Allowed Glycine 0 CA--C 1.53 1.017 0 C-N-CA 123.579 0.609 . . . . 0.0 114.445 -166.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.64 -62.41 0.09 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.247 1.419 . . . . 0.0 109.183 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -65.1 6.4 0.26 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.997 2.519 . . . . 0.0 114.653 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.63 71.6 1.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 63.54 173.06 0.17 Allowed 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.499 1.919 . . . . 0.0 111.188 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.54 49.1 0.87 Allowed Glycine 0 C--O 1.222 -0.605 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -157.97 163.55 37.7 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.7 p -121.17 161.75 21.32 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.381 1.072 . . . . 0.0 108.805 -175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 pt -123.34 162.94 23.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.061 0.934 . . . . 0.0 110.132 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.77 140.31 40.55 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 107.862 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.75 121.04 18.22 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.6 p -110.2 168.47 7.6 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -64.97 -10.52 25.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.507 1.471 . . . . 0.0 112.224 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.1 p -114.58 7.2 16.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.797 1.239 . . . . 0.0 112.758 -170.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.52 -172.5 15.76 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -171.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.437 ' HG2' HG21 ' A' ' 70' ' ' VAL . 43.3 mm-40 -77.07 149.98 35.74 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.666 -0.902 . . . . 0.0 108.751 174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -130.17 164.02 25.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.588 1.155 . . . . 0.0 108.498 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.52 122.39 22.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -73.99 -62.33 1.54 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -154.66 145.58 22.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -89.19 136.64 23.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.7 mt -119.63 -8.94 9.87 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 111.313 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -155.81 108.51 2.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.362 2.265 . . . . 0.0 106.842 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 95.0 mt -57.97 -53.7 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.16 0.984 . . . . 0.0 110.07 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -72.86 -4.19 30.31 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.065 -1.022 . . . . 0.0 112.521 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.77 -16.17 79.31 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.15 -0.969 . . . . 0.0 111.797 163.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.819 ' HA ' HG22 ' A' ' 16' ' ' ILE . 25.7 p -150.23 57.99 2.9 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 118.956 1.378 . . . . 0.0 113.541 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -62.27 112.32 1.53 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.342 2.028 . . . . 0.0 111.534 -170.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.75 -5.96 37.57 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.514 1.53 . . . . 0.0 113.62 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.3 tp -75.81 139.37 41.72 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.377 1.589 . . . . 0.0 109.795 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.8 m -123.82 9.84 8.88 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 66.2 152.3 0.07 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.056 2.142 . . . . 0.0 112.784 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.88 -3.0 0.17 Allowed Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.896 1.236 . . . . 0.0 115.31 -170.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.98 158.43 19.34 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.286 2.043 . . . . 0.0 109.718 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -111.86 114.11 26.85 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.626 1.57 . . . . 0.0 109.978 -161.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 62' ' ' VAL . 53.1 mt -65.26 129.53 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.812 1.245 . . . . 0.0 109.298 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 62' ' ' VAL . 59.8 t -124.78 -51.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 C-N-CA 124.253 1.021 . . . . 0.0 108.429 173.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -130.5 145.54 51.87 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 120.834 1.652 . . . . 0.0 109.873 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.6 mt -125.06 122.26 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 45.05 42.26 6.33 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.264 1.426 . . . . 0.0 111.656 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 65.76 8.39 5.22 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.177 1.391 . . . . 0.0 113.609 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -77.68 138.6 39.16 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.641 -1.287 . . . . 0.0 108.031 163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.67 116.86 22.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.672 2.389 . . . . 0.0 108.33 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG12 HD22 ' A' ' 65' ' ' LEU . 7.2 m -135.53 13.61 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 C-N-CA 125.449 1.5 . . . . 0.0 112.016 -169.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.44 -55.41 35.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 118.319 -2.738 . . . . 0.0 112.562 170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -81.45 -6.77 59.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.596 0.758 . . . . 0.0 111.095 -174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.679 HD22 HG12 ' A' ' 62' ' ' VAL . 6.4 mp -64.46 135.17 55.81 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.28 1.832 . . . . 0.0 111.203 176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 m -63.41 160.81 15.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.037 171.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -48.77 -49.57 38.01 Favored 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 123.25 0.62 . . . . 0.0 111.012 176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.2 -42.92 73.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.043 1.737 . . . . 0.0 112.227 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -63.97 -43.29 96.19 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.442 1.497 . . . . 0.0 108.069 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 34' ' ' GLN . 62.6 t -68.22 -43.76 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 110.617 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.33 -42.58 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 124.26 1.024 . . . . 0.0 109.926 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -44.47 91.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.183 0.993 . . . . 0.0 110.156 -176.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.6 mt -63.04 -44.48 99.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 O-C-N 121.519 -0.738 . . . . 0.0 109.146 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -65.5 -23.73 66.96 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.57 -0.706 . . . . 0.0 111.571 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -72.95 -42.92 62.92 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.943 1.247 . . . . 0.0 109.977 171.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -55.55 -35.45 65.72 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.109 0.868 . . . . 0.0 110.304 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 81.9 m -54.67 138.8 61.38 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -67.3 141.14 55.52 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 124.827 3.685 . . . . 0.0 110.814 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mm -70.86 142.28 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.97 -2.08 28.16 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.446 1.974 . . . . 0.0 113.385 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.4 m -103.01 165.02 11.27 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.076 1.35 . . . . 0.0 107.862 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -69.21 153.35 43.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 123.128 1.442 . . . . 0.0 111.216 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -140.6 141.46 35.16 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.061 2.144 . . . . 0.0 105.653 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.6 m -112.62 115.9 29.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.406 HD13 HD11 ' A' ' 16' ' ' ILE . 6.1 mp -113.04 153.01 28.8 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.9 mt -126.55 122.41 60.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.72 164.14 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.708 0.803 . . . . 0.0 110.764 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -84.13 124.02 30.69 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.383 0.673 . . . . 0.0 111.13 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -153.95 175.59 13.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 108.471 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 60.24 82.37 0.07 OUTLIER Glycine 0 C--N 1.336 0.557 0 C-N-CA 126.542 2.02 . . . . 0.0 113.708 168.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -67.8 -54.17 21.19 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.983 0.892 . . . . 0.0 110.51 167.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.51 163.89 32.29 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.7 1.136 . . . . 0.0 111.789 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.27 128.33 9.66 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.319 2.013 . . . . 0.0 110.689 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.82 118.23 0.94 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 167.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.9 m 46.85 48.12 15.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.404 1.481 . . . . 0.0 112.017 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.273 0 CA-C-O 117.877 -1.513 . . . . 0.0 109.493 -177.12 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.519 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.0 m 52.67 48.12 23.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.61 1.164 . . . . 0.0 112.685 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.1 t -60.69 164.66 4.47 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.395 1.078 . . . . 0.0 110.553 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.66 178.68 53.87 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 153.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m 66.19 117.68 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.239 1.816 . . . . 0.0 113.045 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 m -72.54 82.97 1.11 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 170.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.89 -72.99 0.72 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -165.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -67.24 145.64 54.99 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.411 0.624 . . . . 0.0 110.329 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -152.24 -8.71 0.2 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.673 1.189 . . . . 0.0 112.603 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.46 109.34 0.87 Allowed 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.905 2.882 . . . . 0.0 110.435 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.404 HD23 ' CD2' ' A' ' 88' ' ' HIS . 18.4 mt -64.36 161.11 17.52 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.505 1.922 . . . . 0.0 109.124 165.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 mtm -88.78 150.06 23.12 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.9 m -116.04 148.29 40.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 167.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -145.46 168.3 20.88 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 128.62 2.768 . . . . 0.0 107.457 -172.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.12 153.97 51.03 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.247 -0.908 . . . . 0.0 108.591 170.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.0 pt -134.07 167.38 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 126.461 1.905 . . . . 0.0 109.227 173.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.7 t -132.7 139.67 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HG2' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.24 152.56 40.98 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.653 176.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.09 74.72 0.28 Allowed Glycine 0 C--O 1.238 0.377 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 54.27 -166.92 0.08 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.051 1.34 . . . . 0.0 111.157 -167.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 40.47 9.7 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 131.579 3.952 . . . . 0.0 118.643 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.16 67.93 1.86 Allowed Glycine 0 N--CA 1.445 -0.736 0 O-C-N 120.65 -1.281 . . . . 0.0 110.553 -165.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CE1' HD22 ' A' ' 74' ' ' LEU . 23.1 m-85 63.75 174.61 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.227 2.211 . . . . 0.0 111.544 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.81 34.96 4.95 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.545 1.545 . . . . 0.0 110.233 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -140.89 167.03 23.17 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 p -129.96 151.38 50.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.6 pt -114.22 144.96 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -129.77 131.36 46.21 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.09 144.41 50.33 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.6 p -138.57 167.0 21.23 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 127.676 2.391 . . . . 0.0 105.567 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.71 -36.45 97.13 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.413 2.075 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.5 p -79.0 -28.39 43.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.576 1.95 . . . . 0.0 111.684 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.99 -134.34 4.79 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -162.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 -106.63 147.2 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.952 . . . . 0.0 110.094 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -146.78 161.13 41.28 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.234 1.014 . . . . 0.0 108.342 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.0 t -77.26 114.49 17.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -63.37 -61.36 2.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.105 1.362 . . . . 0.0 108.759 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -157.08 154.23 29.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -111.86 114.25 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.9 mt -87.63 -25.11 23.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.798 0.839 . . . . 0.0 110.106 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -150.1 96.15 2.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.011 1.724 . . . . 0.0 107.598 -169.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 mt -60.47 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 109.949 -166.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -64.12 -12.39 39.0 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.48 -34.96 63.22 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 119.232 0.924 . . . . 0.0 111.426 170.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.493 ' HA ' HG22 ' A' ' 16' ' ' ILE . 79.3 m -126.87 67.64 69.19 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.467 1.107 . . . . 0.0 108.703 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.55 132.92 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.38 2.053 . . . . 0.0 109.124 -172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.05 -3.4 71.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.259 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.94 135.08 49.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 119.22 1.51 . . . . 0.0 107.003 166.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 68.7 m -137.17 131.69 32.88 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -72.85 153.47 41.03 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.245 0.618 . . . . 0.0 111.89 -163.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.94 37.14 93.92 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -166.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -58.48 -173.32 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.081 1.352 . . . . 0.0 110.389 160.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.5 tp -136.38 122.45 20.25 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 154.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.7 mt -69.52 129.51 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.28 -58.08 2.16 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 C-N-CA 124.521 1.128 . . . . 0.0 111.425 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 22.1 mt-10 -136.61 131.67 34.05 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.9 mt -123.19 127.24 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 45.55 38.56 4.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.105 1.762 . . . . 0.0 111.575 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 61.1 18.47 9.04 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.14 1.776 . . . . 0.0 114.056 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -92.49 135.52 33.99 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 156.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 23.1 t-20 -80.83 138.62 36.22 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.227 0.536 . . . . 0.0 110.067 173.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.798 HG12 HD22 ' A' ' 65' ' ' LEU . 16.6 m -137.89 10.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 126.35 1.86 . . . . 0.0 108.347 -170.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -65.72 -24.51 66.99 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 119.265 -2.147 . . . . 0.0 112.477 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -104.55 -13.01 16.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.137 0.88 . . . . 0.0 110.598 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.798 HD22 HG12 ' A' ' 62' ' ' VAL . 5.6 mp -59.38 127.73 33.57 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 126.366 1.866 . . . . 0.0 111.67 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.09 162.11 3.65 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 124.362 1.039 . . . . 0.0 110.316 176.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -49.85 -48.33 51.18 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.169 0.588 . . . . 0.0 109.989 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -58.38 -36.13 73.05 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.724 1.21 . . . . 0.0 111.848 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -71.45 -47.71 54.08 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.198 1.399 . . . . 0.0 107.818 -176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -58.03 -46.48 87.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.937 0.895 . . . . 0.0 109.462 176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.07 -42.83 91.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 123.886 0.874 . . . . 0.0 110.851 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -67.59 -30.73 70.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.42 0.688 . . . . 0.0 111.914 -177.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 64.2 mt -77.25 -40.48 29.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.414 HD22 ' CE1' ' A' ' 23' ' ' PHE . 35.6 mt -62.03 -27.59 68.99 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.001 -1.062 . . . . 0.0 110.773 172.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' ASP . 8.6 mtpm? -69.6 -29.91 67.54 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.653 -1.279 . . . . 0.0 111.863 172.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.72 -22.45 53.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.213 0.915 . . . . 0.0 111.24 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.8 m -60.57 132.88 91.24 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 118.974 0.806 . . . . 0.0 110.476 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.19 132.45 46.95 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.526 2.818 . . . . 0.0 109.595 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.43 HD13 ' HG2' ' A' ' 18' ' ' LYS . 3.2 mm -72.13 106.84 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 173.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.18 29.85 6.58 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.059 175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -136.09 163.34 30.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 118.839 1.32 . . . . 0.0 109.736 171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.31 143.65 57.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 122.28 1.038 . . . . 0.0 111.025 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -131.03 135.17 47.34 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.478 1.911 . . . . 0.0 105.929 171.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 m -111.5 128.38 55.99 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -164.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.5 mp -129.23 137.09 50.9 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -167.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -112.15 129.94 66.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -129.81 145.61 35.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.976 0.91 . . . . 0.0 109.711 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.404 ' CD2' HD23 ' A' ' 11' ' ' LEU . 6.2 t-160 -76.04 99.84 4.73 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 109.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -152.53 148.74 27.74 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.848 1.259 . . . . 0.0 107.855 172.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.58 -173.3 31.11 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 126.804 2.145 . . . . 0.0 108.436 -171.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.17 114.35 7.36 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.74 0.77 . . . . 0.0 111.508 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.9 173.99 21.35 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 124.263 0.935 . . . . 0.0 113.369 163.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -65.6 116.76 4.11 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.689 2.259 . . . . 0.0 106.601 169.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.2 t -147.89 -63.17 0.26 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 -167.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.2 m -80.35 160.08 25.54 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 153.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.953 0 CA-C-O 117.553 -1.693 . . . . 0.0 111.398 167.016 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.308 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -61.82 97.82 0.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.281 1.432 . . . . 0.0 108.471 171.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 t -66.66 154.32 40.89 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.79 90.45 0.55 Allowed Glycine 0 C--N 1.332 0.359 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 m 72.77 -81.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.253 1.821 . . . . 0.0 110.101 -171.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.1 t 62.52 150.3 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.393 2.277 . . . . 0.0 111.301 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.88 43.32 2.89 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 121.348 -0.845 . . . . 0.0 112.351 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -48.76 128.22 15.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.797 2.439 . . . . 0.0 110.56 175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.98 173.75 16.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.451 1.901 . . . . 0.0 108.83 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -115.01 100.12 7.95 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.704 1.601 . . . . 0.0 106.825 171.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -66.91 161.9 23.01 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 mtm -106.7 118.03 35.61 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.771 0.796 . . . . 0.0 109.682 174.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.3 m -84.33 143.69 29.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.6 mt -143.87 168.08 20.8 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.089 2.156 . . . . 0.0 106.351 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.6 m -127.47 148.5 50.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.167 0.987 . . . . 0.0 109.169 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' A' ' 45' ' ' CYS . 15.7 pt -139.68 160.03 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 124.846 1.258 . . . . 0.0 111.126 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.1 t -129.06 113.69 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 123.011 1.386 . . . . 0.0 108.615 176.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -60.65 102.82 0.2 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.08 2.152 . . . . 0.0 108.643 168.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.83 -62.31 3.88 Favored Glycine 0 CA--C 1.518 0.243 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.32 -62.44 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.189 1.396 . . . . 0.0 109.225 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.0 51.35 0.5 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 127.42 2.288 . . . . 0.0 111.913 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 45.66 47.47 12.98 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.113 1.816 . . . . 0.0 113.597 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 84.9 -11.46 0.78 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 130.54 3.536 . . . . 0.0 113.72 174.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.45 -60.6 1.95 Allowed Glycine 0 CA--C 1.53 1.011 0 CA-C-N 119.86 1.209 . . . . 0.0 111.552 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -49.4 151.05 1.63 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.051 1.426 . . . . 0.0 110.38 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 p -125.18 159.48 31.43 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -171.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.2 pt -126.87 152.44 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.526 -175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.93 137.24 49.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.745 1.218 . . . . 0.0 109.453 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -71.65 124.46 24.77 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 126.064 1.745 . . . . 0.0 109.389 -175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 p -120.69 159.75 47.22 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -58.91 -28.87 88.74 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.388 2.725 . . . . 0.0 111.878 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 p -98.23 -5.63 32.88 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.238 2.615 . . . . 0.0 113.61 -168.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.59 173.72 17.11 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -76.72 145.52 38.62 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.411 -1.052 . . . . 0.0 109.461 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -129.15 151.07 50.23 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.25 108.44 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -66.72 -62.25 1.55 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -155.06 143.19 20.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.3 mt -90.98 126.61 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 127.044 2.138 . . . . 0.0 106.211 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.7 mt -110.78 -17.95 13.24 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.319 0.648 . . . . 0.0 111.029 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -133.96 77.21 1.7 Allowed 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.315 1.446 . . . . 0.0 108.165 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.53 -39.61 81.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.658 1.183 . . . . 0.0 111.222 -169.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -10.4 59.68 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.87 -15.9 66.61 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 119.27 0.941 . . . . 0.0 111.798 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.631 ' HA ' HG22 ' A' ' 16' ' ' ILE . 48.0 m -130.77 70.73 82.55 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 118.56 1.18 . . . . 0.0 109.91 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -60.42 121.56 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.758 2.972 . . . . 0.0 110.484 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.89 -8.85 71.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.843 -0.976 . . . . 0.0 113.687 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.58 144.81 56.94 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.325 1.562 . . . . 0.0 109.822 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 65.0 m -129.53 161.78 29.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.89 1.328 . . . . 0.0 110.444 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.56 136.17 57.76 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.449 1.5 . . . . 0.0 108.261 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.22 17.77 70.5 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.565 1.555 . . . . 0.0 115.044 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -65.76 101.42 0.64 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.16 1.98 . . . . 0.0 111.405 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.69 114.26 6.89 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.531 1.932 . . . . 0.0 111.09 -167.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.55 134.38 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.607 1.094 . . . . 0.0 110.545 -168.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HG2' ' A' ' 63' ' ' GLN . 73.9 t -119.55 -49.51 3.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.232 1.413 . . . . 0.0 110.062 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.89 146.11 49.97 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.545 0.688 . . . . 0.0 109.549 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.9 mt -121.29 135.58 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 153.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 32.28 54.42 0.33 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.638 2.375 . . . . 0.0 113.306 176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 47.78 4.49 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 130.421 3.488 . . . . 0.0 118.813 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -26.16 67.43 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 121.059 1.754 . . . . 0.0 113.055 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 65.88 126.42 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 130.299 3.44 . . . . 0.0 111.336 -170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.607 HG12 HD22 ' A' ' 65' ' ' LEU . 12.5 m -134.87 20.78 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 126.644 1.978 . . . . 0.0 108.49 -163.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -62.99 -59.94 4.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 119.5 -2.0 . . . . 0.0 112.343 173.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -76.89 -12.17 59.92 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.159 0.583 . . . . 0.0 111.794 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.607 HD22 HG12 ' A' ' 62' ' ' VAL . 6.0 mp -56.93 131.6 50.16 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 126.119 1.768 . . . . 0.0 110.396 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.83 160.14 15.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.474 174.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -43.24 -50.85 6.4 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.834 0.854 . . . . 0.0 110.53 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.1 m -60.39 -32.72 71.58 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.814 0.846 . . . . 0.0 112.016 -175.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.39 -45.25 60.56 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.23 -38.22 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.402 0.681 . . . . 0.0 110.319 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.9 -52.07 65.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 125.049 1.34 . . . . 0.0 109.743 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -62.23 -39.6 93.36 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.618 1.167 . . . . 0.0 109.942 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.2 mt -56.92 -55.35 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.65 1.18 . . . . 0.0 110.14 169.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.8 -21.98 66.89 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.411 0.551 . . . . 0.0 111.604 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -70.66 -40.82 72.79 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.543 -1.348 . . . . 0.0 110.226 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -74.31 -21.7 59.6 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.921 0.889 . . . . 0.0 113.272 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.8 m -55.09 128.79 66.34 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 168.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -61.89 140.07 83.18 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 123.761 2.974 . . . . 0.0 111.689 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.1 mt -73.01 117.28 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 165.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.68 49.65 5.32 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -145.63 155.49 43.06 Favored 'General case' 0 CA--C 1.515 -0.392 0 O-C-N 120.939 -1.33 . . . . 0.0 108.681 160.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -70.17 129.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 168.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 62.8 m -101.89 142.75 32.7 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 125.524 1.529 . . . . 0.0 107.414 165.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -104.89 126.8 52.33 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -134.15 156.99 47.33 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mt -127.83 135.11 63.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.42 159.34 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 110.17 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -81.84 122.59 27.9 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.162 0.585 . . . . 0.0 110.826 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -141.61 -45.76 0.36 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.876 0.87 . . . . 0.0 111.738 173.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -48.95 136.4 19.81 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.659 1.123 . . . . 0.0 111.898 -176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 175.51 -41.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.219 2.208 . . . . 0.0 109.58 -166.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.61 -174.52 2.15 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.371 0.986 . . . . 0.0 112.668 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -82.68 65.58 8.12 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.264 2.643 . . . . 0.0 110.924 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.3 t 84.34 102.11 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.408 2.283 . . . . 0.0 109.206 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.5 t 50.83 39.89 23.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.343 1.057 . . . . 0.0 110.681 -173.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 116.392 -2.338 . . . . 0.0 110.945 179.294 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.37 155.93 45.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.101 1.361 . . . . 0.0 110.108 -170.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m 48.5 38.35 10.8 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.643 1.577 . . . . 0.0 114.114 170.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.14 -173.18 42.06 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.055 0.836 . . . . 0.0 113.44 -168.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -119.26 174.1 6.55 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.291 2.237 . . . . 0.0 110.127 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m 53.7 -171.0 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.446 1.099 . . . . 0.0 113.112 -176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.7 -92.87 0.49 Allowed Glycine 0 C--N 1.334 0.455 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 164.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.73 172.53 17.78 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 125.088 1.355 . . . . 0.0 108.248 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.51 154.97 38.43 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.571 1.148 . . . . 0.0 110.657 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -116.35 96.72 5.66 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.646 1.578 . . . . 0.0 106.999 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.39 162.69 32.33 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.543 1.537 . . . . 0.0 108.293 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.8 mtm -111.11 114.82 28.36 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.201 1.0 . . . . 0.0 109.07 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.1 m -83.72 130.2 34.95 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 168.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 50.5 mt -138.99 168.67 19.32 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 127.136 2.174 . . . . 0.0 107.258 -172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 82' ' ' GLU . 11.7 m -123.09 149.85 43.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 45' ' ' CYS . 24.9 pt -130.82 154.37 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.898 1.679 . . . . 0.0 108.637 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 104.6 3.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -68.85 118.09 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.998 1.719 . . . . 0.0 109.629 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.84 -63.29 2.22 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.176 0.893 . . . . 0.0 111.007 -176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.34 -58.11 0.06 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.396 1.078 . . . . 0.0 110.87 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -76.69 56.54 1.16 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.879 2.072 . . . . 0.0 110.138 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.76 61.59 2.9 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.178 1.371 . . . . 0.0 111.796 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 69.69 -71.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 126.988 2.115 . . . . 0.0 109.418 -172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.21 -52.4 0.66 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.09 158.68 1.05 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-O 122.647 1.213 . . . . 0.0 111.76 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.3 p -115.51 151.92 33.95 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.252 -173.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.1 159.92 16.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.96 129.67 42.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.146 2.578 . . . . 0.0 106.603 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.77 128.35 35.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 p -122.99 168.4 12.17 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.509 1.124 . . . . 0.0 108.081 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.01 -35.56 92.66 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.238 2.625 . . . . 0.0 110.595 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -82.37 6.81 15.88 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.221 2.209 . . . . 0.0 113.367 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.47 -157.02 18.35 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -84.76 141.45 30.52 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 121.788 -0.83 . . . . 0.0 110.176 -169.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -132.02 165.56 23.69 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 124.639 1.176 . . . . 0.0 108.74 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 62.4 t -89.38 124.44 42.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -73.71 -68.4 0.51 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.114 1.366 . . . . 0.0 108.663 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -155.06 137.93 15.39 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.1 mt -85.09 129.21 38.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 mt -108.57 -8.11 15.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.576 0.75 . . . . 0.0 111.225 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -149.64 114.17 5.27 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.9 mt -68.44 -55.93 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.571 1.148 . . . . 0.0 110.055 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -57.16 -32.73 66.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.931 0.787 . . . . 0.0 110.889 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.04 75.03 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 123.413 0.53 . . . . 0.0 113.287 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.567 ' HA ' HG22 ' A' ' 16' ' ' ILE . 59.7 m -132.94 73.34 75.74 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 119.132 1.466 . . . . 0.0 111.159 -175.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -50.95 110.55 0.41 Allowed 'Trans proline' 0 C--N 1.352 0.718 1 C-N-CA 125.971 4.447 . . . . 0.0 115.671 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.69 -10.82 55.25 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.061 -1.025 . . . . 0.0 113.446 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 49' ' ' CYS . 1.7 tm? -55.73 152.92 8.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.769 2.027 . . . . 0.0 109.768 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.552 ' N ' HD13 ' A' ' 48' ' ' LEU . 57.2 m -144.69 151.12 38.45 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.108 1.363 . . . . 0.0 111.515 -173.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -60.39 142.65 54.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.693 168.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.52 10.3 48.31 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 116.886 -2.063 . . . . 0.0 114.712 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -53.86 115.96 2.28 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.614 1.707 . . . . 0.0 106.405 166.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -78.54 103.62 8.6 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.85 143.59 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.514 1.052 . . . . 0.0 109.043 -172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 63' ' ' GLN . 57.8 t -130.46 -52.24 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.294 1.038 . . . . 0.0 110.021 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -130.05 145.72 51.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.8 mt -126.49 125.25 66.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 167.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.45 38.99 11.86 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.153 2.181 . . . . 0.0 110.551 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 72.77 -1.42 3.01 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.956 2.102 . . . . 0.0 113.263 176.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -78.85 135.47 37.04 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.744 -1.222 . . . . 0.0 108.066 168.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -71.8 121.53 19.12 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.718 0.807 . . . . 0.0 109.977 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.411 ' HB ' HG22 ' A' ' 70' ' ' VAL . 32.6 m -121.88 6.37 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.818 0.847 . . . . 0.0 111.913 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.429 ' HG3' HG13 ' A' ' 55' ' ' VAL . 19.1 mt-30 -59.97 -45.12 93.73 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 120.289 1.404 . . . . 0.0 110.097 172.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -88.27 24.86 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.574 1.549 . . . . 0.0 111.384 -171.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.7 mt -122.83 140.62 52.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.483 1.513 . . . . 0.0 110.133 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.8 m -67.93 158.23 33.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.596 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -47.57 -51.55 20.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.057 0.943 . . . . 0.0 110.996 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 96.6 m -67.1 -27.03 67.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.618 -0.706 . . . . 0.0 111.828 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.8 -43.53 71.93 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 119.471 1.032 . . . . 0.0 108.965 174.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.411 HG22 ' HB ' ' A' ' 62' ' ' VAL . 47.4 t -66.1 -36.97 78.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.154 -0.966 . . . . 0.0 110.325 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.8 t -57.74 -47.72 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 123.58 0.752 . . . . 0.0 109.411 169.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -68.9 -30.61 69.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 122.022 0.915 . . . . 0.0 112.575 -172.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.4 mt -67.88 -48.15 76.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 170.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.4 mt -62.21 -25.26 67.7 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.959 -1.088 . . . . 0.0 111.893 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -74.39 -35.33 63.48 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.345 -1.472 . . . . 0.0 110.808 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.68 -49.72 56.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.974 0.806 . . . . 0.0 108.944 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.7 m -42.03 115.33 1.5 Allowed Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 125.696 1.599 . . . . 0.0 112.376 -170.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -57.88 127.61 25.79 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.913 3.075 . . . . 0.0 107.391 175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.73 141.09 18.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.43 16.19 48.89 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.805 1.669 . . . . 0.0 114.019 -171.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.8 t -87.28 160.68 18.33 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.691 1.745 . . . . 0.0 106.975 164.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 15' ' ' THR . 0.0 OUTLIER -80.29 135.45 36.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 165.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.9 m -120.52 109.8 15.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 m -87.05 104.28 16.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.904 2.482 . . . . 0.0 108.474 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.29 160.27 14.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.394 0.543 . . . . 0.0 109.565 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -128.74 130.76 68.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.32 150.56 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 124.5 1.12 . . . . 0.0 108.853 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.31 116.98 22.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.041 1.736 . . . . 0.0 108.55 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -160.67 113.94 2.05 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.37 -98.11 0.16 Allowed Glycine 0 C--O 1.228 -0.25 0 N-CA-C 107.027 -2.429 . . . . 0.0 107.027 172.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 74.17 152.31 0.13 Allowed 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 110.553 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -152.46 -164.99 12.81 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -167.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.8 6.63 4.02 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.626 3.55 . . . . 0.0 113.903 -177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.8 t 132.95 107.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 130.956 3.702 . . . . 0.0 106.175 -174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 80.4 142.57 0.07 Allowed 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 127.807 2.443 . . . . 0.0 109.35 -176.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -172.414 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.046 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 p -59.92 -55.31 35.64 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 158.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m 51.87 73.45 0.32 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.707 1.603 . . . . 0.0 110.748 176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.83 94.32 0.17 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 171.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 p 54.32 117.64 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 129.284 3.033 . . . . 0.0 114.946 -177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.7 m -154.49 85.53 1.13 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.475 1.11 . . . . 0.0 109.559 168.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.77 170.21 22.79 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 167.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -144.15 164.54 30.4 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.308 1.843 . . . . 0.0 108.866 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 50.59 86.08 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.692 2.397 . . . . 0.0 111.636 -169.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -150.31 101.26 2.97 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 74.7 mt 51.05 167.8 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 130.971 3.708 . . . . 0.0 115.728 -171.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.41 ' CE ' HD11 ' A' ' 87' ' ' ILE . 3.9 mtp -131.48 114.71 15.25 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.739 1.216 . . . . 0.0 108.383 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.5 m -78.27 142.77 37.58 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 164.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.2 mt -142.84 168.48 19.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.78 2.432 . . . . 0.0 107.006 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.86 155.6 37.75 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 121.14 -0.975 . . . . 0.0 108.731 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 45' ' ' CYS . 15.3 pt -132.83 169.85 21.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 166.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.7 t -115.65 151.14 17.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 162.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 56.9 tttt -70.02 165.4 21.91 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.809 -1.182 . . . . 0.0 110.091 172.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -136.62 165.61 24.99 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 171.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.07 -24.25 60.65 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -165.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -75.89 12.86 0.97 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.222 1.374 . . . . 0.0 111.004 165.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 72.71 69.71 1.35 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 125.729 1.633 . . . . 0.0 109.817 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 77.0 168.08 0.24 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.69 2.796 . . . . 0.0 111.236 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.86 28.16 9.11 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.152 1.834 . . . . 0.0 111.71 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -138.45 172.92 12.18 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.2 p -131.01 146.8 52.51 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.134 1.374 . . . . 0.0 108.039 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.8 pt -117.48 152.17 19.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -126.48 154.16 44.11 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 126.53 1.932 . . . . 0.0 108.032 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.06 128.62 36.29 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.538 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 p -121.79 159.01 52.89 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 11.33 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.037 3.158 . . . . 0.0 114.332 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 64.4 p -127.18 -6.1 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.38 0.991 . . . . 0.0 112.863 -168.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.56 170.0 12.6 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -160.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -72.95 151.44 41.85 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.497 -1.002 . . . . 0.0 110.0 175.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -139.63 161.04 38.49 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.835 0.826 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 48' ' ' LEU . 51.0 t -78.39 122.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 125.547 1.539 . . . . 0.0 107.88 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -71.59 -55.93 6.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.608 162.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -162.24 146.13 12.01 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.244 0.474 . . . . 0.0 110.476 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.8 mt -108.85 93.72 2.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.3 mt -70.57 -28.08 64.62 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.286 1.034 . . . . 0.0 109.945 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -136.78 91.09 2.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.214 1.406 . . . . 0.0 109.674 -171.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.62 -41.57 92.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 123.67 0.788 . . . . 0.0 110.322 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -71.46 -5.16 30.82 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.128 -0.983 . . . . 0.0 113.13 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.77 -23.47 28.04 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.636 1.107 . . . . 0.0 111.471 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.442 ' HA ' HG22 ' A' ' 16' ' ' ILE . 84.2 m -136.14 67.47 62.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 109.857 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 136.38 68.76 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.326 2.017 . . . . 0.0 111.75 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.82 -9.25 3.82 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.266 -1.296 . . . . 0.0 115.295 174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' CD2' HG21 ' A' ' 36' ' ' VAL . 5.6 tt -61.56 145.49 51.84 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.216 1.508 . . . . 0.0 108.956 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 88.9 m -110.94 147.24 35.07 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.93 0.892 . . . . 0.0 111.527 -174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -72.76 151.0 42.33 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 165.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 43.92 44.84 7.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.388 0.994 . . . . 0.0 111.805 -170.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -57.15 -174.99 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.65 1.98 . . . . 0.0 109.615 159.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.45 104.03 4.34 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 119.801 -1.812 . . . . 0.0 106.665 163.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -66.13 131.47 31.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.24 -50.37 4.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 125.129 1.372 . . . . 0.0 109.731 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -136.53 143.79 43.9 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.86 125.28 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.509 -2.775 . . . . 0.0 103.509 168.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 44.8 51.91 8.21 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.21 1.404 . . . . 0.0 111.258 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 65.64 -24.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.978 2.511 . . . . 0.0 115.094 -175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -69.31 135.79 50.92 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.55 118.65 36.8 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.429 -157.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.484 HG12 HD12 ' A' ' 65' ' ' LEU . 34.6 m -125.05 2.14 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.516 -156.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -14.98 0.57 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.543 1.137 . . . . 0.0 113.156 172.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.96 6.81 6.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.061 2.544 . . . . 0.0 112.828 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.484 HD12 HG12 ' A' ' 62' ' ' VAL . 23.8 mt -90.28 160.57 16.09 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.174 1.352 . . . . 0.0 110.101 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.4 m -83.87 162.77 20.42 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 122.95 0.5 . . . . 0.0 110.831 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -49.21 -51.43 33.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.763 0.825 . . . . 0.0 112.022 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.5 m -59.05 -35.63 73.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.381 0.673 . . . . 0.0 111.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -74.49 -39.99 62.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.9 t -65.85 -41.85 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.41 -46.4 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.79 1.236 . . . . 0.0 110.37 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.75 -38.78 70.37 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.595 0.56 . . . . 0.0 111.732 -171.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.26 -44.3 91.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 124.226 1.01 . . . . 0.0 109.315 171.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -65.59 -32.75 74.51 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.757 -0.59 . . . . 0.0 110.761 176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -64.2 -42.11 96.78 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 120.049 1.295 . . . . 0.0 109.847 171.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -66.63 -20.25 65.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.526 1.53 . . . . 0.0 112.678 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.55 143.31 93.62 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 124.797 1.239 . . . . 0.0 110.578 172.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.51 142.45 49.05 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 124.447 3.431 . . . . 0.0 111.049 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.5 mt -66.37 144.69 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.9 -1.08 64.0 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.892 170.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.45 158.09 16.71 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 119.703 1.751 . . . . 0.0 107.474 173.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.21 153.73 37.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.978 0.911 . . . . 0.0 111.034 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.2 m -126.21 128.26 46.95 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.737 1.615 . . . . 0.0 106.795 169.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 m -80.06 126.32 30.91 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.25 152.19 40.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.04 128.6 59.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 ' CE ' ' A' ' 12' ' ' MET . 1.3 pp -125.83 164.56 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.33 1.052 . . . . 0.0 110.546 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.78 118.7 36.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.651 0.78 . . . . 0.0 110.887 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.35 87.41 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.905 2.082 . . . . 0.0 109.399 174.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.74 56.4 0.07 OUTLIER Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 p -126.54 20.72 7.24 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.624 1.169 . . . . 0.0 112.88 -160.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.92 -160.92 15.14 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -170.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.98 159.33 38.86 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.633 1.555 . . . . 0.0 110.18 171.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.3 m -133.45 117.13 16.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.1 m -143.71 175.82 9.69 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.541 1.537 . . . . 0.0 109.243 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.811 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 -170.49 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 CA-C-O 117.516 -1.713 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.9 m 73.11 93.43 0.08 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.121 1.769 . . . . 0.0 109.151 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.3 86.64 2.03 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.11 -73.84 0.44 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.2 m 56.0 -63.36 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.035 2.534 . . . . 0.0 113.069 -171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 t -60.25 114.4 2.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.439 1.096 . . . . 0.0 109.184 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.18 117.79 0.8 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 174.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.43 135.67 57.76 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -156.75 177.01 11.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.195 2.198 . . . . 0.0 107.847 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 54.83 58.66 4.62 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.275 1.43 . . . . 0.0 109.893 -166.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.6 mt -116.88 157.32 25.85 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.398 1.479 . . . . 0.0 107.665 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.1 mtm -128.16 146.07 50.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.074 0.95 . . . . 0.0 108.954 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 m -122.56 112.21 17.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -171.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.9 mt -117.69 168.3 10.57 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 127.215 2.206 . . . . 0.0 108.464 -171.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.8 m -133.66 150.03 51.56 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.837 -0.539 . . . . 0.0 109.601 170.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.657 HG22 ' HA ' ' A' ' 45' ' ' CYS . 5.4 pt -140.13 145.7 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.651 1.18 . . . . 0.0 110.258 173.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.91 118.5 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.506 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 9.6 tttt -56.08 129.92 41.95 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.166 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.05 -81.99 0.63 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -154.91 143.69 20.75 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.659 1.184 . . . . 0.0 108.522 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 55.71 -3.31 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.294 3.038 . . . . 0.0 115.557 -176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 163.26 -177.3 39.29 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -92.66 3.81 54.88 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.236 1.014 . . . . 0.0 111.088 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.11 -52.85 3.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 120.751 -1.218 . . . . 0.0 112.066 -172.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -61.67 166.75 4.01 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 123.165 1.459 . . . . 0.0 111.886 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 p -126.9 151.33 48.58 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.617 -1.629 . . . . 0.0 108.235 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 39.4 pt -119.9 171.45 8.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.65 161.52 36.27 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 125.181 1.393 . . . . 0.0 109.207 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.96 143.49 45.64 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 161.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.6 p -130.17 176.68 2.66 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 168.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.28 -19.1 62.1 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.319 2.013 . . . . 0.0 112.166 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.4 p -109.47 3.27 21.16 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.529 1.132 . . . . 0.0 112.496 -169.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.11 -163.17 12.4 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.722 ' HG3' HG21 ' A' ' 70' ' ' VAL . 4.1 mm100 -82.3 145.57 29.9 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 117.835 0.817 . . . . 0.0 109.986 -167.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -131.69 156.65 45.52 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 123.265 0.626 . . . . 0.0 109.369 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.17 140.67 17.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 171.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -106.09 -64.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.036 1.335 . . . . 0.0 108.581 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.3 tp60 -142.84 134.45 26.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.74 136.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.742 1.617 . . . . 0.0 107.298 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -122.26 -50.57 2.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.955 -174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -93.23 95.26 9.26 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.9 mt -65.53 -54.28 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.256 1.822 . . . . 0.0 109.975 -171.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -60.0 -28.32 67.62 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.702 0.683 . . . . 0.0 111.067 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.15 -25.62 72.28 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 118.024 -1.431 . . . . 0.0 112.277 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.657 ' HA ' HG22 ' A' ' 16' ' ' ILE . 4.7 m -140.31 75.9 27.07 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 119.686 1.743 . . . . 0.0 112.42 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.77 154.8 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.135 2.557 . . . . 0.0 110.218 170.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.82 -45.1 2.4 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.753 1.168 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.7 tp -51.57 132.05 30.01 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.093 2.157 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.44 -173.3 2.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.076 1.351 . . . . 0.0 109.038 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.17 104.72 14.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.49 -15.67 3.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.946 1.736 . . . . 0.0 111.653 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.51 105.53 0.11 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 128.416 2.686 . . . . 0.0 110.659 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.2 101.34 4.59 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.084 1.354 . . . . 0.0 109.102 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.4 mt -64.65 129.95 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.438 1.895 . . . . 0.0 109.944 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.5 t -120.79 -43.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.57 1.548 . . . . 0.0 110.435 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -133.44 149.42 51.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.937 0.895 . . . . 0.0 109.53 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.1 mt -130.67 127.2 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 163.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 42.45 58.33 3.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.625 1.57 . . . . 0.0 112.223 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 67.06 -18.78 0.12 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 127.598 2.359 . . . . 0.0 114.886 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -76.89 132.42 39.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.05 126.84 32.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.434 HG12 HD12 ' A' ' 65' ' ' LEU . 27.8 m -124.31 8.29 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -171.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -59.56 -13.61 9.94 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -129.63 38.62 3.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.055 1.342 . . . . 0.0 109.107 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.434 HD12 HG12 ' A' ' 62' ' ' VAL . 17.5 mt -121.5 146.04 47.33 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 126.5 1.92 . . . . 0.0 108.662 171.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -76.53 155.98 33.27 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 116.993 -1.479 . . . . 0.0 109.413 179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.609 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 7.6 t60 -49.21 -28.72 4.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.739 175.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.5 m -74.32 -31.2 62.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 120.117 1.326 . . . . 0.0 111.945 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -78.82 -47.87 15.83 Favored 'General case' 0 C--O 1.22 -0.489 0 C-N-CA 125.004 1.322 . . . . 0.0 110.554 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.722 HG21 ' HG3' ' A' ' 34' ' ' GLN . 2.7 m -54.56 -37.84 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 130.591 3.556 . . . . 0.0 111.726 168.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.98 -47.18 83.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 123.279 0.632 . . . . 0.0 109.843 169.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.59 -42.55 99.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.433 1.093 . . . . 0.0 111.759 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.7 mt -52.86 -58.45 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 126.288 1.835 . . . . 0.0 108.879 169.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.3 mt -59.45 -33.44 71.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.118 0.417 . . . . 0.0 111.406 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -64.66 -46.78 80.98 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.434 173.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.07 -28.89 69.18 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.174 0.99 . . . . 0.0 112.493 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 66.1 m -50.81 135.98 26.82 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.111 1.364 . . . . 0.0 112.39 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.84 150.31 83.85 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.254 3.303 . . . . 0.0 110.615 173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.506 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 75.7 mt -91.89 148.78 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.29 13.78 55.04 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.47 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -109.23 136.02 49.37 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.78 140.5 58.22 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.6 m -134.53 124.18 25.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.183 1.793 . . . . 0.0 106.997 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.0 m -91.45 127.94 37.08 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 mp -124.89 125.04 43.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.38 129.23 58.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -127.44 150.37 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.37 1.068 . . . . 0.0 108.833 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -84.74 107.8 17.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 108.889 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -159.86 138.99 10.94 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.468 1.031 . . . . 0.0 110.299 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.23 176.78 45.61 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 127.797 2.617 . . . . 0.0 107.467 166.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.9 t 51.8 89.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.171 1.788 . . . . 0.0 112.185 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.65 -164.39 26.29 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -80.6 -29.21 2.4 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.913 2.409 . . . . 0.0 115.048 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.6 m -158.57 120.92 3.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.968 1.258 . . . . 0.0 110.577 -156.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.8 m -56.88 -28.52 61.93 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.143 0.883 . . . . 0.0 112.378 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 N-CA-C 104.869 -3.293 . . . . 0.0 104.869 -170.961 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -156.42 177.58 11.3 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 170.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.22 12.04 3.11 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.811 1.645 . . . . 0.0 114.466 173.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.78 81.66 1.67 Allowed Glycine 0 C--N 1.337 0.637 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 m -175.13 83.6 0.03 OUTLIER 'General case' 0 C--O 1.233 0.222 0 C-N-CA 127.354 2.262 . . . . 0.0 107.872 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.6 m -76.07 178.28 6.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.787 0.327 . . . . 0.0 110.33 161.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.56 167.95 40.02 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-O 122.714 1.174 . . . . 0.0 113.897 -165.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -139.18 166.43 24.55 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.863 2.065 . . . . 0.0 107.78 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.75 67.53 1.21 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -92.05 100.89 13.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.83 -156.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.513 2.325 . . . . 0.0 108.803 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.5 mtm -128.02 136.34 51.13 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.424 HG23 HG12 ' A' ' 86' ' ' ILE . 76.6 m -134.82 104.97 6.22 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 -168.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.37 168.43 9.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.116 1.767 . . . . 0.0 108.53 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.26 144.88 50.96 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.705 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.7 pt -137.94 131.94 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.111 0.965 . . . . 0.0 111.148 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 75.1 t -90.4 114.59 28.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 122.292 1.044 . . . . 0.0 109.063 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 34.7 tttm -65.11 126.43 28.07 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 170.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.04 -71.85 1.3 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 119.43 1.013 . . . . 0.0 111.719 -171.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.55 -52.87 0.03 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.866 1.266 . . . . 0.0 109.893 172.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . 0.256 5.8 pt20 -74.28 58.22 0.72 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.966 1.365 . . . . 0.0 110.555 171.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 56.72 -150.59 26.85 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.739 -161.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -81.95 157.89 24.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 160.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.36 -45.36 30.54 Favored Glycine 0 C--O 1.223 -0.586 0 C-N-CA 119.403 -1.38 . . . . 0.0 112.05 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -52.07 155.94 1.73 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.667 1.233 . . . . 0.0 111.225 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.2 p -120.39 161.15 21.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.193 1.397 . . . . 0.0 108.04 -172.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.5 pt -123.31 159.41 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 O-C-N 121.525 -0.735 . . . . 0.0 110.079 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 149.0 52.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.091 1.756 . . . . 0.0 107.527 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -76.5 141.08 41.38 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.277 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.08 165.36 29.77 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.646 1.179 . . . . 0.0 108.578 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.04 -2.86 8.67 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.791 2.994 . . . . 0.0 116.084 -164.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.5 p -136.81 2.53 2.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.468 1.031 . . . . 0.0 112.723 175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.32 -176.63 28.85 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.7 mm-40 -77.93 148.62 34.43 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 122.15 -0.618 . . . . 0.0 110.332 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -131.63 162.64 29.9 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 123.814 0.845 . . . . 0.0 109.633 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.16 127.63 32.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -76.57 -69.05 0.54 Allowed 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.097 1.359 . . . . 0.0 107.625 172.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -152.33 141.1 20.98 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.5 0.591 . . . . 0.0 109.915 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 91.8 mt -85.57 114.76 25.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 mt -104.35 -9.8 18.24 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.968 0.907 . . . . 0.0 110.888 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -140.23 81.28 1.8 Allowed 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.561 1.944 . . . . 0.0 105.952 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 80.5 mt -67.51 -45.2 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.169 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.22 -34.44 59.25 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.514 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.53 -8.94 87.03 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.783 0.719 . . . . 0.0 111.889 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.705 ' HA ' HG22 ' A' ' 16' ' ' ILE . 12.4 m -126.21 67.44 63.41 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 118.755 1.278 . . . . 0.0 110.748 170.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -58.53 158.69 22.47 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.656 2.237 . . . . 0.0 112.393 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.18 -20.72 0.41 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.598 1.57 . . . . 0.0 114.314 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.8 tp -63.52 133.61 54.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.258 1.823 . . . . 0.0 107.902 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.2 t -125.37 10.9 8.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.904 0.881 . . . . 0.0 112.438 -167.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 65.29 150.96 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 130.502 3.521 . . . . 0.0 114.849 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 8.06 32.8 Favored Glycine 0 CA--C 1.537 1.427 0 O-C-N 121.206 -0.934 . . . . 0.0 113.542 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.46 113.07 2.46 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.603 1.561 . . . . 0.0 109.623 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -72.43 106.32 4.49 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.703 1.201 . . . . 0.0 109.79 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.49 142.29 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.336 1.054 . . . . 0.0 110.229 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.49 -55.74 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 125.338 1.455 . . . . 0.0 110.504 -174.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.27 155.22 46.67 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.892 0.877 . . . . 0.0 109.463 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.2 mt -133.59 132.92 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 163.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 42.04 44.22 2.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.581 1.952 . . . . 0.0 113.654 173.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 59.06 42.52 18.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.636 1.175 . . . . 0.0 112.815 -177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -128.55 136.48 50.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.421 1.888 . . . . 0.0 107.12 160.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.16 120.59 23.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.411 1.084 . . . . 0.0 109.67 175.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.694 HG12 HD22 ' A' ' 65' ' ' LEU . 10.4 m -115.89 16.94 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 128.046 2.538 . . . . 0.0 107.86 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -42.45 97.24 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 119.714 -1.866 . . . . 0.0 111.223 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.9 -25.53 58.99 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.347 0.976 . . . . 0.0 111.285 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 HG12 ' A' ' 62' ' ' VAL . 5.6 mp -60.11 138.69 57.84 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.966 1.706 . . . . 0.0 112.887 -163.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.9 m -63.58 165.33 8.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.43 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -51.47 -53.61 35.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.199 0.599 . . . . 0.0 110.624 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.4 m -62.52 -34.36 76.75 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.803 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -62.94 -47.04 84.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.24 0.927 . . . . 0.0 108.814 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.6 t -62.7 -44.5 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.704 1.202 . . . . 0.0 110.275 176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.28 -43.11 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 O-C-N 121.64 -0.662 . . . . 0.0 109.987 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -44.6 78.99 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.96 0.904 . . . . 0.0 110.5 -172.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.49 -51.47 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.474 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 50.7 mt -68.24 -13.58 62.35 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.537 -0.727 . . . . 0.0 112.646 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -83.44 -33.64 25.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.397 1.453 . . . . 0.0 110.657 170.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -72.3 -36.01 68.83 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.912 0.778 . . . . 0.0 109.409 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 92.0 m -47.84 137.65 10.13 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.875 1.27 . . . . 0.0 112.208 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.63 127.33 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.503 3.469 . . . . 0.0 111.873 -172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 53.4 mt -66.88 134.7 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.54 10.94 85.93 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.236 0.922 . . . . 0.0 112.391 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.1 m -113.89 158.96 20.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.307 1.443 . . . . 0.0 108.54 170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.19 150.32 43.25 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 162.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.6 m -131.46 146.25 52.16 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 127.803 2.441 . . . . 0.0 106.36 172.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.87 122.7 45.71 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -168.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -123.65 157.3 34.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 119.563 1.074 . . . . 0.0 109.308 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 13' ' ' THR . 4.1 mt -129.62 140.54 48.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 167.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.52 156.06 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.543 1.137 . . . . 0.0 109.939 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.96 84.96 5.41 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.178 -0.951 . . . . 0.0 110.824 -168.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 -135.6 154.62 51.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 162.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.27 -98.25 1.99 Allowed Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 105.811 -2.916 . . . . 0.0 105.811 157.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.7 t -147.24 154.24 40.77 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.937 0.875 . . . . 0.0 109.469 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.59 167.08 35.26 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.69 98.13 0.94 Allowed 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.366 2.71 . . . . 0.0 109.225 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.9 m -127.42 156.65 41.74 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 127.043 2.137 . . . . 0.0 107.273 163.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.82 105.0 0.07 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.482 1.913 . . . . 0.0 108.837 -172.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.265 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 175.196 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -64.53 88.29 0.06 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 117.771 0.785 . . . . 0.0 109.332 168.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.2 p -135.37 -4.09 2.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.372 1.069 . . . . 0.0 112.486 -174.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.69 -79.18 0.27 Allowed Glycine 0 C--N 1.337 0.589 0 N-CA-C 107.551 -2.22 . . . . 0.0 107.551 168.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -54.24 104.63 0.11 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.625 1.17 . . . . 0.0 109.026 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.2 m -159.3 170.29 22.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 127.651 2.38 . . . . 0.0 107.485 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.51 -66.43 2.67 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 124.844 1.212 . . . . 0.0 110.885 174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -61.14 138.4 58.21 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.555 1.142 . . . . 0.0 110.589 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.45 -170.69 3.51 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 126.057 1.743 . . . . 0.0 107.951 166.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -73.23 107.86 5.79 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 154.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -68.53 -176.97 0.85 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.07 1.748 . . . . 0.0 108.932 164.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.3 mtp -89.69 135.77 33.42 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 162.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.8 m -112.92 142.72 45.28 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 68.3 mt -133.54 167.83 19.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.159 1.784 . . . . 0.0 109.24 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.4 m -135.5 153.08 51.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.307 1.043 . . . . 0.0 108.687 168.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.581 HG22 ' HA ' ' A' ' 45' ' ' CYS . 13.6 pt -144.18 161.82 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.252 1.421 . . . . 0.0 110.071 174.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.52 115.15 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 122.363 1.077 . . . . 0.0 108.418 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -67.77 115.17 7.02 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.425 1.49 . . . . 0.0 109.824 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.86 -81.98 0.4 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-O 118.811 -0.994 . . . . 0.0 113.174 -171.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.35 139.77 18.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 119.512 1.656 . . . . 0.0 111.071 -175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 61.64 -35.68 0.11 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.014 2.126 . . . . 0.0 112.45 -166.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.52 -141.48 3.37 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.634 1.588 . . . . 0.0 109.472 168.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -94.04 153.48 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 170.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.12 -42.33 58.74 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.134 -1.032 . . . . 0.0 112.194 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.479 ' HD1' ' HG ' ' A' ' 45' ' ' CYS . 12.8 p90 -62.96 166.96 5.16 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 122.419 1.104 . . . . 0.0 111.786 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.0 p -125.79 153.34 44.17 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.593 1.157 . . . . 0.0 109.514 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.22 170.58 11.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.079 0.952 . . . . 0.0 109.823 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.1 149.71 41.94 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.95 2.1 . . . . 0.0 108.674 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.95 148.47 47.66 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 162.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.5 p -147.29 163.05 30.12 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.575 1.95 . . . . 0.0 106.726 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.96 12.73 0.21 Allowed 'Trans proline' 0 CA--C 1.543 0.961 1 C-N-CA 125.521 4.148 . . . . 0.0 113.884 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -144.17 -3.72 0.84 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.887 2.075 . . . . 0.0 111.134 -162.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.86 -164.4 17.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -169.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -82.91 146.98 28.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 119.094 1.447 . . . . 0.0 110.369 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -127.57 163.66 23.69 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 126.018 1.727 . . . . 0.0 109.298 173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.52 117.43 25.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -70.16 -61.63 1.7 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 125.052 1.341 . . . . 0.0 108.502 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -151.13 154.29 36.65 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.097 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.8 mt -106.18 110.13 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.795 2.438 . . . . 0.0 106.811 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.52 -5.58 22.63 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.918 1.287 . . . . 0.0 111.723 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -154.68 69.58 0.75 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.765 1.626 . . . . 0.0 109.192 -161.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.45 -62.56 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 125.186 1.395 . . . . 0.0 110.579 -159.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -67.92 -12.38 60.58 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.703 0.683 . . . . 0.0 112.658 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.02 -25.09 62.72 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.87 0.748 . . . . 0.0 111.856 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.581 ' HA ' HG22 ' A' ' 16' ' ' ILE . 34.9 m -128.35 76.88 77.79 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.199 1.0 . . . . 0.0 109.095 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -62.82 159.54 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.413 2.075 . . . . 0.0 110.833 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.27 -48.46 0.71 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.179 1.847 . . . . 0.0 114.238 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.9 tp -44.9 140.21 2.72 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 129.176 2.99 . . . . 0.0 112.357 -170.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.8 m -132.37 159.63 38.66 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.346 1.459 . . . . 0.0 110.255 170.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -60.09 146.46 42.92 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 165.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 2.44 59.75 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.444 -0.642 . . . . 0.0 113.673 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -62.8 112.6 2.61 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 163.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tp -80.52 129.52 34.56 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 mt -95.04 130.66 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -167.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.99 -51.02 6.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.633 1.573 . . . . 0.0 109.8 -170.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -138.6 150.43 46.29 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.935 0.894 . . . . 0.0 108.764 -176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.3 mt -131.72 124.96 54.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.163 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 168.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 38.92 54.92 2.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.801 1.641 . . . . 0.0 111.244 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 61.66 -6.89 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 128.769 2.828 . . . . 0.0 116.437 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -72.14 125.06 26.35 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.378 1.444 . . . . 0.0 108.052 171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.1 129.68 41.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.648 HG12 HD12 ' A' ' 65' ' ' LEU . 22.5 m -127.75 4.03 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.647 0.779 . . . . 0.0 111.833 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -50.67 -38.9 49.17 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.627 1.171 . . . . 0.0 110.861 165.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -105.36 21.31 17.38 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.802 0.841 . . . . 0.0 110.899 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.648 HD12 HG12 ' A' ' 62' ' ' VAL . 17.3 mt -117.67 150.33 39.24 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.913 1.233 . . . . 0.0 113.821 -171.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.92 154.16 42.52 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.507 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -51.18 -52.07 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.145 0.578 . . . . 0.0 111.951 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 m -63.93 -24.71 67.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 118.711 -0.662 . . . . 0.0 111.898 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -73.54 -42.12 62.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.628 1.104 . . . . 0.0 109.546 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.441 HG22 ' HB ' ' A' ' 62' ' ' VAL . 57.8 t -64.84 -40.66 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.548 0.739 . . . . 0.0 109.48 175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.5 t -55.9 -46.25 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.497 0.719 . . . . 0.0 109.492 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.42 -41.91 99.05 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.621 1.169 . . . . 0.0 110.909 -173.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -66.62 -44.54 89.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.31 -31.91 72.58 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.902 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 121.651 2.023 . . . . 0.0 110.82 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -59.85 -36.87 77.75 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.359 1.063 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 71.3 m -55.67 136.86 71.21 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.853 0.861 . . . . 0.0 111.546 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -63.37 144.16 90.4 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.146 3.231 . . . . 0.0 111.575 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.8 mt -76.89 134.07 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 168.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.05 28.43 68.5 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.63 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.6 m -129.83 159.89 35.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.13 134.96 41.16 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -105.36 129.8 53.61 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 168.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.2 m -87.59 135.58 33.3 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 174.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mp -135.57 167.65 20.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 118.692 0.678 . . . . 0.0 109.303 172.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -132.7 141.55 44.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.35 150.89 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.405 1.082 . . . . 0.0 110.404 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.7 97.14 8.95 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.077 1.751 . . . . 0.0 107.911 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -151.51 -70.04 0.17 Allowed 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 168.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 63.39 -167.41 23.68 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.84 124.11 22.04 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.544 1.138 . . . . 0.0 109.519 172.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -176.71 169.64 42.15 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.48 1.038 . . . . 0.0 110.713 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.98 136.39 37.96 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.79 2.326 . . . . 0.0 110.854 -170.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 m -62.81 145.36 55.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 158.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.4 m 46.74 78.87 0.06 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.78 1.276 . . . . 0.0 110.535 -156.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 117.136 -1.925 . . . . 0.0 110.605 169.031 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.776 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 m -73.87 112.08 9.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -149.25 151.48 34.32 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 169.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.32 -153.58 35.4 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -162.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.7 m -143.0 86.16 1.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.304 -1.115 . . . . 0.0 108.404 168.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.7 m 61.46 121.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.643 1.977 . . . . 0.0 111.56 -161.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.16 67.29 0.13 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -161.98 86.2 0.62 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.359 1.064 . . . . 0.0 108.211 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.77 161.61 20.61 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.366 0.666 . . . . 0.0 111.984 159.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -128.88 102.21 6.43 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.18 2.192 . . . . 0.0 105.855 165.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 88' ' ' HIS . 2.8 mm? -82.39 179.93 7.63 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 19.6 mtp -88.57 135.81 33.3 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.406 HG23 HG12 ' A' ' 86' ' ' ILE . 85.3 m -134.45 103.82 5.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -172.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.36 168.36 9.45 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 126.085 1.754 . . . . 0.0 108.748 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.3 m -126.94 142.91 51.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.634 HG22 ' HA ' ' A' ' 45' ' ' CYS . 26.9 pt -127.62 167.85 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.764 1.626 . . . . 0.0 108.943 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.0 t -129.22 149.7 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.253 1.821 . . . . 0.0 106.963 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -113.24 99.82 8.1 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.822 1.249 . . . . 0.0 111.359 -164.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.6 54.23 4.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.744 1.64 . . . . 0.0 114.183 -172.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.07 -42.43 0.53 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.583 . . . . 0.0 116.53 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -80.21 -11.52 59.73 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 121.001 1.728 . . . . 0.0 113.106 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' CD2' HD12 ' A' ' 16' ' ' ILE . 19.1 m-85 65.91 149.92 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 128.015 2.526 . . . . 0.0 110.32 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.62 -53.77 18.74 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -52.23 153.24 2.91 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.044 1.337 . . . . 0.0 111.831 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.3 p -116.96 148.47 41.38 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.465 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 pt -110.34 153.78 12.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 170.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -131.88 156.67 45.68 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.128 1.371 . . . . 0.0 108.757 173.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -77.79 139.52 39.35 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.623 1.569 . . . . 0.0 108.16 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.02 175.91 2.7 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.847 1.659 . . . . 0.0 108.831 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.39 -21.42 11.71 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.963 3.109 . . . . 0.0 113.373 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 p -104.27 -4.31 23.15 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -162.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.1 177.26 14.81 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 -162.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -71.35 148.43 47.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 118.351 1.075 . . . . 0.0 108.855 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -133.63 154.74 50.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG21 HD21 ' A' ' 48' ' ' LEU . 53.4 t -82.57 116.92 27.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -64.32 -58.96 5.02 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.603 169.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -153.74 144.34 22.47 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -173.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.0 mt -91.39 124.57 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 166.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.4 mt -119.06 -3.24 10.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.512 1.125 . . . . 0.0 112.336 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -136.0 91.54 2.7 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.58 -55.38 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -63.58 -29.83 71.02 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.692 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.67 -16.98 61.96 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.642 1.11 . . . . 0.0 112.869 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.634 ' HA ' HG22 ' A' ' 16' ' ' ILE . 98.3 m -136.7 66.92 57.67 Favored Pre-proline 0 CA--C 1.548 0.87 0 CA-C-N 120.0 1.9 . . . . 0.0 111.124 -171.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.68 117.8 4.93 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.684 2.923 . . . . 0.0 112.581 -173.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.45 -7.49 81.85 Favored Glycine 0 C--N 1.335 0.493 0 CA-C-O 119.174 -0.792 . . . . 0.0 114.213 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.556 HD21 HG21 ' A' ' 36' ' ' VAL . 2.1 tt -66.07 153.27 42.73 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 82.6 m -124.46 159.8 29.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.517 1.127 . . . . 0.0 111.036 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.64 145.95 24.88 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 47.84 43.69 23.53 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -167.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -65.9 -170.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.494 1.117 . . . . 0.0 108.766 161.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -144.96 119.0 9.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.2 mt -89.63 127.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -171.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.5 t -124.05 -48.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.861 -163.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -134.74 132.6 38.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mt -115.62 129.41 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 101.982 -3.34 . . . . 0.0 101.982 167.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.86 16.77 7.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.48 1.912 . . . . 0.0 114.809 164.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 58.87 50.3 8.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.19 1.359 . . . . 0.0 112.019 -165.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.56 -15.38 10.85 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 54.95 133.19 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 130.712 3.605 . . . . 0.0 113.53 -165.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.29 7.34 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.001 0.921 . . . . 0.0 112.882 -172.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.46 -18.22 64.56 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.61 -1.306 . . . . 0.0 113.597 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -110.37 -21.85 11.99 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.891 0.877 . . . . 0.0 110.047 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.23 139.47 58.49 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.916 0.865 . . . . 0.0 111.735 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.8 m -65.54 158.18 27.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.238 1.415 . . . . 0.0 110.553 173.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -50.61 -54.07 25.73 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 124.353 1.061 . . . . 0.0 110.154 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.04 -17.78 63.69 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.11 1.764 . . . . 0.0 112.819 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.44 -36.81 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.433 1.093 . . . . 0.0 108.996 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -74.21 -43.45 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.662 1.185 . . . . 0.0 109.286 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.9 t -51.54 -43.73 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.039 0 C-N-CA 123.875 0.87 . . . . 0.0 108.894 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.506 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -65.02 -42.97 93.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.2 mt -60.44 -44.36 96.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -65.35 -31.28 72.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.465 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 47.8 mtmt -62.37 -43.4 98.91 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 121.219 1.827 . . . . 0.0 111.298 165.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.66 -32.78 71.95 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.984 1.314 . . . . 0.0 112.547 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 96.5 m -53.67 139.33 50.57 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.053 1.341 . . . . 0.0 111.811 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.19 122.33 9.38 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 123.727 2.951 . . . . 0.0 110.048 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.4 mt -61.1 147.66 10.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.27 9.8 13.25 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.36 -1.244 . . . . 0.0 114.144 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 m -121.29 173.59 7.24 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.667 1.587 . . . . 0.0 108.192 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.3 153.19 25.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.687 0.756 . . . . 0.0 111.425 -175.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.2 m -142.22 144.34 33.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.415 1.486 . . . . 0.0 108.834 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -110.93 107.62 17.12 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.049 2.14 . . . . 0.0 109.144 -157.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.3 112.53 16.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 121.159 1.8 . . . . 0.0 111.615 -170.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 13' ' ' THR . 3.4 mt -87.23 130.12 37.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 125.595 1.558 . . . . 0.0 108.608 171.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.25 150.21 30.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.011 1.324 . . . . 0.0 111.187 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.76 ' HA ' HD12 ' A' ' 11' ' ' LEU . 6.1 t-160 -78.11 77.34 4.62 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 0.0 111.329 -168.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -152.13 -177.87 6.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.487 1.915 . . . . 0.0 108.216 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.98 179.73 40.55 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 129.224 3.297 . . . . 0.0 106.887 171.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.3 m -54.07 156.82 2.82 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.637 1.718 . . . . 0.0 112.629 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.88 -176.51 41.52 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.96 -52.77 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.621 2.214 . . . . 0.0 110.729 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m 64.66 -178.37 0.17 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.028 1.331 . . . . 0.0 110.44 -160.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.1 m 55.11 47.91 20.8 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.069 1.347 . . . . 0.0 112.26 -176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 106.596 -2.602 . . . . 0.0 106.596 174.846 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.198 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 m 59.71 -174.22 0.11 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.849 0.86 . . . . 0.0 110.91 -171.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.3 t -122.94 1.72 9.31 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.503 1.121 . . . . 0.0 110.011 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.39 166.68 33.29 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 126.893 2.187 . . . . 0.0 108.084 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.1 p -157.14 -59.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.215 1.406 . . . . 0.0 108.56 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -155.53 158.88 39.18 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.719 2.007 . . . . 0.0 108.018 172.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.85 171.28 14.86 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 159.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.69 169.11 3.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.127 0.571 . . . . 0.0 109.909 165.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -129.79 -4.36 4.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.693 0.797 . . . . 0.0 111.805 171.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -43.66 98.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 129.607 3.163 . . . . 0.0 113.134 -168.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.7 mt -124.9 169.58 11.93 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 127.236 2.214 . . . . 0.0 107.853 163.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.78 137.09 41.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.825 1.25 . . . . 0.0 107.913 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.8 m -125.45 120.03 29.87 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -168.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.8 mt -137.19 167.07 22.26 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.804 1.242 . . . . 0.0 107.943 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.58 143.83 51.09 Favored 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.545 HG21 HD12 ' A' ' 48' ' ' LEU . 20.9 pt -137.91 161.85 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.779 1.232 . . . . 0.0 109.733 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.1 t -117.46 147.5 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 171.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HG2' HD13 ' A' ' 79' ' ' ILE . 75.3 tttt -97.12 86.7 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.527 -0.733 . . . . 0.0 110.519 -171.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.6 71.87 0.68 Allowed Glycine 0 CA--C 1.525 0.675 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.614 -160.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 60.52 154.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 128.823 2.849 . . . . 0.0 115.043 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 47.78 -0.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.211 2.204 . . . . 0.0 115.58 -158.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.98 -129.97 5.46 Favored Glycine 0 N--CA 1.44 -1.058 0 N-CA-C 104.453 -3.459 . . . . 0.0 104.453 -172.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE2' HD12 ' A' ' 16' ' ' ILE . 48.7 m-85 -97.79 168.06 10.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 166.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.17 -45.12 57.52 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 121.706 -0.621 . . . . 0.0 111.895 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -64.47 -179.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 127.052 2.141 . . . . 0.0 113.388 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 p -132.81 147.04 52.31 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.834 1.254 . . . . 0.0 109.76 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.7 pt -110.7 167.68 4.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 124.286 1.035 . . . . 0.0 109.28 166.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -138.35 161.96 35.61 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.433 1.893 . . . . 0.0 107.217 168.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -74.33 148.73 41.07 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.687 1.195 . . . . 0.0 108.11 163.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.07 163.6 23.04 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.163 0.985 . . . . 0.0 108.41 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.16 -1.34 2.85 Favored 'Trans proline' 0 C--N 1.345 0.371 1 C-N-CA 126.166 4.577 . . . . 0.0 116.993 -170.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.8 p -132.62 -13.34 2.95 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.337 1.055 . . . . 0.0 111.848 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 147.08 172.32 17.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -164.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -68.03 124.87 24.58 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.856 1.262 . . . . 0.0 109.15 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -102.71 163.48 12.2 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-O 122.188 0.994 . . . . 0.0 109.625 171.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.48 HG21 HD21 ' A' ' 48' ' ' LEU . 92.8 t -72.03 128.03 34.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 163.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -71.62 -69.26 0.39 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 168.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -154.22 141.33 19.4 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.987 0.915 . . . . 0.0 108.592 -175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.487 HD11 HD23 ' A' ' 48' ' ' LEU . 30.8 mt -89.72 135.35 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 170.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -121.15 -31.0 4.22 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.445 0.698 . . . . 0.0 110.778 -171.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -130.65 95.92 3.98 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 76.6 mt -70.57 -40.71 77.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.548 0.739 . . . . 0.0 110.513 -171.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.06 -19.21 61.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.915 -1.116 . . . . 0.0 111.656 175.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.38 -23.16 75.05 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 121.135 -0.978 . . . . 0.0 111.562 166.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 16' ' ' ILE . 90.2 m -147.51 74.48 11.51 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 119.559 1.68 . . . . 0.0 110.067 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -58.29 158.94 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.54 1.493 . . . . 0.0 112.531 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.46 -46.51 1.64 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.824 -0.987 . . . . 0.0 113.251 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.545 HD12 HG21 ' A' ' 16' ' ' ILE . 3.0 tt -52.74 146.12 10.99 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 127.253 2.221 . . . . 0.0 109.993 -166.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.54 162.02 31.25 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.045 0.926 . . . . 0.0 111.71 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -69.32 148.39 49.78 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.033 -1.042 . . . . 0.0 109.453 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.56 7.13 25.85 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 118.007 -1.441 . . . . 0.0 114.176 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -51.53 126.53 17.62 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.576 1.688 . . . . 0.0 106.542 166.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -96.11 110.94 23.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 67.6 mt -70.91 141.58 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 120.321 1.419 . . . . 0.0 109.254 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.4 t -127.81 -43.64 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.061 1.344 . . . . 0.0 110.261 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -135.87 156.74 48.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.272 0.558 . . . . 0.0 109.53 171.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 42.5 mt -131.34 125.67 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 164.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 45.87 37.83 3.91 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.237 1.415 . . . . 0.0 114.819 169.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 54.59 60.55 3.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.187 1.795 . . . . 0.0 112.629 -169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -134.79 133.93 40.36 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 151.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -92.24 122.51 34.79 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.293 1.037 . . . . 0.0 108.595 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.45 -1.35 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -162.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -24.29 40.11 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.869 1.668 . . . . 0.0 113.447 177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -91.25 1.13 57.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.723 1.609 . . . . 0.0 112.126 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.0 mt -99.54 173.48 6.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.287 1.435 . . . . 0.0 111.255 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.2 m -109.27 159.98 16.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.208 1.803 . . . . 0.0 108.814 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -50.21 -50.73 48.62 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.367 0.667 . . . . 0.0 111.922 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.5 m -64.57 -31.33 72.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.562 0.745 . . . . 0.0 111.068 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.24 -45.49 84.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.725 0.693 . . . . 0.0 109.273 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -68.87 -37.35 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.566 1.147 . . . . 0.0 108.942 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.0 t -58.2 -45.62 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.057 0.943 . . . . 0.0 109.152 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -34.25 71.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.329 0.585 . . . . 0.0 112.345 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.7 mt -60.24 -56.08 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.775 1.63 . . . . 0.0 107.654 168.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.6 mt -61.53 -27.39 68.57 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.603 -0.686 . . . . 0.0 111.933 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -66.25 -41.07 90.47 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 120.738 -1.226 . . . . 0.0 109.889 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -59.66 -40.77 88.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.582 1.153 . . . . 0.0 110.736 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.9 m -49.41 139.65 14.23 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.747 1.219 . . . . 0.0 112.173 -177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -67.15 118.74 5.8 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.299 3.333 . . . . 0.0 110.995 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.437 HD13 ' HG2' ' A' ' 18' ' ' LYS . 4.4 mm -56.36 137.25 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.09 18.86 71.42 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 125.223 1.392 . . . . 0.0 113.372 177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 t -113.72 163.87 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.391 1.477 . . . . 0.0 107.403 167.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -62.99 153.92 32.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 122.43 1.109 . . . . 0.0 110.309 163.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -133.15 140.94 47.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 128.167 2.587 . . . . 0.0 105.166 163.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.3 m -89.32 135.77 33.39 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.237 1.815 . . . . 0.0 106.259 168.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 16' ' ' ILE . 3.9 mp -117.28 164.31 15.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 162.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.9 mt -132.26 137.49 54.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 164.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -134.47 157.25 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.932 1.693 . . . . 0.0 109.112 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.92 98.62 11.7 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.311 1.044 . . . . 0.0 109.144 -171.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -155.22 162.98 40.79 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.56 -0.713 . . . . 0.0 110.01 168.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.29 -63.49 0.03 OUTLIER Glycine 0 C--N 1.332 0.334 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 t -149.09 -162.61 1.6 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-N 117.881 0.84 . . . . 0.0 110.451 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -108.91 177.06 20.24 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.793 1.663 . . . . 0.0 111.278 171.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.46 -34.15 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.976 2.45 . . . . 0.0 113.023 -174.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.5 p -86.93 108.02 18.62 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.682 1.193 . . . . 0.0 111.213 -158.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.8 m 72.27 -176.35 0.18 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.816 2.046 . . . . 0.0 111.568 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 -174.622 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 p -157.92 170.23 22.79 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 117.985 0.893 . . . . 0.0 109.28 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m 51.09 -166.72 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.18 1.392 . . . . 0.0 110.299 -166.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 53.11 -153.6 7.12 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 123.933 0.778 . . . . 0.0 111.819 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 p -140.77 137.71 33.58 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.865 0.866 . . . . 0.0 109.312 173.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.32 153.98 33.2 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.673 0.789 . . . . 0.0 109.488 170.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.54 -160.81 7.69 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 167.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -32.36 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 128.055 2.542 . . . . 0.0 111.93 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.62 -17.14 64.67 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -164.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 43.56 76.6 0.08 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.147 2.179 . . . . 0.0 111.503 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mp -96.72 167.41 11.14 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.497 -0.752 . . . . 0.0 109.499 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 38.2 mtm -105.32 114.97 29.47 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 m -76.74 140.9 40.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 157.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -140.57 168.51 19.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.01 2.124 . . . . 0.0 106.955 174.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.8 m -125.07 147.7 48.86 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.142 -0.974 . . . . 0.0 108.487 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 45' ' ' CYS . 30.0 pt -131.97 163.47 37.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 124.524 1.129 . . . . 0.0 109.216 171.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 t -136.04 137.68 48.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 72.7 tttt -108.38 81.9 1.54 Allowed 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.177 -0.952 . . . . 0.0 113.452 -153.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -47.69 -78.7 0.08 OUTLIER Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.514 1.054 . . . . 0.0 115.236 -165.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -147.82 -60.34 0.26 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.362 1.581 . . . . 0.0 112.392 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -82.74 44.73 0.93 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.892 0.853 . . . . 0.0 111.046 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 64.48 74.94 0.41 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 124.64 1.114 . . . . 0.0 111.896 177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 62.09 -86.85 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 125.774 1.63 . . . . 0.0 108.737 -176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.48 -31.61 0.58 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.643 1.592 . . . . 0.0 111.159 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.427 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 34.0 p90 -61.44 165.72 4.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.046 1.339 . . . . 0.0 110.353 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.412 HG23 HD23 ' A' ' 40' ' ' LEU . 17.3 p -119.8 147.46 44.62 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.34 -0.845 . . . . 0.0 108.771 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 pt -113.32 162.66 11.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 123.353 0.661 . . . . 0.0 109.332 167.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.51 157.8 41.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 127.521 2.329 . . . . 0.0 106.713 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -74.53 148.07 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.6 p -137.52 162.73 53.23 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.17 1.45 0.91 Allowed 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.319 3.346 . . . . 0.0 114.567 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -131.73 -0.87 3.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.014 1.326 . . . . 0.0 112.453 -166.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.63 179.26 15.73 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -168.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -77.06 154.84 32.96 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 118.541 1.171 . . . . 0.0 111.053 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -148.37 159.83 43.62 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 123.961 0.904 . . . . 0.0 112.579 -178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.41 115.4 22.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 125.554 1.541 . . . . 0.0 107.56 -173.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -72.93 -44.2 61.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.598 171.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' HB3' HD21 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -163.25 160.4 23.88 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -171.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 35.5 mt -124.67 104.21 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' A' ' 38' ' ' GLN . 1.4 mm? -105.2 -4.25 21.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.061 1.745 . . . . 0.0 112.466 -171.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -143.42 96.38 2.9 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 157.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.23 -42.49 84.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.3 1.84 . . . . 0.0 109.403 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.93 -33.53 75.8 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.368 -0.833 . . . . 0.0 111.144 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.19 -21.41 79.26 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.109 -0.828 . . . . 0.0 112.371 171.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.675 ' HA ' HG22 ' A' ' 16' ' ' ILE . 4.4 m -129.47 68.62 80.57 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 118.891 1.345 . . . . 0.0 110.123 -174.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.03 149.77 88.89 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.143 1.895 . . . . 0.0 110.246 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.02 -21.44 0.37 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 118.298 -1.279 . . . . 0.0 115.077 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.29 136.15 57.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.357 1.578 . . . . 0.0 110.004 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.9 m -127.72 160.62 31.13 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.969 1.308 . . . . 0.0 109.633 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -71.97 139.85 48.85 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.193 0.997 . . . . 0.0 109.418 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.22 50.02 66.32 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -64.57 -167.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.575 1.95 . . . . 0.0 110.105 151.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.73 115.86 6.96 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.411 HG22 HG23 ' A' ' 62' ' ' VAL . 2.7 mm -70.74 125.58 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 125.353 1.461 . . . . 0.0 110.546 -171.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.68 -56.9 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.67 1.188 . . . . 0.0 111.381 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -133.96 145.84 49.91 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.5 mt -134.36 123.81 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 50.85 33.62 8.95 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.871 1.268 . . . . 0.0 112.543 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.7 11.48 8.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 128.635 2.774 . . . . 0.0 115.162 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.24 132.26 34.96 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.187 1.395 . . . . 0.0 107.451 163.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -80.13 138.81 36.99 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 174.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 54' ' ' ILE . 35.3 m -135.99 13.46 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.403 1.481 . . . . 0.0 111.659 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.852 -1.155 . . . . 0.0 113.383 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -120.37 30.09 7.13 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.978 0.808 . . . . 0.0 109.698 -174.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -98.04 164.88 12.16 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.194 0.998 . . . . 0.0 110.606 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -84.91 162.5 19.43 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.076 1.35 . . . . 0.0 109.984 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -45.69 -58.46 3.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 126.608 1.963 . . . . 0.0 110.551 174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.4 m -58.53 -40.36 82.74 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.284 1.033 . . . . 0.0 110.694 -172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -65.68 -44.48 86.09 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.851 1.26 . . . . 0.0 109.962 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.63 -39.75 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.957 177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.1 t -62.15 -40.48 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 O-C-N 121.617 -0.677 . . . . 0.0 109.579 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -48.63 78.87 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.551 1.54 . . . . 0.0 110.199 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.4 mt -60.09 -43.75 93.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.979 1.312 . . . . 0.0 109.24 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.4 mt -69.05 -27.11 65.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.024 -0.989 . . . . 0.0 111.783 175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -65.57 -44.39 86.86 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 121.15 1.795 . . . . 0.0 108.268 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.47 -26.14 68.31 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 123.711 0.632 . . . . 0.0 112.374 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 94.6 m -53.51 134.13 53.79 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.045 0.538 . . . . 0.0 110.67 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -68.0 135.13 34.01 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.217 3.278 . . . . 0.0 110.698 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.4 mm -71.27 127.69 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 125.534 1.534 . . . . 0.0 107.983 -175.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.96 11.87 59.05 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 126.935 2.207 . . . . 0.0 113.134 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 m -92.2 167.36 12.09 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 164.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 149.17 34.45 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 173.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -131.44 126.35 34.84 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.3 m -101.23 113.63 26.86 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -167.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.55 153.84 34.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.198 0.908 . . . . 0.0 109.733 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 mt -129.55 136.36 59.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.06 153.27 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.845 1.258 . . . . 0.0 110.869 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 105.95 17.61 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.641 1.977 . . . . 0.0 107.316 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 -159.12 -51.56 0.06 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.221 1.809 . . . . 0.0 109.872 170.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.07 -148.64 44.74 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.939 -0.865 . . . . 0.0 110.939 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.4 m -69.69 -70.73 0.27 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.33 -167.66 12.72 Favored Glycine 0 CA--C 1.54 1.612 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.72 59.63 7.34 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.638 3.559 . . . . 0.0 111.106 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.1 t -70.07 107.77 3.79 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.2 168.91 0.19 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.567 1.147 . . . . 0.0 111.698 -164.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -166.145 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.693 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -145.46 76.75 1.49 Allowed 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 164.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.9 m 60.14 168.52 0.08 Allowed 'General case' 0 C--O 1.238 0.458 0 C-N-CA 127.756 2.422 . . . . 0.0 113.568 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.85 -162.28 25.39 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 125.194 1.378 . . . . 0.0 110.131 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.9 t 74.97 125.03 0.04 OUTLIER 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.845 2.458 . . . . 0.0 112.452 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.7 t -89.99 173.23 8.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.594 1.958 . . . . 0.0 108.805 172.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.44 -146.08 15.23 Favored Glycine 0 C--O 1.238 0.393 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 66.8 -176.44 0.2 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.22 1.008 . . . . 0.0 109.76 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.43 144.96 49.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -87.55 89.23 7.92 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.44 149.82 24.07 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.07 0.948 . . . . 0.0 108.638 172.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.2 mtm -113.38 146.47 39.43 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.459 HG23 HG12 ' A' ' 86' ' ' ILE . 44.8 m -135.22 98.8 4.07 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.028 1.331 . . . . 0.0 107.996 -173.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.86 167.6 9.61 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.352 1.461 . . . . 0.0 109.82 -172.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -122.27 145.81 47.87 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.906 0.883 . . . . 0.0 110.537 -177.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 45' ' ' CYS . 13.4 pt -139.65 134.89 39.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 C-N-CA 125.562 1.545 . . . . 0.0 108.832 173.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.6 t -102.45 121.76 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 73.6 tttt -69.93 116.85 10.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.282 1.033 . . . . 0.0 109.58 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.73 -68.86 1.43 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.861 -169.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.21 -73.5 0.13 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 118.809 1.304 . . . . 0.0 112.01 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -76.41 36.22 0.15 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.112 0.965 . . . . 0.0 111.164 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 87.85 -126.68 8.16 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 107.449 -2.26 . . . . 0.0 107.449 -158.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CD2' HD12 ' A' ' 16' ' ' ILE . 97.9 m-85 -113.71 166.8 11.18 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 109.507 -178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.72 25.62 3.37 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.087 1.803 . . . . 0.0 113.611 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -151.07 167.64 27.09 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.892 1.346 . . . . 0.0 108.472 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.9 p -129.37 159.84 34.95 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.241 0.617 . . . . 0.0 109.797 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.7 pt -125.21 152.4 31.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 123.09 0.556 . . . . 0.0 110.502 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.22 145.42 30.41 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.446 1.099 . . . . 0.0 108.202 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.48 148.45 48.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 122.057 0.932 . . . . 0.0 110.809 -169.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 p -137.44 166.57 25.72 Favored Pre-proline 0 N--CA 1.448 -0.528 0 C-N-CA 126.389 1.875 . . . . 0.0 105.985 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -70.75 -5.33 16.57 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.406 2.737 . . . . 0.0 112.871 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 p -129.33 -6.91 4.77 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 119.074 0.852 . . . . 0.0 112.804 -169.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 158.89 -177.7 35.37 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.848 1.213 . . . . 0.0 110.587 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -94.12 92.62 7.38 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.57 -0.959 . . . . 0.0 110.601 -175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -86.88 161.56 18.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 119.629 1.104 . . . . 0.0 111.791 -162.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.54 115.01 9.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -71.63 -61.63 1.71 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 170.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -150.29 143.57 25.0 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.4 mt -96.11 110.51 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 30.2 mt -78.27 -36.28 47.01 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.798 0.839 . . . . 0.0 109.022 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -132.02 93.36 3.27 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.153 1.781 . . . . 0.0 109.083 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.8 mt -56.81 -44.06 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 110.154 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -68.07 -12.28 60.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.1 -14.01 52.87 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 119.509 1.05 . . . . 0.0 111.349 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.668 ' HA ' HG22 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -132.52 54.96 15.22 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.709 1.204 . . . . 0.0 109.67 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.07 124.3 10.83 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.922 1.748 . . . . 0.0 111.233 -164.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -16.24 61.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.971 1.272 . . . . 0.0 113.411 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.94 152.69 39.26 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.8 p -124.84 151.79 44.81 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.724 0.81 . . . . 0.0 108.901 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -76.4 138.57 40.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.06 96.32 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -168.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -58.63 -177.0 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 117.852 0.826 . . . . 0.0 111.554 163.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 53' ' ' LEU . 0.7 OUTLIER -140.59 91.19 2.41 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 168.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.552 HG22 HG23 ' A' ' 62' ' ' VAL . 37.2 mt -55.84 135.84 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.559 1.544 . . . . 0.0 109.196 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -128.17 -45.98 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.166 1.387 . . . . 0.0 110.367 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -128.79 148.84 50.9 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 171.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.8 mt -113.75 138.75 42.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 152.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 67.82 -54.42 0.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 128.979 2.911 . . . . 0.0 116.203 167.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 165.27 13.85 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 130.793 3.637 . . . . 0.0 113.584 -156.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -131.76 141.9 49.63 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 120.909 1.686 . . . . 0.0 109.194 -176.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -69.55 128.83 37.87 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.592 HG12 HD22 ' A' ' 65' ' ' LEU . 10.8 m -133.75 22.31 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 125.402 1.481 . . . . 0.0 107.563 176.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -60.43 3.69 Favored 'General case' 0 C--N 1.346 0.431 0 O-C-N 119.977 -1.702 . . . . 0.0 110.719 176.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.22 -21.15 62.17 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.456 0.169 . . . . 0.0 111.193 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.592 HD22 HG12 ' A' ' 62' ' ' VAL . 6.8 mp -52.89 134.58 37.24 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.867 1.667 . . . . 0.0 111.61 -167.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.7 m -56.63 162.33 2.31 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.674 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -49.28 -51.38 34.07 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 123.69 0.796 . . . . 0.0 109.311 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -52.07 17.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.036 2.534 . . . . 0.0 111.495 176.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.31 -46.71 82.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.516 1.126 . . . . 0.0 108.531 -170.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.37 -46.46 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.471 1.509 . . . . 0.0 110.443 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.413 HG12 ' HD3' ' A' ' 75' ' ' LYS . 54.2 t -55.57 -45.17 78.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.4 -40.55 77.27 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.126 0.97 . . . . 0.0 111.473 -172.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.1 mt -59.59 -48.95 85.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 123.996 0.919 . . . . 0.0 109.109 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.12 -26.96 68.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.737 0.415 . . . . 0.0 111.58 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HD3' HG12 ' A' ' 71' ' ' VAL . 39.1 mtpt -71.51 -41.47 69.19 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.808 1.186 . . . . 0.0 110.382 174.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -67.51 -27.65 67.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.447 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 84.9 m -49.72 127.17 19.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 123.275 0.63 . . . . 0.0 110.739 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -60.04 132.84 46.73 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.937 3.092 . . . . 0.0 110.773 176.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.3 mm -64.01 127.75 25.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 166.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.44 17.71 75.36 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.323 0.963 . . . . 0.0 112.294 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.9 m -115.24 159.45 20.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 123.313 1.53 . . . . 0.0 108.823 159.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HG2' HG22 ' A' ' 15' ' ' THR . 3.8 tm-20 -65.05 153.58 40.32 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.876 168.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.6 m -137.77 149.11 46.14 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 126.936 2.094 . . . . 0.0 107.869 165.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.1 126.1 54.47 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.627 2.371 . . . . 0.0 105.941 -168.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.405 HD13 HD11 ' A' ' 16' ' ' ILE . 4.9 mp -128.46 115.69 18.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.996 1.271 . . . . 0.0 109.171 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.459 HG12 HG23 ' A' ' 13' ' ' THR . 3.6 mt -97.62 125.59 50.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.06 155.11 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.607 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -108.81 74.86 0.93 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.041 2.136 . . . . 0.0 109.693 -170.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -108.45 68.7 0.7 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -161.71 92.06 0.11 Allowed Glycine 0 N--CA 1.454 -0.128 0 N-CA-C 107.582 -2.207 . . . . 0.0 107.582 -170.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.5 t -141.16 -160.73 1.11 Allowed 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.668 1.187 . . . . 0.0 108.729 -166.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.32 -163.2 13.83 Favored Glycine 0 CA--C 1.524 0.598 0 O-C-N 120.83 -1.169 . . . . 0.0 111.732 -171.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.48 167.06 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.029 3.152 . . . . 0.0 113.381 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.2 p -152.13 147.8 26.88 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.643 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.1 m -145.88 92.35 2.2 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.909 1.684 . . . . 0.0 107.291 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -177.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.701 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t -145.53 -38.86 0.25 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 162.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.9 m -76.92 98.29 4.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 157.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.63 58.78 0.56 Allowed Glycine 0 CA--C 1.52 0.394 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 167.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m 60.92 174.6 0.1 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.213 1.805 . . . . 0.0 111.357 -158.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -158.68 -163.59 1.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.48 78.71 1.42 Allowed Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -141.09 157.87 44.71 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.445 1.898 . . . . 0.0 106.111 165.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.04 114.83 2.1 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.599 0.562 . . . . 0.0 110.956 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -82.83 50.95 1.8 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.482 1.513 . . . . 0.0 110.263 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 88' ' ' HIS . 0.2 OUTLIER 56.45 -162.69 0.17 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.122 2.169 . . . . 0.0 110.833 -176.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.471 ' HE2' HD11 ' A' ' 87' ' ' ILE . 23.1 mtm -89.72 125.1 35.15 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 175.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -96.66 142.94 28.1 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 159.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.16 145.4 51.71 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.789 1.636 . . . . 0.0 108.06 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.5 m -103.06 135.15 45.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.179 0.592 . . . . 0.0 109.882 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.739 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.9 pt -143.98 137.59 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.285 1.034 . . . . 0.0 111.595 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG12 ' HG3' ' A' ' 82' ' ' GLU 0.254 0.2 OUTLIER -110.35 136.03 47.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 122.598 1.189 . . . . 0.0 112.338 178.654 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HE3' ' O ' ' A' ' 74' ' ' LEU . 66.3 tttt -79.06 117.6 20.26 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 125.813 1.645 . . . . 0.0 111.924 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 23' ' ' PHE . . . -81.73 171.98 52.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 166.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.55 -59.64 3.59 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.686 1.994 . . . . 0.0 113.882 -168.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -82.16 10.83 6.04 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.695 -0.628 . . . . 0.0 111.096 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.7 82.23 1.64 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 126.298 1.904 . . . . 0.0 108.364 169.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HA ' ' H ' ' A' ' 19' ' ' GLY . 43.9 m-85 61.13 -175.97 0.12 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.995 1.318 . . . . 0.0 111.049 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.2 -63.61 1.5 Allowed Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 166.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -60.17 170.92 1.12 Allowed 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.536 1.135 . . . . 0.0 113.775 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -131.43 158.38 40.98 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.026 1.33 . . . . 0.0 109.541 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.3 pt -123.68 162.01 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 124.732 1.213 . . . . 0.0 108.717 171.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.21 158.17 43.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.89 114.82 9.34 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.849 1.259 . . . . 0.0 107.962 -176.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 p -99.31 168.36 9.75 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -66.35 -8.83 21.76 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.308 2.005 . . . . 0.0 114.568 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -129.12 -4.43 5.0 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 120.104 1.32 . . . . 0.0 114.022 -169.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.59 -172.94 33.73 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -162.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -84.82 143.32 29.16 Favored 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 121.526 -0.985 . . . . 0.0 108.655 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -134.48 154.24 51.52 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.588 171.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.09 126.13 19.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 113.916 -1.493 . . . . 0.0 107.597 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -81.07 -57.05 3.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.739 1.216 . . . . 0.0 108.526 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -157.32 149.53 22.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -170.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 48' ' ' LEU . 22.1 mt -122.54 132.77 70.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.3 mt -123.67 -58.2 1.6 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.204 1.002 . . . . 0.0 109.45 -164.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -88.04 87.98 7.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.8 1.24 . . . . 0.0 110.107 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.02 -38.55 67.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.062 0.945 . . . . 0.0 112.116 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -72.85 -36.17 67.38 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.772 -0.58 . . . . 0.0 111.123 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.19 -9.74 81.59 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-O 118.784 -1.009 . . . . 0.0 113.183 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.801 ' HB3' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -131.27 64.59 73.97 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 119.454 1.627 . . . . 0.0 108.614 172.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.41 125.41 6.97 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.201 1.934 . . . . 0.0 112.057 -165.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.62 0.38 84.09 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.125 -0.819 . . . . 0.0 112.696 -174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -67.99 140.95 56.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.781 1.291 . . . . 0.0 108.387 178.016 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 151.29 43.12 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 122.177 0.989 . . . . 0.0 110.464 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -77.78 148.83 34.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.85 5.14 56.75 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 117.4 -1.778 . . . . 0.0 114.383 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -63.63 126.75 28.57 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.926 1.863 . . . . 0.0 109.424 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 123.05 25.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.784 1.633 . . . . 0.0 108.363 175.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.4 mt -88.83 146.23 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.5 t -130.2 -53.62 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.708 0.803 . . . . 0.0 110.916 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -141.5 131.61 24.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -172.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG13 HG21 ' A' ' 62' ' ' VAL . 3.2 mt -116.95 124.3 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 170.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.591 HD21 HG23 ' A' ' 83' ' ' THR . 77.5 m-20 46.1 46.35 12.83 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.791 1.636 . . . . 0.0 113.002 175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.266 0.2 OUTLIER 61.15 31.7 19.62 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.271 1.829 . . . . 0.0 115.22 -177.554 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.15 132.11 55.28 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.121 1.768 . . . . 0.0 106.752 165.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -83.4 120.76 26.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.33 1.452 . . . . 0.0 110.85 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.45 HG21 HG13 ' A' ' 57' ' ' ILE . 21.3 m -121.98 7.01 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.679 1.992 . . . . 0.0 109.412 -171.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.35 -37.97 39.82 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 120.029 1.286 . . . . 0.0 112.085 -173.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -115.71 7.75 14.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD22 HG12 ' A' ' 62' ' ' VAL . 3.4 mp -62.06 143.37 56.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.382 1.873 . . . . 0.0 109.991 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -54.77 159.16 2.35 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.939 0.774 . . . . 0.0 110.069 165.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -50.38 -49.65 53.77 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 168.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -55.57 -44.73 77.13 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.873 1.269 . . . . 0.0 112.725 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.77 -39.89 95.37 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.398 1.079 . . . . 0.0 109.715 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.2 -49.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.497 0.719 . . . . 0.0 109.814 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -56.5 -38.12 54.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.472 1.509 . . . . 0.0 109.888 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.68 -46.11 80.3 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.771 0.828 . . . . 0.0 111.024 -175.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mt -59.16 -46.14 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 124.604 1.161 . . . . 0.0 109.52 172.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.469 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 98.0 mt -61.09 -17.41 52.45 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.222 177.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -86.19 -33.64 20.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.379 1.445 . . . . 0.0 111.523 173.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -42.57 69.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.473 1.109 . . . . 0.0 109.406 165.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 91.9 m -51.35 135.55 31.9 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.632 0.773 . . . . 0.0 111.776 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -67.56 112.67 2.69 Favored 'Trans proline' 0 N--CA 1.454 -0.822 1 C-N-CA 125.636 4.224 . . . . 0.0 112.098 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.2 mm -51.32 117.76 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.382 1.473 . . . . 0.0 107.548 170.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.49 8.75 57.21 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.862 1.22 . . . . 0.0 113.249 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.85 151.74 51.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.972 1.386 . . . . 0.0 110.339 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' HG3' HG12 ' A' ' 17' ' ' VAL . 50.4 mp0 -72.38 153.37 41.49 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.329 1.452 . . . . 0.0 112.123 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.591 HG23 HD21 ' A' ' 58' ' ' ASN . 1.4 m -131.23 143.82 50.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 130.083 3.353 . . . . 0.0 105.905 -176.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.4 m -109.02 116.62 32.33 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -116.56 115.62 26.09 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.572 1.149 . . . . 0.0 108.549 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 mt -78.37 134.47 28.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 168.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' A' ' 12' ' ' MET . 1.8 pp -129.43 152.61 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.278 1.031 . . . . 0.0 110.723 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.539 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.2 t-160 -88.01 67.69 9.01 Favored 'General case' 0 C--N 1.342 0.241 0 O-C-N 121.185 -0.947 . . . . 0.0 110.768 -170.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -51.24 69.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.8 -96.69 2.12 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.7 t -143.58 157.05 44.71 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.608 1.204 . . . . 0.0 108.595 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.7 168.89 33.88 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -83.96 144.14 10.72 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.681 2.921 . . . . 0.0 110.019 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.4 m -123.95 -21.45 5.1 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.333 0.653 . . . . 0.0 112.072 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.0 t -142.68 148.42 37.31 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 153.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 150.959 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 105.702 -2.959 . . . . 0.0 105.702 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 m 52.32 -178.52 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 O-C-N 124.47 0.747 . . . . 0.0 110.538 -138.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 t -142.72 -23.3 0.65 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.287 1.035 . . . . 0.0 111.073 171.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.3 -168.82 23.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 p -104.38 137.84 41.67 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.884 0.874 . . . . 0.0 110.178 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.3 p -77.62 108.55 10.89 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.425 1.09 . . . . 0.0 108.299 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.29 -163.24 7.84 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.219 0.914 . . . . 0.0 112.242 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -125.8 -172.01 2.51 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.059 1.343 . . . . 0.0 109.481 172.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.71 151.53 48.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -160.58 115.23 2.19 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.013 1.325 . . . . 0.0 107.571 -175.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mp -134.3 171.84 13.71 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 127.359 2.264 . . . . 0.0 106.713 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 45.7 mtm -111.09 153.69 25.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.601 0.637 . . . . 0.0 109.543 165.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.9 m -132.17 120.25 22.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 44.4 mt -126.85 168.41 14.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.532 1.533 . . . . 0.0 107.936 -175.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.1 m -134.67 141.97 46.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 45' ' ' CYS . 44.6 pt -138.46 151.31 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 110.981 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.5 153.19 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.625 1.97 . . . . 0.0 108.942 175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 tttt -113.23 105.69 13.73 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.341 1.456 . . . . 0.0 109.022 -145.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.69 61.39 3.82 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 125.662 1.601 . . . . 0.0 112.577 -165.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.23 152.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.975 2.51 . . . . 0.0 112.459 -169.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 65.42 -25.42 0.09 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 127.336 2.255 . . . . 0.0 115.56 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.79 -164.16 31.13 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 106.681 -2.568 . . . . 0.0 106.681 -159.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -102.29 12.89 35.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -174.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.34 -66.15 1.28 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.609 1.1 . . . . 0.0 110.879 -171.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -54.05 158.04 2.31 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 122.143 0.973 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -114.56 159.88 19.9 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.586 1.154 . . . . 0.0 109.418 -174.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.7 pt -118.31 154.33 20.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.548 0.69 . . . . 0.0 110.432 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.91 170.26 9.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.263 2.225 . . . . 0.0 108.286 177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -110.08 122.04 46.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.71 1.604 . . . . 0.0 107.512 173.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.4 p -126.03 171.51 7.7 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.959 1.303 . . . . 0.0 109.734 -167.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.15 -14.69 45.17 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.164 1.909 . . . . 0.0 112.64 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.6 p -104.67 -11.83 16.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.019 1.328 . . . . 0.0 111.72 -169.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.28 -162.25 23.63 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -168.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -73.34 147.58 44.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 173.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -139.73 165.09 28.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.306 0.574 . . . . 0.0 109.465 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.19 117.1 16.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.6 -74.18 0.15 Allowed 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -140.12 153.61 46.75 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.0 mt -99.54 106.86 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.095 1.758 . . . . 0.0 108.168 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -101.82 -0.0 34.94 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 125.267 1.427 . . . . 0.0 110.957 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -149.83 114.06 5.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.037 1.735 . . . . 0.0 108.596 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 77.9 mt -80.09 -58.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 125.484 1.513 . . . . 0.0 109.216 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -58.69 -37.1 75.34 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.037 1.335 . . . . 0.0 111.636 -172.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.25 -25.75 72.3 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.68 ' HA ' HG22 ' A' ' 16' ' ' ILE . 46.3 m -126.94 67.61 69.72 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 118.947 1.373 . . . . 0.0 111.198 -172.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.8 128.16 20.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.718 2.279 . . . . 0.0 111.224 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.12 76.66 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 124.401 1.001 . . . . 0.0 114.297 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 48' ' ' LEU . 11.1 tp -66.84 153.12 44.23 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 118.444 1.122 . . . . 0.0 108.754 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.5 m -135.78 0.76 2.72 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -169.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 62.6 151.22 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.641 2.376 . . . . 0.0 112.205 -166.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.99 6.52 25.5 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.683 -1.065 . . . . 0.0 113.73 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.38 128.88 38.12 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.429 1.492 . . . . 0.0 107.817 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -81.28 109.96 16.29 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 118.465 -0.779 . . . . 0.0 109.843 -175.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.99 124.66 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.94 -57.8 3.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 125.128 1.371 . . . . 0.0 108.893 -176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -128.56 150.47 50.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.284 1.034 . . . . 0.0 109.229 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.2 mt -127.86 126.65 67.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 164.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 43.64 52.84 6.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 111.046 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 59.94 -7.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.973 2.509 . . . . 0.0 116.371 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -69.63 117.08 10.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 63' ' ' GLN . 19.0 t-20 -58.11 115.9 3.2 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 163.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -109.32 0.8 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 O-C-N 124.057 0.848 . . . . 0.0 112.397 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.532 ' HB2' HD21 ' A' ' 61' ' ' ASN . 15.8 mt-30 -54.49 -21.9 11.34 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -170.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -112.03 -2.86 14.93 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 121.319 1.872 . . . . 0.0 112.663 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.6 mt -65.55 160.25 22.81 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.321 -0.862 . . . . 0.0 109.198 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -89.53 157.11 18.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.209 1.004 . . . . 0.0 109.793 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -40.83 -56.8 2.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.984 1.714 . . . . 0.0 112.132 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.7 m -67.0 -26.26 66.71 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.896 0.878 . . . . 0.0 111.038 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -70.29 -44.96 67.3 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.243 0.928 . . . . 0.0 109.364 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -63.6 -40.57 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.384 1.073 . . . . 0.0 109.646 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.7 t -54.68 -53.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 123.715 0.806 . . . . 0.0 109.029 169.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.559 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 12.9 t70 -57.22 -46.39 82.98 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.352 0.661 . . . . 0.0 111.722 -172.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.4 mt -55.27 -45.52 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.649 1.18 . . . . 0.0 109.494 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.9 mt -67.74 -35.72 79.24 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.716 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' A' ' 72' ' ' ASP . 9.0 mtmp? -55.01 -47.9 74.05 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 121.266 1.848 . . . . 0.0 109.589 167.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -34.73 75.53 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.218 1.007 . . . . 0.0 112.478 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 84.8 m -52.76 138.04 43.4 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 124.157 0.983 . . . . 0.0 109.689 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 77' ' ' CYS . 33.8 Cg_exo -54.29 144.27 61.04 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.347 2.698 . . . . 0.0 110.119 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.5 mt -80.43 131.43 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 161.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.91 35.79 72.86 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 119.941 -0.366 . . . . 0.0 113.268 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.7 m -146.43 131.79 18.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.746 1.273 . . . . 0.0 108.831 161.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -61.45 152.7 29.18 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.616 1.198 . . . . 0.0 111.094 -173.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.6 m -137.55 135.57 36.82 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.966 2.906 . . . . 0.0 105.116 -168.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.3 m -112.49 110.85 21.28 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.822 1.249 . . . . 0.0 108.29 -162.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.96 112.63 18.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.514 0.597 . . . . 0.0 110.84 -169.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.9 mt -89.17 141.72 13.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.37 146.58 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 121.851 0.834 . . . . 0.0 111.819 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.0 96.61 5.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.205 1.002 . . . . 0.0 109.327 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -150.49 124.25 9.18 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -176.75 95.28 0.1 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -169.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -145.02 -105.88 0.11 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 169.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -156.29 179.83 31.86 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 156.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -80.08 102.17 1.42 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 123.419 2.746 . . . . 0.0 108.715 171.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.9 p -138.21 142.84 39.96 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.912 0.885 . . . . 0.0 109.606 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.1 m -111.57 103.56 11.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 169.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.821 0 CA-C-O 115.272 -2.96 . . . . 0.0 111.246 -177.79 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.941 0 N-CA-C 107.917 -2.073 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -168.9 162.72 11.41 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 -172.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -125.2 166.25 16.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.549 0.74 . . . . 0.0 109.877 -175.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.52 166.95 33.8 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 155.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -151.82 148.52 27.94 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.049 0.939 . . . . 0.0 108.498 176.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -111.77 12.1 20.97 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.344 1.858 . . . . 0.0 110.7 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.97 -111.45 4.11 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -162.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 tm0? 64.09 136.62 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.802 2.041 . . . . 0.0 111.201 -170.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.04 -178.3 5.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.093 1.757 . . . . 0.0 108.332 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -116.47 104.65 11.65 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.01 155.72 32.38 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.3 mtm -87.35 145.8 26.17 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.2 m -123.45 139.17 54.29 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 62.3 mt -142.81 167.88 21.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.444 2.297 . . . . 0.0 106.837 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.8 m -128.95 154.61 46.4 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.3 -0.875 . . . . 0.0 108.694 174.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.693 HG22 ' HA ' ' A' ' 45' ' ' CYS . 11.1 pt -145.66 166.08 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 126.054 1.741 . . . . 0.0 109.907 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -122.82 143.37 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 125.636 1.575 . . . . 0.0 107.582 172.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -88.62 145.68 25.54 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.26 1.024 . . . . 0.0 111.232 -175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.32 82.8 0.35 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.264 1.411 . . . . 0.0 113.899 -168.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.97 -84.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.035 2.134 . . . . 0.0 115.697 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.25 -15.4 46.86 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.934 1.243 . . . . 0.0 112.862 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.39 28.73 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.448 ' CE1' HD22 ' A' ' 74' ' ' LEU . 71.3 m-85 -66.36 146.0 55.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 118.869 1.334 . . . . 0.0 108.173 170.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.24 -51.84 53.79 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -61.82 164.02 6.81 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.368 1.08 . . . . 0.0 110.198 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.0 p -117.37 156.78 27.29 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.973 0.909 . . . . 0.0 109.25 -174.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.02 158.32 18.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 167.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -128.12 163.1 25.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 165.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -71.83 147.13 47.48 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 159.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.3 p -139.7 161.9 53.92 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 163.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.32 -42.66 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.016 2.477 . . . . 0.0 113.256 -174.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.8 p -73.29 -23.84 60.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.143 0.977 . . . . 0.0 111.159 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.75 178.86 26.9 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -172.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.421 ' CD ' HG21 ' A' ' 70' ' ' VAL . 24.0 mp0 -62.42 145.74 53.26 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -134.17 161.11 35.8 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 123.134 0.574 . . . . 0.0 111.134 177.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -76.86 107.27 7.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 -58.2 9.65 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.112 0.965 . . . . 0.0 109.553 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -151.69 148.14 27.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.788 1.635 . . . . 0.0 106.778 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.482 HG23 ' SG ' ' A' ' 45' ' ' CYS . 57.6 mt -91.2 97.14 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 166.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -72.7 -26.15 61.49 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.219 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -142.71 95.57 2.8 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.446 1.898 . . . . 0.0 108.998 -158.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.9 mt -72.4 -57.06 7.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 124.76 1.224 . . . . 0.0 109.105 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.15 -25.32 66.92 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.802 0.728 . . . . 0.0 111.608 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.06 -32.35 66.77 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.335 -1.258 . . . . 0.0 112.213 170.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.693 ' HA ' HG22 ' A' ' 16' ' ' ILE . 29.3 p -130.08 70.36 82.13 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 120.058 1.929 . . . . 0.0 112.774 -171.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.39 111.59 1.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.748 2.299 . . . . 0.0 111.636 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.11 -5.04 85.34 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.407 1.479 . . . . 0.0 114.844 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.79 152.97 43.15 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.03 1.415 . . . . 0.0 108.089 169.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 91.7 m -129.12 156.0 44.58 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.303 1.041 . . . . 0.0 110.023 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.24 137.48 53.17 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.14 12.41 79.5 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 117.494 -1.725 . . . . 0.0 114.182 -175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -58.43 129.53 42.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.093 1.946 . . . . 0.0 110.117 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.1 tp -78.5 144.42 35.71 Favored 'General case' 0 CA--C 1.523 -0.092 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.2 mt -108.0 135.9 45.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 125.359 1.464 . . . . 0.0 108.206 -168.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -122.45 -57.04 2.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 124.274 1.03 . . . . 0.0 110.085 -170.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 64.0 mt-10 -129.89 149.7 51.5 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.3 mt -135.93 129.39 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 168.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 41.13 45.33 2.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.392 2.277 . . . . 0.0 111.573 -173.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 57.51 4.54 0.24 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.391 2.276 . . . . 0.0 115.795 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -74.1 126.04 29.65 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 160.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.532 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 21.8 t-20 -73.02 132.22 43.11 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 168.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.84 -2.16 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.516 1.126 . . . . 0.0 110.844 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -6.69 1.27 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -121.03 -2.28 9.72 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.022 1.329 . . . . 0.0 111.659 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.5 mt -77.42 167.97 20.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.581 1.082 . . . . 0.0 110.517 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.5 m -88.66 155.53 19.55 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 164.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -47.76 -50.65 24.9 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.839 1.256 . . . . 0.0 112.341 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 m -65.73 -29.43 69.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.251 1.02 . . . . 0.0 111.266 -174.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.37 -44.46 83.09 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 174.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 34' ' ' GLN . 21.6 t -67.44 -39.95 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 121.172 -0.955 . . . . 0.0 110.564 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -52.53 -50.68 38.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 C-N-CA 124.493 1.117 . . . . 0.0 108.893 171.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -66.25 -37.38 85.34 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.23 0.956 . . . . 0.0 112.011 -172.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.88 -44.23 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.469 -0.769 . . . . 0.0 109.308 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.448 HD22 ' CE1' ' A' ' 23' ' ' PHE . 85.8 mt -65.06 -17.59 64.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.946 -1.096 . . . . 0.0 112.29 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -74.03 -46.58 42.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.776 1.625 . . . . 0.0 108.993 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.07 -27.22 68.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.039 0.836 . . . . 0.0 112.85 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.8 m -56.95 123.82 61.46 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 118.849 0.75 . . . . 0.0 109.432 169.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -68.69 157.71 60.74 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.921 3.08 . . . . 0.0 113.276 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mm -90.08 124.56 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.575 1.55 . . . . 0.0 106.953 -170.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.86 28.41 73.77 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.571 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.2 m -110.64 157.75 19.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 162.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.98 153.83 41.07 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.797 1.284 . . . . 0.0 109.756 166.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -140.78 131.37 25.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.512 1.925 . . . . 0.0 105.961 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.6 m -97.17 121.12 38.71 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.923 1.689 . . . . 0.0 106.537 -171.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.68 149.87 42.6 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 119.815 1.189 . . . . 0.0 110.017 -173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -127.03 125.24 66.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 170.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.72 177.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.966 1.306 . . . . 0.0 109.549 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -107.21 124.32 49.57 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.077 0.853 . . . . 0.0 111.683 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 90' ' ' GLY . 4.0 tpm_? -159.63 -145.67 0.13 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 130.539 3.536 . . . . 0.0 106.344 -170.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 89' ' ' ARG . . . 131.38 161.15 10.1 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 128.57 2.986 . . . . 0.0 110.455 -175.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 72.2 m -138.4 172.59 12.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.088 1.355 . . . . 0.0 109.971 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.96 162.42 9.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 126.011 1.767 . . . . 0.0 110.466 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -74.16 160.41 42.6 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 N-CA-C 108.203 -1.499 . . . . 0.0 108.203 156.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 t -65.74 -29.39 69.9 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.114 -0.991 . . . . 0.0 109.98 174.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.8 m -161.37 152.04 17.98 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 128.13 2.572 . . . . 0.0 105.872 157.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.218 0 N-CA-C 105.124 -3.19 . . . . 0.0 105.124 173.586 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.873 0 N-CA-C 107.438 -2.265 . . . . 0.0 107.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.6 t -66.77 141.39 57.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.818 1.309 . . . . 0.0 108.166 166.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.18 170.44 21.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.045 1.338 . . . . 0.0 108.503 166.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.58 120.78 0.77 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.7 t -155.69 162.66 40.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 m 59.76 174.73 0.08 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.147 1.379 . . . . 0.0 111.231 -165.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.97 -37.2 4.48 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.659 -1.079 . . . . 0.0 111.472 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.37 164.67 18.38 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.579 1.19 . . . . 0.0 110.101 163.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.57 -174.75 4.69 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.73 2.012 . . . . 0.0 108.381 168.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 65.41 97.78 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.234 1.813 . . . . 0.0 110.424 -176.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.7 mt -102.27 172.94 6.6 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.337 2.255 . . . . 0.0 108.594 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.57 129.87 50.55 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.467 1.107 . . . . 0.0 108.413 171.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 m -95.33 136.2 35.99 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.57 168.45 20.12 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.369 1.867 . . . . 0.0 108.509 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 m -135.64 131.17 35.43 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.322 -0.861 . . . . 0.0 108.909 -174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.497 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.5 pt -120.67 166.39 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.262 1.025 . . . . 0.0 110.11 177.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 t -128.72 132.9 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.12 106.51 17.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.632 -0.668 . . . . 0.0 109.735 -173.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.31 171.73 6.36 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-O 121.876 0.709 . . . . 0.0 112.408 171.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.48 -52.78 64.13 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.581 1.152 . . . . 0.0 111.009 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -80.3 29.52 0.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.511 1.124 . . . . 0.0 110.31 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.58 -171.43 54.27 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 125.439 1.495 . . . . 0.0 109.512 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' CD2' HD12 ' A' ' 16' ' ' ILE . 94.3 m-85 -67.15 -0.79 3.6 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.423 1.889 . . . . 0.0 114.715 -172.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.54 -61.03 3.24 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 119.819 -1.801 . . . . 0.0 111.198 -173.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -54.09 152.35 6.05 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 118.659 1.229 . . . . 0.0 111.232 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.4 p -118.84 159.17 24.23 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.199 1.4 . . . . 0.0 108.151 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 71' ' ' VAL . 35.9 pt -123.56 166.72 18.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.639 0.733 . . . . 0.0 109.996 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -137.09 170.04 16.77 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 128.547 2.739 . . . . 0.0 108.168 177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.25 115.93 31.27 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.37 2.268 . . . . 0.0 106.834 169.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 52.4 p -111.27 169.28 6.47 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.064 1.346 . . . . 0.0 108.251 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 23.4 Cg_endo -64.09 10.52 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 125.14 3.893 . . . . 0.0 115.065 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.3 p -131.33 -11.76 3.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.358 1.463 . . . . 0.0 111.632 -171.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 133.61 -165.09 24.27 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 -169.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.508 ' CG ' HG21 ' A' ' 70' ' ' VAL . 12.8 mp0 -66.48 141.36 57.92 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -130.57 162.82 28.47 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.544 0.688 . . . . 0.0 109.643 166.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG21 HD21 ' A' ' 48' ' ' LEU . 86.6 t -71.11 138.3 22.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 168.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 tttt -93.19 -48.42 6.47 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.434 1.094 . . . . 0.0 109.418 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -161.81 159.13 26.61 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.091 1.756 . . . . 0.0 106.88 -178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.2 139.99 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 170.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 46.3 mt -123.13 -54.52 1.8 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -87.57 77.7 8.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.9 mt -61.82 -51.37 73.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 125.472 1.509 . . . . 0.0 108.666 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -57.5 -35.29 70.04 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.047 0.939 . . . . 0.0 112.41 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.34 -23.48 70.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.172 0.897 . . . . 0.0 112.115 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.497 ' HA ' HG22 ' A' ' 16' ' ' ILE . 75.5 m -118.84 60.5 4.64 Favored Pre-proline 0 C--O 1.237 0.425 0 CA-C-N 119.007 1.404 . . . . 0.0 110.824 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.4 138.58 51.12 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.678 2.252 . . . . 0.0 110.722 -167.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.19 -9.16 27.88 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.893 177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 36' ' ' VAL . 2.4 tt -73.54 146.19 44.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.152 1.476 . . . . 0.0 108.728 177.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.73 162.12 27.34 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.734 1.214 . . . . 0.0 112.155 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -70.69 149.58 46.83 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.476 -0.765 . . . . 0.0 109.845 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.89 14.13 58.06 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.363 -0.836 . . . . 0.0 113.916 176.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.3 129.68 36.18 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.169 1.484 . . . . 0.0 108.37 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 tp -76.64 133.4 39.6 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.3 mt -95.18 125.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 124.529 1.132 . . . . 0.0 109.293 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -112.71 -51.94 5.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.845 1.258 . . . . 0.0 110.713 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 6.3 mt-10 -123.28 153.32 40.37 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.416 0.686 . . . . 0.0 109.558 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.68 134.85 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 161.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 35.89 57.11 0.97 Allowed 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.702 2.001 . . . . 0.0 113.774 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 59.0 24.47 12.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.483 1.113 . . . . 0.0 112.856 172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -117.39 120.59 38.62 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 127.904 2.482 . . . . 0.0 106.323 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.96 126.31 28.17 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG12 HD12 ' A' ' 65' ' ' LEU . 34.2 m -126.22 -3.42 5.01 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.57 -9.98 0.09 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 169.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -110.79 -8.27 14.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 120.303 1.41 . . . . 0.0 112.222 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 62' ' ' VAL . 15.7 mt -77.57 158.6 29.76 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.534 0.734 . . . . 0.0 111.856 -172.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.669 ' O ' HG22 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -71.75 148.69 46.09 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 165.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.656 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 3.1 t60 -54.86 -22.86 16.03 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.333 1.453 . . . . 0.0 112.241 173.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -79.45 -17.24 54.66 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 119.912 -1.743 . . . . 0.0 112.805 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -87.66 -51.4 5.91 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 120.325 -1.484 . . . . 0.0 108.105 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 66' ' ' SER . 2.5 m -49.24 -38.19 11.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 131.558 3.943 . . . . 0.0 112.776 166.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 27' ' ' ILE . 10.9 t -63.56 -54.5 31.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.775 0.83 . . . . 0.0 109.53 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.84 -40.79 89.7 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.746 0.654 . . . . 0.0 111.095 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.5 mt -62.15 -45.69 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 125.837 1.655 . . . . 0.0 110.996 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.75 -33.86 76.59 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.933 -0.479 . . . . 0.0 110.949 174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -68.24 -34.85 76.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 117.79 -1.1 . . . . 0.0 110.287 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -74.14 -12.41 60.58 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 173.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 87.6 m -59.47 141.71 87.72 Favored Pre-proline 0 CA--C 1.536 0.438 0 O-C-N 120.444 -1.41 . . . . 0.0 109.342 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.19 125.79 14.64 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 123.536 2.824 . . . . 0.0 110.594 175.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.9 mt -58.98 135.59 23.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.91 85.25 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.823 1.202 . . . . 0.0 113.268 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.7 t -103.64 147.76 26.83 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -66.98 142.33 57.29 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 165.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.9 m -127.49 132.55 49.97 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 128.772 2.829 . . . . 0.0 105.591 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -88.04 130.26 35.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 mp -130.6 149.53 52.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 56' ' ' GLU . 6.1 mt -128.82 123.5 59.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 172.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -111.49 152.71 13.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 125.037 1.335 . . . . 0.0 107.552 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -88.07 106.17 17.97 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.94 123.59 9.81 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 172.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.82 115.69 0.54 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.0 m 50.93 51.71 16.49 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.685 1.594 . . . . 0.0 112.542 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.1 169.19 28.01 Favored Glycine 0 CA--C 1.54 1.65 0 C-N-CA 123.933 0.778 . . . . 0.0 114.543 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -78.32 -164.17 0.26 Allowed 'Trans proline' 0 CA--C 1.544 1.017 1 C-N-CA 126.158 4.572 . . . . 0.0 113.05 -175.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.4 m -107.02 177.56 4.82 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.765 1.626 . . . . 0.0 111.452 175.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.8 m -67.34 -175.69 0.5 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.551 1.54 . . . . 0.0 110.019 167.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 CA-C-O 116.736 -2.147 . . . . 0.0 108.073 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.219 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 m -145.02 162.8 36.04 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 p -134.44 165.0 26.18 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.559 1.143 . . . . 0.0 108.62 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.41 -174.8 41.47 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 t 109.83 159.93 0.0 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 130.617 3.567 . . . . 0.0 106.471 -172.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.56 -23.79 63.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.079 0.952 . . . . 0.0 112.856 -170.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.34 -136.98 39.89 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 170.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -142.06 163.04 33.95 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.499 1.519 . . . . 0.0 107.855 173.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.05 83.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -160.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -80.83 98.34 7.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.208 1.403 . . . . 0.0 108.078 -177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 88' ' ' HIS . 2.4 mm? -53.86 133.31 42.73 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.654 1.581 . . . . 0.0 108.611 169.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.5 mtm -88.98 155.91 19.2 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.42 HG23 HG12 ' A' ' 86' ' ' ILE . 35.8 m -134.78 108.91 8.22 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 73.0 mt -98.77 169.23 9.62 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.547 2.339 . . . . 0.0 107.532 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -135.25 151.38 50.54 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.315 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.577 HG22 ' HA ' ' A' ' 45' ' ' CYS . 28.9 pt -144.35 128.28 12.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 C-N-CA 125.17 1.388 . . . . 0.0 110.249 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.93 120.92 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 123.523 1.63 . . . . 0.0 109.291 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 79' ' ' ILE . 7.1 mttt -57.66 118.23 5.04 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.034 174.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.36 -75.49 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.29 165.87 30.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 117.599 0.699 . . . . 0.0 109.47 171.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 60.87 -16.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 129.191 2.996 . . . . 0.0 116.809 172.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 123.61 138.03 5.1 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 -167.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -52.08 131.49 31.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.64 84.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -55.09 145.04 21.83 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 118.26 1.03 . . . . 0.0 110.995 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.3 p -107.27 156.43 18.88 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.3 pt -120.13 149.16 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.446 0.641 . . . . 0.0 110.535 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -124.95 143.28 50.96 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.076 2.15 . . . . 0.0 108.087 -177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -89.12 87.12 7.06 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -171.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -70.39 167.29 27.44 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 124.64 1.176 . . . . 0.0 109.09 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -70.03 9.36 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.387 2.724 . . . . 0.0 112.968 174.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.63 -2.64 0.56 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -152.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.64 -169.1 22.52 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.043 -2.023 . . . . 0.0 108.043 -166.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.637 ' HG2' HG21 ' A' ' 70' ' ' VAL . 2.5 mm100 -87.52 142.08 28.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.012 -1.287 . . . . 0.0 109.188 174.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -124.19 162.81 22.86 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 123.49 0.716 . . . . 0.0 110.995 175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 48' ' ' LEU . 54.9 t -88.28 116.57 30.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -69.51 -68.71 0.39 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.995 1.318 . . . . 0.0 108.519 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -148.41 154.87 40.49 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.441 1.496 . . . . 0.0 107.26 -171.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.402 ' CD1' HD13 ' A' ' 48' ' ' LEU . 65.0 mt -120.53 107.84 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.005 1.322 . . . . 0.0 108.222 -173.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.2 -53.49 3.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.918 0.866 . . . . 0.0 109.971 -172.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.18 74.45 7.98 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.0 mt -50.36 -48.81 24.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 124.748 1.219 . . . . 0.0 109.516 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -63.62 -37.88 88.99 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.588 -172.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.85 -5.15 60.57 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.373 -0.682 . . . . 0.0 113.694 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HA ' HG22 ' A' ' 16' ' ' ILE . 40.9 m -131.08 71.9 81.97 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 120.191 1.996 . . . . 0.0 109.528 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.2 129.13 23.33 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.009 2.473 . . . . 0.0 111.136 -174.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.59 -7.77 52.15 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.69 -1.061 . . . . 0.0 114.04 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.566 HD12 ' CB ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -61.69 147.07 47.17 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.988 1.394 . . . . 0.0 109.26 -176.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.4 m -138.14 141.5 40.13 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.312 1.445 . . . . 0.0 107.297 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.58 158.39 27.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.47 47.53 56.75 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 121.815 -0.553 . . . . 0.0 111.729 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.44 -159.78 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.225 2.21 . . . . 0.0 109.595 152.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -154.95 110.18 3.07 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 160.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.8 mt -70.18 134.8 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 120.785 1.63 . . . . 0.0 109.106 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.55 -50.29 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 124.806 1.243 . . . . 0.0 110.347 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 61' ' ' ASN . 40.4 mt-10 -133.85 151.04 51.41 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.393 0.677 . . . . 0.0 109.427 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.4 mt -124.45 127.34 72.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 65.68 -36.96 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 131.027 3.731 . . . . 0.0 115.741 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . 0.26 19.7 pt20 162.31 -7.54 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.796 3.638 . . . . 0.0 112.592 -171.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -99.84 142.25 31.57 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 120.79 -1.194 . . . . 0.0 109.502 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 19.4 t-20 -72.73 137.74 46.11 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 124.808 1.243 . . . . 0.0 110.381 171.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.587 HG12 HD22 ' A' ' 65' ' ' LEU . 6.3 m -139.73 19.63 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 126.966 2.107 . . . . 0.0 108.394 -175.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.99 -58.47 4.07 Favored 'General case' 0 C--N 1.343 0.316 0 O-C-N 120.382 -1.449 . . . . 0.0 109.994 171.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -67.7 -19.96 65.22 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.341 0.657 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.587 HD22 HG12 ' A' ' 62' ' ' VAL . 6.7 mp -56.09 137.44 51.35 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 127.216 2.206 . . . . 0.0 111.744 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m -60.61 156.4 16.65 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.198 168.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -46.98 -51.14 17.82 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.0 0.92 . . . . 0.0 110.192 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.4 m -55.82 -35.59 66.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 128.198 2.599 . . . . 0.0 111.669 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.38 -50.06 49.58 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.848 1.259 . . . . 0.0 107.613 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.637 HG21 ' HG2' ' A' ' 34' ' ' GLN . 97.3 t -63.55 -39.31 84.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 123.593 0.757 . . . . 0.0 109.348 -176.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.78 -51.96 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' HA ' ' CE ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -66.86 -33.49 75.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.433 0.56 . . . . 0.0 112.1 -170.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.9 mt -59.94 -52.28 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 124.043 0.937 . . . . 0.0 109.584 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.07 -35.75 81.29 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.008 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' CE ' ' HA ' ' A' ' 72' ' ' ASP . 43.9 mtmt -59.38 -48.56 81.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 121.189 1.813 . . . . 0.0 111.38 168.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.5 -33.28 74.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.618 -174.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 97.0 m -46.7 125.29 8.01 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.06 0.944 . . . . 0.0 110.087 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' CYS . 7.1 Cg_exo -58.17 145.31 93.14 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.685 2.924 . . . . 0.0 109.991 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.489 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 17.7 mm -72.63 139.66 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.856 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.42 -5.84 75.59 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.05 1.31 . . . . 0.0 113.352 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.0 m -99.27 128.19 45.37 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.784 1.292 . . . . 0.0 108.152 -176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.19 139.63 58.47 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.9 m -124.17 125.93 45.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 m -88.68 122.47 32.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.79 112.67 19.12 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 13' ' ' THR . 6.5 mt -80.13 131.51 33.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 169.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.36 150.75 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.361 0.601 . . . . 0.0 109.815 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.466 ' HA ' HD13 ' A' ' 11' ' ' LEU . 1.6 t-160 -81.26 113.88 19.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.829 0.852 . . . . 0.0 109.685 -176.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -144.81 179.3 7.41 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.106 1.363 . . . . 0.0 107.709 171.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.13 64.54 0.53 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 123.557 0.598 . . . . 0.0 111.61 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.2 t -153.27 158.46 41.67 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 170.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.47 164.01 30.76 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -92.57 -26.3 0.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.704 2.936 . . . . 0.0 114.295 -170.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.2 m -178.3 149.34 0.52 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.99 2.916 . . . . 0.0 107.625 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.42 177.99 0.16 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.954 1.702 . . . . 0.0 113.585 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.753 0 N-CA-C 106.368 -2.693 . . . . 0.0 106.368 177.732 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -148.78 127.24 12.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.024 2.13 . . . . 0.0 106.448 163.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.9 p 55.01 173.63 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.802 2.441 . . . . 0.0 113.314 -162.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.97 -175.24 50.77 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.202 0.906 . . . . 0.0 112.231 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m -81.95 -51.0 8.5 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 121.801 -0.823 . . . . 0.0 111.914 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 t 57.16 85.66 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.265 1.426 . . . . 0.0 111.101 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.66 117.06 4.51 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.774 0.702 . . . . 0.0 112.145 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -144.58 174.66 10.76 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.094 1.358 . . . . 0.0 109.542 162.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.62 135.51 36.6 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.343 0.657 . . . . 0.0 110.853 -174.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -140.42 147.25 39.43 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 166.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 49.5 -160.75 0.05 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.049 2.139 . . . . 0.0 111.943 173.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.9 mtm -142.18 148.17 37.78 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.484 1.514 . . . . 0.0 107.914 153.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 m -99.7 142.47 31.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 165.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.9 mt -138.1 160.79 38.47 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.717 1.607 . . . . 0.0 106.791 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -130.8 144.8 51.71 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 16' ' ' ILE . 11.5 pt -138.69 152.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 125.351 1.46 . . . . 0.0 110.442 -174.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.91 98.34 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.236 1.014 . . . . 0.0 109.641 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 52.1 tttt -43.58 112.41 0.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.574 2.35 . . . . 0.0 111.1 177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.38 -67.52 1.88 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.72 150.77 3.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.458 1.503 . . . . 0.0 108.557 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 40.9 57.49 2.71 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.105 1.362 . . . . 0.0 110.813 -171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 76.99 -144.16 29.57 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -112.46 160.17 18.03 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.516 1.526 . . . . 0.0 108.084 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.33 -46.04 7.73 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 124.4 1.0 . . . . 0.0 110.615 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -58.56 170.25 0.79 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.346 1.069 . . . . 0.0 111.093 172.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.0 p -132.73 159.08 40.73 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.529 -175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.2 pt -118.78 141.83 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 122.268 1.032 . . . . 0.0 109.031 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.04 133.56 43.13 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 127.232 2.213 . . . . 0.0 105.77 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 141.85 50.09 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 163.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -128.9 169.84 12.09 Favored Pre-proline 0 N--CA 1.448 -0.541 0 C-N-CA 125.47 1.508 . . . . 0.0 108.216 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.63 4.14 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.127 3.218 . . . . 0.0 113.452 172.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.1 p -131.55 -27.49 1.94 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.543 1.065 . . . . 0.0 112.115 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.26 -166.1 37.44 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -83.65 137.96 33.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -128.34 162.78 26.29 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 126.888 2.075 . . . . 0.0 107.466 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.6 t -77.91 123.38 34.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -75.36 -70.57 0.41 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -149.13 158.45 44.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 119.37 0.986 . . . . 0.0 109.049 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.432 HG23 ' SG ' ' A' ' 45' ' ' CYS . 69.0 mt -117.46 120.65 65.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.2 mt -105.21 -17.67 14.39 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.265 1.426 . . . . 0.0 111.008 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -142.22 82.78 1.8 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.702 2.001 . . . . 0.0 106.548 -162.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.59 -36.56 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.931 1.292 . . . . 0.0 110.682 -169.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.43 -26.11 65.36 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 121.034 -1.041 . . . . 0.0 113.11 172.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -71.2 -11.74 71.33 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.708 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.432 ' SG ' HG23 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -153.03 67.15 6.31 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.588 1.694 . . . . 0.0 110.678 -179.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -73.7 130.15 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.838 2.359 . . . . 0.0 109.849 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.68 -5.96 72.01 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.202 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.1 tp -77.79 142.73 38.45 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.493 1.146 . . . . 0.0 109.091 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 71.4 m -132.21 159.36 39.27 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.811 1.245 . . . . 0.0 109.554 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.51 144.29 57.11 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 -1.0 84.22 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 117.585 -1.675 . . . . 0.0 114.446 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -63.62 106.33 0.94 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.44 1.62 . . . . 0.0 110.005 -175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -70.86 126.04 28.48 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 125.695 1.598 . . . . 0.0 109.571 -176.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.2 mt -79.57 144.58 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 119.33 0.968 . . . . 0.0 109.208 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -123.42 -43.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 126.293 1.837 . . . . 0.0 108.847 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -136.12 153.59 51.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.579 0.752 . . . . 0.0 110.161 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 58' ' ' ASN . 6.8 mt -111.41 -157.03 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 167.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.676 ' H ' HG22 ' A' ' 57' ' ' ILE . 85.7 m-20 -53.25 76.56 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.268 2.227 . . . . 0.0 110.92 168.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 55.76 38.97 30.74 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.182 1.393 . . . . 0.0 111.989 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -128.75 125.82 38.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.834 1.654 . . . . 0.0 107.212 162.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -85.35 114.77 22.67 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.417 1.487 . . . . 0.0 108.141 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.582 HG12 HD12 ' A' ' 65' ' ' LEU . 28.2 m -117.47 6.61 7.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -163.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -53.48 -19.88 4.16 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -114.96 -10.09 12.33 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 125.064 1.346 . . . . 0.0 112.116 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.582 HD12 HG12 ' A' ' 62' ' ' VAL . 15.2 mt -68.11 147.15 52.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.977 0.894 . . . . 0.0 108.635 175.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.4 m -74.76 164.68 26.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.419 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -48.08 -56.3 8.11 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 123.644 0.777 . . . . 0.0 109.535 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.9 m -60.85 -28.76 69.08 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.958 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.68 -45.97 27.54 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.13 1.372 . . . . 0.0 110.73 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.3 t -59.25 -41.51 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.7 t -64.11 -43.0 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.137 0.975 . . . . 0.0 109.225 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.75 89.76 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.853 1.261 . . . . 0.0 110.722 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.81 -51.33 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.035 0.934 . . . . 0.0 108.76 175.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.404 ' O ' ' HE3' ' A' ' 18' ' ' LYS . 29.9 mt -62.9 -26.4 68.77 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.757 -0.589 . . . . 0.0 111.729 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -68.92 -40.31 79.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 117.645 -1.169 . . . . 0.0 110.305 172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -67.58 -33.88 75.9 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.527 1.058 . . . . 0.0 113.193 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 89.8 m -49.62 134.25 19.3 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.778 1.231 . . . . 0.0 111.563 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -67.13 121.47 8.63 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.234 3.289 . . . . 0.0 111.777 -174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.5 mt -58.16 124.13 11.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.206 1.402 . . . . 0.0 107.742 173.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.19 14.92 70.59 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.24 -0.756 . . . . 0.0 113.208 -176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.4 m -115.62 147.94 40.22 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 118.655 1.227 . . . . 0.0 108.165 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.98 141.18 58.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.885 1.274 . . . . 0.0 108.487 171.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -128.89 124.9 36.4 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.081 1.753 . . . . 0.0 106.419 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.2 m -89.46 128.74 36.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 104.449 -2.426 . . . . 0.0 104.449 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 mp -133.46 158.28 43.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.1 130.83 73.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.0 148.25 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 124.715 1.206 . . . . 0.0 110.18 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -82.99 84.71 7.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.716 0.807 . . . . 0.0 109.502 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -85.93 158.99 19.77 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 166.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.63 -59.87 0.08 OUTLIER Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.5 m -150.2 -172.93 4.3 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 162.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -141.96 153.33 24.2 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 164.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.94 -42.91 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.482 2.122 . . . . 0.0 110.968 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 p -71.23 128.89 37.42 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.3 1.44 . . . . 0.0 109.591 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.0 m -57.45 -39.15 75.67 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.824 0.449 . . . . 0.0 111.414 169.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -153.259 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.823 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -130.16 118.94 22.21 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.354 1.461 . . . . 0.0 107.709 -173.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -171.47 100.61 0.19 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.39 -150.14 14.68 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.171 1.367 . . . . 0.0 110.795 -174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.61 115.06 2.12 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.057 1.343 . . . . 0.0 109.895 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -73.1 167.94 20.11 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 168.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.75 136.47 4.03 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 169.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.83 77.8 6.46 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.726 0.763 . . . . 0.0 109.536 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.91 165.84 12.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.77 0.828 . . . . 0.0 109.948 173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -103.77 111.12 23.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 155.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.79 155.43 37.61 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 166.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.572 ' HE2' HD11 ' A' ' 87' ' ' ILE . 31.6 mtm -92.53 113.84 26.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 118.742 0.701 . . . . 0.0 109.292 174.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.3 m -82.95 129.07 34.98 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 169.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -145.7 142.56 29.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.685 1.594 . . . . 0.0 107.641 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.6 m -125.08 140.18 53.13 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.322 0.965 . . . . 0.0 110.665 -166.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.563 HG22 ' HA ' ' A' ' 45' ' ' CYS . 17.0 pt -129.51 158.29 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.174 1.389 . . . . 0.0 111.03 -172.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.2 t -128.14 116.79 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.858 1.263 . . . . 0.0 108.516 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HG2' HD13 ' A' ' 79' ' ' ILE . 55.6 tttt -75.26 104.81 5.98 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.571 1.148 . . . . 0.0 109.915 -174.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.76 -67.63 1.87 Allowed Glycine 0 CA--C 1.523 0.564 0 CA-C-O 119.703 -0.498 . . . . 0.0 112.599 -169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.9 -70.68 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.514 0.657 . . . . 0.0 111.243 -172.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -78.11 72.0 4.62 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.023 1.329 . . . . 0.0 107.922 172.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' HA2' ' HE2' ' A' ' 18' ' ' LYS . . . 61.6 -149.75 45.84 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -174.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD12 ' A' ' 16' ' ' ILE . 97.5 m-85 -83.51 1.41 42.03 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.701 1.2 . . . . 0.0 112.031 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.53 -63.14 1.48 Allowed Glycine 0 CA--C 1.528 0.878 0 O-C-N 120.761 -1.212 . . . . 0.0 111.623 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -52.58 155.14 2.3 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.028 1.414 . . . . 0.0 111.765 -173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 67.6 p -122.17 157.38 31.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.438 -1.255 . . . . 0.0 107.915 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.38 174.68 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 109.232 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -119.13 165.18 14.49 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.496 1.918 . . . . 0.0 107.513 172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.15 141.01 49.12 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 151.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.64 154.92 60.16 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 172.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.58 16.06 1.5 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.292 2.661 . . . . 0.0 113.983 -160.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -144.63 4.04 1.14 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.768 1.627 . . . . 0.0 112.092 -160.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.76 169.48 21.72 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -156.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -77.08 160.77 28.8 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.995 0.897 . . . . 0.0 111.856 -166.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -131.48 146.46 52.25 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-O 121.001 0.429 . . . . 0.0 110.968 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.64 127.07 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.9 tttm -100.73 -52.54 3.3 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.376 1.07 . . . . 0.0 109.862 -173.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -150.39 133.9 16.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.7 mt -91.05 128.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 mt -118.43 9.29 12.33 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.409 1.083 . . . . 0.0 110.509 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -164.55 81.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.678 HD12 ' H ' ' A' ' 42' ' ' ILE . 3.5 mp -59.2 -60.4 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 124.834 1.253 . . . . 0.0 109.073 -166.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.81 -9.99 59.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.14 -38.15 94.94 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 164.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.563 ' HA ' HG22 ' A' ' 16' ' ' ILE . 80.4 m -123.31 67.07 34.87 Favored Pre-proline 0 N--CA 1.45 -0.468 0 C-N-CA 123.47 0.708 . . . . 0.0 111.96 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.88 142.56 93.71 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.216 1.944 . . . . 0.0 109.641 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.22 -31.66 3.72 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 117.984 -1.453 . . . . 0.0 113.065 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.6 tp -63.9 147.34 52.17 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.204 1.502 . . . . 0.0 110.387 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.6 m -137.08 168.95 18.62 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.342 1.857 . . . . 0.0 109.421 170.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.53 146.23 31.41 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.218 -0.926 . . . . 0.0 110.598 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.63 -3.16 80.17 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.132 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -55.59 115.83 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.403 1.481 . . . . 0.0 108.211 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -75.26 98.13 3.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.1 mt -67.56 119.73 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 125.525 1.53 . . . . 0.0 108.229 177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.7 t -102.18 -52.15 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 C-N-CA 126.038 1.735 . . . . 0.0 109.123 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -136.03 143.65 44.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.879 1.272 . . . . 0.0 108.543 -169.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 74' ' ' LEU . 97.7 mt -131.21 134.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 124.961 1.304 . . . . 0.0 107.574 170.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 39.95 47.99 2.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.787 2.035 . . . . 0.0 110.402 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 66.41 13.19 9.12 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.261 1.425 . . . . 0.0 112.79 171.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.01 130.18 46.15 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.884 1.673 . . . . 0.0 107.828 167.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -58.21 123.87 17.51 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.994 0.918 . . . . 0.0 110.476 166.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.29 -3.79 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 118.176 -0.916 . . . . 0.0 113.251 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -54.21 -37.03 64.13 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.48 1.491 . . . . 0.0 112.502 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -97.51 2.28 49.97 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.327 1.051 . . . . 0.0 111.649 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.7 mt -87.5 160.77 18.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.155 0.982 . . . . 0.0 108.894 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.4 m -79.33 152.26 30.57 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -41.14 -52.51 3.27 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 125.675 1.59 . . . . 0.0 111.715 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.5 m -56.97 -42.28 79.89 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.149 1.379 . . . . 0.0 112.224 -177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -64.19 -38.22 90.28 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.704 ' O ' HD22 ' A' ' 74' ' ' LEU . 19.4 t -69.8 -51.47 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.567 0.747 . . . . 0.0 109.473 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.86 -38.03 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.172 1.389 . . . . 0.0 110.268 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.41 -34.47 70.38 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 124.048 0.842 . . . . 0.0 111.97 -175.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.3 mt -54.31 -60.3 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -56.5 -31.61 64.23 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 174.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -63.07 -50.94 68.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 121.109 1.777 . . . . 0.0 108.736 174.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -60.68 -35.28 75.87 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.14 0.976 . . . . 0.0 111.455 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 50.6 m -56.64 144.28 65.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.574 0.749 . . . . 0.0 112.704 -169.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -69.36 123.44 10.24 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 124.454 3.436 . . . . 0.0 112.311 -172.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.463 HD13 ' HG2' ' A' ' 18' ' ' LYS . 5.5 mm -59.29 131.58 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.5 26.57 72.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.462 1.029 . . . . 0.0 112.988 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.3 m -103.84 157.44 17.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 154.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.83 152.69 30.92 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.196 152.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.2 m -139.97 125.68 19.36 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 105.174 -2.158 . . . . 0.0 105.174 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 m -89.36 119.44 29.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -166.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.27 154.94 35.68 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' A' ' 56' ' ' GLU . 5.7 mt -134.04 129.81 54.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 172.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.572 HD11 ' HE2' ' A' ' 12' ' ' MET . 1.2 pp -119.69 167.39 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.518 1.127 . . . . 0.0 108.122 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -75.29 -120.32 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 110.93 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 59.28 -107.22 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.508 1.923 . . . . 0.0 110.791 175.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.89 60.71 8.39 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.832 1.206 . . . . 0.0 112.024 178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 m -137.36 -25.94 1.02 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.16 174.24 0.27 Allowed Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.159 1.361 . . . . 0.0 113.593 -167.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -84.53 -179.29 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.644 2.896 . . . . 0.0 109.597 166.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.4 m 51.19 67.03 1.01 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.387 1.475 . . . . 0.0 111.308 -174.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.3 t -77.8 177.87 7.84 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 151.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.785 0 C-N-CA 126.204 1.859 . . . . 0.0 108.774 -174.902 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.759 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m 67.72 173.12 0.27 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.58 1.952 . . . . 0.0 111.398 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.0 p -150.3 159.17 44.64 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.828 -0.545 . . . . 0.0 111.569 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.31 128.87 1.42 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.237 1.398 . . . . 0.0 112.435 173.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.8 m 45.08 -81.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 128.274 2.63 . . . . 0.0 114.484 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -56.45 144.58 30.58 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.229 1.377 . . . . 0.0 108.263 172.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.66 -178.71 48.58 Favored Glycine 0 N--CA 1.449 -0.453 0 O-C-N 120.573 -1.329 . . . . 0.0 110.094 -168.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -156.16 147.93 22.95 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -168.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.06 161.66 0.13 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.478 2.711 . . . . 0.0 111.731 -164.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.55 100.83 2.89 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -170.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 mp -132.29 178.0 7.15 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.737 1.615 . . . . 0.0 109.175 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 mtm -113.92 154.73 27.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.004 0.922 . . . . 0.0 109.309 168.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.9 m -131.06 134.58 46.76 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 170.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.31 167.73 22.15 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.035 1.734 . . . . 0.0 108.62 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.1 m -122.97 153.06 40.26 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.133 -0.979 . . . . 0.0 110.438 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 45' ' ' CYS . 23.1 pt -139.9 155.39 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.203 1.801 . . . . 0.0 110.013 174.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.26 99.31 4.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.011 1.725 . . . . 0.0 107.968 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.427 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 53.2 tttt -53.64 109.17 0.42 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.268 2.227 . . . . 0.0 111.617 -174.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.35 33.44 4.32 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.15 1.357 . . . . 0.0 115.862 -163.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . 59.56 162.41 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.387 2.275 . . . . 0.0 113.69 -171.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 52.32 -10.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.249 1.82 . . . . 0.0 114.854 -153.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 20' ' ' ALA . . . 147.39 -155.58 26.57 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 107.285 -2.326 . . . . 0.0 107.285 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' CD2' HD12 ' A' ' 16' ' ' ILE . 54.5 m-85 -83.96 152.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 153.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.57 -56.0 26.83 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 170.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -54.75 159.94 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.488 1.137 . . . . 0.0 111.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.5 p -128.65 161.44 29.64 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.882 1.673 . . . . 0.0 108.368 -172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.6 pt -126.2 162.97 28.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 122.066 0.936 . . . . 0.0 109.758 173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.98 146.97 39.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.017 1.327 . . . . 0.0 107.864 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.57 136.01 47.26 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.253 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 p -133.74 165.72 34.63 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -68.61 -12.74 35.54 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.085 1.857 . . . . 0.0 112.574 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -109.36 5.63 23.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.44 1.496 . . . . 0.0 111.817 -168.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.0 -159.47 15.55 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -165.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.537 ' CG ' HG21 ' A' ' 70' ' ' VAL . 93.6 mm-40 -87.44 152.58 22.12 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.274 -1.133 . . . . 0.0 110.274 173.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -120.51 158.93 26.23 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 124.531 1.132 . . . . 0.0 109.552 169.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.33 119.09 17.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -69.06 -68.89 0.37 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 171.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -151.98 151.89 31.78 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -174.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.26 92.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 64.4 mt -82.78 -18.44 40.6 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.117 1.367 . . . . 0.0 112.162 -174.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -124.06 91.58 3.49 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 mt -70.04 -29.21 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.499 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -73.65 -60.25 2.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.631 0.772 . . . . 0.0 110.003 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -5.01 87.68 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 123.694 0.664 . . . . 0.0 112.663 -173.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HA ' HG22 ' A' ' 16' ' ' ILE . 12.0 m -120.02 66.18 10.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 118.976 1.388 . . . . 0.0 107.759 165.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.38 146.58 56.78 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.624 2.216 . . . . 0.0 110.404 -170.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.14 -7.89 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.099 -0.834 . . . . 0.0 114.941 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.433 HD12 ' CG2' ' A' ' 16' ' ' ILE . 2.8 tt -73.86 132.81 42.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 64.7 m -110.98 155.02 23.31 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 123.416 1.579 . . . . 0.0 110.415 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -66.35 148.38 51.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.579 -173.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.18 8.83 12.77 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 117.841 -1.533 . . . . 0.0 116.098 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -59.98 139.45 57.42 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.8 1.8 . . . . 0.0 109.219 177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -91.75 129.39 37.72 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.862 1.665 . . . . 0.0 110.34 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mt -81.66 130.1 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.844 0.858 . . . . 0.0 110.598 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -116.25 -55.03 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 126.265 1.826 . . . . 0.0 109.205 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -125.29 152.92 44.03 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.55 135.08 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 157.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 33.57 56.66 0.54 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 128.411 2.685 . . . . 0.0 113.351 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 61.29 25.92 15.83 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -121.51 129.49 52.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 170.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -72.46 126.62 30.3 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.277 0.631 . . . . 0.0 111.018 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.503 HG12 HD12 ' A' ' 65' ' ' LEU . 21.2 m -128.76 17.47 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.98 0.912 . . . . 0.0 112.272 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.8 -15.98 62.46 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.931 -1.106 . . . . 0.0 112.196 173.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.33 17.32 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.429 1.892 . . . . 0.0 110.664 -169.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 62' ' ' VAL . 17.7 mt -110.66 147.19 34.83 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.095 -1.003 . . . . 0.0 111.173 -174.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.557 ' O ' HG22 ' A' ' 70' ' ' VAL . 14.1 m -75.12 147.5 40.47 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 117.173 -1.394 . . . . 0.0 108.115 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.596 ' HA ' ' CG2' ' A' ' 70' ' ' VAL . 70.1 t60 -42.99 -34.21 0.95 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.774 2.029 . . . . 0.0 113.943 178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.69 -34.01 76.91 Favored 'General case' 0 C--N 1.319 -0.752 0 O-C-N 120.969 -1.082 . . . . 0.0 112.208 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.02 -49.09 16.17 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.248 2.219 . . . . 0.0 110.748 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.596 ' CG2' ' HA ' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -59.4 -42.62 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 1 C-N-CA 132.589 4.355 . . . . 0.0 111.896 172.518 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -58.6 -50.49 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 167.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.51 -40.97 93.34 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.603 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.7 mt -59.34 -50.68 78.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.949 1.3 . . . . 0.0 109.918 174.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.8 mt -60.94 -28.87 69.28 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.876 -0.515 . . . . 0.0 110.144 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -72.77 -42.19 64.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.672 -1.268 . . . . 0.0 109.632 174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -68.32 -16.49 63.97 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.39 1.45 . . . . 0.0 112.852 177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 93.0 m -60.61 140.49 92.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 O-C-N 121.17 -0.956 . . . . 0.0 110.004 170.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -58.62 142.92 98.8 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.609 3.54 . . . . 0.0 111.501 173.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.07 136.74 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 159.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.22 51.47 54.71 Favored Glycine 0 CA--C 1.523 0.557 0 O-C-N 123.293 0.37 . . . . 0.0 112.358 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.2 m -150.03 151.49 33.36 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 164.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -61.89 102.31 0.26 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.862 1.265 . . . . 0.0 109.461 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.6 m -83.04 146.11 28.91 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 160.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.6 m -120.56 131.2 54.55 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.8 mp -127.04 149.93 49.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mt -122.87 126.11 73.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -122.58 154.48 27.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-O 122.004 0.907 . . . . 0.0 110.814 -175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -91.25 80.24 5.6 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.514 -170.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.88 -155.67 0.19 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.455 -0.783 . . . . 0.0 108.941 170.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.75 -6.11 4.46 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 119.678 1.126 . . . . 0.0 114.774 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -115.96 -65.18 1.22 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.109 1.454 . . . . 0.0 110.773 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.11 -160.02 26.21 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 118.863 0.756 . . . . 0.0 111.634 -174.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -69.7 166.92 25.91 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.677 1.585 . . . . 0.0 111.416 -176.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 46.99 59.57 3.93 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.421 1.888 . . . . 0.0 112.81 165.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 m -89.17 -30.96 18.19 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.586 0.755 . . . . 0.0 112.335 -178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.463 0 C-N-CA 126.058 1.789 . . . . 0.0 110.054 178.13 . . . . . . . . 0 0 . 1 stop_ save_